8-K
Eureka Acquisition Corp (EURK)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) ofthe Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 1, 2024
| EUREKA ACQUISITION CORP | ||
|---|---|---|
| (Exact name of registrant as specified in its charter) | ||
| Cayman Islands | 001-42152 | N/A |
| --- | --- | --- |
| (State or other jurisdiction | (Commission File Number) | (IRS Employer |
| of incorporation) | Identification Number) | |
| 899 Ruining Road, Yangguang Binjiang CenterSouth Building, Unit 808Shanghai 200030, PRC | ||
| --- | ||
| (Address of principal executive offices) |
+86 135 0189 0555
**(**Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---|
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| --- | --- |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| --- | --- |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| --- | --- |
Securities registered pursuant to Section 12(b) of the Act.
| Title of each class | Trading Symbol | Name of each exchange on which registered |
|---|---|---|
| Units, consisting of one Class A ordinary share, $0.0001 par value, and one Right to acquire one-fifth of one Class A ordinary share | EURKU | The Nasdaq Stock Market LLC |
| Class A ordinary shares, par value $0.0001 per share | EURK | The Nasdaq Stock Market LLC |
| Rights, each whole right to acquire one-fifth of one Class A ordinary share | EURKR | The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01 Entry into a Material Definitive Agreement
On July 1, 2024, the Registration Statement on Form S-1 (File No. 333-277780) (the “Registration Statement”) relating to the initial public offering (the “IPO”) of Eureka Acquisition Corp (the “Company”) was declared effective by the U.S. Securities and Exchange Commission. On July 3, 2024, the Company consummated the IPO of 5,000,000 units (the “Units”). Each Unit consists of one Class A ordinary share, $0.0001 par value per share (each, a “Class A Ordinary Share”), and one right (each, a “Right”), each one Right entitling the holder thereof to exchange for one-fifth of one Class A Ordinary Share upon the completion of the Company’s initial business combination. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $50,000,000.
Substantially concurrently with the closing of the IPO, the Company completed the private sale of 216,750 units (the “Initial Private Units”) to the Company’s sponsor, Hercules Capital Management Corp (the “Sponsor”). Each Initial Private Unit consists of one Class A Ordinary Share and one right. The Initial Private Units were sold at a purchase price of $10.00 per Initial Private Units, generating gross proceeds to the Company of $2,167,500. The Initial Private Units are identical to the Units sold in the IPO, subject to limited exceptions as further described in the Registration Statement.
The Company also issued to the Maxim Group LLC, the representative of the underwriters of the IPO (the “Representative”), 230,000 Class A Ordinary Shares as part of the underwriting compensation (the “Representative Shares”) on the closing of the IPO. The Representative Shares are identical to the Class A Ordinary Shares included in the Units, except that the Representative has agreed not to transfer, assign, sell, pledge, or hypothecate any such representative shares, or subject such Representative Shares to hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person until 180 days immediately following the commencement of sales of the IPO pursuant to FINRA Rule 5110(e)(1), subject to exceptions pursuant to FINRA Rule 5110(e)(2). The Representative has agreed not to transfer, assign or sell any such Representative Shares without prior consent of the Company until the completion of the initial business combination. In addition, the Representative has agreed (i) to waive its redemption rights (or right to participate in any tender offer) with respect to such shares in connection with the completion of the Company’s initial business combination and (ii) to waive its rights to liquidating distributions from the trust account with respect to such shares if the Company fails to complete its initial business combination within the period as provided in the Company’s Amended and Restated Memorandum and Articles of Association.
On July 3, 2024, the Representative notified the Company of its exercise of the over-allotment option in full to purchase additional 750,000 Units of the Company (the “Over-Allotment Option”). On July 8, 2024, 750,000 Units were sold to the Representative at an offering price of $10.00 per Option Unit (the “Option Units” and together with the Units, collecitvley, the “Public Units”), generating gross proceeds of $7,500,000. Simultaneously with the issuance and sale of the Option Units, the Company completed a private placement sale of additional 11,250 units (the “Additional Private Units” and together with the Initial Private Units, collecitvley, the “Private Units”) to the Sponsor at a purchase prive of $10.00 per Additional Private Unit, generating gross proceeds of $112,500. In connection with the issuance and sales of the Option Units, the Company issued additional 30,000 Representative Shares to the Representative.
1
In connection with the IPO, the Company entered into the following agreements, the forms of which were previously filed as exhibits to the Registration Statement:
| ● | an Underwriting Agreement,<br>dated July 2, 2024, between the Company and the Representative; |
|---|---|
| ● | a Rights Agreement, dated July<br>2, 2024, between the Company and Continental Stock Transfer & Trust Company (“CST”), as rights agent; |
| --- | --- |
| ● | a Private Units Subscription<br>Agreement, dated July 2, 2024, between the Company and the Sponsor; |
| --- | --- |
| ● | a Securities Transfer Agreement,<br>dated June 27, 2024, between the Company, the Sponsor, and certain directors of the Company; |
| --- | --- |
| ● | an Investment Management Trust<br>Agreement, dated July 2, 2024, between the Company and CST, as trustee; |
| --- | --- |
| ● | a Registration Rights Agreement,<br>dated July 2, 2024, between the Company, the Sponsor, the Representative and certain directors of the Company; |
| --- | --- |
| ● | a Letter Agreement, dated July<br>2, 2024, between the Company, the Sponsor, and the officers and directors of the Company; |
| --- | --- |
| ● | Indemnity Agreements, dated<br>July 2, 2024, between the Company and each of the officer and directors of the Company; and |
| --- | --- |
| ● | an Administrative Service Agreement,<br>dated July 2, 2024, between the Company and the Sponsor. |
| --- | --- |
The Underwriting Agreement is included as Exhibit 1.1, the Rights Agreement is included as Exhibit 4.1, the Unit Subscription Agreement, the Securities Transfer Agreement, the Investment Management Trust Agreement, the Registration Rights Agreement, the Letter Agreement, the form of Indemnity Agreement, and the Administrative Service Agreement are included as Exhibits 10.1, 10.2, 10.3, 10.4, 10.5, 10.6 and 10.7, respectively, hereto, and each of such exhibits is incorporated by reference herein.
Item 3.02 Unregistered Sales ofEquity Securities
Substantially concurrently with the closing of the IPO and the Over-allotment Option, the Company completed the private sale of the aggregated amount of 228,000 Private Units (including 216,750 Initial Private Units and 11,250 Additinoal Private Units) to the Sponsor at a purchase price of $10.00 per Private Unit, generating gross proceeds to the Company of $2,280,000. The Private Units are identical to the Public Units issued in the IPO, subject to limited exceptions as further described in the Registration Statement. The issuance of the Private Units was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.
Item 5.02 Departure of Directorsor Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective on July 1, 2024, in connection with the effectiveness of the Registration Statement, Dr. M. Anthony Wong, Ms. Lauren Simmons, and Mr. Kevin McKenzie became directors of the Company.
The board has determined that each of Dr. M. Anthony Wong, Ms. Lauren Simmons, and Mr. Kevin McKenzie are independent directors under the requirements of the Nasdaq listing standards and under the Securities Exchange Act of 1934 (“Exchange Act”), and has determined that Dr. M. Anthony Wong qualifies as an “audit committee financial expert” as that term is defined in Item 407(d)(5) of Regulation S-K under the Exchange Act. Dr. M. Anthony Wong, Ms. Lauren Simmons, and Mr. Kevin McKenzie will serve as members of the audit committee, with Dr. M. Anthony Wong serving as chair of the audit committee.
2
The Company will reimburse the officers and directors for reasonable out-of-pocket expenses incurred in connection with fulfilling their roles as directors at the closing of our initial business combination.
Substantially concurrently with the effectiveness of the Registration Statement and closing of the IPO, the Sponsor transferred to each of Dr. M. Anthony Wong, Ms. Lauren Simmons, and Mr. Kevin McKenzie, 10,000 Class B ordinary shares of the Compay (collectively “Founder Shares”) at the same price originally paid by the Sponsor for such shares, approximately $0.0174 per share, pursuant to a certain securities transfer agreement (the “Securities Transfer Agreement”) dated June 27, 2024 by and among the Company, the transferees and the Sponsor.
Other than as set forth in Item 1.01 and above, none of the directors are party to any arrangement or understanding with any person pursuant to which they were appointed as directors, nor are they party to any transactions required to be disclosed under Item 404(a) of Regulation S-K involving the Company.
Item 5.03 Amendments to the Memorandumand Articles of Association.
On June 27, 2024, the Company adopted and filed its Second Amended and Restated Memorandum and Articles of Association. The Second Amended and Restated Memorandum and Articles of Association is attached as Exhibit 3.1 hereto and is incorporated by reference herein.
Item 8.01 Other Events.
A total of $57,500,000 from the proceeds of the offerings of the Public Units and the sale of the Private Units (net of transaction expenses and working capital) were placed in the trust account. Except with respect to interest earned on the funds in the trust account that may be released to the Company to pay its taxes and dissolution expenses, the proceeds from the offerings of the Public Units and the sale of the Private Units held in the trust account will not be released until the earliest of (a) the completion of the Company’s initial business combination, (b) the redemption of any public shares properly tendered in connection with a shareholder vote to amend the Company’s Amended and Restated Memorandum and Articles of Association (i) to modify the substance or timing of its obligation to allow redemption in connection with its initial business combination or redeem 100% of its public shares if the Company does not complete its initial business combination by July 3, 2025 (or up to July 3, 2026, if extended), and (ii) with respect to any other provision relating to shareholders’ rights or pre-business combination activity, (c) the redemption of all of the Company’s public shares if it is unable to complete its business combination by July 3, 2025 (or up to January 3, 2026, if extended), subject to applicable law.
On July 2, 2024, the Company issued a press release, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K, announcing the pricing of the IPO.
On July 3, 2024, the Company issued a press release, a copy of which is attached as Exhibit 99.2 to this Current Report on Form 8-K, announcing the closing of the IPO.
3
Item 9.01 Financial Statements and Exhibits.
4
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Eureka Acquisition Corp | ||
|---|---|---|
| By: | /s/ Fen Zhang | |
| Name: | Fen Zhang | |
| Title: | Chief Executive Officer | |
| Date: July 8, 2024 |
5
Exhibit 1.1
Execution Version
EUREKA ACQUISITION CORPUNDERWRITING AGREEMENT
New York, New York
July 2, 2024
Maxim Group LLC
300 Park Avenue, 16th Floor
New York, NY 10022
As Representative of the Underwriters
named on Schedule A hereto
Ladies and Gentlemen:
Eureka Acquisition Corp, a Cayman Islands exempted company (the “Company”), hereby confirms its agreement with Maxim Group LLC (the “Representative” or “Maxim”), as representative of the several underwriters named on Schedule A hereto (the “Underwriters” or, each underwriter individually, an “Underwriter”), as follows:
- Purchase and Sale of Securities.
1.1 Firm Securities.
1.1.1 Purchase of Firm Units. On the basis of the representations and warranties contained herein, but subject to the terms and conditions set forth herein, the Company agrees to issue and sell to the several Underwriters, severally and not jointly, and the Underwriters agree to purchase from the Company, severally and not jointly, an aggregate of 5,000,000 units (the “Firm Units”) of the Company, as set forth opposite the respective names of the Underwriters on Schedule A hereto, at a purchase price (net of discounts and commissions) of $9.85 per Firm Unit. The Firm Units are to be offered initially to the public (the “Offering”) at the offering price of $10.00 per Firm Unit. Each Firm Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (the “Ordinary Shares”) and one right to receive one-fifth of (1/5) of one Ordinary Share (the “Rights”) upon the consummation by the Company of a merger, capital stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses (the “Business Combination”) pursuant to the Rights Agreement (as defined in Section 2.24). The Ordinary Shares and Rights included in the Firm Units will trade separately on the 52^nd^ Business Day (as defined in Section 1.1.2 below) following the date hereof unless the Representative determines to allow earlier separate trading. Notwithstanding the immediately preceding sentence, in no event will the Ordinary Shares and Rights included in the Firm Units trade separately until (i) the Company has filed with the Securities and Exchange Commission (the “Commission”) a Current Report on Form 8-K that includes an audited balance sheet reflecting the Company’s receipt of the proceeds of the Offering and the Unit Private Placement (as defined in Section 1.3.2) and updated financial information with respect to any proceeds the Company receives from the exercise of the Over-allotment Option (defined below) if such option is exercised prior to the filing of the Form 8-K, and (ii) the Company has filed with the Commission a Current Report on Form 8-K and issued a press release announcing when such separate trading will begin.
1.1.2 Payment and Delivery. Delivery and payment for the Firm Units shall be made at 10:00 a.m., New York City time, on the second (2nd) Business Day following the commencement of trading of the Firm Units, or at such earlier time as shall be agreed upon by the Representative and the Company, at the offices of Ellenoff Grossman & Schole LLP, counsel to the Underwriters (“EGS”), or at such other place as shall be agreed upon by the Representative and the Company. The hour and date of delivery and payment for the Firm Units is called the “Closing Date.” Payment for the Firm Units shall be made on the Closing Date by wire transfer in Federal (same day) funds, payable as follows: $50,000,000 of the proceeds received by the Company for the Firm Units and the sale of Placement Units (as defined in Section 1.3.2) shall be deposited in the trust account (“Trust Account”) established by the Company for the benefit of the Public Shareholders, as described in the Registration Statement (as defined in Section 2.1.1) pursuant to the terms of an Investment Management Trust Agreement (the “Trust Agreement”) between the Company and Continental Stock Transfer & Trust Company (“CST”). The remaining proceeds (less commissions and actual expense payments or other fees payable pursuant to this Agreement), if any, shall be paid to the order of the Company upon delivery to the Representative of certificates (in form and substance satisfactory to the Representative) representing the Firm Units (or through the facilities of the Depository Trust Company (“DTC”)) for the account of the Underwriters. The Firm Units shall be registered in such name or names and in such authorized denominations as the Representative may request in writing at least two (2) full Business Days prior to the Closing Date. The Company will permit the Representative to examine and package the Firm Units for delivery, at least one (1) full Business Day prior to the Closing Date. The Company shall not be obligated to sell or deliver any of the Firm Units except upon tender of payment by the Representative for all the Firm Units. As used herein, the term “Public Shareholders” means the holders of Ordinary Shares sold as part of the Units in the Offering or acquired in the aftermarket, including the Initial Shareholders (defined below) to the extent such Initial Shareholders acquire such Ordinary Shares in the aftermarket (and solely with respect to such Ordinary Shares). “Business Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to “stay at home”, “shelter-in-place”, “non-essential employee” or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally are open for use by customers on such day.
1.2 Over-Allotment Option.
1.2.1 Option Units. The Representative is hereby granted an option (the “Over-allotment Option”) to purchase up to an additional 750,000 units (the “Option Units”), the gross proceeds of which will be deposited in the Trust Account, for the purposes of covering any over-allotments in connection with the distribution and sale of the Firm Units. Such Option Units shall be identical in all respects to the Firm Units. Such Option Units shall be purchased for each account of the several Underwriters in the same proportion as the number of Firm Units, set forth opposite such Underwriter’s name on Schedule A hereto, bears to the total number of Firm Units (subject to adjustment by the Representative to eliminate fractions). The Firm Units and the Option Units are hereinafter collectively referred to as the “Units,” and the Units, the Ordinary Shares and Rights included in the Units, and the Ordinary Shares issuable upon conversion of the Rights are hereinafter referred to collectively as the “Public Securities.” No Option Units shall be sold or delivered unless the Firm Units previously have been, or simultaneously are, sold and delivered. The right to purchase the Option Units, or any portion thereof, may be exercised from time to time and to the extent not previously exercised may be surrendered and terminated at any time upon notice by the Representative to the Company. The purchase price to be paid for each Option Unit will be the same price per Firm Unit set forth in Section 1.1.1 hereof.
1.2.2 Exercise of Option. The Over-allotment Option granted pursuant to Section 1.2.1 hereof may be exercised by the Representative as to all (at any time) or any part (from time to time) of the Option Units within 45 days after the effective date (“Effective Date”) of the Registration Statement (as defined in Section 2.1.1 hereof). The Underwriters will not be under any obligation to purchase any Option Units prior to the exercise of the Over-allotment Option. The Over-allotment Option granted hereby may be exercised by the giving of written notice (which may be by email) to the Company by the Representative, which must be confirmed in accordance with Section 10.1 herein setting forth the number of Option Units to be purchased and the date and time for delivery of and payment for the Option Units (the “Option Closing Date”), which will not be later than five (5) full Business Days after the date of the notice or such other time and in such other manner as shall be agreed upon by the Company and the Representative, at the offices of EGS or at such other place (including remotely by facsimile or other electronic transmission) as shall be agreed upon by the Company and the Representative. If such delivery and payment for the Option Units does not occur on the Closing Date, the Option Closing Date will be as set forth in the notice. Upon exercise of the Over-allotment Option, the Company will become obligated to convey to the Underwriters, and, subject to the terms and conditions set forth herein, the Underwriters will become obligated to purchase, the number of Option Units specified in such notice.
1.2.3 Payment and Delivery. Payment for the Option Units shall be made on the Option Closing Date by wire transfer in Federal (same day) funds, payable as follows: $9.85 per Option Unit shall be deposited by the Representative in the Trust Account pursuant to the Trust Agreement upon delivery to the Representative of certificates (in form and substance satisfactory to the Representative) representing the Option Units (or through the facilities of DTC) for the account of the Representative. The certificates representing the Option Units to be delivered will be in such denominations and registered in such names as the Representative requests in writing not less than two full Business Days prior to the Closing Date or the Option Closing Date, as the case may be, and will be made available to the Representative for inspection, checking and packaging at the aforesaid office of the Company’s transfer agent or correspondent not less than one full Business Day prior to such Closing Date. The Company shall not be obligated to sell or deliver the Option Units except upon tender of payment by the Underwriters for applicable Option Units.
2
1.3 Private Placements.
1.3.1 Founder Shares. In July 2023 and September 2023, Hercules Capital Management Corp (the “Sponsor”) acquired an aggregate of 1,437,500 Class B ordinary shares of the Company, par value $0.0001 per share (the “Founder Shares”), for an aggregate consideration of $25,000 to. No underwriting discounts, commissions, or placement fees have been or will be payable in connection with the purchase of Founder Shares. Except as described in the Registration Statement, none of the Founder Shares may be sold, assigned or transferred by the Sponsor or any of its transferees prior to the date hereof (collectively, the “Initial Shareholders”) until the earlier of: (i) six months following the consummation of the Business Combination; or (ii) subsequent to the consummation of a Business Combination, the date on which the Company completes a liquidation, merger, stock exchange or other similar transaction after the initial Business Combination, that results in all of the Company’s public shareholders having the right to exchange their Ordinary Shares for cash, securities or other property. Notwithstanding the foregoing, if the last sale price of the Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period after the initial Business Combination, 50% of the Founder Shares will be released from such transfer restrictions. The holders of Founder Shares shall have no right to any liquidating distributions with respect to any portion of the Founder Shares in the event the Company fails to consummate a Business Combination within the period of time as provided in its amended and restated memorandum and articles of association. The holders of the Founder Shares shall not have redemption rights with respect to the Founder Shares. In the event that the Over-allotment Option is not exercised in full, the Sponsor will be required to forfeit such number of Founder Shares (up to 187,500 Founder Shares) such that the Founder Shares then outstanding will comprise approximately 20% of the issued and outstanding shares of the Company (excluding the Placement Shares (as defined below) and the Representative Shares (as defined below)) after giving effect to the Offering and exercise, if any, of the Over-allotment Option.
1.3.2 Unit Private Placement. Simultaneously with the Closing Date, the Sponsor (and/or its designees) will purchase from the Company pursuant to a Sponsor Unit Purchase Agreement (as defined in Section 2.21.2 below) an aggregate of 216,750 units of the Company, which units are identical to the Firm Units subject to certain exceptions (collectively, the “Placement Units”) at a purchase price of $10.00 per Placement Unit in a private placement (the “Unit Private Placement”) intended to be exempt from registration under the Act pursuant to Section 4(a)(2) of the Act. The terms of the Placement Units are as described in the Prospectus (as defined in Section 2.1.1 below). Simultaneously with the Option Closing Date (if any), (i) the Sponsor will purchase from the Company pursuant to the Sponsor Unit Purchase Agreement, up to an additional 11,250 Placement Units at a purchase price of $10.00 per Placement Unit in a private placement intended to be exempt from registration under the Act pursuant to Section 4(a)(2) of the Act. The purchase price for the Placement Units to be paid by the Sponsor has been delivered to CST or counsel to the Company or the Representative to hold in a separate escrow account at least 24 hours prior to the date hereof so that such funds are readily available to be delivered to the Trust Account on the Closing Date or the Option Closing Date, as the case may be. The Placement Units, the Ordinary Shares (the “Placement Shares”) and the Rights (the “Placement Rights”) underlying the Placement Units, and the Ordinary Shares issuable upon conversion of the Placement Rights are hereinafter referred to collectively as the “Placement Securities.” No underwriting discounts, commissions, or placement fees have been or will be payable in connection with the Placement Securities sold in the Unit Private Placement. The Placement Units are identical to the Firm Units except that none of the Placement Securities may be sold, assigned or transferred by the Sponsor or its permitted transferees until the consummation of the Company’s initial Business Combination. The Public Securities, the Placement Securities, the Representative Shares (as define in Section 1.5) and the Founder Shares are hereinafter referred to collectively as the “Securities.”
3
1.4 Representative’s Ordinary Shares. Upon the Closing of the Offering, the Company shall issue to the Representative or its designees 200,000 Ordinary Shares, or up to 230,000 Ordinary Shares upon full exercise of the Over-allotment Option (the “Representative Shares”). The Representative has agreed not to transfer, assign or sell any such Representative Shares without prior consent of the Company until the completion of the initial Business Combination. In addition, the Representative has agreed (i) to waive its redemption rights (or right to participate in any tender offer) with respect to such shares in connection with the completion of the initial Business Combination and (ii) to waive its rights to liquidating distributions from the trust account with respect to such shares if the Company fails to complete the initial Business Combination within the period of time as provided in its amended and restated memorandum and articles of association. The Representative Shares will not be sold, transferred, assigned, pledged or hypothecated or the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the Representative Shares by any person, for a period of 180 days from the Effective Date to anyone other than as permitted in accordance with FINRA Rule 5110(e)(2). On and after the 181st day following the Effective Date, transfers to others may be made subject to compliance with or exemptions from applicable securities laws. The certificates for the Representative Shares shall contain legends to reflect the above FINRA and contractual transfer restrictions. The holders of the Representative Shares shall have registration rights as provided for in the Registration Rights Agreement (as defined in Section 2.21.4).
1.5 Working Capital. Upon consummation of the Offering, approximately $825,000 of the net proceeds from the sale of Units and Placement Units will be released to the Company and held outside of the Trust Account to fund the working capital requirements of the Company.
1.6 Interest Income. Prior to the Company’s consummation of a Business Combination or the Company’s liquidation, interest earned on the Trust Account may be released to the Company from the Trust Account in accordance with the terms of the Trust Agreement to pay any taxes incurred by the Company and up to $50,000 for liquidation expenses, all as more fully described in the Prospectus (as defined below).
- Representations and Warranties of the Company. The Company represents and warrants to the Underwriters as follows:
2.1 Filing of Registration Statement.
2.1.1 Pursuant to the Act. The Company has filed with the Commission a registration statement and any amendment thereto, on Form S-1 (File No. 333-277780), including any related preliminary prospectus (the “Preliminary Prospectus”, including any prospectus that is included in the registration statement immediately prior to the effectiveness of the registration statement), for the registration of the Units under the Act, which registration statement and amendment or amendments have been prepared by the Company in conformity in all material respects with the requirements of the Act, and the rules and regulations (the “Regulations”) of the Commission under the Act. The conditions for use of Form S-1 to register the Offering under the Act, as set forth in the General Instructions to such Form, have been satisfied in all material respects. Except as the context may otherwise require, such registration statement, as amended, on file with the Commission at the time the registration statement became effective, including the prospectus, financial statements, schedules, exhibits and all other documents filed as a part thereof or incorporated therein and all information deemed to be a part thereof as of such time pursuant to Rule 430A of the Regulations, together with the registration statement filed by the Company pursuant to Rule 462(b) under the Act registering additional Public Securities (the “Rule 462(b) Registration Statement”), is hereinafter called the “Registration Statement,” and the form of the final prospectus dated the Effective Date included in the Registration Statement (or, if applicable, the form of final prospectus containing information permitted to be omitted at the time of effectiveness by Rule 430A of the Regulations, filed by the Company with the Commission pursuant to Rule 424 of the Regulations), is hereinafter called the “Prospectus.” For purposes of this Agreement, “Applicable Time,” as used in the Act, means 5:00 p.m. New York City time, on the date of this Agreement. Prior to the Applicable Time, the Company prepared a Preliminary Prospectus, which was included in the Registration Statement filed on June 25, 2024, for distribution by the Underwriters (such Preliminary Prospectus used most recently prior to the Applicable Time, the “Statutory Prospectus”). Other than the Registration Statement, together with any correspondence letters between the Company and/or counsel for the Company and the Commission, no other document with respect to the Registration Statement has been filed under the Act with the Commission. All of the Public Securities have been or will be registered for public sale under the Act pursuant to the Registration Statement. The Registration Statement has been declared effective by the Commission on the date hereof. If, subsequent to the date of this Agreement, the Company or the Representative determines that, at the Applicable Time, the Statutory Prospectus included an untrue statement of a material fact or omitted a statement of material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading and the Company and the Representative agree to provide an opportunity to purchasers of the Units to terminate their old purchase contracts and enter into new purchase contracts, then the Statutory Prospectus will be deemed to include any additional information available to purchasers at the time of entry into the first such new purchase contract.
4
2.1.2 Pursuant to the Exchange Act. The Company has filed with the Commission a Registration Statement on Form 8-A (File Number 001-42152) providing for the registration under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), of the Units, Ordinary Shares and Rights. The registration of the Units, Ordinary Shares and Rights under the Exchange Act has been declared effective by the Commission on the date hereof and the Units, Ordinary Shares and Rights have been registered pursuant to Section 12(b) of the Exchange Act.
2.1.3 No Stop Orders, etc. Neither the Commission nor, to the Company’s knowledge, any federal, state or other regulatory authority has issued any order or threatened to issue any order preventing or suspending the use of the Registration Statement, any Preliminary Prospectus, the Statutory Prospectus or Prospectus or any part thereof, or has instituted or, to the Company’s knowledge, threatened to institute any proceedings with respect to such an order.
2.2 Disclosures in Registration Statement.
2.2.1 10b-5 Representation. At the time of effectiveness of the Registration Statement (or at the time of any post-effective amendment to the Registration Statement) and at all times subsequent thereto up to the Closing Date and the Option Closing Date, if any, the Registration Statement, the Statutory Prospectus and the Prospectus do and will contain all material statements that are required to be stated therein in accordance with the Act and the Regulations, and did or will, in all material respects, conform to the requirements of the Act and the Regulations. The Registration Statement, as of the Effective Date and at the Applicable Time, did not, and the amendments and supplements thereto, as of their respective dates, will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading. The Prospectus, as of its date and the Closing Date or the Option Closing Date, as the case may be, did not, and the amendments and supplements thereto, as of their respective dates, will not, include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. The Statutory Prospectus, as of the Applicable Time (or such subsequent Applicable Time pursuant to Section 2.1.1), did not include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. When any Preliminary Prospectus or the Statutory Prospectus was first filed with the Commission (whether filed as part of the Registration Statement for the registration of the Public Securities or any amendment thereto or pursuant to Rule 424(a) of the Regulations) and when any amendment thereof or supplement thereto was first filed with the Commission, such Preliminary Prospectus or the Statutory Prospectus and any amendments thereof and supplements thereto complied or will have been corrected in the Statutory Prospectus and the Prospectus to comply in all material respects with the applicable provisions of the Act and the Regulations and did not and will not contain an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. The representation and warranty made in this Section 2.2.1 does not apply to statements made or statements omitted in reliance upon and in conformity with written information furnished to the Company with respect to the Underwriters by the Underwriters expressly for use in the Registration Statement, the Statutory Prospectus or the Prospectus or any amendment thereof or supplement thereto. The parties acknowledge and agree that such information provided by or on behalf of the Underwriters consists solely of the following: the names of the Underwriters, the table of underwriters in the first paragraph of the section entitled “Underwriting,” the information with respect to stabilization transactions contained in the first and second paragraphs of the section entitled “Underwriting - Regulatory Restrictions on Purchase of Securities,” the information with respect to underwriting discounts and commissions and dealer concessions in the section entitled “Underwriting,” and the identity of counsel to the Underwriters contained in the section entitled “Legal Matters” (such information, collectively, the “Underwriters’ Information”).
5
2.2.2 Disclosure of Agreements. The agreements and documents described in the Registration Statement, the Statutory Prospectus and the Prospectus conform to the descriptions thereof contained therein in all material respects and there are no agreements or other documents required to be described in the Registration Statement, the Statutory Prospectus or the Prospectus or to be filed with the Commission as exhibits to the Registration Statement, that have not been so described or filed. Each agreement or other instrument (however characterized or described) to which the Company is a party or by which its property or business is or may be bound or affected and (i) that is referred to in the Registration Statement, Statutory Prospectus or the Prospectus or attached as an exhibit thereto, or (ii) that is material to the Company’s business, has been duly authorized and validly executed by the Company, is in full force and effect in all material respects and is enforceable against the Company and, to the Company’s knowledge, the other parties thereto, in accordance with its terms, except (x) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors’ rights generally, (y) as enforceability of any indemnification or contribution provision may be limited under the foreign, federal and state securities laws, and (z) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor may be brought, and no such agreement or instrument has been assigned by the Company, and neither the Company nor, to the Company’s knowledge, any other party is in breach or default thereunder and, to the Company’s knowledge, no event has occurred that, with the lapse of time or the giving of notice, or both, would constitute a breach or default thereunder. To the Company’s knowledge, the performance by the Company of the material provisions of such agreements or instruments will not result in a material violation of any existing applicable law, rule, regulation, judgment, order or decree of any governmental agency or court, domestic or foreign, having jurisdiction over the Company or any of its assets or businesses, including, without limitation, those relating to environmental laws and regulations.
2.2.3 Prior Securities Transactions. No securities of the Company have been sold by the Company or by or on behalf of, or for the benefit of, any person or persons controlling, controlled by, or under common control with the Company since the date of the Company’s formation, except as disclosed in the Registration Statement.
2.2.4 Regulations. The disclosures in the Registration Statement, the Statutory Prospectus and Prospectus concerning the effects of federal, foreign, state and local regulation on the Company’s business as currently contemplated are correct in all material respects and do not omit to state a material fact necessary to make the statements therein, in light of the circumstances in which they were made, not misleading.
2.3 Changes After Dates in Registration Statement.
2.3.1 No Material Adverse Change. Since the respective dates as of which information is given in the Registration Statement, the Statutory Prospectus and the Prospectus, except as otherwise specifically stated therein, (i) there has been no material adverse change in the condition, financial or otherwise, or business prospects of the Company, (ii) there have been no material transactions entered into by the Company, other than as contemplated pursuant to this Agreement, (iii) no member of the Company’s board of directors (the “Board of Directors”) or management has resigned from any position with the Company and (iv) no event or occurrence has taken place which materially impairs, or would likely materially impair, with the passage of time, the ability of the members of the Board of Directors or management to act in their capacities with the Company as described in the Registration Statement, the Statutory Prospectus and the Prospectus.
2.3.2 Recent Securities Transactions. Subsequent to the respective dates as of which information is given in the Registration Statement, the Statutory Prospectus and the Prospectus, and except as may otherwise be indicated or contemplated herein or therein, the Company has not: (i) issued any securities or incurred any liability or obligation, direct or contingent, for borrowed money; or (ii) declared or paid any dividend or made any other distribution on or in respect to its share capital.
6
2.4 Independent Accountants. Marcum Asia CPAs LLP (“Marcum”), whose report is filed with the Commission as part of, and is included in, the Registration Statement, the Statutory Prospectus, and the Prospectus, are, to the Company’s knowledge, independent registered public accountants as required by the Act, the Regulations and the Public Company Accounting Oversight Board (the “PCAOB”), including the rules and regulations promulgated by such entity. To the Company’s knowledge, Marcum is currently registered with the PCAOB and in good standing. Marcum has not, during the periods covered by the financial statements included in the Registration Statement, the Statutory Prospectus and the Prospectus, provided to the Company any non-audit services, as such term is used in Section 10A(g) of the Exchange Act.
2.5 Financial Statements; Statistical Data.
2.5.1 Financial Statements. The financial statements, including the notes thereto and supporting schedules (if any) included in the Registration Statement, the Statutory Prospectus and the Prospectus fairly present the financial position, the results of operations and the cash flows of the Company at the dates and for the periods to which they apply; such financial statements have been prepared in conformity with United States generally accepted accounting principles (“GAAP”), consistently applied throughout the periods involved; and the supporting schedules included in the Registration Statement, the Statutory Prospectus and the Prospectus present fairly the information required to be stated therein in conformity with the Regulations. No other financial statements or supporting schedules are required to be included or incorporated by reference in the Registration Statement, the Statutory Prospectus or the Prospectus. The Registration Statement, the Statutory Prospectus and the Prospectus disclose all material off-balance sheet transactions, arrangements, obligations (including contingent obligations), and other relationships of the Company with unconsolidated entities or other persons that may have a material current or future effect on the Company’s financial condition, changes in financial condition, results of operations, liquidity, capital expenditures, capital resources, or significant components of revenues or expenses. There are no pro forma or as adjusted financial statements which are required to be included in the Registration Statement, the Statutory Prospectus and the Prospectus in accordance with Regulation S-X or Form S-1 that have not been included as so required.
2.5.2 Statistical Data. The statistical, industry-related and market-related data included in the Registration Statement, the Statutory Prospectus and/or the Prospectus are based on or derived from sources that the Company reasonably and in good faith believes are reliable and accurate, and such data agree with the sources from which they are derived.
2.6 Authorized Capital; Options. The Company had at the date or dates indicated in each of the Registration Statement, the Statutory Prospectus, and the Prospectus, as the case may be, duly authorized, issued and outstanding capitalization as set forth in the Registration Statement, the Statutory Prospectus, and the Prospectus. Based on the assumptions stated in the Registration Statement, the Statutory Prospectus, and the Prospectus, the Company will have on the Closing Date or on the Option Closing Date, as the case may be, the adjusted share capitalization set forth therein. Except as set forth in, or contemplated by, the Registration Statement, the Statutory Prospectus and the Prospectus, on the Effective Date and on the Closing Date or Option Closing Date, as the case may be, there will be no options, warrants, or other rights to purchase or otherwise acquire any authorized but unissued Ordinary Shares or any security convertible into Ordinary Shares, or any contracts or commitments to issue or sell Ordinary Shares or any such options, warrants, rights or convertible securities.
2.7 Valid Issuance of Securities.
2.7.1 Outstanding Securities. All issued and outstanding securities of the Company issued prior to the transactions contemplated by this Agreement have been duly authorized and validly issued and are fully paid and non-assessable; the holders thereof have no rights of rescission with respect thereto, and are not subject to personal liability by reason of being such holders; and none of such securities were issued in violation of the preemptive rights of any holders of any security of the Company or similar contractual rights granted by the Company. The authorized and outstanding securities of the Company conform in all material respects to all statements relating thereto contained in the Registration Statement, the Statutory Prospectus and the Prospectus. All offers, sales and any transfers of the outstanding securities of the Company were at all relevant times either registered under the Act and the applicable state securities or Blue Sky laws or exempt from such registration requirements (based in part on the representations and warranties of the purchasers of such securities).
7
2.7.2 Public Securities; Representative Shares. The Public Securities and the Representative Shares have been duly authorized and reserved for issuance and when issued and paid for in accordance with this Agreement, will be validly issued, fully paid and non-assessable; the holders thereof are not and will not be subject to personal liability by reason of being such holders; the Public Securities and the Representative Shares are not and will not be subject to the preemptive rights of any holders of any security of the Company or similar contractual rights granted by the Company; and all corporate action required to be taken for the authorization, issuance and sale of the Public Securities and the Representative Shares has been duly and validly taken. The form of certificates for the Public Securities conform to the corporate law of the jurisdiction of the Company’s incorporation and applicable securities laws. The Public Securities conform in all material respects to the descriptions thereof contained in the Registration Statement, the Statutory Prospectus and the Prospectus, as the case may be. When paid for and issued, the Rights will constitute valid and binding obligations of the Company to issue the number and type of securities of the Company called for thereby in accordance with the terms thereof and such Rights are enforceable against the Company in accordance with their respective terms, except: (i) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors’ rights generally; (ii) as enforceability of any indemnification or contribution provision may be limited under foreign, federal and state securities laws; and (iii) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor may be brought.
2.7.3 Placement Securities.
2.7.3.1 The Placement Rights constitute valid and binding obligations of the Company to issue the number and type of securities of the Company called for thereby in accordance with the terms thereof, and are, or will be enforceable against the Company in accordance with their respective terms, except: (i) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors’ rights generally; (ii) as enforceability of any indemnification or contribution provision may be limited under federal and state securities laws; and (iii) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor may be brought. The Placement Securities have been duly authorized and reserved for issuance and when issued and paid for in accordance with the Sponsor Unit Purchase Agreement will be validly issued, fully paid and non-assessable; the holders thereof are not and will not be subject to personal liability by reason of being such holders; the Placement Securities are not and will not be subject to the preemptive rights of any holders of any security of the Company or similar contractual rights granted by the Company; and all corporate action required to be taken for the authorization, issuance and sale of the Placement Securities has been duly and validly taken. The Placement Securities conform in all material respects to the descriptions thereof contained in the Registration Statement, the Statutory Prospectus, and the Prospectus, as the case may be.
2.7.4 No Integration. Neither the Company nor any of its affiliates has, prior to the date hereof, made any offer or sale of any securities which are required to be or may be “integrated” pursuant to the Act or the Regulations with the offer and sale of the Public Securities pursuant to the Registration Statement or the Placement Securities in the Unit Private Placement.
2.8 Registration Rights of Third Parties. Except as set forth in the Registration Statement, the Statutory Prospectus and the Prospectus, no holders of any securities of the Company or any rights exercisable for or convertible or exchangeable into securities of the Company have the right to require the Company to register any such securities of the Company under the Act or to include any such securities in a registration statement to be filed by the Company.
2.9 Validity and Binding Effect of Agreements. This Agreement, the Insider Letter (as defined in Section 2.21.1), the Trust Agreement, the Services Agreement (as defined in Section 2.21.3), the Registration Rights Agreement, the Rights Agreement (as defined in Section 2.24), and the Sponsor Unit Purchase Agreement (collectively, the “Transaction Documents”) have been duly and validly authorized by the Company and, when executed and delivered by the Company and the other parties thereto, will constitute the valid and binding agreements of the Company, enforceable against the Company in accordance with their respective terms, except (i) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors’ rights generally, (ii) as enforceability of any indemnification or contribution provision may be limited under the foreign, federal, and state securities laws, and (iii) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor may be brought.
8
2.10 No Conflicts, Etc. The execution, delivery, and performance by the Company of the Transaction Documents, the consummation by the Company of the transactions herein and therein contemplated and the compliance by the Company with the terms hereof and thereof do not and will not, with or without the giving of notice or the lapse of time or both: (i) result in a material breach or violation of, or conflict with any of the terms and provisions of, or constitute a material default under, or result in the creation, modification, termination or imposition of any lien, charge or encumbrance upon any property or assets of the Company pursuant to the terms of any agreement, obligation, condition, covenant or instrument to which the Company is a party or bound or to which its property is subject except pursuant to the Trust Agreement; (ii) result in any violation of the provisions of the Memorandum and Articles of Association of the Company, as amended (the “Charter Document”); or (iii) violate any existing applicable statute, law, rule, regulation, judgment, order or decree of any governmental agency or court, domestic or foreign, having jurisdiction over the Company or any of its properties, assets or business constituted as of the date hereof.
2.11 No Defaults; Violations. No material default or violation exists in the due performance and observance of any term, covenant or condition of any material license, contract, indenture, mortgage, deed of trust, note, loan or credit agreement, or any other material agreement or instrument evidencing an obligation for borrowed money, or any other agreement or instrument to which the Company is a party or by which the Company may be bound or to which any of the properties or assets of the Company is subject. The Company is not in violation of any term or provision of its Charter Document. The Company is not in violation of any franchise, license, permit, applicable law, rule, regulation, judgment or decree of any governmental agency or court, domestic or foreign, having jurisdiction over the Company or any of its properties or businesses, except for such violations which would not reasonably be expected to have a material adverse effect on the condition (financial or otherwise), earnings, assets, prospects, business, operations or properties of the Company, whether or not arising from transactions in the ordinary course of business (a “Material Adverse Effect”).
2.12 Corporate Power; Licenses; Consents.
2.12.1 Conduct of Business. The Company has all requisite corporate power and authority, and has all necessary authorizations, approvals, orders, licenses, certificates and permits of and from all governmental regulatory officials and bodies that it needs as of the date hereof to conduct its business for the purpose as described in the Registration Statement, the Statutory Prospectus and the Prospectus. The disclosures in the Registration Statement, the Statutory Prospectus and the Prospectus concerning the effects of foreign, federal, state and local regulation on this Offering and the Company’s business purpose as currently contemplated are correct in all material respects and do not omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. Since its formation, the Company has conducted no business and has incurred no liabilities other than in connection with its formation and in furtherance of this Offering.
2.12.2 Transactions Contemplated Herein. The Company has all requisite corporate power and authority to enter into this Agreement and to carry out the provisions and conditions hereof, and all consents, authorizations, approvals and orders required in connection herewith have been obtained. No consent, authorization, or order of, and no filing with, any court, government agency or other body, foreign or domestic, is required for the valid issuance, sale and delivery, of the Public Securities and the Placement Securities and the consummation of the transactions and agreements contemplated by the Transaction Documents and as contemplated by the Registration Statement, the Statutory Prospectus and the Prospectus, except with respect to applicable foreign, federal and state securities laws and the rules and regulations promulgated by FINRA.
2.13 D&O Questionnaires. All information contained in the questionnaires (“Questionnaires”) completed by each of the Company’s officers, directors and shareholders (“Insiders”) and provided to the Representative and its counsel and the biographies of the Insiders contained in the Registration Statement, Statutory Prospectus and the Prospectus (to the extent a biography is contained) is, true and correct in all material respects and the Company has not become aware of any information which would cause the information disclosed in the Questionnaires completed by each Insider to become inaccurate, incorrect or incomplete in any material respect.
9
2.14 Litigation; Governmental Proceedings. There is no action, suit, proceeding, inquiry, arbitration, investigation, litigation or governmental proceeding pending, or to the Company’s knowledge, threatened against or involving the Company or, to the Company’s knowledge, any Insider that has not been disclosed, that is required to be disclosed, in the Registration Statement, the Statutory Prospectus, the Prospectus or the Questionnaires.
2.15 Good Standing. The Company has been duly organized and is validly existing as a corporation and is in good standing under the laws of its jurisdiction of incorporation. The Company is duly qualified to do business and is in good standing as a foreign corporation in each jurisdiction in which its ownership or lease of property or the conduct of business requires such qualification, except where the failure to qualify would not have a Material Adverse Effect.
2.16 No Contemplation of a Business Combination. The Company has not identified any Business Combination target (each a “Target Business”) and it has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any Business Combination target.
2.17 Transactions Requiring Disclosure to FINRA.
2.17.1 Finder’s Fees. There are no claims, payments, arrangements, agreements or understandings relating to the payment of a finder’s, consulting or origination fee by the Company or any Insider with respect to the sale of the Securities hereunder or any other arrangements, agreements or understandings of the Company or to the Company’s knowledge, any Insider that may affect the Underwriters’ compensation, as defined by FINRA.
2.17.2 Payments Within 180 Days. The Company has not made any direct or indirect payments (in cash, securities or otherwise) to: (i) any person, as a finder’s fee, consulting fee or otherwise, in consideration of such person raising capital for the Company or introducing to the Company persons who raised or provided capital to the Company; (ii) any FINRA member participating in the Offering as defined in FINRA Rule 5110(j)(15) (“Participating FINRA Member”); or (iii) any person or entity that has any direct or indirect affiliation or association with any Participating FINRA Member, within the 180-day period prior to the initial filing of the Registration Statement, other than the prior payments to the Representative in connection with the Offering. The Company has not issued any warrants or other securities, or granted any options, directly or indirectly, to anyone who is a potential underwriter in the Offering or an associated person or affiliate (as defined by FINRA rules) of such an underwriter within the 180-day period prior to the initial filing date of the Registration Statement. No person to whom securities of the Company have been privately issued within the 180-day period prior to the initial filing date of the Registration Statement has any relationship or affiliation or association with any Participating FINRA Member. Except with respect to the Representative in connection with the Offering, the Company has not entered into any agreement or arrangement (including, without limitation, any consulting agreement or any other type of agreement) during the 180-day period prior to the initial filing date of the Registration Statement with the Commission, which arrangement or agreement provides for the receipt of any underwriting compensation from the Company to a Participating FINRA Member.
2.17.3 FINRA Affiliation. Other than as disclosed to the Representative, no officer or director or any direct or indirect beneficial owner (including the Insiders) of any class of the Company’s unregistered securities (whether debt or equity, registered or unregistered, regardless of the time acquired or the source from which derived) has any direct or indirect affiliation or association with any Participating FINRA Member. The Company will advise the Representative and EGS if it learns that any officer or director or any direct or indirect beneficial owner (including the Insiders) is or becomes an affiliate or associated person of a Participating FINRA Member.
2.17.4 Share Ownership. No officer or director or any direct or indirect beneficial owner (including the Insiders) of any class of the Company’s unregistered securities is an owner of shares or other securities of any member of FINRA participating in the Offering (other than securities purchased on the open market).
2.17.5 Loans. No officer or director or any direct or indirect beneficial owner (including the Insiders) of any class of the Company’s unregistered securities has made a subordinated loan to any member of FINRA participating in the Offering.
10
2.17.6 Proceeds of the Offering. No proceeds from the sale of the Public Securities (excluding underwriting compensation) or the Placement Securities will be paid to any FINRA member participating in the Offering, or any persons associated or affiliated with a member of FINRA participating in the Offering, except as specifically authorized herein.
2.17.7 Conflicts of Interest. To the Company’s knowledge, no Participating FINRA Member has a conflict of interest with the Company. For this purpose, a “conflict of interest” exists when a member of FINRA and/or its associated persons, parent or affiliates in the aggregate beneficially own 10% or more of the Company’s outstanding subordinated debt or common equity, or 10% or more of the Company’s preferred equity. Participating FINRA Members include managing agents, syndicate group members and all dealers which are members of FINRA.
2.18 Taxes.
2.18.1 There are no transfer taxes or other similar fees or charges under U.S. federal law or the laws of any U.S. state or any political subdivision of the United States, required to be paid in connection with the execution and delivery of this Agreement or the issuance or sale by the Company of the Public Securities.
2.18.2 The Company has filed all foreign, U.S. federal, state and local tax returns required to be filed with taxing authorities prior to the date hereof in a timely manner or has duly obtained extensions of time for the filing thereof, except in any case in which the failure to so file would not have a Material Adverse Effect. The Company has paid all taxes shown as due on such returns that were filed and has paid all taxes imposed on it and any other assessment, fine or penalty levied against it, to the extent that any of the foregoing is due and payable, except for any such assessment, fine or penalty that is currently being contested in good faith or as would not have a Material Adverse Effect. The Company has made appropriate provisions in the applicable financial statements referred to in Section 2.5.1 above in respect of all federal, state, local and foreign income and franchise taxes for all current or prior periods as to which the tax liability of the Company has not been finally determined, if any.
2.19 Foreign Corrupt Practices Act; Anti-Money Laundering; Patriot Act.
2.19.1 Foreign Corrupt Practices Act. Neither the Company nor to the Company’s knowledge, any of the Insiders or any other person acting on behalf of the Company has, directly or indirectly, given or agreed to give any money, gift or similar benefit (other than legal price concessions to customers in the ordinary course of business) to any customer, supplier, employee or agent of a customer or supplier, or official or employee of any governmental agency or instrumentality of any government (domestic or foreign) or any political party or candidate for office (domestic or foreign) or other person who was, is, or may be in a position to help or hinder the business of the Company (or assist it in connection with any actual or proposed transaction) that (i) might subject the Company to any damage or penalty in any civil, criminal or governmental litigation or proceeding, (ii) if not given in the past, might have had a Material Adverse Effect, or (iii) if not continued in the future, might adversely affect the assets, business or operations of the Company. The Company has taken reasonable steps to ensure that its accounting controls and procedures are sufficient to cause the Company to comply in all material respects with the Foreign Corrupt Practices Act of 1977, as amended.
2.19.2 Currency and Foreign Transactions Reporting Act. The operations of the Company are and have been conducted at all times in compliance with (i) the requirements of the U.S. Treasury Department Office of Foreign Asset Control and (ii) applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transaction Reporting Act of 1970, as amended, including the Money Laundering Control Act of 1986, as amended, the rules and regulations thereunder and any related or similar money laundering statutes, rules, regulations or guidelines, issued, administered or enforced by any Federal governmental agency (collectively, the “Money Laundering Laws”) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company with respect to the Money Laundering Laws is pending or, to the Company’s knowledge, threatened.
2.19.3 Patriot Act. Neither the Company nor to the Company’s knowledge, any Insider has violated the Bank Secrecy Act of 1970, as amended, or the Uniting and Strengthening of America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism (USA PATRIOT) Act of 2001, and/or the rules and regulations promulgated under any such law, or any successor law.
11
2.20 Officers’ Certificate. Any certificate signed by any duly authorized officer of the Company in connection with the Offering and delivered to the Representative or to EGS shall be deemed a representation and warranty by the Company to the Underwriters as to the matters covered thereby.
2.21 Agreements With Insiders.
2.21.1 Insider Letter. The Company has caused to be duly executed a legally binding and enforceable agreement (except (i) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors’ rights generally, (ii) as enforceability of any indemnification, contribution or non-compete provision may be limited under foreign, federal and state securities laws, and (iii) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor may be brought), a form of which is annexed as an exhibit to the Registration Statement (the “Insider Letter”), pursuant to which each of the Insiders of the Company agree to certain matters. The Insider Letter shall not be amended, modified or otherwise changed without the prior written consent of the Representative.
2.21.2 Purchase Agreement. The Sponsor has executed and delivered a Unit Subscription Agreement, the form of which is filed as an exhibit to the Registration Statement (the “Sponsor Unit Purchase Agreement”), pursuant to which the Sponsor will, among other things, on the Closing Date, consummate the purchase of and deliver the purchase price for the Placement Units as provided for in such Sponsor Unit Purchase Agreement. Pursuant to the Sponsor Unit Purchase Agreement, (i) the Sponsor has waived any and all rights and claims each may have to any proceeds, and any interest thereon, held in the Trust Account in respect of the Placement Securities, and (ii) the proceeds from the sale of the Placement Securities will be deposited by the Company in the Trust Account in accordance with the terms of the Trust Agreement on the Closing Date as provided for in the Sponsor Unit Purchase Agreement.
2.21.3 Administrative Services Agreement. The Company and the Sponsor have entered into an agreement (“Services Agreement”) substantially in the form annexed as an exhibit to the Registration Statement pursuant to which the Sponsor will make available to the Company general and administrative services including office space, utilities and secretarial support for the Company’s use for $10,000 per month payable until the earlier of the consummation by the Company of a Business Combination or the liquidation of the Trust Account, on the terms and subject to the conditions set forth in the Services Agreement.
2.21.4 Registration Rights Agreement. The Company, the Initial Shareholders and the Underwriters have entered into a Registration Rights Agreement (“Registration Rights Agreement”) substantially in the form filed as an exhibit to the Registration Statement, whereby such parties will be entitled to certain registration rights with respect to the securities they hold or may hold, as set forth in such Registration Rights Agreement and described more fully in the Registration Statement, the Statutory Prospectus and the Prospectus.
2.21.5 Loans. The Sponsor has agreed to make loans to the Company in the aggregate amount of up to $500,000 (the “Insider Loans”) pursuant to a promissory note filed as an exhibit to the Registration Statement. The Insider Loans do not bear any interest and are repayable by the Company on the consummation of the Offering.
2.22 Investment Management Trust Agreement. The Company has entered into the Trust Agreement with respect to certain proceeds of the Offering and the Unit Private Placement substantially in the form filed as an exhibit to the Registration Statement, pursuant to which the funds held in the Trust Account may be released under limited circumstances.
12
2.23 Intentionally Omitted.
2.24 Rights Agreement. The Company has entered into a rights agreement with respect to the Rights included in the Units and the Placement Rights with CST substantially in the form filed as an exhibit to the Registration Statement (the “Rights Agreement”).
2.25 No Existing Non-Competition Agreements. No Insider is subject to any non-competition agreement or non-solicitation agreement with any employer or prior employer which could materially affect his ability to be an employee, officer and/or director of the Company, except as disclosed in the Registration Statement.
2.26 Investments. No more than 45% of the “value” (as defined in Section 2(a)(41) of the Investment Company Act of 1940, as amended (“Investment Company Act”)) of the Company’s total assets consist of, and no more than 45% of the Company’s net income after taxes is derived from, securities other than “Government Securities” (as defined in Section 2(a)(16) of the Investment Company Act) or money market funds meeting the conditions of Rule 2a-7 under the Investment Company Act.
2.27 Investment Company Act. The Company is not required, and upon the issuance and sale of the Securities as herein contemplated and the application of the net proceeds therefrom as described in the Statutory Prospectus and Prospectus will not be required, to register as an “investment company” under the Investment Company Act.
2.28 Subsidiaries. The Company does not own an interest in any corporation, partnership, limited liability company, joint venture, trust or other business entity.
2.29 Related Party Transactions. No relationship, direct or indirect, exists between or among the Company, on the one hand, and any Insider, on the other hand, which is required by the Act, the Exchange Act or the Regulations to be described in the Registration Statement, the Statutory Prospectus and the Prospectus which is not so described as required. There are no outstanding loans, advances (except normal advances for business expenses in the ordinary course of business), or guarantees of indebtedness by the Company to or for the benefit of any of the officers or directors of the Company or any of their respective family members, except as disclosed in the Registration Statement, the Statutory Prospectus and Prospectus. The Company has not extended or maintained credit, arranged for the extension of credit, or renewed an extension of credit, in the form of a personal loan to or for any director or officer of the Company.
2.30 No Influence. The Company has not offered, or caused the Underwriters to offer, the Firm Units to any person or entity with the intention of unlawfully influencing: (a) a customer or supplier of the Company or any affiliate of the Company to alter the customer’s or supplier’s level or type of business with the Company or such affiliate or (b) a journalist or publication to write or publish favorable information about the Company or any such affiliate.
2.31 Sarbanes-Oxley. The Company is, or on the Closing Date will be, in material compliance with the provisions of the Sarbanes-Oxley Act of 2002, as amended, and the rules and regulations promulgated thereunder and related or similar rules or regulations promulgated by any governmental or self-regulatory entity or agency, that are applicable to it as of the date hereof.
2.32 Distribution of Offering Material by the Company. The Company has not distributed and will not distribute, prior to the later of the Closing Date and the completion of the distribution of the Units, any offering material in connection with the offering and sale of the Units other than the Statutory Prospectus and the Prospectus, in each case as supplemented and amended.
2.33 Nasdaq Stock Market. The Public Securities have been authorized for listing, subject to official notice of issuance and evidence of satisfactory distribution, on The Nasdaq Stock Market LLC (the “Nasdaq”), and the Company knows of no reason or set of facts that is likely to adversely affect such authorization.
2.34 Board of Directors. As of the Effective Date, the Board of Directors of the Company will be comprised of the persons set forth as “Directors” or “Director nominees” under the heading of the Statutory Prospectus and the Prospectus captioned “Management.” As of the Effective Date, the qualifications of the persons serving as board members and the overall composition of the board will comply with the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder and the rules of the Nasdaq that are, in each case, applicable to the Company. As of the Effective Date, the Company will have an Audit Committee that satisfies the applicable requirements under the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder and the rules of the Nasdaq.
13
2.35 Emerging Growth Company. From its formation through the date hereof, the Company has been and is an “emerging growth company,” as defined in Section 2(a) of the Act (an “Emerging Growth Company”).
2.36 No Disqualification Events. Neither the Company, nor any of its predecessors or any affiliated issuer, nor any director, executive officer, or other officer of the Company participating in the Offering, nor any beneficial owner of 20% or more of the Company’s outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Act) connected with the Company in any capacity at the Applicable Time (each, a “Company Covered Person” and, together, “Company Covered Persons”) is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii) under the Act (a “Disqualification Event”), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any Company Covered Person is subject to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Underwriters a copy of any disclosures provided thereunder.
2.37 Free-Writing Prospectus and Testing-the-Waters. The Company has not made any offer relating to the Public Securities that would constitute an issuer free writing prospectus, as defined in Rule 433 under the Act, or that would otherwise constitute a “free writing prospectus” as defined in Rule 405. The Company: (a) has not engaged in any Testing-the-Waters Communication other than Testing-the-Waters Communications with the consent of the Representative with entities that are qualified institutional buyers within the meaning of Rule 144A under the Act or institutions that are accredited investors within the meaning of Rule 501 under the Act and (b) has not authorized anyone to engage in Testing-the-Waters Communications other than its officers and the Representative and individuals engaged by the Representative. The Company has not distributed any written Testing-the-Waters Communications other than those listed on Schedule B hereto. “Testing-the-Waters Communication” means any oral or written communication with potential investors undertaken in reliance on Section 5(d) of the Act.
2.38 Dividends and Distributions. Except as disclosed in the Registration Statement, the Statutory Prospectus and the Prospectus, under current laws and regulations of the Cayman Islands and any political subdivision thereof, all dividends and other distributions declared and payable on the Securities may be paid by the Company to the holder thereof in United States dollars. No taxes, fees or charges (other than stamp duty) are payable (either by director assessment or withholding to the government or other taxing authority in the Cayman Islands under the laws of the Cayman Islands in respect of payments made to the holders of Securities.
- Covenants of the Company. The Company covenants and agrees as follows:
3.1 Amendments to Registration Statement. The Company will deliver to the Representative, prior to filing, any amendment or supplement to the Registration Statement, any Preliminary Prospectus or the Prospectus proposed to be filed after the Effective Date and the Company shall not file any such amendment or supplement to which the Representative reasonably objects in writing.
3.2 Federal Securities Laws.
3.2.1 Compliance. During the time when a Prospectus is required to be delivered under the Act, the Company will use its best efforts to comply with all requirements imposed upon it by the Act, the Regulations, and the Exchange Act, and by the regulations under the Exchange Act, as from time to time in force, so far as necessary to permit the continuance of sales of or dealings in the Public Securities in accordance with the provisions hereof and the Statutory Prospectus and the Prospectus. If at any time when a Prospectus relating to the Public Securities is required to be delivered under the Act, any event shall have occurred as a result of which, in the opinion of counsel for the Company or counsel for the Underwriters, the Prospectus, as then amended or supplemented, includes an untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, or if it is necessary at any time to amend or supplement the Prospectus to comply with the Act, the Company will notify the Representative promptly and prepare and file with the Commission, subject to Section 3.1 hereof, an appropriate amendment or supplement in accordance with Section 10 of the Act.
14
3.2.2 Filing of Final Prospectus. The Company will file the Prospectus (in form and substance satisfactory to the Underwriters) with the Commission pursuant to the requirements of Rule 424 of the Regulations.
3.2.3 Exchange Act Registration. The Company will use its best efforts to maintain the registration of the Public Securities under the provisions of the Exchange Act (except in connection with a going-private transaction) for a period of five years from the Effective Date, or until the Company is required to be liquidated or is acquired, if earlier. The Company will not deregister the Public Securities under the Exchange Act without the prior written consent of the Representative.
3.2.4 Exchange Act Filings. From the Effective Date until the earlier of the Company’s initial Business Combination, or its liquidation and dissolution, the Company shall timely file with the Commission via the Electronic Data Gathering, Analysis and Retrieval System (“EDGAR”) such statements and reports as are required to be filed by a company registered under Section 12(b) of the Exchange Act.
3.2.5 Sarbanes-Oxley Compliance. As soon as it is legally required to do so, the Company shall take all actions necessary to obtain and thereafter maintain material compliance with each applicable provision of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated thereunder and related or similar rules and regulations promulgated by any other governmental or self-regulatory entity or agency with jurisdiction over the Company.
3.3 Free-Writing Prospectus. The Company agrees that it will not make any offer relating to the Public Securities that would constitute an issuer free writing prospectus, as defined in Rule 433 under the Act, or that would otherwise constitute a “free writing prospectus” as defined in Rule 405.
3.4 Delivery to Underwriters of Prospectuses. The Company will deliver to the Underwriters, without charge and from time to time during the period when the Prospectus is required to be delivered under the Act or the Exchange Act, such number of copies of each Preliminary Prospectus and the Prospectus as the Underwriters may reasonably request and, as soon as the Registration Statement or any amendment or supplement thereto becomes effective, deliver to the Underwriters, upon their request, two manually executed Registration Statements, including exhibits, and all post-effective amendments thereto and copies of all exhibits filed therewith or incorporated therein by reference and all manually executed consents of certified experts.
3.5 Effectiveness and Events Requiring Notice to the Representative. The Company will use its best efforts to cause the Registration Statement to remain effective and will notify the Representative immediately and confirm the notice in writing: (i) of the effectiveness of the Registration Statement and any amendment thereto; (ii) of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or any post-effective amendment thereto or preventing or suspending the use of any Preliminary Prospectus or the Prospectus or of the initiation, or the threatening, of any proceeding for that purpose; (iii) of the issuance by any foreign or state securities commission of any proceedings for the suspension of the qualification of the Public Securities for offering or sale in any jurisdiction or of the initiation, or the threatening, of any proceeding for that purpose; (iv) of the mailing and delivery to the Commission for filing of any amendment or supplement to the Registration Statement or Prospectus; (v) of the receipt of any comments or request for any additional information from the Commission; and (vi) of the happening of any event that, in the reasonable judgment of the Company, makes any statement of a material fact made in the Registration Statement or the Prospectus untrue or that requires the making of any changes in the Registration Statement or the Prospectus in order to make the statements therein, and in light of the circumstances under which they were made, not misleading in any material respect. If the Commission or any foreign or state securities commission shall enter a stop order or suspend such qualification at any time, the Company will make every reasonable effort to obtain promptly the lifting of such order.
15
3.6 Affiliated Transactions.
3.6.1 Business Combinations. The Company will not consummate a Business Combination with any entity that is affiliated with any Insider unless (i) the Company obtains an opinion from an independent investment banking firm or another independent entity that commonly renders valuation opinions that the Business Combination is fair to the Company from a financial point of view and (ii) a majority of the Company’s disinterested and independent directors (if there are any) approve such transaction.
3.6.2 Compensation to Insiders. Except as disclosed in the Registration Statement, the Statutory Prospectus and the Prospectus, the Company shall not pay any of the Insiders or any of their affiliates any fees or compensation from the Company, for services rendered to the Company prior to, or in connection with, the consummation of a Business Combination.
3.7 Reports to the Representative. For a period of five years from the Effective Date or until such earlier time upon which the Company is required to be liquidated or is no longer required to file reports under the Exchange Act, the Company will furnish to the Representative and its counsel copies of such financial statements and other periodic and special reports as the Company from time to time furnishes generally to holders of any class of its securities, and promptly furnish to the Underwriters, (i) a copy of each periodic report the Company shall be required to file with the Commission, (ii) a copy of every press release and every news item and article with respect to the Company or its affairs that was released by the Company, (iii) a copy of each current Report on Form 8-K or Schedule 13D, 13G, 14D-1 or 13E-4 received or prepared by the Company, (iv) two (2) copies of each registration statement filed by the Company with the Commission under the Act, and (v) such additional documents and information with respect to the Company and the affairs of any future subsidiaries of the Company as the Representative may from time to time reasonably request; provided the Representative shall sign, if requested by the Company, a Regulation FD compliant confidentiality agreement which is reasonably acceptable to the Representative and its counsel in connection with the Representative’s receipt of such information. Documents filed with the Commission pursuant to its EDGAR system shall be deemed to have been delivered to the Representative pursuant to this Section.
3.8 Transfer Agent. For a period of five years following the Effective Date or until such earlier time upon which the Company is required to be liquidated, the Company shall retain a transfer agent and rights agent acceptable to the Representative. CST is acceptable to the Representative.
3.9 Payment of Expenses. The Company hereby agrees to pay on each of the Closing Date and the Option Closing Date, if any, to the extent not paid at the Closing Date, all Company expenses incident to the performance of the obligations of the Company under this Agreement, including but not limited to (i) the Company’s legal and accounting fees and disbursements, (ii) the preparation, printing, filing, mailing and delivery (including the payment of postage with respect to such mailing) of the Registration Statement, the Statutory Prospectus and the Prospectus, including any pre or post effective amendments or supplements thereto, and the printing and mailing of this Agreement and related documents, including the cost of all copies thereof and any amendments thereof or supplements thereto supplied to the Underwriters in quantities as may be required by the Underwriters, (iii) the preparation, printing, engraving, issuance and delivery of the Units, the Ordinary Shares and the Rights included in the Units, including any transfer or other taxes payable thereon, (iv) filing fees incurred in registering the Offering with FINRA and the reasonable fees of counsel of the Underwriters in connection therewith, (v) fees, costs and expenses incurred in listing the Securities on the Nasdaq or such other stock exchanges as the Company and the Underwriters together determine, (vi) all fees and disbursements of the transfer and rights agent, (vii) all of the Company’s expenses associated with “due diligence” and “road show” meetings arranged by the Representative and any presentations made available by way of a net roadshow, including without limitation trips for the Company’s management to meet with prospective investors, all travel, food and lodging expenses associated with such trips incurred by the Company or such management, and (viii) all other costs and expenses customarily borne by an issuer incident to the performance of its obligations hereunder which are not otherwise specifically provided for in this Section 3.9. If the Offering is consummated, the Representative may deduct from the net proceeds of the Offering payable to the Company on the Closing Date the expenses set forth above up to a maximum aggregate accountable expense allowance of $125,000 (including any advances for such expenses). The Company paid the Representative $25,000 upon the execution of the engagement letter, as an advance against out-of-pocket accountable expenses actually anticipated to be incurred by the underwriters. Concurrently with the filing of the Registration Statement, the Company paid Maxim an additional $25,000. If the Offering is not consummated for any reason (other than a breach by the Representative of any of its obligations hereunder), then the Company shall reimburse the Representative in full for its out-of-pocket accountable expenses actually incurred through such date, including, without limitation, reasonable fees and disbursements of counsel to the Representative, up to a maximum of $50,000 (provided, however, that such expense cap in no way limits or impairs the indemnification and contribution provisions of the Company’s engagement letter with the Representative), such amount including the advance in the amount of $25,000 paid by the Company to the Representative.
16
3.10 Application of Net Proceeds. The Company will apply the net proceeds from the Offering and Unit Private Placement and received by it in a manner consistent with the application described under the caption “Use of Proceeds” in the Prospectus.
3.11 Delivery of Earnings Statements to Security Holders. The Company will make generally available to its security holders as soon as practicable, but not later than the first day of the fifteenth full calendar month following the Effective Date, an earnings statement (which need not be certified by independent public or independent certified public accountants unless required by the Act or the Regulations, but which shall satisfy the provisions of Rule 158(a) under Section 11(a) of the Act) covering a period of at least twelve consecutive months beginning after the Effective Date.
3.12 Notice to FINRA.
3.12.1 Notice to FINRA. For a period of sixty (60) days after the date of the Prospectus, in the event any person or entity (regardless of any FINRA affiliation or association) is engaged, in writing, to assist the Company in its search for a Target Business or to provide any other services in connection therewith, the Company will provide the following to the Representative prior to the consummation of the Business Combination: (i) complete details of all services and copies of agreements governing such services; and (ii) explanation as to why the person or entity providing the merger and acquisition services should not be considered a “Participating Member” with respect to the Offering, as such term is defined in FINRA Rule 5110. The Company also agrees that, if required by law, proper disclosure of such arrangement or potential arrangement will be made in the tender offer documents or proxy statement which the Company will file with the Commission in connection with the Business Combination.
3.12.2 FINRA. The Company shall advise the Representative (who shall make an appropriate filing with FINRA) if it is aware that any 10% or greater shareholder of the Company becomes an affiliate or associated person of a FINRA member participating in the distribution of the Public Securities.
3.12.3 Broker/Dealer. In the event the Company intends to register as a broker/dealer, merge with or acquire a registered broker/dealer, or otherwise become a member of FINRA, it shall promptly notify FINRA.
3.13 Stabilization. Neither the Company, nor to its knowledge, any of its employees, directors or stockholders (without the consent of the Representative) has taken and the Company will not take, and has directed its employees, directors and stockholders not to take, directly or indirectly, any action designed to or that has constituted or that might reasonably be expected to cause or result in, under the Exchange Act, or otherwise, stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Units.
3.14 Intentionally Omitted.
3.15 Intentionally Omitted.
3.16 Internal Controls. The Company will maintain a system of internal accounting controls sufficient to provide reasonable assurances that (i) transactions are executed in accordance with management’s general or specific authorization, (ii) transactions are recorded as necessary in order to permit preparation of financial statements in accordance with GAAP and to maintain accountability for assets, (iii) access to assets is permitted only in accordance with management’s general or specific authorization, and (iv) the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any differences.
3.17 Accountants. Until the earlier of five years from the Effective Date or when the Company is required to be liquidated, the Company shall retain Marcum or another independent registered public accounting firm reasonably acceptable to the Representative.
17
3.18 Form 8-K. The Company shall, on or prior to the date hereof, retain its independent registered public accounting firm to audit the balance sheet of the Company as of the Closing Date (“Audited Financial Statements”) reflecting the receipt by the Company of the proceeds of the Offering and the Unit Private Placement. Within four (4) Business Days after the Closing Date, the Company shall use its commercially reasonable efforts to file a Current Report on Form 8-K with the Commission, which Report shall contain the Company’s Audited Financial Statements. Promptly after the Option Closing Date, if the Over-allotment Option is exercised after the Closing Date, the Company shall file with the Commission a Current Report on Form 8-K or an amendment to the Form 8-K to disclose the exercise of such option.
3.19 Corporate Proceedings. All corporate proceedings and other legal matters necessary to carry out the provisions of this Agreement and the transactions contemplated hereby shall have been done to the reasonable satisfaction of the Representative (or its counsel).
3.20 Investment Company. The Company shall cause the proceeds of the Offering to be held in the Trust Account to be invested only as provided for in the Trust Agreement and disclosed in the Prospectus. The Company will otherwise conduct its business in a manner so that it will not become subject to the Investment Company Act. Furthermore, once the Company consummates a Business Combination, it shall be engaged in a business other than that of investing, reinvesting, owning, holding or trading securities.
3.21 Amendments to Charter Document. The Company covenants and agrees, that prior to its initial Business Combination it will not seek to amend or modify its Charter Document, except as set forth therein. The Company acknowledges that the purchasers of the Public Securities in the Offering shall be deemed to be third party beneficiaries of this Agreement and specifically this Section 3.21.
3.22 Press Releases. The Company agrees that it will not issue press releases or engage in any other publicity, without the Representative’s prior written consent (not to be unreasonably withheld), for a period of forty-five (45) days after the Closing Date. Notwithstanding the foregoing, in no event shall the Company be prohibited from issuing any press releases or engaging in any other publicity required by law, except that including the name of any Underwriter therein shall require the prior written consent of such Underwriter.
3.23 Insurance. The Company will maintain directors’ and officers’ insurance (including, without limitation, insurance covering the Company, its directors and officers for liabilities or losses arising in connection with this Offering, including, without limitation, liabilities or losses arising under the Act, the Exchange Act, the Regulations and any applicable foreign securities laws).
3.24 Electronic Prospectus. The Company shall cause to be prepared and delivered to the Underwriters, at the Company’s expense, promptly, but in no event later than two (2) Business Days from the effective date of this Agreement, an Electronic Prospectus to be used by the Underwriters in connection with the Offering. As used herein, the term “Electronic Prospectus” means a form of prospectus, and any amendment or supplement thereto, that meets each of the following conditions: (i) it shall be encoded in an electronic format, satisfactory to the Representative, that may be transmitted electronically by the Underwriters to offerees and purchasers of the Units for at least the period during which a prospectus relating to the Units is required to be delivered under the Act; (ii) it shall disclose the same information as the paper prospectus and prospectus filed pursuant to EDGAR, except to the extent that graphic and image material cannot be disseminated electronically, in which case such graphic and image material shall be replaced in the electronic prospectus with a fair and accurate narrative description or tabular representation of such material, as appropriate; and (iii) it shall be in or convertible into a paper format or an electronic format, satisfactory to the Representative, that will allow recipients thereof to store and have continuously ready access to the prospectus at any future time, without charge to such recipients (other than any fee charged for subscription to the Internet as a whole and for on-line time).
3.25 Private Placement Proceeds. On the Closing Date, the Company shall cause to be deposited proceeds from the Unit Private Placement into the Trust Account, or such other amount such that the amount of the funds in the Trust Account shall be $10.00 per Public Share sold in the Offering. On the Option Closing Date, if any, the Company shall cause to be deposited an amount of additional proceeds from the additional Placement Units sold on the Option Closing Date into the Trust Account such that the amount of funds in the Trust Account shall be $10.00 per Public Share sold in the Offering.
18
3.26 Future Financings. The Company agrees that neither it, nor any successor or subsidiary of the Company, will consummate any public or private equity or debt financing prior to the consummation of a Business Combination, unless all investors in such financing expressly waive, in writing, any rights in or claims against the Trust Account.
3.27 Amendments to Agreements. The Company shall not amend, modify or otherwise change the Trust Agreement, the Registration Rights Agreement, the Rights Agreement, the Sponsor Unit Purchase Agreement, the Services Agreement, or the Insider Letter without the prior written consent of the Representative which will not be unreasonably withheld.
3.28 Nasdaq. Until the consummation of a Business Combination, the Company will use its best efforts to maintain the listing of the Public Securities on the Nasdaq or a national securities exchange acceptable to the Representative.
3.29 Reservation of Shares. The Company will reserve and keep available that maximum number of its authorized but unissued securities which are issuable upon conversion of the Rights outstanding from time to time.
3.30 Notice of Disqualification Events. The Company will notify the Underwriters in writing, prior to the Closing Date, of (i) any Disqualification Event relating to any Company Covered Person and (ii) any event that would, with the passage of time, become a Disqualification Event relating to any Company Covered Person.
3.31 Disqualification of S-1. Until the earlier of seven years from the date hereof or until the Rights have either expired and are no longer convertible or have all been converted, the Company will not take any action or actions that prevent or disqualify the Company’s use of Form S-1 (or other appropriate form) for the registration of the Ordinary Shares issuable upon conversion of the Rights under the Act.
3.32 Emerging Growth Company Status. The Company will promptly notify the Representative if the Company ceases to be an Emerging Growth Company at any time prior to the earlier of five years after the consummation of the Company’s initial Business Combination, or the liquidation of the Trust Account if a Business Combination is not consummated as required by its Charter Document (the “Termination Date”).
3.33 Review of Financial Statements. Until the earlier of five years from the Effective Date or until the liquidation of the Trust Account if a Business Combination is not consummated by the Termination Date, the Company, at its expense, shall cause its regularly engaged independent certified public accountants to review (but not audit) the Company’s financial statements for each of the first three fiscal quarters prior to the announcement of quarterly financial information and the filing of the Company’s Form 10-Q quarterly report.
3.34 Right of First Refusal. The Company agrees that if the Firm Units are sold in accordance with the terms of this Underwriting Agreement, the Company shall grant Representative the right of first refusal to act as the sole underwriter and sole book-running manager, and/or sole placement agent, for any and all future public and private equity, equity linked, convertible and debt offerings of the Company, or any successor to or any subsidiary of the Company, provided, however, that such right of first refusal shall not apply to offerings that are directly-sourced by the Company and for which the Company does not use an underwriter, agent, advisor or other financial intermediary . The right of first refusal shall commence on the Closing Date and terminate on the eighteen (18) month anniversary of the closing of a Business Combination. Notwithstanding the foregoing, in accordance with FINRA Rule 5110(g)(6)(A), such right of first refusal shall not have a duration of more than three (3) years from the commencement of sales of the Offering. If the Representative fails to accept an offer within ten (10) Business Days after the mailing of a notice containing the material terms of a proposed financing by registered mail or overnight courier service addressed to the Representative, then the Representative shall have no further claim or right with respect to the financing proposal contained in such notice. If, however, the terms of such financing proposal are subsequently modified in any material respect, the preferential right referred to herein shall apply to such modified proposal as if the original proposal had not been made. The Representative’s failure to exercise its preferential right with respect to any particular proposal shall not affect its preferential rights relative to future proposals.
19
3.35 Tail fee. If, within twelve (12) months following the Closing Date, the Company completes any financing of equity, equity-linked, convertible or debt securities, or other capital raising activity (other than the exercise by any person or entity of any options, warrants or other convertible securities) with any investor that participated in the distribution of the Offering, was furnished of customer and/or broker lists for solicitation, or participated in any advisory or consulting capacity to the Company related to the Offering, then the Company will pay to Maxim 5.5% of the gross proceeds received from such investors upon the closing of such offering.
3.36 Obligations in Connection with Business Combination. If requested by the Representative:
3.36.1 Prior to entering into any definitive agreement with respect to the Business Combination and until such time as such Business Combination is consummated:
(a) The Company will furnish or arrange to have furnished to the Representative all information concerning the Company, the target business of such proposed Business Combination, any entity that succeeds or will succeed the Company as a public company in connection with the Business Combination, or any direct or indirect parent or subsidiary of any of them (any such issuer or co-issuer, a “Registrant”) and the proposed Business Combination that the Representative deems appropriate and will provide the Representative with access to the Company’s officers, directors, employees, affiliates, appraisers, independent accountants, financial advisors, legal counsel and other agents, consultants and advisors (“Registrant Representatives”) and properties of any Registrant as requested by the Representative. The Company shall take all reasonable steps requested by the Representative to ensure that each Registrant and each of the Registrant Representatives cooperate fully with all requests by the Representative for such information and access.
(b) The Company agrees to notify the Representative with respect to, and to permit the Representative, at their request, to participate in all diligence sessions with any Registrant or its Registrant Representatives and all drafting sessions in respect of any registration statement, preliminary or final prospectus, proxy statement, tender offer document or offering memorandum, including, without limitation, any document incorporated by reference into any of the foregoing, or any amendment or supplement to any of the foregoing, related to or in connection with the Business Combination (“Business Combination Securities Disclosure Documents”).
(c) The Company shall provide drafts of all Business Combination Securities Disclosure Documents to the Representative and their legal counsel reasonably in advance of the filing of any Business Combination Securities Disclosure Document with the Commission or the circulation of any Business Combination Securities Disclosure Document to any prospective investor, sufficient to allow the Representative and their legal counsel a reasonable time to request changes determined by them to be necessary or appropriate to such Business Combination Securities Disclosure Document before its filing or circulation. The Company shall not permit the filing with or furnishing to the Commission of any document (including, without limitation, any Business Combination Securities Disclosure Documents), the issuance of any press release or the publication of any other communication in any form, in each case relating to the issuance of Business Combination securities, without the prior written consent of the Representative, which consent shall not unreasonably be withheld, delayed or conditioned.
3.36.2 Notwithstanding any provision to the contrary herein, in connection with any Business Combination, the Company shall use all reasonable efforts to (i) require counsel to the Company and the Registrant to provide customary negative assurance letters to the Representative as of the consummation of the Business Combination in form and substance reasonably satisfactory to the Representative, (ii) require the accounting firm or firms that have audited any financial statements set forth in any Business Combination Securities Disclosure Document to provide customary “comfort letters” to the Representative pursuant to AU 634 of the Public Company Accounting Oversight Board as of the effectiveness of any Business Combination Securities Disclosure Document that was filed with, and declared effective by, the Commission, and as of the consummation of the Business Combination, (iii) require the Target Business to deliver certificates executed by the management of the Target Business as reasonably requested by Maxim, and (iv) take any other actions reasonably requested by the Representative. The Company agrees that it shall be responsible for the payment of all costs associated therewith and shall promptly reimburse the Representative for all out-of-pocket costs and expenses reasonably incurred by the Representative in connection with the foregoing, including the reasonable cost of any counsel retained by the Representative as they may deem necessary or desirable.
20
3.36.3 In connection with the Business Combination, to the extent the Company retains services (the “Fairness Opinion Provider”) to prepare a report and provide an opinion (the “Fairness Opinion”) concerning the fairness, from a financial point of view, of the Business Combination to the Company and its unaffiliated shareholders based upon, among other things, a financial review of the target business in the Business Combination (“Target Business”) and its business and operations, the Company shall disclose in reasonable detail in a Business Combination Securities Disclosure Document the results of that report and, as necessary or appropriate, a copy of that report. Each Registrant shall provide the Fairness Opinion Provider with all information and access to persons and documents that the Fairness Opinion Provider deems reasonably necessary and appropriate in connection with the preparation of its Fairness Opinion.
3.36.4 In connection with the Business Combination, the Company will engage an investigative search firm to conduct an investigation of the directors and executive officers of the Target Business and shall provide copies of the search reports to the Representative.
3.36.5 Prior to the consummation of the Business Combination, if the Business Combination does not directly or indirectly provide for the assumption of the Company’s obligations hereunder and the Company is not and will not be the surviving public company of such Business Combination, the Company shall ensure that each Target Business or other Registrant agrees to execute and deliver to the Representative a joinder agreement, in form and substance reasonably satisfactory to the Representative (such satisfaction not to be unreasonably withheld, delayed or conditioned), pursuant to which it shall join this Agreement as a signatory and a party and thus to be subject to all of the terms and conditions of this Agreement that remain in full force and effect after consummation of the Business Combination. In addition, in connection with the Business Combination, the Company will, and will use all reasonable efforts to cause each Registrant to, comply with the obligations and covenants of the Company set forth in this Agreement that then remain in full force and effect and comply in all material respects with all laws, rules and regulations applicable either to any Registrant and its business activities or to the Business Combination, as such laws, rules and regulations may be in effect at the time of the consummation of the Business Combination.
3.36.6 To the extent that the Representative determines, in its sole judgment, that the Underwriters are required to make any filing with FINRA other than in connection with the Offering or otherwise to comply with FINRA rules in connection with the Business Combination, the Company shall, upon the reasonable request of the Underwriters accompanied by a reasonable explanation of the applicable requirement(s), provide all necessary cooperation to the Representative and shall provide or cause to be provided to the Representative all information that the Representative deems necessary in order to make any such filings and in order to comply with FINRA rules. The Company shall be responsible for the fees and expenses of the Representative in connection with such filings, including the reasonable fees and expenses of counsel in an amount mutually agreed upon by the parties, and all filing fees associated therewith.
3.36.7 The Company acknowledges and agrees that nothing in this Section 3.36 shall be interpreted to obligate the Underwriters to take any action, or to refrain from taking any action, in connection with the Business Combination and any such actions will be undertaken by each Underwriter, in respect of itself, in its sole discretion and may be governed by a separate, definitive written agreement between such Underwriter and the Company or another Registrant as such parties may mutually agree.
21
- Conditions of Underwriters’ Obligations. The obligations of the Underwriters to purchase and pay for the Units, as provided herein, shall be subject to the continuing accuracy of the representations and warranties of the Company as of the date hereof and as of each of the Closing Date and the Option Closing Date, if any, to the accuracy of the statements of officers of the Company made pursuant to the provisions hereof and to the performance by the Company of its obligations hereunder and to the following conditions:
4.1 Regulatory Matters.
4.1.1 Effectiveness of Registration Statement. The Registration Statement shall have become effective not later than 5:00 p.m., New York time, on the date of this Agreement or such later date and time as shall be consented to in writing by the Representative, and, at each of the Closing Date and the Option Closing Date, no stop order suspending the effectiveness of the Registration Statement shall have been issued and no proceedings for the purpose shall have been instituted or shall be pending or contemplated by the Commission and any request on the part of the Commission for additional information shall have been complied with to the reasonable satisfaction of EGS.
4.1.2 FINRA Clearance. By the Effective Date, the Underwriters shall have received a letter of no objections from FINRA as to the underwriting terms and arrangements and amount of compensation allowable or payable to the Underwriters as described in the Registration Statement.
4.1.3 No Commission Stop Order. At the Closing Date and on each Option Closing Date, the Commission has not issued any order or threatened to issue any order preventing or suspending the use of any Preliminary Prospectus, the Prospectus or any part thereof, and has not instituted or, to the Company’s knowledge, threatened to institute any proceedings with respect to such an order.
4.1.4 Nasdaq. The Public Securities shall have been approved for listing on the Nasdaq, subject to official notice of issuance and evidence of satisfactory distribution, satisfactory evidence of which shall have been provided to the Representative.
4.2 Company Counsel Matters.
4.2.1 Closing Date and Option Closing Date Opinions of Counsel. On the Closing Date and the Option Closing Date, if any, the Representative shall have received the favorable opinions and negative assurance statements of each of Robinson & Cole LLP and Ogier, Cayman Islands, dated the Closing Date or the Option Closing Date, as the case may be, addressed to the Representative as representative for the several Underwriters and in form and substance reasonably satisfactory to the Representative and EGS.
4.2.2 Reliance. In rendering such opinions, such counsels may rely as to matters of fact, to the extent they deem proper, on certificates or other written statements of officers of the Company and officers of departments of various jurisdictions having custody of documents respecting the corporate existence or good standing of the Company, provided that copies of any such statements or certificates shall be delivered to the Representative’s counsel if requested.
4.3 Comfort Letter. At the time this Agreement is executed, and at the Closing Date and Option Closing Date, if any, the Representative shall have received a letter, addressed to the Representative as representative for the several Underwriters and in form and substance satisfactory in all respects (including the non-material nature of the changes or decreases, if any, referred to in Section 4.3.3 below) to the Representative from Marcum dated, respectively, as of the date of this Agreement and as of the Closing Date and Option Closing Date, if any:
4.3.1 Confirming that they are independent accountants with respect to the Company within the meaning of the Act and the applicable Regulations and that they have not, during the periods covered by the financial statements included in the Registration Statement, Preliminary Prospectus, Statutory Prospectus and the Prospectus, provided to the Company any non-audit services, as such term is used in Section 10A(g) of the Exchange Act;
4.3.2 Stating that in their opinion the financial statements of the Company included in the Registration Statement, the Statutory Prospectus and the Prospectus comply as to form in all material respects with the applicable accounting requirements of the Act and the published Regulations thereunder;
22
4.3.3 Stating that, on the basis of their review, which included a reading of the latest available unaudited interim financial statements of the Company (with an indication of the date of the latest available unaudited interim financial statements), a reading of the latest available minutes of the shareholders and Board of Directors and the various committees of the Board of Directors, consultations with officers and other employees of the Company responsible for financial and accounting matters and other specified procedures and inquiries, nothing has come to their attention that would lead them to believe that (a) the unaudited financial statements of the Company included in the Registration Statement, the Statutory Prospectus and the Prospectus do not comply as to form in all material respects with the applicable accounting requirements of the Act and the Regulations or are not fairly presented in conformity with GAAP applied on a basis substantially consistent with that of the audited financial statements of the Company included in the Registration Statement, the Statutory Prospectus and the Prospectus, or (b) at a date immediately prior to the Effective Date, Closing Date or Option Closing Date, as the case may be, there was any change in the share capital or long-term debt of the Company, or any decrease in the stockholders’ equity of the Company as compared with amounts shown in the March 31, 2023 balance sheet included in the Registration Statement, the Statutory Prospectus and the Prospectus, other than as set forth in or contemplated by the Registration Statement, the Statutory Prospectus and the Prospectus or, if there was any decrease, setting forth the amount of such decrease, and (c) during the period from March 31, 2023 to a specified date immediately prior to the Effective Date, Closing Date or Option Closing Date, as the case may be, there were any changes in revenues, net earnings (losses) or net earnings (losses) per Ordinary Share, in each case as compared with the Statement of Operations for the period from June 13, 2023 (inception) through March 31, 2023 included in the Registration Statement, the Statutory Prospectus and the Prospectus, or, if there was any such change, setting forth the amount of such change;
4.3.4 Setting forth, at a date not later than five days prior to the Effective Date, the amount of liabilities of the Company (including a break-down of commercial papers and notes payable to banks);
4.3.5 Stating that they have compared specific dollar amounts, numbers of shares, percentages of revenues and earnings, statements and other financial information pertaining to the Company set forth in the Registration Statement, the Statutory Prospectus and the Prospectus in each case to the extent that such amounts, numbers, percentages, statements and information may be derived from the general accounting records, including work sheets, of the Company and excluding any questions requiring an interpretation by legal counsel, with the results obtained from the application of specified readings, inquiries and other appropriate procedures (which procedures do not constitute an examination in accordance with generally accepted auditing standards) set forth in the letter and found them to be in agreement;
4.3.6 Stating that they have not, since the Company’s incorporation, brought to the attention of the Company’s management any reportable condition related to internal structure, design or operation as defined in the Statement on Auditing Standards No. 60 “Communication of Internal Control Structure Related Matters Noted in an Audit,” in the Company’s internal controls; and
4.3.7 Statements as to such other matters incident to the transaction contemplated hereby as the Representative or its counsel may reasonably request, including: (i) that Marcum is registered with the Public Company Accounting Oversight Board; (ii) that Marcum has sufficient assets and insurance to pay for any liability incurred by it relating to providing the letter; and (iii) that Marcum is not insolvent.
4.4 Officers’ Certificates.
4.4.1 Officers’ Certificate. At each of the Closing Date and the Option Closing Date, if any, the Representative shall have received a certificate of the Company signed by the Chairman of the Board or the Chief Executive Officer and the Secretary or Assistant Secretary of the Company (in their capacities as such), dated the Closing Date or the Option Closing Date, as the case may be, respectively, to the effect that the Company has performed all covenants and complied with all conditions required by this Agreement to be performed or complied with by the Company prior to and as of the Closing Date, or the Option Closing Date, as the case may be, and that the conditions set forth in Section 4 hereof have been satisfied as of such date and that, as of Closing Date and the Option Closing Date, as the case may be, the representations and warranties of the Company set forth in Section 2 hereof are true and correct. In addition, the Representative will have received such other and further certificates of officers of the Company (in their capacities as such) as the Representative may reasonably request.
4.4.2 Director’s Certificate. At each of the Closing Date and the Option Closing Date, if any, the Representative shall have received a certificate of the Company signed by a Director of the Company, dated the Closing Date or the Option Date, as the case may be, respectively, certifying (i) that the Charter Document are true and complete, have not been modified and are in full force and effect, (ii) that the resolutions of the Company’s Board of Directors relating to the public offering contemplated by this Agreement are in full force and effect and have not been modified, (iii) as to the accuracy and completeness of all correspondence between the Company or its counsel and the Commission, (iv) as to the accuracy and completeness of all correspondence between the Company or its counsel and the Nasdaq and (v) as to the incumbency of the officers of the Company. The documents referred to in such certificate shall be attached to such certificate.
23
4.5 No Material Changes. Prior to and on each of the Closing Date and the Option Closing Date, if any, (i) there shall have been no material adverse change or development involving a prospective material adverse change in the condition or prospects or the business activities, financial or otherwise, of the Company from the latest dates as of which such condition is set forth in the Registration Statement and the Prospectus, (ii) no action suit or proceeding, at law or in equity, shall have been pending or threatened against the Company or any Insider before or by any court or federal, foreign or state commission, board or other administrative agency wherein an unfavorable decision, ruling or finding may materially adversely affect the business, operations, or financial condition or income of the Company, except as set forth in the Registration Statement and the Prospectus, (iii) no stop order shall have been issued under the Act and no proceedings therefor shall have been initiated or, to the Company’s knowledge, threatened by the Commission, and (iv) the Registration Statement, the Statutory Prospectus and the Prospectus and any amendments or supplements thereto shall contain all material statements which are required to be stated therein in accordance with the Act and the Regulations and shall conform in all material respects to the requirements of the Act and the Regulations, and neither the Registration Statement, the Statutory Prospectus nor the Prospectus nor any amendment or supplement thereto shall contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.
4.6 Delivery of Agreements. On the Effective Date, the Company shall have delivered to the Representative executed copies of the Transaction Documents.
4.7 Placement Units. On the Closing Date and the Option Closing Date, as applicable, the Placement Units have been purchased as provided for in the Sponsor Unit Purchase Agreement and the requisite portion of the purchase price for such securities specified herein and therein shall be deposited into the Trust Account.
- Indemnification and Contribution.
5.1 Indemnification.
5.1.1 Indemnification of the Underwriters. The Company agrees to indemnify and hold harmless each Underwriter, its affiliates and their respective partners, members, directors, officers, employees and agents, and each person, if any, who controls each Underwriter or any affiliate within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act as follows:
(a) against any and all loss, liability, claim, damage and expense whatsoever, as incurred, joint or several, arising out of or based upon any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (or any amendment thereto), or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements therein not misleading, or arising out of any untrue statement or alleged untrue statement of a material fact included in any preliminary prospectus, Statutory Prospectus, any Testing-the-Waters Communication or the Prospectus (or any amendment or supplement to the foregoing), or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading;
(b) against any and all loss, liability, claim, damage and expense whatsoever, as incurred, joint or several, to the extent of the aggregate amount paid in settlement of any litigation, or any investigation or proceeding by any governmental authority, commenced or threatened, or of any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission; provided that (subject to Section 5.1(c)) any such settlement is effected with the written consent of the Company, which consent shall not unreasonably be delayed, conditioned or withheld; and
24
(c) against any and all expense whatsoever, as reasonably incurred (including the fees and disbursements of counsel), in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental authority, commenced or threatened, or any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission (whether or not a party), to the extent that any such expense is not paid under (a) or (b) above; provided, however, that this indemnity agreement shall not apply to any loss, liability, claim, damage or expense to the extent arising out of any untrue statement or omission or alleged untrue statement or omission made solely in reliance upon and in conformity with the Underwriters’ Information.
5.1.2 Indemnification of the Company, its Directors and Officers. Each Underwriter agrees, severally and not jointly, to indemnify and hold harmless the Company, and its directors, each officer of the Company who signed the Registration Statement and each person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, against any and all loss, liability, claim, damage and expense described in the indemnity contained in Section 5.1.1, as incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions, made in the Registration Statement, any preliminary prospectus, the Statutory Prospectus, any Testing-the-Waters Communication or the Prospectus (or any amendment or supplement to the foregoing), solely in reliance upon and in conformity with the Underwriters’ Information.
5.1.3 Notifications and Other Indemnification Procedures. Any party that proposes to assert the right to be indemnified under this Section 5.1 will, promptly after receipt of notice of commencement of any action against such party in respect of which a claim is to be made against an indemnifying party or parties under this Section 5.1, notify each such indemnifying party of the commencement of such action, enclosing a copy of all papers served, but the omission so to notify such indemnifying party will not relieve the indemnifying party from (i) any liability that it might have to any indemnified party otherwise than under this Section 5.1 and (ii) any liability that it may have to any indemnified party under the foregoing provision of this Section 5.1 unless, and only to the extent that, such omission results in the forfeiture of substantive rights or defenses by the indemnifying party. If any such action is brought against any indemnified party and it notifies the indemnifying party of its commencement, the indemnifying party will be entitled to participate in and, to the extent that it elects by delivering written notice to the indemnified party promptly after receiving notice of the commencement of the action from the indemnified party, jointly with any other indemnifying party similarly notified, to assume the defense of, the action, with counsel reasonably satisfactory to the indemnified party, and after notice from the indemnifying party to the indemnified party of its election to assume the defense, the indemnifying party will not be liable to the indemnified party for any other legal expenses except as provided below and except for the reasonable costs of investigation subsequently incurred by the indemnified party in connection with the defense. The indemnified party will have the right to employ its own counsel in any such action, but the fees, expenses and other charges of such counsel will be at the expense of such indemnified party unless (A) the employment of counsel by the indemnified party has been authorized in writing by the indemnifying party, (B) the indemnified party has reasonably concluded (based on advice of counsel) that there may be legal defenses available to it or other indemnified parties that are different from or in addition to those available to the indemnifying party, (C) a conflict or potential conflict exists (based on advice of counsel to the indemnified party) between the indemnified party and the indemnifying party (in which case the indemnifying party will not have the right to direct the defense of such action on behalf of the indemnified party) or (D) the indemnifying party has not in fact employed counsel to assume the defense of such action or counsel reasonably satisfactory to the indemnified party, in each case, within a reasonable time after receiving notice of the commencement of the action; in each of which cases the reasonable fees, disbursements and other charges of counsel will be at the expense of the indemnifying party or parties. It is understood that the indemnifying party or parties shall not, in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable fees, disbursements and other charges of more than one separate firm admitted to practice in such jurisdiction (plus local counsel) at any one time for all such indemnified party or parties. All such fees, disbursements and other charges will be reimbursed by the indemnifying party promptly as they are incurred. An indemnifying party will not, in any event, be liable for any settlement of any action or claim effected without its written consent. No indemnifying party shall, without the prior written consent of each indemnified party, settle or compromise or consent to the entry of any judgment in any pending or threatened claim, action or proceeding relating to the matters contemplated by this Section 5 (whether or not any indemnified party is a party thereto), unless such settlement, compromise or consent (x) includes an express and unconditional release of each indemnified party, in form and substance reasonably satisfactory to such indemnified party, from all liability arising out of such litigation, investigation, proceeding or claim and (y) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party.
25
5.1.4 Settlement Without Consent if Failure to Reimburse. If an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for reasonable fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement of the nature contemplated by Section 5.1.1(b) effected without its written consent if (i) such settlement is entered into more than 45 days after receipt by such indemnifying party of the aforesaid request, (ii) such indemnifying party shall have received notice of the terms of such settlement at least 30 days prior to such settlement being entered into and (iii) such indemnifying party shall not have reimbursed such indemnified party in accordance with such request prior to the date of such settlement.
5.2 Contribution. In order to provide for just and equitable contribution in circumstances in which the indemnification provided for in the foregoing paragraphs of Section 5.1 is applicable in accordance with its terms but for any reason is held to be unavailable or insufficient from the Company or the Underwriters, the Company and the Underwriters will contribute to the total losses, claims, liabilities, expenses and damages (including any investigative, legal and other expenses reasonably incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding or any claim asserted) to which any indemnified party may be subject in such proportion as shall be appropriate to reflect the relative benefits received by the Company on the one hand and the Underwriters on the other hand. The relative benefits received by the Company on the one hand and the Underwriters on the other hand shall be deemed to be in the same proportion as the total net proceeds from the sale of the Units (before deducting expenses) received by the Company bear to the total compensation received by the Underwriters (before deducting expenses) from the sale of Units on behalf of the Company. If, but only if, the allocation provided by the foregoing sentence is not permitted by applicable law, the allocation of contribution shall be made in such proportion as is appropriate to reflect not only the relative benefits referred to in the foregoing sentence but also the relative fault of the Company, on the one hand, and the Underwriters, on the other hand, with respect to the statements or omission that resulted in such loss, claim, liability, expense or damage, or action in respect thereof, as well as any other relevant equitable considerations with respect to such offering. Such relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or the Underwriters, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and the Underwriters agree that it would not be just and equitable if contributions pursuant to this Section 5.2 were to be determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to herein. The amount paid or payable by an indemnified party as a result of the loss, claim, liability, expense or damage, or action in respect thereof, referred to above in this Section 5.2 shall be deemed to include, for the purpose of this Section 5.2, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim to the extent consistent with Section 5.1.3. Notwithstanding the foregoing provisions of Section 5.1 and this Section 5.2, the Underwriters shall not be required to contribute any amount in excess of the commissions actually received by it under this Agreement and no person found guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this Section 5.2, any person who controls a party to this Agreement within the meaning of the Securities Act, any affiliates of the respective Underwriters and any officers, directors, partners, employees or agents of the Underwriters or their respective affiliates, will have the same rights to contribution as that party, and each director of the Company and each officer of the Company who signed the Registration Statement will have the same rights to contribution as the Company, subject in each case to the provisions hereof. Any party entitled to contribution, promptly after receipt of notice of commencement of any action against such party in respect of which a claim for contribution may be made under this Section 5.2, will notify any such party or parties from whom contribution may be sought, but the omission to so notify will not relieve that party or parties from whom contribution may be sought from any other obligation it or they may have under this Section 5.2 except to the extent that the failure to so notify such other party materially prejudiced the substantive rights or defenses of the party from whom contribution is sought. Except for a settlement entered into pursuant to the last sentence of Section 5.1.3, no party will be liable for contribution with respect to any action or claim settled without its written consent if such consent is required pursuant to Section 5.1.3.
- Default by an Underwriter.
6.1 Default Not Exceeding 10% of Firm Units. If any Underwriter or Underwriters shall default in its or their obligations to purchase the Firm Units and if the number of the Firm Units with respect to which such default relates does not exceed in the aggregate 10% of the number of Firm Units that all Underwriters have agreed to purchase hereunder, then such Firm Units to which the default relates shall be purchased by the non-defaulting Underwriters in proportion to their respective commitments hereunder.
26
6.2 Default Exceeding 10% of Firm Units. In the event that the default addressed in Section 6.1 above relates to more than 10% of the Firm Units, the Representative may, in its discretion, arrange for it or for another party or parties to purchase such Firm Units to which such default relates on the terms contained herein. If within one (1) Business Day after such default relating to more than 10% of the Firm Units the Representative do not arrange for the purchase of such Firm Units, then the Company shall be entitled to a further period of one (1) Business Day within which to procure another party or parties satisfactory to the Representative to purchase said Firm Units on such terms. In the event that neither the Representative nor the Company arrange for the purchase of the Firm Units to which a default relates as provided in this Section 6, this Agreement may be terminated by the Representative or the Company without liability on the part of the Company (except as provided in Sections 3.9, 5, and 9.3 hereof) or the several Underwriters (except as provided in Section 5 hereof); provided that nothing herein shall relieve a defaulting Underwriter of its liability, if any, to the other several Underwriters and to the Company for damages occasioned by its default hereunder.
6.3 Postponement of Closing Date. In the event that the Firm Units to which the default relates are to be purchased by the non-defaulting Underwriters, or are to be purchased by another party or parties as aforesaid, the Representative or the Company shall have the right to postpone the Closing Date for a reasonable period, but not in any event exceeding five (5) Business Days, in order to effect whatever changes may thereby be made necessary in the Registration Statement and/or the Prospectus, as the case may be, or in any other documents and arrangements, and the Company agrees to file promptly any amendment to, or to supplement, the Registration Statement and/or the Prospectus, as the case may be, that in the reasonable opinion of counsel for the Underwriters may thereby be made necessary. The term “Underwriter” as used in this Agreement shall include any party substituted under this Section 6 with like effect as if it had originally been a party to this Agreement with respect to such securities.
- Additional Covenants.
7.1 Additional Shares or Options. The Company hereby agrees that until the consummation of a Business Combination, it shall not issue any Ordinary Shares or any options or other securities convertible into Ordinary Shares, or any preferred shares or other securities of the Company which participate in any manner in the Trust Account or which vote as a class with the Ordinary Shares on a Business Combination.
7.2 Trust Account Waiver Acknowledgments. As of the Effective Date, the Company does not receive waivers from all material vendors and service providers to all claims on amounts in the Trust Account which are to be distributed to the Company’s shareholders in accordance with the terms of the Trust Agreement, except for Maxim and Beyond Century Consulting, LLC. The payment payable by the Company as set forth in the service agreements with vendors and service providers has been or is expected to be paid off by the Company upon or promptly following the closing of the Offering. To the extent (i) that any remaining payment payable in excess of $50,000 in aggregate is in existence 4 business days following the Closing or (ii) that the Company shall incur additional payments under existing service agreements following the Closing, the Company will use best efforts to obtain trust waiver from current vendors and service providers. The Company hereby agrees that it will use its reasonable best efforts prior to commencing its due diligence investigation of any prospective Target Business or obtaining the services of any vendor to have such Target Business and/or vendor acknowledge in writing whether through a letter of intent, memorandum of understanding or other similar document (and subsequently acknowledges the same in any definitive document replacing any of the foregoing), that (a) it has read the Prospectus and understands that the Company has established the Trust Account, initially in an amount of $50,000,000 (without giving effect to any exercise of the Over-allotment Option) for the benefit of the Public Shareholders and that, except for a portion of the interest earned on the amounts held in the Trust Account, the Company may disburse monies from the Trust Account only (i) to the Public Shareholders in the event they elect to redeem Ordinary Shares contained in the Public Securities in connection with the consummation of a Business Combination, (ii) to the Public Shareholders if the Company fails to consummate a Business Combination within the time period set forth in the Charter Document, (iii) to the Public Shareholders in connection with a shareholder vote to amend the Charter Document to modify the substance or timing of the Company’s obligation to redeem 100% of the Ordinary Shares included in the Public Securities if the Company has not consummated a Business Combination within the period of time provided in the Charter Document or with respect to any other material provisions relating to shareholders’ rights or pre- Business Combination activity; or (iv) to the Company after or concurrently with the consummation of a Business Combination and (b) for and in consideration of the Company (i) agreeing to evaluate such Target Business for purposes of consummating a Business Combination with it or (ii) agreeing to engage the services of the vendor, as the case may be, such Target Business or vendor agrees that it does not have any right, title, interest or claim of any kind in or to any monies in the Trust Account (“Claim”) and waives any Claim it may have in the future as a result of, or arising out of, any negotiations, contracts or agreements with the Company and will not seek recourse against the Trust Account for any reason whatsoever. The foregoing letters shall substantially be in the form attached hereto as Exhibits A and B, respectively. The Company may forego obtaining such waivers only if the Company shall have received the approval of its Chief Executive Officer and the approving vote of at least a majority of its Board of Directors.
27
7.3 Insider Letter. The Company shall not take any action or omit to take any action which would cause a breach of the Insider Letter and will not allow any amendments to, or waivers of, such Insider Letter without the prior written consent of the Representative, which consent shall not be unreasonably withheld.
7.4 Rule 419. The Company agrees that it will use its best efforts to prevent the Company from becoming subject to Rule 419 under the Act prior to the consummation of any Business Combination, including but not limited to using its best efforts to prevent any of the Company’s outstanding securities from being deemed to be a “penny stock” as defined in Rule 3a-51-1 under the Exchange Act during such period.
7.5 Tender Offer Documents, Proxy Materials and Other Information. The Company shall provide to the Representative or their counsel (if so instructed by the Representative) with 10 copies of all tender offer documents or proxy information and all related material filed with the Commission in connection with a Business Combination concurrently with such filing with the Commission. Documents filed with the Commission pursuant to its EDGAR system shall be deemed to have been provided to the Representative pursuant to this Section. In addition, the Company shall furnish any other state in which its initial public offering was registered, such information as may be requested by such state.
7.6 Emerging Growth Company. The Company shall promptly notify the Representative if the Company ceases to be an Emerging Growth Company at any time prior to the completion of the distribution of the Public Securities within the meaning of the Act.
7.7 Target Fair Market Value. The Company agrees that the Target Business that it acquires must have a fair market value equal to at least 80% of the balance in the Trust Account at the time of signing the definitive agreement for the Business Combination with such Target Business (excluding taxes payable). The fair market value of such business must be determined by the Board of Directors of the Company based upon standards generally accepted by the financial community, such as actual and potential sales, earnings, cash flow and book value. If the Board of Directors of the Company is not able to independently determine that the target business meets such fair market value requirement, the Company will obtain an opinion from an independent investment banking firm or another independent entity that commonly renders valuation opinions with respect to the satisfaction of such criteria. The Company is not required to obtain an opinion as to the fair market value if the Company’s Board of Directors independently determines that the Target Business does have sufficient fair market value.
Representations and Agreements to Survive Delivery. Except as the context otherwise requires, all representations, warranties and agreements contained in this Agreement shall be deemed to be representations, warranties and agreements as of the Closing Date or the Option Closing Date, if any, and such representations, warranties and agreements of the Underwriters and the Company, including the indemnity agreements contained in Section 5 hereof, shall remain operative and in full force and effect regardless of any investigation made by or on behalf of the Underwriters, the Company or any Controlling Person, and shall survive termination of this Agreement or the issuance and delivery of the Public Securities to the Underwriters until the earlier of the expiration of any applicable statute of limitations and the seventh (7th) anniversary of the later of the Closing Date or the Option Closing Date, if any, at which time the representations, warranties and agreements shall terminate and be of no further force and effect.
28
Effective Date of This Agreement and Termination Thereof.
9.1 Effective Date. This Agreement shall become effective on the Effective Date at the time the Registration Statement is declared effective by the Commission.
9.2 Termination. The Representative shall have the right to terminate this Agreement at any time prior to the Closing Date, (i) if any domestic or international event or act or occurrence has materially disrupted, or in the Representative’s opinion will in the immediate future materially disrupt, general securities markets in the United States, or (ii) if trading on the New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq Global Market, or the Nasdaq Capital Market shall have been suspended, or minimum or maximum prices for trading shall have been fixed, or maximum ranges for prices for securities shall have been fixed, or maximum ranges for prices for securities shall have been required by FINRA or by order of the Commission or any other government authority having jurisdiction, or (iii) if the United States shall have become involved in a new war or an increase in existing major hostilities, or (iv) if a banking moratorium has been declared by a New York State or Federal authority, or (v) if a moratorium on foreign exchange trading has been declared which materially adversely impacts the United States securities market, or (vi) if the Company shall have sustained a material loss by fire, flood, accident, hurricane, earthquake, theft, sabotage or other calamity or malicious act which, whether or not such loss shall have been insured, will, in the Representative’s sole opinion, make it inadvisable to proceed with the delivery of the Units, or (vii) if the Company is in material breach of any of its representations, warranties or covenants hereunder, or (viii) if the Representative shall have become aware after the date hereof of such a material adverse change in the conditions of the Company, or such adverse material change in general market conditions, including without limitation as a result of terrorist activities after the date hereof, as in the Representative’s sole judgment would make it impracticable to proceed with the offering, sale and/or delivery of the Units or to enforce contracts made by the Underwriters for the sale of the Public Securities.
9.3 Expenses. In the event that this Agreement shall not be carried out for any reason whatsoever, except as a result of the any Underwriters’ breach or default with respect to any of its material obligations pursuant to this Agreement or with respect to a termination pursuant to Section 9.2(i) to (vi) hereof, within the time specified herein or any extensions thereof pursuant to the terms herein, (i) the obligations of the Company to pay the out of pocket expenses related to the transactions contemplated herein shall be governed by Section 3.9 hereof, and (ii) the Company shall reimburse the Representative for any costs and expenses incurred in connection with enforcing any provisions of this Agreement.
9.4 Indemnification. Notwithstanding any contrary provision contained in this Agreement, any election hereunder or any termination of this Agreement, and whether or not this Agreement is otherwise carried out, the provisions of Section 5 shall not be in any way affected by such election or termination or failure to carry out the terms of this Agreement or any part hereof.
- Miscellaneous.
10.1 Notices. All communications hereunder, except as herein otherwise specifically provided, shall be in writing and shall be mailed, delivered by hand or reputable overnight courier or delivered by facsimile transmission (with printed confirmation of receipt) and confirmed and shall be deemed given when so mailed, delivered or faxed or if mailed, two days after such mailing.
If to the Representative:
Maxim Group LLC
300 Park Avenue, 16th Floor
New York, NY 10022
Attn: James Siegel, General Counsel
Facsimile: (212) 895-3860
Email: jsiegel@maximgrp.com
29
Copy (which copy shall not constitute notice) to:
Ellenoff Grossman & Schole LLP
1345 Avenue of the Americas
New York, NY 10105
Attn: Barry Grossman, Esq.
Facsimile: (212) 370-1300
Email: bigrossman@egsllp.com
If to the Company:
Eureka Acquisition Corp
3011 Olympic View Dr
Chino Hills, California
United States 91709
Attn: Eric Zhang
Email: eric.zhang@hercules.global
Copy (which copy shall not constitute notice) to:
Robinson & Cole LLP
Chrysler East Building
666 Third Avenue, 20th Floor
New York, NY 10017
Attn: Arila Zhou, Esq.
Tel: (212) 451-2908
Email: azhou@rc.com
10.2 Headings. The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or affect the meaning or interpretation of any of the terms or provisions of this Agreement.
10.3 Amendment. This Agreement may only be amended by a written instrument executed by each of the parties hereto.
10.4 Entire Agreement. This Agreement (together with the other agreements and documents being delivered pursuant to or in connection with this Agreement) constitute the entire agreement of the parties hereto with respect to the subject matter hereof and thereof, and supersede all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof.
10.5 Binding Effect. This Agreement shall inure solely to the benefit of and shall be binding upon the Representative, the Underwriters, the Selected Dealers, the Company and the Controlling Persons, directors, agents, partners, members, employees and officers referred to in Section 5 hereof, and their respective successors, legal representatives and assigns, and no other person shall have or be construed to have any legal or equitable right, remedy or claim under or in respect of or by virtue of this Agreement or any provisions herein contained. The term “successors and assigns” shall not include a purchaser, in its capacity as such, of securities from the Underwriters.
10.6 Waiver of Immunity. To the extent that the Company may be entitled in any jurisdiction in which judicial proceedings may at any time be commenced hereunder, to claim for itself or its revenues or assets any immunity, including sovereign immunity, from suit, jurisdiction, attachment in aid of execution of a judgment or prior to a judgment, execution of a judgment or any other legal process with respect to its obligations hereunder and to the extent that in any such jurisdiction there may be attributed to the Company such an immunity (whether or not claimed), the Company hereby irrevocably agrees not to claim and irrevocably waives such immunity to the maximum extent permitted by law.
30
10.7 Submission to Jurisdiction. Each of the Company and the Representative irrevocably submit to the nonexclusive jurisdiction of any New York State or United States Federal court sitting in The City of New York, Borough of Manhattan, over any suit, action or proceeding arising out of or relating to this Agreement, the Registration Statement, the Statutory Prospectus and the Prospectus or the offering of the Securities. Each of the Company and the Representative irrevocably waives, to the fullest extent permitted by law, any objection that they may now or hereafter have to the laying of venue of any such suit, action or proceeding brought in such a court and any claim that any such suit, action or proceeding brought in such a court has been brought in an inconvenient forum. Any such process or summons to be served upon the Company or the Representative may be served by transmitting a copy thereof by registered or certified mail, return receipt requested, postage prepaid, addressed to it at the address set forth in Section 10.1 hereof. Such mailing shall be deemed personal service and shall be legal and binding upon the Company or the Representative in any action, proceeding or claim. Each of the Company and the Representative waives, to the fullest extent permitted by law, any other requirements of or objections to personal jurisdiction with respect thereto. Notwithstanding the foregoing, any action based on this Agreement may be instituted by the Underwriters in any competent court. The Company agrees that prevailing party(ies) in any such action shall be entitled to recover all of their reasonable attorneys’ fees and expenses relating to such action or proceeding and/or incurred in connection with the preparation therefor if any of them are the prevailing party in such action or proceeding.
10.8 Governing Law. This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction.
10.9 Execution in Counterparts. This Agreement may be executed in one or more counterparts, and by the different parties hereto in separate counterparts, each of which shall be deemed to be an original, but all of which taken together shall constitute one and the same agreement, and shall become effective when one or more counterparts has been signed by each of the parties hereto and delivered to each of the other parties hereto. Delivery of a signed counterpart of this Agreement by facsimile or email/pdf transmission shall constitute valid and sufficient delivery thereof.
10.10 Waiver. The failure of any of the parties hereto to at any time enforce any of the provisions of this Agreement shall not be deemed or construed to be a waiver of any such provision, nor to in any way affect the validity of this Agreement or any provision hereof or the right of any of the parties hereto to thereafter enforce each and every provision of this Agreement. No waiver of any breach, non-compliance or non-fulfillment of any of the provisions of this Agreement shall be effective unless set forth in a written instrument executed by the party or parties against whom or which enforcement of such waiver is sought; and no waiver of any such breach, non-compliance or non-fulfillment shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance or non-fulfillment.
10.11 No Fiduciary Relationship. The Company acknowledges and agrees that (i) the purchase and sale of the Units pursuant to this Agreement is an arm’s-length commercial transaction pursuant to a contractual relationship between the Company and the Underwriters, (ii) in connection therewith and with the process leading to such transaction, each Underwriter is acting solely as a principal and not the agent or fiduciary of the Company, (iii) the Underwriters have not assumed an advisory or fiduciary responsibility in favor of the Company with respect to the offering contemplated hereby or the process leading thereto (irrespective of whether the Underwriters have advised or are currently advising the Company on other matters) or any other obligation to the Company except the obligations expressly set forth in this Agreement, (iv) in no event do the parties intend that the Underwriters act or be responsible as a fiduciary to the Company, its management, stockholders, creditors or any other person in connection with any activity that the Underwriters may undertake or have undertaken in furtherance of this offering of the Company’s securities, either before or after the date hereof and (v) the Company has consulted its own legal and financial advisors to the extent it deemed appropriate. The Underwriters hereby expressly disclaim any fiduciary or similar obligations to the Company, either in connection with the transactions contemplated by this Agreement or any matters leading up to such transactions, and the Company hereby confirms its understanding and agreement to that effect. The Company agrees that it will not claim that the Underwriters have rendered advisory services of any nature or respect, or owe a fiduciary or similar duty to the Company, in connection with such transaction or the process leading thereto. The Company and the Underwriters agree that they are each responsible for making their own independent judgment with respect to any such transactions, and that any opinions or views expressed by the Underwriters to the Company regarding such transactions, including but not limited to any opinions or views with respect to the price or market for the Company’s securities, do not constitute advice or recommendations to the Company. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against the Underwriters with respect to any breach or alleged breach of any fiduciary or similar duty to the Company in connection with the transactions contemplated by this Agreement or any matters leading up to such transactions.
[Remainder of page intentionally left blank]
31
If the foregoing correctly sets forth the understanding between the Underwriters and the Company, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between us.
| Very truly yours, |
|---|
| EKA ACQUISITION CORP |
| By: |
| Name: |
| Title: |
All values are in Euros.
Accepted on the date first above written.
MAXIM GROUP LLC
as Representative of the Underwriters
| By: | /s/ Clifford A. Teller |
|---|---|
| Name: | Clifford A. Teller |
| Title: | Co-President |
[Signature page to Underwriting Agreement]
32
EXHIBIT A
FORM OF TARGET BUSINESS LETTER
EUREKA ACQUISITION CORP
Ladies and Gentlemen:
Reference is made to the Final Prospectus of EUREKA ACQUISITION CORP (the “Company”), dated as of _________, 2024 (the “Prospectus”). Capitalized terms used and not otherwise defined herein shall have the meanings assigned to them in Prospectus.
We have read the Prospectus and understand that the Company has established the Trust Account, initially in an amount of at least $50,000,000 for the benefit of the Public Shareholders and that, except for a portion of the interest earned on the amounts held in the Trust Account, the Company may disburse monies from the Trust Account only: (i) to the Public Shareholders in the event they elect to redeem their public shares in connection with the consummation of a Business Combination, (ii) to the Public Shareholders if the Company fails to consummate a Business Combination within the required time period set forth in its Memorandum and Articles of Association as the same may be amended from time to time, (iii) to the Public Shareholders in connection with a shareholder vote to amend the Charter Document to modify the substance or timing of the Company’s obligation to redeem 100% of the Ordinary Shares included in the Public Securities if the Company has not consummated a Business Combination within the period of time provided in the Charter Document or with respect to any other material provisions relating to shareholders’ rights or pre- Business Combination activity; or (iv) to the Company after or concurrently with the consummation of a Business Combination.
For and in consideration of the Company agreeing to evaluate the undersigned for purposes of consummating a Business Combination with it, the undersigned hereby agrees that it does not have any right, title, interest or claim of any kind in or to any monies in the Trust Account (each, a “Claim”) and hereby waives any Claim it may have in the future as a result of, or arising out of, any negotiations, contracts or agreements with the Company and will not seek recourse against the Trust Account for any reason whatsoever.
| Print Name of Target Business |
|---|
| Authorized Signature of Target Business |
33
EXHIBIT B
FORM OF VENDOR LETTER
EUREKA ACQUISITION CORP
Ladies and Gentlemen:
Reference is made to the Final Prospectus of EUREKA ACQUISITION CORP (the “Company”), dated as of ______________, 2024 (the “Prospectus”). Capitalized terms used and not otherwise defined herein shall have the meanings assigned to them in Prospectus.
We have read the Prospectus and understand that the Company has established the Trust Account, initially in an amount of at least $50,000,000 for the benefit of the Public Shareholders and that, except for a portion of the interest earned on the amounts held in the Trust Account, the Company may disburse monies from the Trust Account only: (i) to the Public Shareholders in the event they elect to redeem their public shares in connection with the consummation of a Business Combination, (ii) to the Public Shareholders if the Company fails to consummate a Business Combination within the required time period set forth in its Memorandum and Articles of Association as the same may be amended from time to time, (iii) to the Public Shareholders in connection with a shareholder vote to amend the Charter Document to modify the substance or timing of the Company’s obligation to redeem 100% of the Ordinary Shares included in the Public Securities if the Company has not consummated a Business Combination within the period of time provided in the Charter Document or with respect to any other material provisions relating to shareholders’ rights or pre- Business Combination activity; or (iv) to the Company after or concurrently with the consummation of a Business Combination.
For and in consideration of the Company agreeing to engage the services of the undersigned, the undersigned hereby agrees that it does not have any right, title, interest or claim of any kind in or to any monies in the Trust Account (each, a “Claim”) and hereby waives any Claim it may have in the future as a result of, or arising out of, any services provided to the Company and will not seek recourse against the Trust Account for any reason whatsoever.
| Print Name of Vendor |
|---|
| Authorized Signature of Vendor |
34
Exhibit 3.1
COMPANIES ACT (REVISED)
COMPANY LIMITED BY SHARES
SECOND AMENDED AND RESTATED
MEMORANDUM OF ASSOCIATION
OF
EUREKA ACQUISITION CORP
ADOPTED BY SPECIAL RESOLUTION PASSED ON JUNE 27, 2024
| www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
|---|
Companies Act (Revised)
Company Limited by Shares
Second Amended and Restated
Memorandum of Association
of
Eureka Acquisition Corp
Adopted by special resolution passed on June 27, 2024
| 1 | The name of the Company is Eureka Acquisition Corp. |
|---|---|
| 2 | The Company’s registered office will be situated at the office of Ogier Global (Cayman) Limited,<br>89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands, or at such other place in the Cayman Islands as the directors may at<br>any time decide. |
| --- | --- |
| 3 | The Company’s objects are unrestricted. As provided by section 7(4) of the Companies Act (Revised),<br>the Company has full power and authority to carry out any object not prohibited by any law of the Cayman Islands. |
| --- | --- |
| 4 | The Company has unrestricted corporate capacity. Without limitation to the foregoing, as provided by section 27<br>(2) of the Companies Act (Revised), the Company has and is capable of exercising all the functions of a natural person of full capacity<br>irrespective of any question of corporate benefit. |
| --- | --- |
| 5 | Nothing in any of the preceding paragraphs permits the Company to carry on any of the following businesses<br>without being duly licensed, namely: |
| --- | --- |
| (a) | the business of a bank or trust company without being licensed in that behalf under the Banks and Trust<br>Companies Act (Revised); or |
| --- | --- |
| (b) | insurance business from within the Cayman Islands or the business of an insurance manager, agent, sub-agent<br>or broker without being licensed in that behalf under the Insurance Act (Revised);or |
| --- | --- |
| (c) | the business of company management without being licensed in that behalf under the Companies Management<br>Act (Revised). |
| --- | --- |
| 6 | Unless licensed to do so, the Company will not trade in the Cayman Islands with any person, firm or corporation<br>except in furtherance of its business carried on outside the Cayman Islands. Despite this, the Company may effect and conclude contracts<br>in the Cayman Islands and exercise in the Cayman Islands any of its powers necessary for the carrying on of its business outside the Cayman<br>Islands. |
| --- | --- |
| www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| 7 | The Company is a company limited by shares and accordingly the liability of each member is limited to<br>the amount (if any) unpaid on that member’s shares. |
| --- | --- |
| 8 | The share capital of the Company is US$50,000 divided into 390,000,000 Class A Shares of a par value of<br>US$0.0001 each, 100,000,000 Class B Shares of par value US$0.0001 each and 10,000,000 Preference Shares of par value US$0.0001 each.<br>However, subject to the Companies Act (Revised) and the Company’s articles of association, the Company has power to do any one or<br>more of the following: |
| --- | --- |
| (a) | to redeem or repurchase any of its shares; and |
| --- | --- |
| (b) | to increase or reduce its capital; and |
| --- | --- |
| (c) | to issue any part of its capital (whether original, redeemed, increased or reduced): |
| --- | --- |
| (i) | (with or without any preferential, deferred, qualified or special rights, privileges or conditions; or |
| --- | --- |
| (ii) | subject to any limitations or restrictions |
| --- | --- |
and unless the condition of issue expressly declares otherwise, every issue of shares (whether declared to be ordinary, preference or otherwise) is subject to this power; or
| (d) | to alter any of those rights, privileges, conditions, limitations or restrictions. |
|---|---|
| 9 | The Company has power to register by way of continuation as a body corporate limited by shares under the<br>laws of any jurisdiction outside the Cayman Islands and to be deregistered in the Cayman Islands. |
| --- | --- |
| www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
COMPANIES ACT (REVISED)
COMPANY LIMITED BY SHARES
SECOND AMENDED AND RESTATED
ARTICLES OF ASSOCIATION
OF
EUREKA ACQUISITION CORP
ADOPTED BY SPECIAL RESOLUTION PASSED ON JUNE 27, 2024
| www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 | |
|---|---|---|
| 1. | Definitions, interpretation and exclusion of Table A | 1 |
| --- | --- | --- |
| Definitions | 1 | |
| Interpretation | 5 | |
| Exclusion of Table A Articles | 6 | |
| 2. | Commencement of Business | 6 |
| 3. | Shares | 6 |
| Power to issue Shares and options, with or without special rights | 6 | |
| Power to issue fractions of a Share | 7 | |
| Power to pay commissions and brokerage fees | 7 | |
| Trusts not recognised | 8 | |
| Power to vary class rights | 8 | |
| Effect of new Share issue on existing class rights | 8 | |
| Capital contributions without issue of further Shares | 8 | |
| No bearer Shares or warrants | 9 | |
| Treasury Shares | 9 | |
| Rights attaching to Treasury Shares and related matters | 9 | |
| Designation of Preference Shares Rights | 9 | |
| 4. | Register of Members | 10 |
| 5. | Share certificates | 11 |
| Issue of share certificates | 11 | |
| Renewal of lost or damaged share certificates | 11 | |
| 6. | Lien on Shares | 11 |
| Nature and scope of lien | 11 | |
| Company may sell Shares to satisfy lien | 12 | |
| Authority to execute instrument of transfer | 12 | |
| Consequences of sale of Shares to satisfy lien | 12 | |
| Application of proceeds of sale | 13 | |
| 7. | Calls on Shares and forfeiture | 13 |
| Power to make calls and effect of calls | 13 | |
| Time when call made | 13 | |
| Liability of joint holders | 13 | |
| Interest on unpaid calls | 13 | |
| Deemed calls | 14 | |
| Power to accept early payment | 14 | |
| Power to make different arrangements at time of issue of Shares | 14 | |
| Notice of default | 14 | |
| Forfeiture or surrender of Shares | 14 | |
| Disposal of forfeited or surrendered Share and power to cancel forfeiture or surrender | 15 | |
| Effect of forfeiture or surrender on former Member | 15 | |
| Evidence of forfeiture or surrender | 15 | |
| Sale of forfeited or surrendered Shares | 15 | |
| i<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 | |
| --- | --- | |
| 8. | Transfer of Shares | 16 |
| --- | --- | --- |
| Form of transfer | 16 | |
| Power to refuse registration | 16 | |
| Power to suspend registration | 16 | |
| Company may retain instrument of transfer | 16 | |
| 9. | Transmission of Shares | 16 |
| Persons entitled on death of a Member | 16 | |
| Registration of transfer of a Share following death or bankruptcy | 17 | |
| Indemnity | 17 | |
| Rights of person entitled to a Share following death or bankruptcy | 17 | |
| 10. | Alteration of capital | 18 |
| Increasing, consolidating, converting, dividing and cancelling share capital | 18 | |
| Dealing with fractions resulting from consolidation of Shares | 18 | |
| Reducing share capital | 18 | |
| 11. | Redemption and purchase of own Shares | 19 |
| Power to issue redeemable Shares and to purchase own Shares | 19 | |
| Power to pay for redemption or purchase in cash or in specie | 19 | |
| Effect of redemption or purchase of a Share | 19 | |
| 12. | Class B Share Conversion | 20 |
| 13. | Meetings of Members | 21 |
| Power to call meetings | 21 | |
| Content of notice | 22 | |
| Period of notice | 23 | |
| Persons entitled to receive notice | 23 | |
| Publication of notice on a website | 23 | |
| Time a website notice is deemed to be given | 23 | |
| Required duration of publication on a website | 23 | |
| Accidental omission to give notice or non-receipt of notice | 24 | |
| 14. | Proceedings at meetings of Members | 24 |
| Quorum | 24 | |
| Lack of quorum | 24 | |
| Use of technology | 24 | |
| Chairman | 25 | |
| Right of a director to attend and speak | 25 | |
| Adjournment and Postponement | 26 | |
| Method of voting | 26 | |
| Taking of a poll | 26 | |
| Chairman’s casting vote | 26 | |
| Amendments to resolutions | 26 | |
| Written resolutions | 27 | |
| Sole-member company | 28 | |
| ii<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 | |
| --- | --- | |
| 15. | Voting rights of Members | 28 |
| --- | --- | --- |
| Right to vote | 28 | |
| Rights of joint holders | 28 | |
| Representation of corporate Members | 28 | |
| Member with mental disorder | 29 | |
| Objections to admissibility of votes | 29 | |
| Form of proxy | 29 | |
| How and when proxy is to be delivered | 30 | |
| Voting by proxy | 31 | |
| 16. | Number of directors | 31 |
| 17. | Appointment, disqualification and removal of directors | 31 |
| No age limit | 31 | |
| Corporate directors | 31 | |
| No shareholding qualification | 31 | |
| Appointment and removal of directors | 32 | |
| Resignation of directors | 33 | |
| Termination of the office of director | 33 | |
| 18. | Alternate directors | 33 |
| Appointment and removal | 33 | |
| Notices | 34 | |
| Rights of alternate director | 34 | |
| Appointment ceases when the appointor ceases to be a director | 35 | |
| Status of alternate director | 35 | |
| Status of the director making the appointment | 35 | |
| 19. | Powers of directors | 35 |
| Powers of directors | 35 | |
| Appointments to office | 35 | |
| Remuneration | 36 | |
| Disclosure of information | 37 | |
| 20. | Delegation of powers | 37 |
| Power to delegate any of the directors’ powers to a committee | 37 | |
| Power to appoint an agent of the Company | 38 | |
| Power to appoint an attorney or authorised signatory of the Company | 38 | |
| Power to appoint a proxy | 38 | |
| 21. | Meetings of directors | 38 |
| Regulation of directors’ meetings | 38 | |
| Calling meetings | 39 | |
| Notice of meetings | 39 | |
| Use of technology | 39 | |
| Place of meetings | 39 | |
| Quorum | 39 | |
| Voting | 39 | |
| iii<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 | |
| --- | --- | |
| Validity | 39 | |
| --- | --- | --- |
| Recording of dissent | 40 | |
| Written resolutions | 40 | |
| Sole director’s minute | 40 | |
| 22. | Permissible directors’ interests and disclosure | 40 |
| Permissible interests subject to disclosure | 40 | |
| Notification of interests | 41 | |
| Voting where a director is interested in a matter | 41 | |
| 23. | Minutes | 41 |
| 24. | Accounts and audit | 41 |
| Accounting and other records | 41 | |
| No automatic right of inspection | 41 | |
| Sending of accounts and reports | 42 | |
| Validity despite accidental error in publication on website | 42 | |
| Audit | 42 | |
| 25. | Financial year | 43 |
| 26. | Record dates | 44 |
| 27. | Dividends | 44 |
| Declaration of dividends by Members | 44 | |
| Payment of interim dividends and declaration of final dividends by directors | 44 | |
| Apportionment of dividends | 45 | |
| Right of set off | 45 | |
| Power to pay other than in cash | 45 | |
| How payments may be made | 45 | |
| Dividends or other moneys not to bear interest in absence of special rights | 46 | |
| Dividends unable to be paid or unclaimed | 46 | |
| 28. | Capitalisation of profits | 46 |
| Capitalisation of profits or of any share premium account or capital redemption reserve | 46 | |
| Applying an amount for the benefit of members | 47 | |
| 29. | Share premium account | 47 |
| Directors to maintain share premium account | 47 | |
| Debits to share premium account | 47 | |
| 30. | Seal | 47 |
| Company seal | 47 | |
| Duplicate seal | 48 | |
| When and how seal is to be used | 48 | |
| If no seal is adopted or used | 48 | |
| Power to allow non-manual signatures and facsimile printing of seal | 48 | |
| Validity of execution | 48 | |
| iv<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 | |
| --- | --- | |
| 31. | Indemnity | 48 |
| --- | --- | --- |
| Indemnity | 48 | |
| Release | 49 | |
| Insurance | 49 | |
| 32. | Notices | 50 |
| Form of notices | 50 | |
| Electronic communications | 50 | |
| Persons authorised to give notices | 50 | |
| Delivery of written notices | 50 | |
| Joint holders | 51 | |
| Signatures | 51 | |
| Evidence of transmission | 51 | |
| Giving notice to a deceased or bankrupt Member | 51 | |
| Date of giving notices | 51 | |
| Saving provision | 52 | |
| 33. | Authentication of Electronic Records | 52 |
| Application of Articles | 52 | |
| Authentication of documents sent by Members by Electronic means | 52 | |
| Authentication of document sent by the Secretary or Officers of the Company by Electronic means | 52 | |
| Manner of signing | 53 | |
| Saving provision | 53 | |
| 34. | Transfer by way of continuation | 53 |
| 35. | Winding up | 54 |
| Distribution of assets in specie | 54 | |
| No obligation to accept liability | 54 | |
| 36. | Amendment of Memorandum and Articles | 54 |
| Power to change name or amend Memorandum | 54 | |
| Power to amend these Articles | 54 | |
| 37. | Mergers and Consolidations | 54 |
| 38. | Business Combination | 55 |
| 39. | Certain Tax Filings | 58 |
| 40. | Business Opportunities | 59 |
| v<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 | |
| --- | --- |
Companies Act (Revised)
Company Limited by Shares
Second Amended and Restated
Articles of Association
of
Eureka Acquisition Corp
Adopted by special resolution passed on June 27, 2024
| 1. | Definitions, interpretation and exclusion of Table A |
|---|
Definitions
| 1.1 | In these Articles, the following definitions apply: |
|---|
Amendment Redemption has the meaning ascribed to it in Article 38.9.
Act means the Companies Act (Revised) of the Cayman Islands.
Affiliate in respect of a person, means any other person that, directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, such person, and (a) in the case of a natural person, shall include, without limitation, such person’s spouse, parents, children, siblings, mother-in-law and father-in-law and brothers and sisters-in-law, whether by blood, marriage or adoption or anyone residing in such person’s home, a trust for the benefit of any of the foregoing, a company, partnership or any natural person or entity wholly or jointly owned by any of the foregoing and (b) in the case of an entity, shall include a partnership, a corporation or any natural person or entity which directly, or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with, such entity.
Applicable Law means, with respect to any person, all provisions of laws, statutes, ordinances, rules, regulations, permits, certificates, judgments, decisions, decrees or orders of any governmental authority applicable to such person.
Articles means, as appropriate:
| (a) | these Second Amended and Restated Articles of Association as amended, restated, supplemented and/or otherwise<br>modified from time to time: or |
|---|---|
| (b) | two or more particular Articles of these Articles; |
| --- | --- |
and Article refers to a particular Article of these Articles.
Audit Committee means the audit committee of the board of directors of the Company established pursuant to Article 24.8 hereof, or any successor audit committee.
| 1<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
|---|
Auditor means the person for the time being performing the duties of auditor of the Company.
Business Combination means a merger, share exchange, asset acquisition, share purchase, reorganisation or similar business combination involving the Company, with one or more businesses or entities (each a target business), which Business Combination: (a) must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the trust account (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any taxes payable on the interest earned on the trust account); and (b) must not be effectuated solely with another blank cheque company or a similar company with nominal operations.
Business Day means a day other than a day on which banking institutions or trust companies are authorised or obligated by law to close in New York City, a Saturday or a Sunday.
Cayman Islands means the British Overseas Territory of the Cayman Islands.
Class A Share means a Class A ordinary share of a par value of US$0.0001 in the share capital of the Company.
Class B Share means a Class B ordinary share of a par value of US$0.0001 in the share capital of the Company.
Clear Days, in relation to a period of notice, means that period excluding:
| (a) | the day when the notice is given or deemed to be given; and |
|---|---|
| (b) | the day for which it is given or on which it is to take effect. |
| --- | --- |
Clearing House means a clearing house recognised by the laws of the jurisdiction in which the Shares (or depositary receipts therefor) are listed or quoted on a stock exchange or interdealer quotation system in such jurisdiction.
Company means the above-named company.
Compensation Committee means the compensation committee of the board of directors of the Company established pursuant to the Articles, or any successor committee.
Default Rate means [10% (ten per cent)] per annum.
Designated Stock Exchange means any United States national securities exchange, including the Nasdaq Stock Market LLC, the NYSE American LLC or The New York Stock Exchange LLC or any OTC market on which the Shares are listed for trading.
Electronic has the meaning given to that term in the Electronic Transactions Act (Revised).
Electronic Communication Facilities means video, video-conferencing, internet or online conferencing applications, telephone or tele-conferencing and/or any other video-communications, internet or online conferencing application or telecommunications facilities by means of which all persons participating in a meeting are capable of hearing and being heard by each other;
| 2<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
|---|
Electronic Record has the meaning given to that term in the Electronic Transactions Act (Revised).
Electronic Signature has the meaning given to that term in the Electronic Transactions Act (Revised).
Equity-linked Securities means any debt or equity securities that are convertible, exercisable or exchangeable for Ordinary Shares issued in a financing transaction in connection with a Business Combination, including but not limited to a private placement of equity or debt.
Exchange Act means the United States Securities Exchange Act of 1934, as amended.
Founders means all Members immediately prior to the consummation of the IPO.
Fully Paid and Paid Up:
| (a) | in relation to a Share with par value, means that the par value for that Share and any premium payable<br>in respect of the issue of that Share, has been fully paid or credited as paid in money or money’s worth; |
|---|---|
| (b) | in relation to a Share without par value, means that the agreed issue price for that Share has been fully<br>paid or credited as paid in money or money’s worth. |
| --- | --- |
Independent Director means a director who is an independent director as defined in the rules and regulations of the Designated Stock Exchange as determined by the directors.
Investor Group means the Sponsor and its Affiliates, successors and assigns.
IPO means the Company’s initial public offering of securities.
IPO Redemption has the meaning given to it in Article 38.6.
Member means any person or persons entered on the Register of Members from time to time as the holder of a Share.
Memorandum means the Amended and Restated Memorandum of Association of the Company as amended, restated, supplemented and/or otherwise modified from time to time.
Nominating Committee means the nominating committee of the board of directors of the Company established pursuant to the Articles, or any successor committee.
Officer means a person then appointed to hold an office in the Company; and the expression includes a director, alternate director or liquidator.
Ordinary Resolution means a resolution of a duly constituted general meeting of the Company passed by a simple majority of the votes cast by, or on behalf of, the Members entitled to vote thereon. The expression also includes a unanimous written resolution.
Ordinary Share means an ordinary share, including Class A Share and Class B Share, of a par value of US$0.0001 in the share capital of the Company.
| 3<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
|---|
Over-Allotment Option means the option of the Underwriters to purchase up to an additional 15% of the firm units (as described at Article 3.4) issued in the IPO at a price equal to US$10.00 per unit, less underwriting discount and commissions.
Preference Share means a preference share of a par value of US$0.0001 in the share capital of the Company.
Public Share means a Class A Share issued as part of the units (as described in Article 3.4) issued in the IPO.
Redemption Price has the meaning given to it in Article 38.6.
Register of Members means the register of Members maintained in accordance with the Act and includes (except where otherwise stated) any branch or duplicate register of Members.
Representative means a representative of the Underwriters.
SEC means the United States Securities and Exchange Commission.
Secretary means a person appointed to perform the duties of the secretary of the Company, including a joint, assistant or deputy secretary.
Share means an Ordinary Share or a Preference Share in the share capital of the Company; and the expression:
| (a) | includes stock (except where a distinction between shares and stock is expressed or implied); and |
|---|---|
| (b) | where the context permits, also includes a fraction of a share. |
| --- | --- |
Special Resolution has the meaning given to that term in the Act; and the expression includes a unanimous written resolution.
Sponsor means Hercules Capital Management Corp, a British Virgin Islands company.
Tax Filing Authorised Person means such person as any director shall designate from time to time, acting severally.
Tender Offer has the meaning ascribed to it in Article 38.2.
Treasury Shares means Shares of the Company held in treasury pursuant to the Act and Article 3.14.
Trust Account means the trust account established by the Company upon the consummation of its IPO and into which a certain amount of the net proceeds of the IPO, together with a certain amount of the proceeds of a private placement of like units comprising like securities to those included in the IPO by the Company simultaneously with the closing date of the IPO, will be deposited; interest on the balance of which may be released to the Company from to time to time to pay the Company’s income or other tax obligations, and up to US$ 50,000 of such interest on the balance of the Trust Account may also be released to pay the liquidation expenses of the Company if applicable.
| 4<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
|---|
Underwriter means an underwriter of the IPO from time to time, and any successor underwriter.
Virtual Meeting means any general meeting of the Members at which the Members (and any other permitted participants of such meeting, including without limitation the chairman of the meeting and any Directors) are permitted to attend and participate solely by means of Electronic Communication Facilities.
Interpretation
| 1.2 | In the interpretation of these Articles, the following provisions apply unless the context otherwise requires: |
|---|---|
| (a) | A reference in these Articles to a statute is a reference to a statute of the Cayman Islands as known<br>by its short title, and includes: |
| --- | --- |
| (i) | any statutory modification, amendment or re-enactment; and |
| --- | --- |
| (ii) | any subordinate legislation or regulations issued under that statute. |
| --- | --- |
Without limitation to the preceding sentence, a reference to a revised Act of the Cayman Islands is taken to be a reference to the revision of that Act in force from time to time as amended from time to time.
| (b) | Headings are inserted for convenience only and do not affect the interpretation of these Articles, unless<br>there is ambiguity. |
|---|---|
| (c) | If a day on which any act, matter or thing is to be done under these Articles is not a Business Day, the<br>act, matter or thing must be done on the next Business Day. |
| --- | --- |
| (d) | A word which denotes the singular also denotes the plural, a word which denotes the plural also denotes<br>the singular, and a reference to any gender also denotes the other genders. |
| --- | --- |
| (e) | A reference to a person includes, as appropriate, a company, trust, partnership, joint venture, association,<br>body corporate or government agency. |
| --- | --- |
| (f) | Where a word or phrase is given a defined meaning another part of speech or grammatical form in respect<br>to that word or phrase has a corresponding meaning. |
| --- | --- |
| (g) | All references to time are to be calculated by reference to time in the place where the Company’s<br>registered office is located. |
| --- | --- |
| (h) | The words written and in writing include all modes of representing or reproducing words in a visible form,<br>but do not include an Electronic Record where the distinction between a document in writing and an Electronic Record is expressed or implied. |
| --- | --- |
| (i) | The words including, include and in particular or any similar expression are to be construed without limitation. |
| --- | --- |
| (j) | Any requirements as to execution or signature under the Articles including the execution of the Articles<br>themselves can be satisfied in the form of an Electronic Signature. |
| --- | --- |
| 5<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| (k) | Sections 8 and 19(3) of the Electronic Transactions Act shall not apply. |
| --- | --- |
| (l) | The term “holder” in relation to a Share means a person whose name is entered in the Register<br>of Members as the holder of such Share. |
| --- | --- |
| (m) | The term “present” means, in respect of any person attending a meeting, such person’s<br>presence at a general meeting of Members (or any meeting of the holders of any class of Shares), which may be satisfied by means of such<br>person or, if a corporation or other non-natural person, its duly authorized representative (or, in the case of any Member, a proxy which<br>has been validly appointed by such Member in accordance with these Articles), being: (a) physically present at the meeting; or (b) in<br>the case of any meeting at which Electronic Communication Facilities are permitted in accordance with these Articles, including any Virtual<br>Meeting, connected by means of the use of such Electronic Communication Facilities. |
| --- | --- |
| (n) | Where a general meeting of Members (or any meeting of the holders of any class of Shares) is required<br>to be convened for a place, such place may be: (a) a physical place; or (b) a virtual place in the case of any meeting at which Electronic<br>Communication Facilities are permitted in accordance with these Articles, including any Virtual Meeting, connected by means of the use<br>of such Electronic Communication Facilities; or (c) both physical and virtual places, and the term “virtual place” includes<br>Electronic Communication Facilities. |
| --- | --- |
Exclusion of Table A Articles
| 1.3 | The regulations contained in Table A in the First Schedule of the Act and any other regulations contained<br>in any statute or subordinate legislation are expressly excluded and do not apply to the Company. |
|---|---|
| 2. | Commencement of Business |
| --- | --- |
| 2.1 | The business of the Company may be commenced as soon after incorporation of the Company as the directors<br>see fit. |
| --- | --- |
| 2.2 | The directors may pay, out of the capital or any other monies of the Company, all expenses incurred in<br>or about the formation and establishment of the Company, including the expenses of registration. |
| --- | --- |
| 3. | Shares |
| --- | --- |
Power to issue Shares and options, with or without special rights
| 3.1 | Subject to the provisions, if any, in the Act the Memorandum (and to any direction that may be given by<br>the Company in general meeting), these Articles and, where applicable, the rules and regulations of the Designated Stock Exchange, the<br>SEC and/or any other competent regulatory authority or otherwise under Applicable Law, and without prejudice to any rights attached to<br>any existing Shares, the directors have general and unconditional authority to allot (with or without confirming rights of renunciation),<br>issue, grant options over or otherwise deal with any unissued Shares of the Company to such persons, at such times and on such terms and<br>conditions as they may decide, save that the directors may not allot, issue, grant options over or otherwise deal with any unissued Shares<br>to the extent that it may affect the ability of the Company to carry out a Class B Share Conversion described at Article 12.<br>No Share may be issued at a discount except in accordance with the provisions of the Act. |
|---|---|
| 6<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| 3.2 | Without limitation to the preceding Article, the directors may so deal with the unissued Shares of the<br>Company: |
| --- | --- |
| (a) | either at a premium or at par; |
| --- | --- |
| (b) | with or without preferred, deferred or other special rights or restrictions whether in regard to dividend,<br>voting, return of capital or otherwise. |
| --- | --- |
| 3.3 | The Company may issue rights, options, warrants or convertible securities or securities of similar nature<br>conferring the right upon the holders thereof to subscribe for, purchase or receive any class of Shares or other securities in the Company<br>at such times and on such terms and conditions as the directors may decide. |
| --- | --- |
| 3.4 | The Company may issue units of securities in the Company, which<br>may be comprised of Shares, rights, options, warrants or convertible securities or securities of similar nature conferring the right<br>upon the holders thereof to subscribe for, purchase or receive any class of Shares or other securities in the Company, on such terms<br>and conditions as the directors may decide. The securities comprising any such units which are issued pursuant to the IPO can only be<br>traded separately from one another on the 52nd Business Day following the date of the prospectus relating to the IPO unless the Representative(s)<br>determines that an earlier date is acceptable, subject to the Company having filed a current report on Form 8-K containing an audited<br>balance sheet reflecting the Company’s receipt of the gross proceeds of the IPO with the SEC and a press release announcing when<br>such separate trading will begin. Prior to such date, the units can be traded, but the securities comprising such units cannot be traded<br>separately from one another. |
| --- | --- |
Power to issue fractions of a Share
| 3.5 | Subject to the Act, the Company may issue fractions of a Share of any class. A fraction of a Share shall<br>be subject to and carry the corresponding fraction of liabilities (whether with respect to calls or otherwise), limitations, preferences,<br>privileges, qualifications, restrictions, rights and other attributes of a Share of that class of Shares. |
|---|
Power to pay commissions and brokerage fees
| 3.6 | The Company may, in so far as the Act permits, pay a commission to any person in consideration of that<br>person: |
|---|---|
| (a) | subscribing or agreeing to subscribe, whether absolutely or conditionally; or |
| --- | --- |
| (b) | procuring or agreeing to procure subscriptions, whether absolute or conditional |
| --- | --- |
for any Shares in the Company. That commission may be satisfied by the payment of cash or the allotment of Fully Paid or partly-paid Shares or partly in one way and partly in another.
| 3.7 | The Company may employ a broker in the issue of its capital and pay him any proper commission or brokerage. |
|---|---|
| 7<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
Trusts not recognised
| 3.8 | Except as required by Applicable Law: |
|---|---|
| (a) | the Company shall not be bound by or compelled to recognise in any way (even when notified) any equitable,<br>contingent, future or partial interest in any Share, or (except only as is otherwise provided by these Articles or the Act) any other<br>rights in respect of any Share other than an absolute right to the entirety thereof in the holder; and |
| --- | --- |
| (b) | no person other than the Member shall be recognised by the Company as having any right in a Share. |
| --- | --- |
Power to vary class rights
| 3.9 | If the share capital is divided into different classes of Shares then, unless the terms on which a class<br>of Shares was issued state otherwise, the rights attaching to a class of Shares may only be varied if one of the following applies: |
|---|---|
| (a) | the Members holding two thirds of the issued Shares of that class consent in writing to the variation;<br>or |
| --- | --- |
| (b) | the variation is made with the sanction of a Special Resolution passed at a separate general meeting of<br>the Members holding the issued Shares of that class. |
| --- | --- |
| 3.10 | For the purpose of paragraph (b) of the preceding Article, all the provisions of these Articles relating<br>to general meetings apply, mutatis mutandis, to every such separate meeting except that: |
| --- | --- |
| (a) | the necessary quorum shall be one or more persons holding, or representing by proxy, not less than one<br>third of the issued Shares of the class; and |
| --- | --- |
| (b) | any Member holding issued Shares of the class, present in person or by proxy or, in the case of a corporate<br>Member, by its duly authorised representative, at the meeting may demand a poll. |
| --- | --- |
Effect of new Share issue on existing class rights
| 3.11 | Unless the terms on which a class of Shares was issued state otherwise, the rights conferred on the Member<br>holding Shares of any class shall not be deemed to be varied by the creation or issue of further Shares ranking pari passu with<br>the existing Shares of that class. For the avoidance of doubt, the creation, designation or issuance of any Preference Shares with rights<br>and privileges ranking in priority to any existing class of Shares pursuant to Article 3.19 shall not be deemed to be a variation<br>of the rights of such existing class. |
|---|
Capital contributions without issue of further Shares
| 3.12 | With the consent of a Member, the directors may accept a voluntary contribution to the capital of the<br>Company from that Member without issuing Shares in consideration for that contribution. In that event, the contribution shall be dealt<br>with in the following manner: |
|---|---|
| (a) | It shall be treated as if it were a share premium. |
| --- | --- |
| (b) | Unless the Member agrees otherwise: |
| --- | --- |
| (i) | if the Member holds Shares in a single class of Shares, it shall be credited to the share premium account<br>for that class of Shares; |
| --- | --- |
| 8<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| (ii) | if the Member holds Shares of more than one class, it shall be credited rateably to the share premium<br>accounts for those classes of Shares (in the proportion that the sum of the issue prices for each class of Shares that the Member holds<br>bears to the total issue prices for all classes of Shares that the Member holds). |
| --- | --- |
| (c) | It shall be subject to the provisions of the Act and these Articles applicable to share premiums. |
| --- | --- |
No bearer Shares or warrants
| 3.13 | The Company shall not issue Shares or warrants to bearers. |
|---|
Treasury Shares
| 3.14 | Shares that the Company purchases, redeems or acquires by way of surrender in accordance with the Act<br>shall be held as Treasury Shares and not treated as cancelled if: |
|---|---|
| (a) | the directors so determine prior to the purchase, redemption or surrender of those shares; and |
| --- | --- |
| (b) | the relevant provisions of the Memorandum and Articles and the Act are otherwise complied with. |
| --- | --- |
Rights attaching to Treasury Shares and related matters
| 3.15 | No dividend may be declared or paid, and no other distribution (whether in cash or otherwise) of the Company’s<br>assets (including any distribution of assets to members on a winding up) may be made to the Company in respect of a Treasury Share. |
|---|---|
| 3.16 | The Company shall be entered in the Register as the holder of the Treasury Shares. However: |
| --- | --- |
| (a) | the Company shall not be treated as a member for any purpose and shall not exercise any right in respect<br>of the Treasury Shares, and any purported exercise of such a right shall be void; |
| --- | --- |
| (b) | a Treasury Share shall not be voted, directly or indirectly, at any meeting of the Company and shall not<br>be counted in determining the total number of issued shares at any given time, whether for the purposes of these Articles or the Act. |
| --- | --- |
| 3.17 | Nothing in the preceding Article prevents an allotment of Shares as fully paid bonus shares in respect<br>of a Treasury Share and Shares allotted as fully paid bonus shares in respect of a Treasury Share shall be treated as Treasury Shares. |
| --- | --- |
| 3.18 | Treasury Shares may be disposed of by the Company in accordance with the Act and otherwise on such terms<br>and conditions as the directors determine. |
| --- | --- |
Designation of Preference Shares Rights
| 3.19 | Before any Preference Shares of any series are issued, the Directors shall fix, by resolution or resolutions,<br>the following provisions of such series: |
|---|---|
| (a) | the designation of such series and the number of Preference Shares to constitute such series; |
| --- | --- |
| 9<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| (b) | whether the shares of such series shall have voting rights, in addition to any voting rights provided<br>by Act, and, if so, the terms of such voting rights, which may be general or limited; |
| --- | --- |
| (c) | the dividends, if any, payable on such series, whether any such dividends shall be cumulative, and, if<br>so, from what dates, the conditions and dates upon which such dividends shall be payable, the preference or relation which such dividends<br>shall bear to the dividends payable on any Shares of any other class of Shares or any other series of Preference Shares; |
| --- | --- |
| (d) | whether the Preference Shares or such series shall be subject to redemption by the Company, and, if so,<br>the times, prices and other conditions of such redemption; |
| --- | --- |
| (e) | the amount or amounts payable upon Preference Shares of such series upon, and the rights of the holders<br>of such series in, a voluntary or involuntary liquidation, dissolution or winding up, or upon any distribution of the assets, of the Company; |
| --- | --- |
| (f) | whether the Preference Shares of such series shall be subject to the operation of a retirement or sinking<br>fund and, if so, the extent to and manner in which any such retirement or sinking fund shall be applied to the purchase or redemption<br>of the Preferred Shares of such series for retirement or other corporate purposes and the terms and provisions relative to the operation<br>of the retirement or sinking fund; |
| --- | --- |
| (g) | whether the Preference Shares of such series shall be convertible into, or exchangeable for, Shares of<br>any other class of Shares or any other series of Preference Shares or any other securities and, if so, the price or prices or the rate<br>or rates of conversion or exchange and the method, if any, of adjusting the same, and any other terms and conditions of conversion or<br>exchange; |
| --- | --- |
| (h) | the limitations and restrictions, if any, to be effective while any Preference Shares or such series are<br>outstanding upon the payment of dividends or the making of other distributions on, and upon the purchase, redemption or other acquisition<br>by the Company of, the existing Shares or Shares of any other class of Shares or any other series of Preference Shares; |
| --- | --- |
| (i) | the conditions or restrictions, if any, upon the creation of indebtedness of the Company or upon the issue<br>of any additional Shares, including additional shares of such series or of any other class of Shares or any other series of Preference<br>Shares; and |
| --- | --- |
| (j) | any other powers, preferences and relative, participating, optional and other special rights, and any<br>qualifications, limitations and restrictions of any other class of Shares or any other series of Preference Shares. |
| --- | --- |
| 4. | Register of Members |
| --- | --- |
| 4.1 | The Company shall maintain or cause to be maintained the Register of Members in accordance with the Act. |
| --- | --- |
| 4.2 | The directors may determine that the Company shall maintain one or more branch registers of Members in<br>accordance with the Act. The directors may also determine which Register of Members shall constitute the principal register and which<br>shall constitute the branch register or registers, and to vary such determination from time to time. |
| --- | --- |
| 10<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| 4.3 | The title to Shares listed on a Designated Stock Exchange may<br>be evidenced and transferred in accordance with the laws applicable to the rules and regulations of the Designated Stock Exchange and,<br>for these purposes, the Register of Members may be maintained in accordance with Section 40B of the Act. |
| --- | --- |
| 5. | Share certificates |
| --- | --- |
Issue of share certificates
| 5.1 | Upon being entered in the Register of Members as the holder of a Share, a Member shall be entitled: |
|---|---|
| (a) | without payment, to one certificate for all the Shares of each class held by that Member (and, upon transferring<br>a part of the Member’s holding of Shares of any class, to a certificate for the balance of that holding); and |
| --- | --- |
| (b) | upon payment of such reasonable sum as the directors may determine for every certificate after the first,<br>to several certificates each for one or more of that Member’s Shares. |
| --- | --- |
| 5.2 | Every certificate shall specify the number, class and distinguishing numbers (if any) of the Shares to<br>which it relates and whether they are Fully Paid or partly paid up. A certificate may be executed under seal or executed in such other<br>manner as the directors determine. |
| --- | --- |
| 5.3 | The Company shall not be bound to issue more than one certificate for Shares held jointly by several persons<br>and delivery of a certificate for a Share to one joint holder shall be a sufficient delivery to all of them. |
| --- | --- |
Renewal of lost or damaged share certificates
| 5.4 | If a share certificate is defaced, worn-out, lost or destroyed, it may be renewed on such terms (if any)<br>as to: |
|---|---|
| (a) | evidence; |
| --- | --- |
| (b) | indemnity; |
| --- | --- |
| (c) | payment of the expenses reasonably incurred by the Company in investigating the evidence; and |
| --- | --- |
| (d) | payment of a reasonable fee, if any, for issuing a replacement share certificate |
| --- | --- |
as the directors may determine, and (in the case of defacement or wearing-out) on delivery to the Company of the old certificate.
| 6. | Lien on Shares |
|---|
Nature and scope of lien
| 6.1 | The Company has a first and paramount lien on all Shares (whether Fully Paid or not) registered in the<br>name of a Member (whether solely or jointly with others). The lien is for all moneys payable to the Company by the Member or the Member’s<br>estate: |
|---|---|
| (a) | either alone or jointly with any other person, whether or not that other person is a Member; and |
| --- | --- |
| 11<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| (b) | whether or not those moneys are presently payable. |
| --- | --- |
| 6.2 | At any time the directors may declare any Share to be wholly or partly exempt from the provisions of this<br>Article. |
| --- | --- |
Company may sell Shares to satisfy lien
| 6.3 | The Company may sell any Shares over which it has a lien if all of the following conditions are met: |
|---|---|
| (a) | the sum in respect of which the lien exists is presently payable; |
| --- | --- |
| (b) | the Company gives notice to the Member holding the Share (or to the person entitled to it in consequence<br>of the death or bankruptcy of that Member) demanding payment and stating that if the notice is not complied with the Shares may be sold;<br>and |
| --- | --- |
| (c) | that sum is not paid within 14 Clear Days after that notice is deemed to be given under these Articles. |
| --- | --- |
| 6.4 | The Shares may be sold in such manner as the directors determine. |
| --- | --- |
| 6.5 | To the maximum extent permitted by Applicable Law, the directors shall incur no personal liability to<br>the Member concerned in respect of the sale. |
| --- | --- |
Authority to execute instrument of transfer
| 6.6 | To give effect to a sale, the directors may authorise any person to execute an instrument of transfer<br>of the Shares sold to, or in accordance with the directions of, the purchaser. The title of the transferee of the Shares shall not be<br>affected by any irregularity or invalidity in the proceedings in respect of the sale. |
|---|
Consequences of sale of Shares to satisfy lien
| 6.7 | On sale pursuant to the preceding Articles: |
|---|---|
| (a) | the name of the Member concerned shall be removed from the Register of Members as the holder of those<br>Shares; and |
| --- | --- |
| (b) | that person shall deliver to the Company for cancellation the certificate for those Shares. |
| --- | --- |
Despite this, that person shall remain liable to the Company for all monies which, at the date of sale, were presently payable by him to the Company in respect of those Shares. That person shall also be liable to pay interest on those monies from the date of sale until payment at the rate at which interest was payable before that sale or, failing that, at the Default Rate. The directors may waive payment wholly or in part or enforce payment without any allowance for the value of the Shares at the time of sale or for any consideration received on their disposal.
| 12<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
|---|
Application of proceeds of sale
| 6.8 | The net proceeds of the sale, after payment of the costs, shall be applied in payment of so much of the<br>sum for which the lien exists as is presently payable. Any residue shall be paid to the person whose Shares have been sold: |
|---|---|
| (a) | if no certificate for the Shares was issued, at the date of the sale; or |
| --- | --- |
| (b) | if a certificate for the Shares was issued, upon surrender to the Company of that certificate for cancellation |
| --- | --- |
but, in either case, subject to the Company retaining a like lien for all sums not presently payable as existed on the Shares before the sale.
| 7. | Calls on Shares and forfeiture |
|---|
Power to make calls and effect of calls
| 7.1 | Subject to the terms of allotment, the directors may make calls on the Members in respect of any moneys<br>unpaid on their Shares including any premium. The call may provide for payment to be by instalments. Subject to receiving at least 14<br>Clear Days’ notice specifying when and where payment is to be made, each Member shall pay to the Company the amount called on his<br>Shares as required by the notice. |
|---|---|
| 7.2 | Before receipt by the Company of any sum due under a call, that call may be revoked in whole or in part<br>and payment of a call may be postponed in whole or in part. Where a call is to be paid in instalments, the Company may revoke the call<br>in respect of all or any remaining instalments in whole or in part and may postpone payment of all or any of the remaining instalments<br>in whole or in part. |
| --- | --- |
| 7.3 | A Member on whom a call is made shall remain liable for that call notwithstanding the subsequent transfer<br>of the Shares in respect of which the call was made. A person shall not be liable for calls made after such person is no longer registered<br>as Member in respect of those Shares. |
| --- | --- |
Time when call made
| 7.4 | A call shall be deemed to have been made at the time when the resolution of the directors authorising<br>the call was passed. |
|---|
Liability of joint holders
| 7.5 | Members registered as the joint holders of a Share shall be jointly and severally liable to pay all calls<br>in respect of the Share. |
|---|
Interest on unpaid calls
| 7.6 | If a call remains unpaid after it has become due and payable the person from whom it is due and payable<br>shall pay interest on the amount unpaid from the day it became due and payable until it is paid: |
|---|---|
| (a) | at the rate fixed by the terms of allotment of the Share or in the notice of the call; or |
| --- | --- |
| (b) | if no rate is fixed, at the Default Rate. |
| --- | --- |
| 13<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
The directors may waive payment of the interest wholly or in part.
Deemed calls
| 7.7 | Any amount payable in respect of a Share, whether on allotment or on a fixed date or otherwise, shall<br>be deemed to be payable as a call. If the amount is not paid when due the provisions of these Articles shall apply as if the amount had<br>become due and payable by virtue of a call. |
|---|
Power to accept early payment
| 7.8 | The Company may accept from a Member the whole or a part of the amount remaining unpaid on Shares held<br>by him although no part of that amount has been called up. |
|---|
Power to make different arrangements at time of issue of Shares
| 7.9 | Subject to the terms of allotment, the directors may make arrangements on the issue of Shares to distinguish<br>between Members in the amounts and times of payment of calls on their Shares. |
|---|
Notice of default
| 7.10 | If a call remains unpaid after it has become due and payable the directors may give to the person from<br>whom it is due not less than 14 Clear Days’ notice requiring payment of: |
|---|---|
| (a) | the amount unpaid; |
| --- | --- |
| (b) | any interest which may have accrued; |
| --- | --- |
| (c) | any expenses which have been incurred by the Company due to that person’s default. |
| --- | --- |
| 7.11 | The notice shall state the following: |
| --- | --- |
| (a) | the place where payment is to be made; and |
| --- | --- |
| (b) | a warning that if the notice is not complied with the Shares in respect of which the call is made will<br>be liable to be forfeited. |
| --- | --- |
Forfeiture or surrender of Shares
| 7.12 | If the notice under the preceding Article is not complied with, the directors may, before the payment<br>required by the notice has been received, resolve that any Share the subject of that notice be forfeited. The forfeiture shall include<br>all dividends or other moneys payable in respect of the forfeited Share and not paid before the forfeiture. Despite the foregoing, the<br>directors may determine that any Share the subject of that notice be accepted by the Company as surrendered by the Member holding that<br>Share in lieu of forfeiture. |
|---|---|
| 7.13 | The directors may accept the surrender for no consideration of any Fully Paid Share. |
| --- | --- |
| 14<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
Disposal of forfeited or surrendered Share and power to cancel forfeiture or surrender
| 7.14 | A forfeited or surrendered Share may be sold, re-allotted or otherwise disposed of on such terms and in<br>such manner as the directors determine either to the former Member who held that Share or to any other person. The forfeiture or surrender<br>may be cancelled on such terms as the directors think fit at any time before a sale, re-allotment or other disposition. Where, for the<br>purposes of its disposal, a forfeited or surrendered Share is to be transferred to any person, the directors may authorise some person<br>to execute an instrument of transfer of the Share to the transferee. |
|---|
Effect of forfeiture or surrender on former Member
| 7.15 | On forfeiture or surrender: |
|---|---|
| (a) | the name of the Member concerned shall be removed from the Register of Members as the holder of those<br>Shares and that person shall cease to be a Member in respect of those Shares; and |
| --- | --- |
| (b) | that person shall surrender to the Company for cancellation the certificate (if any) for the forfeited<br>or surrendered Shares. |
| --- | --- |
| 7.16 | Despite the forfeiture or surrender of his Shares, that person shall remain liable to the Company for<br>all moneys which at the date of forfeiture or surrender were presently payable by him to the Company in respect of those Shares together<br>with: |
| --- | --- |
| (a) | all expenses; and |
| --- | --- |
| (b) | interest from the date of forfeiture or surrender until payment: |
| --- | --- |
| (i) | at the rate of which interest was payable on those moneys before forfeiture; or |
| --- | --- |
| (ii) | if no interest was so payable, at the Default Rate. |
| --- | --- |
The directors, however, may waive payment wholly or in part.
Evidence of forfeiture or surrender
| 7.17 | A declaration, whether statutory or under oath, made by a director or the Secretary shall be conclusive<br>evidence of the following matters stated in it as against all persons claiming to be entitled to forfeited Shares: |
|---|---|
| (a) | that the person making the declaration is a director or Secretary of the Company, and |
| --- | --- |
| (b) | that the particular Shares have been forfeited or surrendered on a particular date. |
| --- | --- |
Subject to the execution of an instrument of transfer, if necessary, the declaration shall constitute good title to the Shares.
Sale of forfeited or surrendered Shares
| 7.18 | Any person to whom the forfeited or surrendered Shares are disposed of shall not be bound to see to the<br>application of the consideration, if any, of those Shares nor shall his title to the Shares be affected by any irregularity in, or invalidity<br>of the proceedings in respect of, the forfeiture, surrender or disposal of those Shares. |
|---|---|
| 15<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| 8. | Transfer of Shares |
| --- | --- |
Form of transfer
| 8.1 | Subject to the following Articles about the transfer of Shares, and provided that such transfer complies<br>with the rules and regulations of the Designated Stock Exchange, the SEC and/or any other competent regulatory authority or otherwise<br>under Applicable Law, a Member may transfer Shares to another person by completing an instrument of transfer in a common form or in a<br>form prescribed by the rules and regulations of the Designated Stock Exchange, the SEC and/or any other competent regulatory authority<br>or otherwise under Applicable Law or in any other form approved by the directors, executed: |
|---|---|
| (a) | where the Shares are Fully Paid, by or on behalf of that Member; and |
| --- | --- |
| (b) | where the Shares are partly paid, by or on behalf of that Member and the transferee. |
| --- | --- |
| 8.2 | The transferor shall be deemed to remain the holder of a Share until the name of the transferee is entered<br>into the Register of Members. |
| --- | --- |
Power to refuse registration
| 8.3 | If the Shares in question were issued in conjunction with rights, options or warrants issued pursuant<br>to Article 3.4 on terms that one cannot be transferred without the other, the directors shall refuse to register the transfer of<br>any such Share without evidence satisfactory to them of the like transfer of such option or warrant. |
|---|
Power to suspend registration
| 8.4 | The directors may suspend registration of the transfer of Shares at such times and for such periods, not<br>exceeding 30 days in any calendar year, as they determine. |
|---|
Company may retain instrument of transfer
| 8.5 | The Company shall be entitled to retain any instrument of transfer which is registered; but an instrument<br>of transfer which the directors refuse to register shall be returned to the person lodging it when notice of the refusal is given. |
|---|---|
| 9. | Transmission of Shares |
| --- | --- |
Persons entitled on death of a Member
| 9.1 | If a Member dies, the only persons recognised by the Company as having any title to the deceased Members’<br>interest are the following: |
|---|---|
| (a) | where the deceased Member was a joint holder, the survivor or survivors; and |
| --- | --- |
| 16<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| (b) | where the deceased Member was a sole holder, that Member’s personal representative or representatives. |
| --- | --- |
| 9.2 | Nothing in these Articles shall release the deceased Member’s estate from any liability in respect<br>of any Share, whether the deceased was a sole holder or a joint holder. |
| --- | --- |
Registration of transfer of a Share following death or bankruptcy
| 9.3 | A person becoming entitled to a Share in consequence of the death or bankruptcy of a Member may elect<br>to do either of the following: |
|---|---|
| (a) | to become the holder of the Share; or |
| --- | --- |
| (b) | to transfer the Share to another person. |
| --- | --- |
| 9.4 | That person must produce such evidence of his entitlement as the directors may properly require. |
| --- | --- |
| 9.5 | If the person elects to become the holder of the Share, he must give notice to the Company to that effect.<br>For the purposes of these Articles, that notice shall be treated as though it were an executed instrument of transfer. |
| --- | --- |
| 9.6 | If the person elects to transfer the Share to another person then: |
| --- | --- |
| (a) | if the Share is Fully Paid, the transferor must execute an instrument of transfer; and |
| --- | --- |
| (b) | if the Share is partly paid, the transferor and the transferee must execute an instrument of transfer. |
| --- | --- |
| 9.7 | All these Articles relating to the transfer of Shares shall apply to the notice or, as appropriate, the<br>instrument of transfer. |
| --- | --- |
Indemnity
| 9.8 | A person registered as a Member by reason of the death or bankruptcy of another Member shall indemnify<br>the Company and the directors against any loss or damage suffered by the Company or the directors as a result of that registration. |
|---|
Rights of person entitled to a Share following death or bankruptcy
| 9.9 | A person becoming entitled to a Share by reason of the death or bankruptcy of a Member shall have the<br>rights to which he would be entitled if he were registered as the holder of the Share. However, until he is registered as Member in respect<br>of the Share, he shall not be entitled to attend or vote at any meeting of the Company or at any separate meeting of the holders of that<br>class of Shares in the Company. |
|---|---|
| 17<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| 10. | Alteration of capital |
| --- | --- |
Increasing, consolidating, converting, dividing and cancelling share capital
| 10.1 | To the fullest extent permitted by the Act, the Company may by Ordinary Resolution do any of the following<br>and amend its Memorandum for that purpose: |
|---|---|
| (a) | increase its share capital by new Shares of the amount fixed by that Ordinary Resolution and with the<br>attached rights, priorities and privileges set out in that Ordinary Resolution; |
| --- | --- |
| (b) | consolidate and divide all or any of its share capital into Shares of larger amount than its existing<br>Shares; |
| --- | --- |
| (c) | convert all or any of its Paid Up Shares into stock, and reconvert that stock into Paid Up Shares of any<br>denomination; |
| --- | --- |
| (d) | sub-divide its Shares or any of them into Shares of an amount smaller than that fixed by the Memorandum,<br>so, however, that in the sub-division, the proportion between the amount paid and the amount, if any, unpaid on each reduced Share shall<br>be the same as it was in case of the Share from which the reduced Share is derived; and |
| --- | --- |
| (e) | cancel Shares which, at the date of the passing of that Ordinary Resolution, have not been taken or agreed<br>to be taken by any person, and diminish the amount of its share capital by the amount of the Shares so cancelled or, in the case of Shares<br>without nominal par value, diminish the number of Shares into which its capital is divided. |
| --- | --- |
Dealing with fractions resulting from consolidation of Shares
| 10.2 | Whenever, as a result of a consolidation of Shares, any Members would become entitled to fractions of<br>a Share the directors may on behalf of those Members: |
|---|---|
| (a) | sell the Shares representing the fractions for the best price reasonably obtainable to any person (including,<br>subject to the provisions of the Act, the Company); and |
| --- | --- |
| (b) | distribute the net proceeds in due proportion among those Members. |
| --- | --- |
For that purpose, the directors may authorise some person to execute an instrument of transfer of the Shares to, or in accordance with the directions of, the purchaser. The transferee shall not be bound to see to the application of the purchase money nor shall the transferee’s title to the Shares be affected by any irregularity in, or invalidity of, the proceedings in respect of the sale.
Reducing share capital
| 10.3 | Subject to the Act and to any rights for the time being conferred on the Members holding a particular<br>class of Shares, the Company may, by Special Resolution, reduce its share capital in any way. |
|---|---|
| 18<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| 11. | Redemption and purchase of own Shares |
| --- | --- |
Power to issue redeemable Shares and to purchase own Shares
| 11.1 | Subject to the Act and Article 38, and to any rights for the time being conferred on the Members<br>holding a particular class of Shares, and, where applicable, the rules and regulations of the Designated Stock Exchange, the SEC and/or<br>any other competent regulatory authority or otherwise under Applicable Law, the Company may by its directors: |
|---|---|
| (a) | issue Shares that are to be redeemed or liable to be redeemed, at the option of the Company or the Member<br>holding those redeemable Shares, on the terms and in the manner its directors determine before the issue of those Shares; |
| --- | --- |
| (b) | with the consent by Special Resolution of the Members holding Shares of a particular class, vary the rights<br>attaching to that class of Shares so as to provide that those Shares are to be redeemed or are liable to be redeemed at the option of<br>the Company on the terms and in the manner which the directors determine at the time of such variation; and |
| --- | --- |
| (c) | purchase all or any of its own Shares of any class including any redeemable Shares on the terms and in<br>the manner which the directors determine at the time of such purchase. |
| --- | --- |
The Company may make a payment in respect of the redemption or purchase of its own Shares in any manner authorised by the Act, including out of any combination of the following: capital, its profits and the proceeds of a fresh issue of Shares.
| 11.2 | With respect to redeeming, repurchasing or surrendering of Shares: |
|---|---|
| (a) | Members who hold Public Shares are entitled to request the redemption of such Shares<br>in the circumstances described in Article 38.3; |
| --- | --- |
| (b) | Shares held by the Sponsor shall be surrendered by the Sponsor for no consideration<br>to the extent that the Over-Allotment Option is not exercised in full so that such shares will equal, in the aggregate, 20% of the sum<br>of all Ordinary Shares outstanding upon completion of the IPO (excluding any shares or equity-linked securities issued, or to be issued,<br>to any seller in the initial Business Combination, any private placement shares or any private placement-equivalent units issued to its<br>sponsor or its affiliates upon conversion of loans made to the Company); and |
| --- | --- |
| (c) | Public Shares shall be repurchased by way of Tender Offer in the circumstances<br>set out in Article 38.2(b). |
| --- | --- |
Power to pay for redemption or purchase in cash or in specie
| 11.3 | When making a payment in respect of the redemption or purchase of Shares, the directors may make the payment<br>in cash or in specie (or partly in one and partly in the other) if so authorised by the terms of the allotment of those Shares, or by<br>the terms applying to those Shares in accordance with Article 11.1, or otherwise by agreement with the Member holding those Shares. |
|---|
Effect of redemption or purchase of a Share
| 11.4 | Upon the date of redemption or purchase of a Share: |
|---|---|
| (a) | the Member holding that Share shall cease to be entitled to any rights in respect of the Share other than<br>the right to receive: |
| --- | --- |
| (i) | the price for the Share; and |
| --- | --- |
| (ii) | any dividend declared in respect of the Share prior to the date of redemption or purchase; |
| --- | --- |
| 19<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| (b) | the Member’s name shall be removed from the Register of Members with respect to the Share; and |
| --- | --- |
| (c) | the Share shall be cancelled or held as a Treasury Shares, as the directors may determine. |
| --- | --- |
For the purpose of this Article, the date of redemption or purchase is the date when the redemption or purchase falls due.
| 11.5 | For the avoidance of doubt, redemptions and repurchases of Shares in the circumstances described in Articles 11.2(a),<br>11.2(b) and 11.2(c) above shall not require further approval of the Members. |
|---|---|
| 12. | Class B Share Conversion |
| --- | --- |
| 12.1 | Class B Shares shall convert into Class A Shares on a one-for-one<br>basis (the Initial Conversion Ratio): (a) at any time and from time to time at the option of the holders thereof; or (b) automatically<br>at the time of the consummation of the Company’s initial Business Combination. |
|---|---|
| 12.2 | Notwithstanding the Initial Conversion Ratio, in the case that<br>additional Class A Shares or any other equity- linked securities, are issued, or deemed issued, by the Company in excess of the amounts<br>offered in the IPO and related to the consummation of the initial Business Combination, all issued Class B Shares shall automatically<br>be converted into such number of Class A Shares on the first business day following the consummation of the Company’s initial Business<br>Combination at a ratio for which the Class B Shares shall convert into Class A Shares will be adjusted (unless the holders of a majority<br>of the Class B Shares in issue agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so<br>that the number of Class A Shares issuable upon conversion of all Class B Shares will equal, in the aggregate, on an as-converted basis,<br>to 20% of the sum of: |
| --- | --- |
| (a) | the total number of Class A Shares outstanding upon the completion<br>of the IPO (including pursuant to the Over-Allotment Option excluding private placement shares), plus |
| --- | --- |
| (b) | the total number of Class A Shares issued or deemed issued, or issuable upon the conversion<br>or exercise of any equity-linked securities issued or deemed issued or rights issued or deemed issued , by the Company in connection with<br>or in relation to the consummation of the initial Business Combination, excluding any Class A Shares or equity-linked securities exercisable<br>for or convertible into Class A Shares issued, or to be issued, to any seller in the initial Business Combination and any units to be<br>issued to the Sponsor upon conversion of working capital loans, if any. |
| --- | --- |
| 12.3 | References in this Article to converted, conversion or exchange shall mean the compulsory redemption without<br>notice of Class B Shares of any Member and, on behalf of such Members, automatic application of such redemption proceeds in paying for<br>such new Class A Shares into which the Class B Shares have been converted or exchanged at a price per Class B Share necessary to give<br>effect to a conversion or exchange calculated on the basis that the Class A Shares to be issued as part of the conversion or exchange<br>will be issued at par. The Class A Shares to be issued on an exchange or conversion shall be registered in the name of such Member or<br>in such name as the Member may direct. |
| --- | --- |
| 12.4 | Notwithstanding anything to the contrary in this Article 12, in no event may any Class B Share convert<br>into Class A Shares at a ratio that is less than one-for-one. Each Class B Share shall convert into its pro rata number of Class A Shares<br>as set forth in this Article 12. The pro rata share for each holder of Class B Shares will be determined as follows: Each Class B Share<br>shall convert into such number of Class A Shares as is equal to the product of 1 multiplied by a fraction, the numerator of which shall<br>be the total number of Class A Shares into which all of the issued Class B Shares shall be converted pursuant to this Article and the<br>denominator of which shall be the total number of issued Class B Shares at the time of conversion. |
| --- | --- |
| 20<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| 12.5 | The directors shall not allot or issue Class A Shares such that the number of authorised but unissued<br>Class A Shares would at any time be insufficient to permit the conversion of all Class B Shares from time to time issued into Class A<br>Shares. |
| --- | --- |
| 13. | Meetings of Members |
| --- | --- |
Power to call meetings
| 13.1 | To the extent required by the rules and regulations of the Designated Stock Exchange, the SEC and/or any<br>other competent regulatory authority or otherwise under Applicable Law, an annual general meeting of the Company shall be held no later<br>than one year after the first financial year end occurring after the IPO, and shall be held in each year thereafter at such time as determined<br>by the directors and the Company may, but shall not (unless required by the Act or the rules and regulations of the Designated Stock Exchange,<br>the SEC and/or any other competent regulatory authority or otherwise under Applicable Law) be obliged to, in each year hold any other<br>general meeting. |
|---|---|
| 13.2 | The agenda of the annual general meeting shall be set by the directors and shall include the presentation<br>of the Company’s annual accounts and the report of the directors (if any). |
| --- | --- |
| 13.3 | Annual general meetings shall be held in New York, USA or in such other places as the directors may determine. |
| --- | --- |
| 13.4 | All general meetings other than annual general meetings shall be called extraordinary general meetings<br>and the Company shall specify the meeting as such in the notices calling it. |
| --- | --- |
| 13.5 | The directors may call a general meeting at any time. |
| --- | --- |
| 13.6 | If there are insufficient directors to constitute a quorum and the remaining directors are unable to agree<br>on the appointment of additional directors, the directors must call a general meeting for the purpose of appointing additional directors. |
| --- | --- |
| 13.7 | The directors must also call a general meeting if requisitioned in the manner set out in the next two<br>Articles. |
| --- | --- |
| 13.8 | The requisition must be in writing and given by one or more Members who together hold at least 40%<br>of the rights to vote at such general meeting. |
| --- | --- |
| 13.9 | The requisition must also: |
| --- | --- |
| (a) | specify the purpose of the meeting. |
| --- | --- |
| (b) | be signed by or on behalf of each requisitioner (and for this purpose each joint holder shall be obliged<br>to sign). The requisition may consist of several documents in like form signed by one or more of the requisitioners. |
| --- | --- |
| 21<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| (c) | be delivered in accordance with the notice provisions. |
| --- | --- |
| 13.10 | Should the directors fail to call a general meeting within 21 Clear Days from the date of receipt<br>of a requisition, the requisitioners or any of them may call a general meeting within three months after the end of that period. |
| --- | --- |
| 13.11 | Without limitation to the foregoing, if there are insufficient directors to constitute a quorum and the<br>remaining directors are unable to agree on the appointment of additional directors, any one or more Members who together hold at least 40%<br>of the rights to vote at a general meeting may call a general meeting for the purpose of considering the business specified in the notice<br>of meeting which shall include as an item of business the appointment of additional directors. |
| --- | --- |
| 13.12 | Members seeking to bring business before the annual general meeting or to nominate candidates for election<br>as directors at the annual general meeting must deliver notice to the principal executive offices of the Company not later than the close<br>of business on the 90th day nor earlier than the close of business on the 120th day prior to the scheduled date of the annual<br>general meeting. |
| --- | --- |
Content of notice
| 13.13 | Notice of a general meeting shall specify each of the following: |
|---|---|
| (a) | the place, the date and the hour of the meeting; |
| --- | --- |
| (b) | if the meeting is to be held in two or more places, or any meeting at which Electronic Communication Facilities<br>will be utilized (including any Virtual Meeting), the Electronic Communication Facilities that will be used to facilitate the meeting,<br>including the procedures to be followed by any Member or other participant of the meeting who wishes to utilize such Electronic Communication<br>Facilities for the purposes of attending and participating in such meeting; |
| --- | --- |
| (c) | subject to paragraph (d), the general nature of the business to be transacted; and |
| --- | --- |
| (d) | if a resolution is proposed as a Special Resolution, the text of that resolution. |
| --- | --- |
| 13.14 | In each notice there shall appear with reasonable prominence the following statements: |
| --- | --- |
| (a) | that a Member who is entitled to attend and vote is entitled to appoint one or more proxies to attend<br>and vote instead of that Member; and |
| --- | --- |
| (b) | that a proxyholder need not be a Member. |
| --- | --- |
| 22<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
Period of notice
| 13.15 | At least five Clear Days’ notice of a general meeting must be given to Members, provided that a<br>general meeting of the Company shall, whether or not the notice specified in this Article has been given and whether or not the provisions<br>of these Articles regarding general meetings have been complied with, be deemed to have been duly convened if it is so agreed: |
|---|---|
| (a) | in the case of an annual general meeting, by all of the Members entitled to attend and vote thereat; and |
| --- | --- |
| (b) | in the case of an extraordinary general meeting, by a majority in number of the Members having a right<br>to attend and vote at the meeting, together holding not less than 95% in par value of the Shares giving that right. |
| --- | --- |
Persons entitled to receive notice
| 13.16 | Subject to the provisions of these Articles and to any restrictions imposed on any Shares, the notice<br>shall be given to the following people: |
|---|---|
| (a) | the Members; |
| --- | --- |
| (b) | persons entitled to a Share in consequence of the death or bankruptcy of a Member; and |
| --- | --- |
| (c) | the directors. |
| --- | --- |
Publication of notice on a website
| 13.17 | Subject to the Act or the rules and regulations of the Designated Stock Exchange, the SEC and/or any other<br>competent regulatory authority or otherwise under Applicable Law, a notice of a general meeting may be published on a website providing<br>the recipient is given separate notice of: |
|---|---|
| (a) | the publication of the notice on the website; |
| --- | --- |
| (b) | the place on the website where the notice may be accessed; |
| --- | --- |
| (c) | how it may be accessed; and |
| --- | --- |
| (d) | the place, date and time of the general meeting. |
| --- | --- |
| 13.18 | If a Member notifies the Company that he is unable for any reason to access the website, the Company must<br>as soon as practicable give notice of the meeting to that Member by any other means permitted by these Articles. This will not affect<br>when that Member is deemed to have received notice of the meeting. |
| --- | --- |
Time a website notice is deemed to be given
| 13.19 | A website notice is deemed to be given when the Member is given notice of its publication. |
|---|
Required duration of publication on a website
| 13.20 | Where the notice of meeting is published on a website, it shall continue to be published in the same place<br>on that website from the date of the notification until at least the conclusion of the meeting to which the notice relates. |
|---|---|
| 23<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
Accidental omission to give notice or non-receipt of notice
| 13.21 | Proceedings at a meeting shall not be invalidated by the following: |
|---|---|
| (a) | an accidental failure to give notice of the meeting to any person entitled to notice; or |
| --- | --- |
| (b) | non-receipt of notice of the meeting by any person entitled to notice. |
| --- | --- |
| 13.22 | In addition, where a notice of meeting is published on a website, proceedings at the meeting shall not<br>be invalidated merely because it is accidentally published: |
| --- | --- |
| (a) | in a different place on the website; or |
| --- | --- |
| (b) | for part only of the period from the date of the notification until the conclusion of the meeting to which<br>the notice relates. |
| --- | --- |
| 14. | Proceedings at meetings of Members |
| --- | --- |
Quorum
| 14.1 | Save as provided in the following Article, no business shall be transacted at any meeting unless a quorum<br>is present in person or by proxy at the meeting. One or more Members who together hold not less than one-third of the Shares entitled<br>to vote at such meeting being individuals present in person or by proxy or if a corporation or other non-natural person by its duly authorised<br>representative or proxy shall be a quorum; provided that a quorum in connection with any meeting that is convened to vote on a Business<br>Combination or any meeting convened with regards to an amendment described in Article 38.9 shall be a majority of the Shares entitled<br>to vote at such meeting being individuals present in person or by proxy or if a corporation or other non-natural person by its duly authorised<br>representative or proxy. |
|---|
Lack of quorum
| 14.2 | If a quorum is not present at the meeting within 15 minutes of the time appointed for the meeting,<br>or if at any time during the meeting it becomes inquorate, then the following provisions apply: |
|---|---|
| (a) | If the meeting was requisitioned by Members, it shall be cancelled. |
| --- | --- |
| (b) | In any other case, the meeting shall stand adjourned to the same time and place seven days hence, or to<br>such other time or place as is determined by the directors. If a quorum is not present at the meeting within 15 minutes of the time<br>appointed for the adjourned meeting, then the meeting shall be dissolved. |
| --- | --- |
Use of technology
| 14.3 | A person may participate in a general meeting through the medium of conference telephone, video or any<br>other form of communications equipment providing all persons participating in the meeting are able to hear and speak to each other throughout<br>the meeting. A person participating in this way is deemed to be present in person at the meeting. |
|---|---|
| 24<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
Chairman
| 14.4 | The chairman of a general meeting (including any Virtual Meeting) shall be the chairman of the board or<br>such other director as the directors have nominated to chair board meetings in the absence of the chairman of the board. Absent any such<br>person being present at the meeting within 15 minutes of the time appointed for the meeting, the directors present shall elect one<br>of their number to chair the meeting. The chairman of the meeting shall be entitled to attend and participate at any such general meeting<br>by means of Electronic Communication Facilities, and to act as the chairman of such general meeting, in which event the chairman of the<br>meeting shall be deemed to be present at the meeting. |
|---|---|
| 14.5 | If no director is present within 15 minutes of the time appointed for the meeting, or if no director<br>is willing to act as chairman, the Members present in person or by proxy and entitled to vote shall choose one of their number to chair<br>the meeting. |
| --- | --- |
Right of a director to attend and speak
| 14.6 | Even if a director is not a Member, he shall be entitled to attend and speak at any general meeting and<br>at any separate meeting of Members holding a particular class of Shares in the Company. |
|---|
Adjournment and Postponement
| 14.7 | The chairman may at any time adjourn a meeting. The chairman must adjourn the meeting if so directed by<br>the meeting. No business, however, can be transacted at an adjourned meeting other than business which might properly have been transacted<br>at the original meeting. |
|---|---|
| 14.8 | Should a meeting be adjourned for more than twenty Clear Days, whether because of a lack of quorum or<br>otherwise, Members shall be given at least five Clear Days’ notice of the date, time and place of the adjourned meeting and the<br>general nature of the business to be transacted. Otherwise it shall not be necessary to give any notice of the adjournment. |
| --- | --- |
| 14.9 | If, prior to a Business Combination, a notice is issued in respect of a general meeting and the directors,<br>in their absolute discretion, consider that it is impractical or undesirable for any reason to hold that general meeting at the place,<br>the day and the hour specified in the notice calling such general meeting, the directors may postpone the general meeting to another place, day<br>and/or hour provided that notice of the place, the day and the hour of the rearranged general meeting is promptly given to all Members.<br>No business shall be transacted at any postponed meeting other than the business specified in the notice of the original meeting. |
| --- | --- |
| 14.10 | When a general meeting is postponed for thirty days or more, notice of the postponed meeting shall be<br>given as in the case of an original meeting. Otherwise it shall not be necessary to give any such notice of a postponed meeting. All proxy<br>forms submitted for the original general meeting shall remain valid for the postponed meeting. The directors may postpone a general meeting<br>which has already been postponed. |
| --- | --- |
| 25<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
Method of voting
| 14.11 | A resolution put to the vote of the meeting shall be decided on a poll. |
|---|
Taking of a poll
| 14.12 | A poll demanded on the question of adjournment shall be taken immediately. |
|---|---|
| 14.13 | A poll demanded on any other question shall be taken either immediately or at an adjourned meeting at<br>such time and place as the chairman directs, not being more than 30 Clear Days after the poll was demanded. |
| --- | --- |
| 14.14 | The demand for a poll shall not prevent the meeting continuing to transact any business other than the<br>question on which the poll was demanded. |
| --- | --- |
| 14.15 | A poll shall be taken in such manner as the chairman directs. He may appoint scrutineers (who need not<br>be Members) and fix a place and time for declaring the result of the poll. If, through the aid of technology, the meeting is held in more<br>than place, the chairman may appoint scrutineers in more than place; but if he considers that the poll cannot be effectively monitored<br>at that meeting, the chairman shall adjourn the holding of the poll to a date, place and time when that can occur. |
| --- | --- |
Chairman’s casting vote
| 14.16 | If the votes on a resolution are equal, the chairman may if he wishes exercise a casting vote. |
|---|
Amendments to resolutions
| 14.17 | An Ordinary Resolution to be proposed at a general meeting may be amended by Ordinary Resolution if: |
|---|---|
| (a) | not less than 48 hours before the meeting is to take place (or such later time as the chairman of<br>the meeting may determine), notice of the proposed amendment is given to the Company in writing by a Member entitled to vote at that meeting;<br>and |
| --- | --- |
| (b) | the proposed amendment does not, in the reasonable opinion of the chairman of the meeting, materially<br>alter the scope of the resolution. |
| --- | --- |
| 26<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| 14.18 | A Special Resolution to be proposed at a general meeting may be amended by Ordinary Resolution, if: |
| --- | --- |
| (a) | the chairman of the meeting proposes the amendment at the general meeting at which the resolution is to<br>be proposed, and |
| --- | --- |
| (b) | the amendment does not go beyond what the chairman considers is necessary to correct a grammatical or<br>other non-substantive error in the resolution. |
| --- | --- |
| 14.19 | If the chairman of the meeting, acting in good faith, wrongly decides that an amendment to a resolution<br>is out of order, the chairman’s error does not invalidate the vote on that resolution. |
| --- | --- |
Written resolutions
| 14.20 | Members may pass a resolution in writing without holding a meeting if the following conditions are met: |
|---|---|
| (a) | all Members entitled so to vote are given notice of the resolution as if the same were being proposed<br>at a meeting of Members; |
| --- | --- |
| (b) | all Members entitled so to vote: |
| --- | --- |
| (i) | sign a document; or |
| --- | --- |
| (ii) | sign several documents in the like form each signed by one or more of those Members; and |
| --- | --- |
| (c) | the signed document or documents is or are delivered to the Company, including, if the Company so nominates,<br>by delivery of an Electronic Record by Electronic means to the address specified for that purpose. |
| --- | --- |
Such written resolution shall be as effective as if it had been passed at a meeting of the Members entitled to vote duly convened and held.
| 27<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
|---|---|
| 14.21 | If a written resolution is described as a Special Resolution or as an Ordinary Resolution, it has effect<br>accordingly. |
| --- | --- |
| 14.22 | The directors may determine the manner in which written resolutions shall be put to Members. In particular,<br>they may provide, in the form of any written resolution, for each Member to indicate, out of the number of votes the Member would have<br>been entitled to cast at a meeting to consider the resolution, how many votes he wishes to cast in favour of the resolution and how many<br>against the resolution or to be treated as abstentions. The result of any such written resolution shall be determined on the same basis<br>as on a poll. |
| --- | --- |
Sole-member company
| 14.23 | If the Company has only one Member, and the Member records in writing his decision on a question, that<br>record shall constitute both the passing of a resolution and the minute of it. |
|---|---|
| 15. | Voting rights of Members |
| --- | --- |
Right to vote
| 15.1 | Subject to any rights or restrictions attached to any Member’s Shares, or unless a call or other<br>amount presently payable has not been paid, all Members are entitled to vote at a general meeting, and all Members holding Shares of a<br>particular class of Shares are entitled to vote at a meeting of the holders of that class of Shares. |
|---|---|
| 15.2 | Members may vote in person or by proxy. |
| --- | --- |
| 15.3 | Every Member shall have one vote for each Share he holds, unless any Share carries special voting rights. |
| --- | --- |
| 15.4 | A fraction of a Share shall entitle its holder to an equivalent fraction of one vote. |
| --- | --- |
| 15.5 | No Member is bound to vote on his Shares or any of them; nor is he bound to vote each of his Shares in<br>the same way. |
| --- | --- |
Rights of joint holders
| 15.6 | If Shares are held jointly, only one of the joint holders may vote. If more than one of the joint holders<br>tenders a vote, the vote of the holder whose name in respect of those Shares appears first in the Register of Members shall be accepted<br>to the exclusion of the votes of the other joint holder. |
|---|
Representation of corporate Members
| 15.7 | Save where otherwise provided, a corporate Member must act by a duly authorised representative. |
|---|---|
| 15.8 | A corporate Member wishing to act by a duly authorised representative must identify that person to the<br>Company by notice in writing. |
| --- | --- |
| 28<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| 15.9 | The authorisation may be for any period of time, and must be delivered to the Company not less than two<br>hours before the commencement of the meeting at which it is first used. |
| --- | --- |
| 15.10 | The directors of the Company may require the production of any evidence which they consider necessary<br>to determine the validity of the notice. |
| --- | --- |
| 15.11 | Where a duly authorised representative is present at a meeting that Member is deemed to be present in<br>person; and the acts of the duly authorised representative are personal acts of that Member. |
| --- | --- |
| 15.12 | A corporate Member may revoke the appointment of a duly authorised representative at any time by notice<br>to the Company; but such revocation will not affect the validity of any acts carried out by the duly authorised representative before<br>the directors of the Company had actual notice of the revocation. |
| --- | --- |
| 15.13 | If a clearing house (or its nominee(s)), being a corporation, is a Member, it may authorise such persons<br>as it sees fit to act as its representative at any meeting of the Company or at any meeting of any class of Members provided that the<br>authorisation shall specify the number and class of Shares in respect of which each such representative is so authorised. Each person<br>so authorised under the provisions of this Article shall be deemed to have been duly authorised without further evidence of the facts<br>and be entitled to exercise the same rights and powers on behalf of the clearing house (or its nominee(s)) as if such person was the registered<br>holder of such Shares held by the clearing house (or its nominee(s)). |
| --- | --- |
Member with mental disorder
| 15.14 | A Member in respect of whom an order has been made by any court having jurisdiction (whether in the Cayman<br>Islands or elsewhere) in matters concerning mental disorder may vote, by that Member’s receiver, curator bonis or other person authorised<br>in that behalf appointed by that court. |
|---|---|
| 15.15 | For the purpose of the preceding Article, evidence to the satisfaction of the directors of the authority<br>of the person claiming to exercise the right to vote must be received not less than 24 hours before holding the relevant meeting<br>or the adjourned meeting in any manner specified for the delivery of forms of appointment of a proxy, whether in writing or by Electronic<br>means. In default, the right to vote shall not be exercisable. |
| --- | --- |
Objections to admissibility of votes
| 15.16 | An objection to the validity of a person’s vote may only be raised at the meeting or at the adjourned<br>meeting at which the vote is sought to be tendered. Any objection duly made shall be referred to the chairman whose decision shall be<br>final and conclusive. |
|---|
Form of proxy
| 15.17 | An instrument appointing a proxy shall be in any common form or in any other form approved by the directors. |
|---|---|
| 29<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| 15.18 | The instrument must be in writing and signed in one of the following ways: |
| --- | --- |
| (a) | by the Member; or |
| --- | --- |
| (b) | by the Member’s authorised attorney; or |
| --- | --- |
| (c) | if the Member is a corporation or other body corporate, under seal or signed by an authorised officer,<br>secretary or attorney. |
| --- | --- |
If the directors so resolve, the Company may accept an Electronic Record of that instrument delivered in the manner specified below and otherwise satisfying these Articles about authentication of Electronic Records.
| 15.19 | The directors may require the production of any evidence which they consider necessary to determine the<br>validity of any appointment of a proxy. |
|---|---|
| 15.20 | A Member may revoke the appointment of a proxy at any time by notice to the Company duly signed in accordance<br>with the Article above about signing proxies; but such revocation will not affect the validity of any acts carried out by the proxy before<br>the directors of the Company had actual notice of the revocation. |
| --- | --- |
How and when proxy is to be delivered
| 15.21 | Subject to the following Articles, the form of appointment of a proxy and any authority under which it<br>is signed (or a copy of the authority certified notarially or in any other way approved by the directors) must be delivered so that it<br>is received by the Company not less than 48 hours before the time for holding the meeting or adjourned meeting at which the person<br>named in the form of appointment of proxy proposes to vote. They must be delivered in either of the following ways: |
|---|---|
| (a) | In the case of an instrument in writing, it must be left at or sent by post: |
| --- | --- |
| (i) | to the registered office of the Company; or |
| --- | --- |
| (ii) | to such other place specified in the notice convening the meeting or in any form of appointment of proxy<br>sent out by the Company in relation to the meeting. |
| --- | --- |
| (b) | If, pursuant to the notice provisions, a notice may be given to the Company in an Electronic Record, an<br>Electronic Record of an appointment of a proxy must be sent to the address specified pursuant to those provisions unless another address<br>for that purpose is specified: |
| --- | --- |
| (i) | in the notice convening the meeting; or |
| --- | --- |
| (ii) | in any form of appointment of a proxy sent out by the Company in relation to the meeting; or |
| --- | --- |
| (iii) | in any invitation to appoint a proxy issued by the Company in relation to the meeting. |
| --- | --- |
| 30<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| 15.22 | Where a poll is taken: |
| --- | --- |
| (a) | if it is taken more than seven Clear Days after it is demanded, the form of appointment of a proxy and<br>any accompanying authority (or an Electronic Record of the same) must be delivered as required under the preceding Article not less than 24<br>hours before the time appointed for the taking of the poll; |
| --- | --- |
| (b) | but if it to be taken within seven Clear Days after it was demanded, the form of appointment of a proxy<br>and any accompanying authority (or an Electronic Record of the same) must be e delivered as required under the preceding Article not less<br>than two hours before the time appointed for the taking of the poll. |
| --- | --- |
| 15.23 | If the form of appointment of proxy is not delivered on time, it is invalid. |
| --- | --- |
Voting by proxy
| 15.24 | A proxy shall have the same voting rights at a meeting or adjourned meeting as the Member would have had<br>except to the extent that the instrument appointing him limits those rights. Notwithstanding the appointment of a proxy, a Member may<br>attend and vote at a meeting or adjourned meeting. If a Member votes on any resolution a vote by his proxy on the same resolution, unless<br>in respect of different Shares, shall be invalid. |
|---|---|
| 16. | Number of directors |
| --- | --- |
Unless otherwise determined by Ordinary Resolution, the minimum number of directors shall be one and the maximum shall be ten.
| 17. | Appointment, disqualification and removal of directors |
|---|
No age limit
| 17.1 | There is no age limit for directors save that they must be aged at least 18 years. |
|---|
Corporate directors
| 17.2 | Unless prohibited by law, a body corporate may be a director. If a body corporate is a director, these<br>Articles about representation of corporate Members at general meetings apply, mutatis mutandis, to these Articles about directors’<br>meetings. |
|---|
No shareholding qualification
| 17.3 | Unless a shareholding qualification for directors is fixed by Ordinary Resolution, no director shall be<br>required to own Shares as a condition of his appointment. |
|---|---|
| 31<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
Appointment and removal of directors
| 17.4 | All directors shall hold office for the term fixed by the Ordinary Resolution of the holders of the Class<br>B Shares or fixed by the resolution of the directors appointing such director, as applicable, but such term shall not exceed two years. |
|---|---|
| 17.5 | Prior to the closing of a Business Combination, the Company may by Ordinary Resolution of the holders<br>of the Class B Shares appoint any person to be a director or may by Ordinary Resolution of the holders of the Class B Shares remove any<br>director. For the avoidance of doubt, prior to the closing of a Business Combination holders of Class A Shares shall have no right to<br>vote on the appointment or removal of any director. |
| --- | --- |
| 17.6 | After the closing of a Business Combination, the Company may by Ordinary Resolution appoint any person<br>to be a director or may by Ordinary Resolution remove any director. |
| --- | --- |
| 17.7 | Article 17.5 may only be amended by a Special Resolution passed by Members representing at least two-thirds<br>of the outstanding Shares who are eligible to vote and attend and vote in a general meeting of the Company’s Members. |
| --- | --- |
| 17.8 | Without prejudice to the Company’s power to appoint a person to be a director pursuant to these<br>Articles, the directors shall have power at any time to appoint any person who is willing to act as a director, either to fill a vacancy<br>or as an additional director. A director elected to fill a vacancy resulting from the death, resignation or removal of a director shall<br>serve for the remainder of the full term of the director whose death, resignation or removal shall have created such vacancy and until<br>his successor shall have been elected and qualified. |
| --- | --- |
| 17.9 | Notwithstanding the other provisions of these Articles, in any case where, as a result of death, the Company<br>has no directors and no shareholders, the personal representatives of the last shareholder to have died have the power, by notice in writing<br>to the Company, to appoint a person to be a director. For the purpose of this Article: |
| --- | --- |
| (a) | where two or more shareholders die in circumstances rendering it uncertain who was the last to die, a<br>younger shareholder is deemed to have survived an older shareholder; |
| --- | --- |
| (b) | if the last shareholder died leaving a will which disposes of that shareholder’s shares in the Company<br>(whether by way of specific gift, as part of the residuary estate, or otherwise): |
| --- | --- |
| (i) | the expression personal representatives of the last shareholder means: |
| --- | --- |
| (A) | until a grant of probate in respect of that will has been obtained from the Grand Court of the Cayman<br>Islands, all of the executors named in that will who are living at the time the power of appointment under this Article is exercised;<br>and |
| --- | --- |
| (B) | after such grant of probate has been obtained, only such of those executors who have proved that will; |
| --- | --- |
| (ii) | without derogating from section 3(1) of the Succession Act (Revised), the executors named in that<br>will may exercise the power of appointment under this Article without first obtaining a grant of probate. |
| --- | --- |
| 17.10 | A remaining director may appoint a director even though there is not a quorum of directors. |
| --- | --- |
| 32<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| 17.11 | No appointment can cause the number of directors to exceed the maximum; and any such appointment shall<br>be invalid. |
| --- | --- |
| 17.12 | For so long as Shares are listed on a Designated Stock Exchange, the directors shall include at least<br>such number of Independent Directors as Applicable Law or the rules and regulations of the Designated Stock Exchange require, subject<br>to applicable phase-in rules of the Designated Stock Exchange. |
| --- | --- |
Resignation of directors
| 17.13 | A director may at any time resign office by giving to the Company notice in writing or, if permitted pursuant<br>to the notice provisions, in an Electronic Record delivered in either case in accordance with those provisions. |
|---|---|
| 17.14 | Unless the notice specifies a different date, the director shall be deemed to have resigned on the date<br>that the notice is delivered to the Company. |
| --- | --- |
Termination of the office of director
| 17.15 | A director’s office shall be terminated forthwith if: |
|---|---|
| (a) | he is prohibited by the law of the Cayman Islands from acting as a director; or |
| --- | --- |
| (b) | he is made bankrupt or makes an arrangement or composition with his creditors generally; or |
| --- | --- |
| (c) | in the opinion of a registered medical practitioner by whom he is being treated he becomes physically<br>or mentally incapable of acting as a director; or |
| --- | --- |
| (d) | he is made subject to any law relating to mental health or incompetence, whether by court order or otherwise; |
| --- | --- |
| (e) | without the consent of the other directors, he is absent from meetings of directors for a continuous period<br>of six months; or |
| --- | --- |
| (f) | all of the other directors (being not less than two in number) determine that he should be removed as<br>a director, either by a resolution passed by all of the other directors at a meeting of the directors duly convened and held in accordance<br>with these Articles or by a resolution in writing signed by all of the other directors. |
| --- | --- |
| 18. | Alternate directors |
| --- | --- |
Appointment and removal
| 18.1 | Until the consummation of a Business Combination, a director may not appoint<br>an alternate director. Following the consummation of a Business Combination, Articles 18.2 to 18.5 inclusive shall apply. |
|---|---|
| 18.2 | Subject to Article 18.1, any director may appoint any other person, including another director, to act<br>in his place as an alternate director. No appointment shall take effect until the director has given notice of the appointment to the<br>other directors. Such notice must be given to each other director by either of the following methods: |
| --- | --- |
| (a) | by notice in writing in accordance with the notice provisions; |
| --- | --- |
| 33<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| (b) | if the other director has an email address, by emailing to that address a scanned copy of the notice as<br>a PDF attachment (the PDF version being deemed to be the notice unless Article 33.7 applies), in which event notice shall be taken<br>to be given on the date of receipt by the recipient in readable form. For the avoidance of doubt, the same email may be sent to the email<br>address of more than one director (and to the email address of the Company pursuant to Article 18.5(c)). |
| --- | --- |
| 18.3 | Without limitation to the preceding Article, a director may appoint an alternate for a particular meeting<br>by sending an email to his fellow directors informing them that they are to take such email as notice of such appointment for such meeting.<br>Such appointment shall be effective without the need for a signed notice of appointment or the giving of notice to the Company in accordance<br>with Article 18.5. |
| --- | --- |
| 18.4 | A director may revoke his appointment of an alternate at any time. No revocation shall take effect until<br>the director has given notice of the revocation to the other directors. Such notice must be given by either of the methods specified in<br>Article 18.2. |
| --- | --- |
| 18.5 | A notice of appointment or removal of an alternate director must also be given to the Company by any of<br>the following methods: |
| --- | --- |
| (a) | by notice in writing in accordance with the notice provisions; |
| --- | --- |
| (b) | if the Company has a facsimile address for the time being, by sending by facsimile transmission to that<br>facsimile address a facsimile copy or, otherwise, by sending by facsimile transmission to the facsimile address of the Company’s<br>registered office a facsimile copy (in either case, the facsimile copy being deemed to be the notice unless Article 33.7 applies),<br>in which event notice shall be taken to be given on the date of an error-free transmission report from the sender’s fax machine; |
| --- | --- |
| (c) | if the Company has an email address for the time being, by emailing to that email address a scanned copy<br>of the notice as a PDF attachment or, otherwise, by emailing to the email address provided by the Company’s registered office a<br>scanned copy of the notice as a PDF attachment (in either case, the PDF version being deemed to be the notice unless Article 33.7<br>applies), in which event notice shall be taken to be given on the date of receipt by the Company or the Company’s registered office<br>(as appropriate) in readable form; or |
| --- | --- |
| (d) | if permitted pursuant to the notice provisions, in some other form of approved Electronic Record delivered<br>in accordance with those provisions in writing. |
| --- | --- |
Notices
| 18.6 | All notices of meetings of directors shall continue to be given to the appointing director and not to<br>the alternate. |
|---|
Rights of alternate director
| 18.7 | An alternate director shall be entitled to attend and vote at any board meeting or meeting of a committee<br>of the directors at which the appointing director is not personally present, and generally to perform all the functions of the appointing<br>director in his absence. |
|---|---|
| 18.8 | For the avoidance of doubt: |
| --- | --- |
| (a) | if another director has been appointed an alternate director for one or more directors, he shall be entitled<br>to a separate vote in his own right as a director and in right of each other director for whom he has been appointed an alternate; and |
| --- | --- |
| (b) | if a person other than a director has been appointed an alternate director for more than one director,<br>he shall be entitled to a separate vote in right of each director for whom he has been appointed an alternate. |
| --- | --- |
| 34<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| 18.9 | An alternate director, however, is not entitled to receive any remuneration from the Company for services<br>rendered as an alternate director. |
| --- | --- |
Appointment ceases when the appointor ceases to be a director
| 18.10 | An alternate director shall cease to be an alternate director if the director who appointed him ceases<br>to be a director. |
|---|
Status of alternate director
| 18.11 | An alternate director shall carry out all functions of the director who made the appointment. |
|---|---|
| 18.12 | Save where otherwise expressed, an alternate director shall be treated as a director under these Articles. |
| --- | --- |
| 18.13 | An alternate director is not the agent of the director appointing him. |
| --- | --- |
| 18.14 | An alternate director is not entitled to any remuneration for acting as alternate director. |
| --- | --- |
Status of the director making the appointment
| 18.15 | A director who has appointed an alternate is not thereby relieved from the duties which he owes the Company. |
|---|
19. Powers of directors
Powers of directors
| 19.1 | Subject to the provisions of the Act, the Memorandum and these Articles, the business of the Company shall<br>be managed by the directors who may for that purpose exercise all the powers of the Company. |
|---|---|
| 19.2 | No prior act of the directors shall be invalidated by any subsequent alteration of the Memorandum or these<br>Articles. However, to the extent allowed by the Act, following the consummation of the IPO Members may by Special Resolution validate<br>any prior or future act of the directors which would otherwise be in breach of their duties. |
| --- | --- |
Appointments to office
| 19.3 | The directors may appoint a director: |
|---|---|
| (a) | as chairman of the board of directors; |
| --- | --- |
| 35<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| (b) | as vice-chairman of the board of directors; |
| --- | --- |
| (c) | as managing director; |
| --- | --- |
| (d) | to any other executive office |
| --- | --- |
for such period and on such terms, including as to remuneration, as they think fit.
| 19.4 | The appointee must consent in writing to holding that office. |
|---|---|
| 19.5 | Where a chairman is appointed he shall, unless unable to do so, preside at every meeting of directors. |
| --- | --- |
| 19.6 | If there is no chairman, or if the chairman is unable to preside at a meeting, that meeting may select<br>its own chairman; or the directors may nominate one of their number to act in place of the chairman should he ever not be available. |
| --- | --- |
| 19.7 | Subject to the provisions of the Act, the directors may also appoint any person, who need not be a director: |
| --- | --- |
| (a) | as Secretary; and |
| --- | --- |
| (b) | to any office that may be required (including, for the avoidance of doubt, one or more chief executive<br>officers, presidents, a chief financial officer, a treasurer, vice-presidents, one or more assistant vice-presidents, one or more assistant<br>treasurers and one or more assistant secretaries), |
| --- | --- |
for such period and on such terms, including as to remuneration, as they think fit. In the case of an Officer, that Officer may be given any title the directors decide.
| 19.8 | The Secretary or Officer must consent in writing to holding that office. |
|---|---|
| 19.9 | A director, Secretary or other Officer of the Company may not hold the office, or perform the services,<br>of Auditor. |
| --- | --- |
Remuneration
| 19.10 | The remuneration to be paid to the directors, if any, shall be such remuneration as the directors shall<br>determine, provided that no cash remuneration shall be paid to any director prior to the consummation of a Business Combination. The directors<br>shall also, whether prior to or after the consummation of a Business Combination, be entitled to be paid all out of pocket expenses properly<br>incurred by them in connection with activities on behalf of the Company, including identifying and consummating a Business Combination. |
|---|---|
| 19.11 | Remuneration may take any form and may include arrangements to pay pensions, health insurance, death or<br>sickness benefits, whether to the director or to any other person connected to or related to him. |
| --- | --- |
| 19.12 | Unless his fellow directors determine otherwise, a director is not accountable to the Company for remuneration<br>or other benefits received from any other company which is in the same group as the Company or which has common shareholdings. |
| --- | --- |
| 36<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
Disclosure of information
| 19.13 | The directors may release or disclose to a third party any information regarding the affairs of the Company,<br>including any information contained in the Register of Members relating to a Member, (and they may authorise any director, Officer or<br>other authorised agent of the Company to release or disclose to a third party any such information in his possession) if: |
|---|---|
| (a) | the Company or that person, as the case may be, is lawfully required to do so under the laws of any jurisdiction<br>to which the Company is subject; or |
| --- | --- |
| (b) | such disclosure is in compliance with the rules of any stock exchange upon which the Company’s shares<br>are listed; or |
| --- | --- |
| (c) | such disclosure is in accordance with any contract entered into by the Company; or |
| --- | --- |
| (d) | the directors are of the opinion such disclosure would assist or facilitate the Company’s operations. |
| --- | --- |
| 20. | Delegation of powers |
| --- | --- |
Power to delegate any of the directors’ powers to a committee
| 20.1 | The directors may delegate any of their powers to any committee consisting of one or more persons who<br>need not be Members (including, without limitation, the Audit Committee, the Compensation Committee and the Nominating Committee). Persons<br>on the committee may include non-directors so long as the majority of those persons are directors. |
|---|---|
| 20.2 | The delegation may be collateral with, or to the exclusion of, the directors’ own powers. |
| --- | --- |
| 20.3 | The delegation may be on such terms as the directors think fit, including provision for the committee<br>itself to delegate to a sub-committee; save that any delegation must be capable of being revoked or altered by the directors at will. |
| --- | --- |
| 20.4 | Unless otherwise permitted by the directors, a committee must follow the procedures prescribed for the<br>taking of decisions by directors. |
| --- | --- |
| 20.5 | The directors may adopt formal written charters for committees and, if so adopted, shall review and assess<br>the adequacy of such formal written charters on an annual basis. Each of these committees shall be empowered to do all things necessary<br>to exercise the rights of such committee set forth in the Articles and shall have such powers as the directors may delegate pursuant to<br>the Articles and as required by the rules and regulations of the Designated Stock Exchange, the SEC and/or any other competent regulatory<br>authority or otherwise under Applicable Law. Each of the Audit Committee, the Compensation Committee and the Nominating Committee, if<br>established, shall consist of such number of directors as the directors shall from time to time determine (or such minimum number as may<br>be required from time to time by the rules and regulations of the Designated Stock Exchange, the SEC and/or any other competent regulatory<br>authority or otherwise under Applicable Law). For so long as any class of Shares is listed on the Designated Stock Exchange, the Audit<br>Committee, the Compensation Committee and the Nominating and Corporate Governance Committee shall be made up of such number of Independent<br>Directors as is required from time to time by the rules and regulations of the rules and regulations of the Designated Stock Exchange,<br>the SEC and/or any other competent regulatory authority or otherwise under Applicable Law. |
| --- | --- |
| 37<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
Power to appoint an agent of the Company
| 20.6 | The directors may appoint any person, either generally or in respect of any specific matter, to be the<br>agent of the Company with or without authority for that person to delegate all or any of that person’s powers. The directors may<br>make that appointment: |
|---|---|
| (a) | by causing the Company to enter into a power of attorney or agreement; or |
| --- | --- |
| (b) | in any other manner they determine. |
| --- | --- |
Power to appoint an attorney or authorised signatory of the Company
| 20.7 | The directors may appoint any person, whether nominated directly or indirectly by the directors, to be<br>the attorney or the authorised signatory of the Company. The appointment may be: |
|---|---|
| (a) | for any purpose; |
| --- | --- |
| (b) | with the powers, authorities and discretions; |
| --- | --- |
| (c) | for the period; and |
| --- | --- |
| (d) | subject to such conditions |
| --- | --- |
as they think fit. The powers, authorities and discretions, however, must not exceed those vested in, or exercisable, by the directors under these Articles. The directors may do so by power of attorney or any other manner they think fit.
| 20.8 | Any power of attorney or other appointment may contain such provision for the protection and convenience<br>for persons dealing with the attorney or authorised signatory as the directors think fit. Any power of attorney or other appointment may<br>also authorise the attorney or authorised signatory to delegate all or any of the powers, authorities and discretions vested in that person. |
|---|
Power to appoint a proxy
| 20.9 | Any director may appoint any other person, including another director, to represent him at any meeting<br>of the directors. If a director appoints a proxy, then for all purposes the presence or vote of the proxy shall be deemed to be that of<br>the appointing director. |
|---|---|
| 20.10 | Articles 18.1 to 18.5 inclusive (relating to the appointment by directors of alternate directors)<br>apply, mutatis mutandis, to the appointment of proxies by directors. |
| --- | --- |
| 20.11 | A proxy is an agent of the director appointing him and is not an Officer. |
| --- | --- |
| 21. | Meetings of directors |
| --- | --- |
Regulation of directors’ meetings
| 21.1 | Subject to the provisions of these Articles, the directors may regulate their proceedings as they think<br>fit. |
|---|---|
| 38<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
Calling meetings
| 21.2 | Any director may call a meeting of directors at any time. The Secretary, if any, must call a meeting of<br>the directors if requested to do so by a director. |
|---|
Notice of meetings
| 21.3 | Every director shall be given notice of a meeting, although a director may waive retrospectively the requirement<br>to be given notice. Notice may be oral. Attendance at a meeting without written objection shall be deemed to be a waiver of such notice<br>requirement. |
|---|
Period of notice
| 21.4 | At least five Clear Days’ notice of a meeting of directors must be given to directors. A meeting<br>may be convened on shorter notice with the consent of all directors. |
|---|
Use of technology
| 21.5 | A director may participate in a meeting of directors through the medium of conference telephone, video<br>or any other form of communications equipment providing all persons participating in the meeting are able to hear and speak to each other<br>throughout the meeting. |
|---|---|
| 21.6 | A director participating in this way is deemed to be present in person at the meeting. |
| --- | --- |
Place of meetings
| 21.7 | If all the directors participating in a meeting are not in the same place, they may decide that the meeting<br>is to be treated as taking place wherever any of them is. |
|---|
Quorum
| 21.8 | The quorum for the transaction of business at a meeting of directors shall be two unless the directors<br>fix some other number or unless the Company has only one director. |
|---|
Voting
| 21.9 | A question which arises at a board meeting shall be decided by a majority of votes. If votes are equal<br>the chairman may, if he wishes, exercise a casting vote. |
|---|
Validity
| 21.10 | Anything done at a meeting of directors is unaffected by the fact that it is later discovered that any<br>person was not properly appointed, or had ceased to be a director, or was otherwise not entitled to vote. |
|---|---|
| 39<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
Recording of dissent
| 21.11 | A director present at a meeting of directors shall be presumed to have assented to any action taken at<br>that meeting unless: |
|---|---|
| (a) | his dissent is entered in the minutes of the meeting; or |
| --- | --- |
| (b) | he has filed with the meeting before it is concluded signed dissent from that action; or |
| --- | --- |
| (c) | he has forwarded to the Company as soon as practical following the conclusion of that meeting signed dissent. |
| --- | --- |
A director who votes in favour of an action is not entitled to record his dissent to it.
Written resolutions
| 21.12 | The directors may pass a resolution in writing without holding a meeting if all directors sign a document<br>or sign several documents in the like form each signed by one or more of those directors. |
|---|---|
| 21.13 | Despite the foregoing, a resolution in writing signed by a validly appointed alternate director or by<br>a validly appointed proxy need not also be signed by the appointing director. If a written resolution is signed personally by the appointing<br>director, it need not also be signed by his alternate or proxy. |
| --- | --- |
| 21.14 | Such written resolution shall be as effective as if it had been passed at a meeting of the directors duly<br>convened and held; and it shall be treated as having been passed on the day and at the time that the last director signs. |
| --- | --- |
Sole director’s minute
| 21.15 | Where a sole director signs a minute recording his decision on a question, that record shall constitute<br>the passing of a resolution in those terms. |
|---|---|
| 22. | Permissible directors’ interests and disclosure |
| --- | --- |
Permissible interests subject to disclosure
| 22.1 | Save as expressly permitted by these Articles or as set out below, a director may not have a direct or<br>indirect interest or duty which conflicts or may possibly conflict with the interests of the Company. |
|---|---|
| 22.2 | If, notwithstanding the prohibition in the preceding Article, a director discloses to his fellow directors<br>the nature and extent of any material interest or duty in accordance with the next Article, he may: |
| --- | --- |
| (a) | be a party to, or otherwise interested in, any transaction or arrangement with the Company or in which<br>the Company is or may otherwise be interested; or |
| --- | --- |
| (b) | be interested in another body corporate promoted by the Company or in which the Company is otherwise interested.<br>In particular, the director may be a director, secretary or officer of, or employed by, or be a party to any transaction or arrangement<br>with, or otherwise interested in, that other body corporate. |
| --- | --- |
| 40<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| 22.3 | Such disclosure may be made at a meeting of the board or otherwise (and, if otherwise, it must be made<br>in writing). The director must disclose the nature and extent of his direct or indirect interest in or duty in relation to a transaction<br>or arrangement or series of transactions or arrangements with the Company or in which the Company has any material interest. |
| --- | --- |
| 22.4 | If a director has made disclosure in accordance with the preceding Article, then he shall not, by reason<br>only of his office, be accountable to the Company for any benefit that he derives from any such transaction or arrangement or from any<br>such office or employment or from any interest in any such body corporate, and no such transaction or arrangement shall be liable to be<br>avoided on the ground of any such interest or benefit. |
| --- | --- |
Notification of interests
| 22.5 | For the purposes of the preceding Articles: |
|---|---|
| (a) | a general notice that a director gives to the other directors that he is to be regarded as having an interest<br>of the nature and extent specified in the notice in any transaction or arrangement in which a specified person or class of persons is<br>interested shall be deemed to be a disclosure that he has an interest in or duty in relation to any such transaction of the nature and<br>extent so specified; and |
| --- | --- |
| (b) | an interest of which a director has no knowledge and of which it is unreasonable to expect him to have<br>knowledge shall not be treated as an interest of his. |
| --- | --- |
Voting where a director is interested in a matter
| 22.6 | A director may vote at a meeting of directors on any resolution concerning a matter in which that director<br>has an interest or duty, whether directly or indirectly, so long as that director discloses any material interest pursuant to these Articles.<br>The director shall be counted towards a quorum of those present at the meeting. If the director votes on the resolution, his vote shall<br>be counted. |
|---|---|
| 22.7 | Where proposals are under consideration concerning the appointment of two or more directors to offices<br>or employment with the Company or any body corporate in which the Company is interested, the proposals may be divided and considered in<br>relation to each director separately and each of the directors concerned shall be entitled to vote and be counted in the quorum in respect<br>of each resolution except that concerning his or her own appointment. |
| --- | --- |
| 23. | Minutes |
| --- | --- |
The Company shall cause minutes to be made in books kept for the purpose in accordance with the Act.
| 24. | Accounts and audit |
|---|
Accounting and other records
| 24.1 | The directors must ensure that proper accounting and other records are kept, and that accounts and associated<br>reports are distributed in accordance with the requirements of the Act. |
|---|
No automatic right of inspection
| 24.2 | Members are only entitled to inspect the Company’s records if they are expressly entitled to do<br>so by law, or by resolution made by the directors or passed by Ordinary Resolution. |
|---|---|
| 41<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
Sending of accounts and reports
| 24.3 | The Company’s accounts and associated directors’ report or auditor’s report that are<br>required or permitted to be sent to any person pursuant to any law shall be treated as properly sent to that person if: |
|---|---|
| (a) | they are sent to that person in accordance with the notice provisions: or |
| --- | --- |
| (b) | they are published on a website providing that person is given separate notice of: |
| --- | --- |
| (i) | the fact that publication of the documents has been published on the website; |
| --- | --- |
| (ii) | the address of the website; and |
| --- | --- |
| (iii) | the place on the website where the documents may be accessed; and |
| --- | --- |
| (iv) | how they may be accessed. |
| --- | --- |
| 24.4 | If, for any reason, a person notifies the Company that he is unable to access the website, the Company<br>must, as soon as practicable, send the documents to that person by any other means permitted by these Articles. This, however, will not<br>affect when that person is taken to have received the documents under the next Article. |
| --- | --- |
Time of receipt if documents are published on a website
| 24.5 | Documents sent by being published on a website in accordance with the preceding two Articles are only<br>treated as sent at least five Clear Days before the date of the meeting at which they are to be laid if: |
|---|---|
| (a) | the documents are published on the website throughout a period beginning at least five Clear Days before<br>the date of the meeting and ending with the conclusion of the meeting; and |
| --- | --- |
| (b) | the person is given at least five Clear Days’ notice of the hearing. |
| --- | --- |
Validity despite accidental error in publication on website
| 24.6 | If, for the purpose of a meeting, documents are sent by being published on a website in accordance with<br>the preceding Articles, the proceedings at that meeting are not invalidated merely because: |
|---|---|
| (a) | those documents are, by accident, published in a different place on the website to the place notified;<br>or |
| --- | --- |
| (b) | they are published for part only of the period from the date of notification until the conclusion of that<br>meeting. |
| --- | --- |
Audit
| 24.7 | The directors may appoint an Auditor of the Company who shall hold office on such terms as the directors<br>determine. |
|---|---|
| 42<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| 24.8 | Without prejudice to the freedom of the directors to establish any other committee, if the Shares (or<br>depositary receipts therefor) are listed or quoted on the Designated Stock Exchange, and if required by the Designated Stock Exchange,<br>the directors shall establish and maintain an Audit Committee as a committee of the directors and shall adopt a formal written Audit Committee<br>charter and review and assess the adequacy of the formal written charter on an annual basis. The composition and responsibilities of the<br>Audit Committee shall comply with the rules and regulations of the SEC and the Designated Stock Exchange. The Audit Committee shall meet<br>at least once every financial quarter, or more frequently as circumstances dictate. |
| --- | --- |
| 24.9 | If the Shares are listed or quoted on the Designated Stock Exchange, the Company shall conduct an appropriate<br>review of all related party transactions on an ongoing basis and shall utilise the Audit Committee for the review and approval of potential<br>conflicts of interest. |
| --- | --- |
| 24.10 | The remuneration of the Auditor shall be fixed by the Audit Committee (if one exists). |
| --- | --- |
| 24.11 | If the office of Auditor becomes vacant by resignation or death of the Auditor, or by his becoming incapable<br>of acting by reason of illness or other disability at a time when his services are required, the directors shall fill the vacancy and<br>determine the remuneration of such Auditor. |
| --- | --- |
| 24.12 | Every Auditor of the Company shall have a right of access at all times to the books and accounts and vouchers<br>of the Company and shall be entitled to require from the directors and officers of the Company such information and explanation as may<br>be necessary for the performance of the duties of the Auditor. |
| --- | --- |
| 24.13 | Auditors shall, if so required by the directors, make a report on the accounts of the Company during their<br>tenure of office at the next annual general meeting following their appointment in the case of a company which is registered with the<br>Registrar of Companies as an ordinary company, and at the next extraordinary general meeting following their appointment in the case of<br>a company which is registered with the Registrar of Companies as an exempted company, and at any other time during their term of office,<br>upon request of the directors or any general meeting of the Members. |
| --- | --- |
| 24.14 | Any payment made to members of the Audit Committee (if one exists) shall require the review and approval<br>of the directors, with any director interested in such payment abstaining from such review and approval. |
| --- | --- |
| 24.15 | The Audit Committee shall monitor compliance with the terms of the IPO and, if any non-compliance is identified,<br>the Audit Committee shall be charged with the responsibility to take all action necessary to rectify such non-compliance or otherwise<br>cause compliance with the terms of the IPO. |
| --- | --- |
| 25. | Financial year |
| --- | --- |
Unless the directors otherwise specify, the financial year of the Company:
| (a) | shall end on 30th September in the year of its incorporation and each following year; and |
|---|---|
| (b) | shall begin when it was incorporated and on 1st October each following year. |
| --- | --- |
| 43<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| 26. | Record dates |
| --- | --- |
Except to the extent of any conflicting rights attached to Shares, the directors may fix any time and date as the record date for:
| (a) | calling a general meeting; |
|---|---|
| (b) | declaring or paying a dividend; |
| --- | --- |
| (c) | making or issuing an allotment of Shares; or |
| --- | --- |
| (d) | conducting any other business required pursuant to these Articles. |
| --- | --- |
The record date may be before or after the date on which a dividend, allotment or issue is declared, paid or made.
| 27. | Dividends |
|---|
Declaration of dividends by Members
| 27.1 | Subject to the provisions of the Act, the Company may by Ordinary Resolution declare dividends in accordance<br>with the respective rights of the Members but no dividend shall exceed the amount recommended by the directors. |
|---|
Payment of interim dividends and declaration of final dividends by directors
| 27.2 | The directors may pay interim dividends or declare final dividends in accordance with the respective rights<br>of the Members if it appears to them that they are justified by the financial position of the Company and that such dividends may lawfully<br>be paid. |
|---|---|
| 27.3 | Subject to the provisions of the Act, in relation to the distinction between interim dividends and final<br>dividends, the following applies: |
| --- | --- |
| (a) | Upon determination to pay a dividend or dividends described as interim by the directors in the dividend<br>resolution, no debt shall be created by the declaration until such time as payment is made. |
| --- | --- |
| (b) | Upon declaration of a dividend or dividends described as final by the directors in the dividend resolution,<br>a debt shall be created immediately following the declaration, the due date to be the date the dividend is stated to be payable in the<br>resolution. |
| --- | --- |
If the resolution fails to specify whether a dividend is final or interim, it shall be assumed to be interim.
| 27.4 | In relation to Shares carrying differing rights to dividends or rights to dividends at a fixed rate, the<br>following applies: |
|---|---|
| (a) | If the share capital is divided into different classes, the directors may pay dividends on Shares which<br>confer deferred or non-preferred rights with regard to dividends as well as on Shares which confer preferential rights with regard to<br>dividends but no dividend shall be paid on Shares carrying deferred or non-preferred rights if, at the time of payment, any preferential<br>dividend is in arrears. |
| --- | --- |
| (b) | The directors may also pay, at intervals settled by them, any dividend payable at a fixed rate if it appears<br>to them that there are sufficient funds of the Company lawfully available for distribution to justify the payment. |
| --- | --- |
| 44<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| (c) | If the directors act in good faith, they shall not incur any liability to the Members holding Shares conferring<br>preferred rights for any loss those Members may suffer by the lawful payment of the dividend on any Shares having deferred or non-preferred<br>rights. |
| --- | --- |
Apportionment of dividends
| 27.5 | Except as otherwise provided by the rights attached to Shares, all dividends shall be declared and paid<br>according to the amounts paid up on the Shares on which the dividend is paid. All dividends shall be apportioned and paid proportionately<br>to the amount paid up on the Shares during the time or part of the time in respect of which the dividend is paid. If a Share is issued<br>on terms providing that it shall rank for dividend as from a particular date, that Share shall rank for dividend accordingly. |
|---|
Right of set off
| 27.6 | The directors may deduct from a dividend or any other amount payable to a person in respect of a Share<br>any amount due by that person to the Company on a call or otherwise in relation to a Share. |
|---|
Power to pay other than in cash
| 27.7 | If the directors so determine, any resolution declaring a dividend may direct that it shall be satisfied<br>wholly or partly by the distribution of assets. If a difficulty arises in relation to the distribution, the directors may settle that<br>difficulty in any way they consider appropriate. For example, they may do any one or more of the following: |
|---|---|
| (a) | issue fractional Shares; |
| --- | --- |
| (b) | fix the value of assets for distribution and make cash payments to some Members on the footing of the<br>value so fixed in order to adjust the rights of Members; and |
| --- | --- |
| (c) | vest some assets in trustees. |
| --- | --- |
How payments may be made
| 27.8 | A dividend or other monies payable on or in respect of a Share may be paid in any of the following ways: |
|---|---|
| (a) | if the Member holding that Share or other person entitled to that Share nominates a bank account for that<br>purpose - by wire transfer to that bank account; or |
| --- | --- |
| (b) | by cheque or warrant sent by post to the registered address of the Member holding that Share or other<br>person entitled to that Share. |
| --- | --- |
| 27.9 | For the purpose of paragraph (a) of the preceding Article, the nomination may be in writing or in<br>an Electronic Record and the bank account nominated may be the bank account of another person. For the purpose of paragraph (b) of<br>the preceding Article, subject to any Applicable Law or regulation, the cheque or warrant shall be made to the order of the Member holding<br>that Share or other person entitled to the Share or to his nominee, whether nominated in writing or in an Electronic Record, and payment<br>of the cheque or warrant shall be a good discharge to the Company. |
| --- | --- |
| 45<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| 27.10 | If two or more persons are registered as the holders of the Share or are jointly entitled to it by reason<br>of the death or bankruptcy of the registered holder (Joint Holders), a dividend (or other amount) payable on or in respect of that Share<br>may be paid as follows: |
| --- | --- |
| (a) | to the registered address of the Joint Holder of the Share who is named first on the Register of Members<br>or to the registered address of the deceased or bankrupt holder, as the case may be; or |
| --- | --- |
| (b) | to the address or bank account of another person nominated by the Joint Holders, whether that nomination<br>is in writing or in an Electronic Record. |
| --- | --- |
| 27.11 | Any Joint Holder of a Share may give a valid receipt for a dividend (or other amount) payable in respect<br>of that Share. |
| --- | --- |
Dividends or other moneys not to bear interest in absence of special rights
| 27.12 | Unless provided for by the rights attached to a Share, no dividend or other monies payable by the Company<br>in respect of a Share shall bear interest. |
|---|
Dividends unable to be paid or unclaimed
| 27.13 | If a dividend cannot be paid to a Member or remains unclaimed within six weeks after it was declared or<br>both, the directors may pay it into a separate account in the Company’s name. If a dividend is paid into a separate account, the<br>Company shall not be constituted trustee in respect of that account and the dividend shall remain a debt due to the Member. |
|---|---|
| 27.14 | A dividend that remains unclaimed for a period of six years after it became due for payment shall be forfeited<br>to, and shall cease to remain owing by, the Company. |
| --- | --- |
| 28. | Capitalisation of profits |
| --- | --- |
Capitalisation of profits or of any share premium account or capital redemption reserve
| 28.1 | The directors may resolve to capitalise: |
|---|---|
| (a) | any part of the Company’s profits not required for paying any preferential dividend (whether or<br>not those profits are available for distribution); or |
| --- | --- |
| (b) | any sum standing to the credit of the Company’s share premium account or capital redemption reserve,<br>if any. |
| --- | --- |
The amount resolved to be capitalised must be appropriated to the Members who would have been entitled to it had it been distributed by way of dividend and in the same proportions. The benefit to each Member so entitled must be given in either or both of the following ways:
| (a) | by paying up the amounts unpaid on that Member’s Shares; |
|---|---|
| (b) | by issuing Fully Paid Shares, debentures or other securities of the Company to that Member or as that<br>Member directs. The directors may resolve that any Shares issued to the Member in respect of partly paid Shares (Original Shares) rank<br>for dividend only to the extent that the Original Shares rank for dividend while those Original Shares remain partly paid. |
| --- | --- |
| 46<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
Applying an amount for the benefit of members
| 28.2 | The amount capitalised must be applied to the benefit of Members in the proportions to which the Members<br>would have been entitled to dividends if the amount capitalised had been distributed as a dividend. |
|---|---|
| 28.3 | Subject to the Act, if a fraction of a Share, a debenture, or other security is allocated to a Member,<br>the directors may issue a fractional certificate to that Member or pay him the cash equivalent of the fraction. |
| --- | --- |
| 29. | Share premium account |
| --- | --- |
Directors to maintain share premium account
| 29.1 | The directors shall establish a share premium account in accordance with the Act. They shall carry to<br>the credit of that account from time to time an amount equal to the amount or value of the premium paid on the issue of any Share or capital<br>contributed or such other amounts required by the Act. |
|---|
Debits to share premium account
| 29.2 | The following amounts shall be debited to any share premium account: |
|---|---|
| (a) | on the redemption or purchase of a Share, the difference between the nominal value of that Share and the<br>redemption or purchase price; and |
| --- | --- |
| (b) | any other amount paid out of a share premium account as permitted by the Act. |
| --- | --- |
| 29.3 | Notwithstanding the preceding Article, on the redemption or purchase of a Share, the directors may pay<br>the difference between the nominal value of that Share and the redemption purchase price out of the profits of the Company or, as permitted<br>by the Act, out of capital. |
| --- | --- |
| 30. | Seal |
| --- | --- |
Company seal
| 30.1 | The Company may have a seal if the directors so determine. |
|---|---|
| 47<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
Duplicate seal
| 30.2 | Subject to the provisions of the Act, the Company may also have a duplicate seal or seals for use in any<br>place or places outside the Cayman Islands. Each duplicate seal shall be a facsimile of the original seal of the Company. However, if<br>the directors so determine, a duplicate seal shall have added on its face the name of the place where it is to be used. |
|---|
When and how seal is to be used
| 30.3 | A seal may only be used by the authority of the directors. Unless the directors otherwise determine, a<br>document to which a seal is affixed must be signed in one of the following ways: |
|---|---|
| (a) | by a director (or his alternate) and the Secretary; or |
| --- | --- |
| (b) | by a single director (or his alternate). |
| --- | --- |
If no seal is adopted or used
| 30.4 | If the directors do not adopt a seal, or a seal is not used, a document may be executed in the following<br>manner: |
|---|---|
| (a) | by a director (or his alternate) or any Officer to which authority has been delegated by resolution duly<br>adopted by the directors; or |
| --- | --- |
| (b) | by a single director (or his alternate); or |
| --- | --- |
| (c) | in any other manner permitted by the Act. |
| --- | --- |
Power to allow non-manual signatures and facsimile printing of seal
| 30.5 | The directors may determine that either or both of the following applies: |
|---|---|
| (a) | that the seal or a duplicate seal need not be affixed manually but may be affixed by some other method<br>or system of reproduction; |
| --- | --- |
| (b) | that a signature required by these Articles need not be manual but may be a mechanical or Electronic Signature. |
| --- | --- |
Validity of execution
| 30.6 | If a document is duly executed and delivered by or on behalf of the Company, it shall not be regarded<br>as invalid merely because, at the date of the delivery, the Secretary, or the director, or other Officer or person who signed the document<br>or affixed the seal for and on behalf of the Company ceased to be the Secretary or hold that office and authority on behalf of the Company. |
|---|---|
| 31. | Indemnity |
| --- | --- |
Indemnity
| 31.1 | To the extent permitted by Applicable Law, the Company shall indemnify each existing or former Secretary,<br>director (including alternate director), and other Officer of the Company (including an investment adviser or an administrator or liquidator)<br>and their personal representatives against: |
|---|---|
| (a) | all actions, proceedings, costs, charges, expenses, losses, damages or liabilities incurred or sustained<br>by the existing or former Secretary, director or Officer in or about the conduct of the Company’s business or affairs or in the<br>execution or discharge of the existing or former Secretary’s, director’s or Officer’s duties, powers, authorities or<br>discretions; and |
| --- | --- |
| 48<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| (b) | without limitation to paragraph (a), all costs, expenses, losses or liabilities incurred by the existing<br>or former Secretary, director or Officer in defending (whether successfully or otherwise) any civil, criminal, administrative or investigative<br>proceedings (whether threatened, pending or completed) concerning the Company or its affairs in any court or tribunal, whether in the<br>Cayman Islands or elsewhere. |
| --- | --- |
Such indemnity only applies if the directors are of the view that, in the absence of fraud, wilful default or wilful neglect, such existing or former Secretary, director or Officer acted honestly and in good faith with a view to what the person believes is in the best interests of the Company and, in the case of criminal proceedings, such person had no reasonable cause to believe that their conduct was unlawful. No such existing or former Secretary, director or Officer, however, shall be indemnified in respect of any matter arising out of his own actual fraud, wilful default or wilful neglect.
| 31.2 | To the extent permitted by Applicable Law, the Company may make a payment, or agree to make a payment,<br>whether by way of advance, loan or otherwise, for any legal costs incurred by an existing or former Secretary, director or Officer of<br>the Company in respect of any matter identified in paragraph (a) or paragraph (b) of the preceding Article on condition that<br>the Secretary, director or Officer must repay the amount paid by the Company to the extent that it is ultimately found not liable to indemnify<br>the Secretary, director or that Officer for those legal costs. |
|---|
Release
| 31.3 | To the extent permitted by Applicable Law, the Company may by Special Resolution release any existing<br>or former director (including alternate director), Secretary or other Officer of the Company from liability for any loss or damage or<br>right to compensation which may arise out of or in connection with the execution or discharge of the duties, powers, authorities or discretions<br>of his office; but there may be no release from liability arising out of or in connection with that person’s own actual fraud, wilful<br>default or wilful neglect. |
|---|
Insurance
| 31.4 | To the extent permitted by Applicable Law, the Company may pay, or agree to pay, a premium in respect<br>of a contract insuring each of the following persons against risks determined by the directors, other than liability arising out of that<br>person’s own dishonesty: |
|---|---|
| (a) | an existing or former director (including alternate director), Secretary or Officer or auditor of: |
| --- | --- |
| (i) | the Company; |
| --- | --- |
| (ii) | a company which is or was a subsidiary of the Company; |
| --- | --- |
| (iii) | a company in which the Company has or had an interest (whether direct or indirect); and |
| --- | --- |
| (b) | a trustee of an employee or retirement benefits scheme or other trust in which any of the persons referred<br>to in paragraph (a) is or was interested. |
| --- | --- |
| 49<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| 32. | Notices |
| --- | --- |
Form of notices
| 32.1 | Save where these Articles provide otherwise, any notice to be given to or by any person pursuant to these<br>Articles shall be: |
|---|---|
| (a) | in writing signed by or on behalf of the giver in the manner set out below for written notices; or |
| --- | --- |
| (b) | subject to the next Article, in an Electronic Record signed by or on behalf of the giver by Electronic<br>Signature and authenticated in accordance with Articles about authentication of Electronic Records; or |
| --- | --- |
| (c) | where these Articles expressly permit, by the Company by means of a website. |
| --- | --- |
Electronic communications
| 32.2 | Without limitation to Articles 18.1 to 18.5 inclusive (relating to the appointment and removal<br>by directors of alternate directors) and to Articles 20.9 to 20.11 inclusive (relating to the appointment by directors of proxies),<br>a notice may only be given to the Company in an Electronic Record if: |
|---|---|
| (a) | the directors so resolve; |
| --- | --- |
| (b) | the resolution states how an Electronic Record may be given and, if applicable, specifies an email address<br>for the Company; and |
| --- | --- |
| (c) | the terms of that resolution are notified to the Members for the time being and, if applicable, to those<br>directors who were absent from the meeting at which the resolution was passed. |
| --- | --- |
If the resolution is revoked or varied, the revocation or variation shall only become effective when its terms have been similarly notified.
| 32.3 | A notice may not be given by Electronic Record to a person other than the Company unless the recipient<br>has notified the giver of an Electronic address to which notice may be sent. |
|---|
Persons authorised to give notices
| 32.4 | A notice by either the Company or a Member pursuant to these Articles may be given on behalf of the Company<br>or a Member by a director or company secretary of the Company or a Member. |
|---|
Delivery of written notices
| 32.5 | Save where these Articles provide otherwise, a notice in writing may be given personally to the recipient,<br>or left at (as appropriate) the Member’s or director’s registered address or the Company’s registered office, or posted<br>to that registered address or registered office. |
|---|---|
| 50<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
Joint holders
| 32.6 | Where Members are joint holders of a Share, all notices shall be given to the Member whose name first<br>appears in the Register of Members. |
|---|
Signatures
| 32.7 | A written notice shall be signed when it is autographed by or on behalf of the giver, or is marked in<br>such a way as to indicate its execution or adoption by the giver. |
|---|---|
| 32.8 | An Electronic Record may be signed by an Electronic Signature. |
| --- | --- |
Evidence of transmission
| 32.9 | A notice given by Electronic Record shall be deemed sent if an Electronic Record is kept demonstrating<br>the time, date and content of the transmission, and if no notification of failure to transmit is received by the giver. |
|---|---|
| 32.10 | A notice given in writing shall be deemed sent if the giver can provide proof that the envelope containing<br>the notice was properly addressed, pre-paid and posted, or that the written notice was otherwise properly transmitted to the recipient. |
| --- | --- |
Giving notice to a deceased or bankrupt Member
| 32.11 | A notice may be given by the Company to the persons entitled to a Share in consequence of the death or<br>bankruptcy of a Member by sending or delivering it, in any manner authorised by these Articles for the giving of notice to a Member, addressed<br>to them by name, or by the title of representatives of the deceased, or trustee of the bankrupt or by any like description, at the address,<br>if any, supplied for that purpose by the persons claiming to be so entitled. |
|---|---|
| 32.12 | Until such an address has been supplied, a notice may be given in any manner in which it might have been<br>given if the death or bankruptcy had not occurred. |
| --- | --- |
Date of giving notices
| 32.13 | A notice is given on the date identified in the following table. |
|---|---|
| Method for giving notices | When taken to be given |
| --- | --- |
| Personally | At the time and date of delivery |
| By leaving it at the member’s registered address | At the time and date it was left |
| If the recipient has an address within the Cayman Islands, by posting it by prepaid post to the street or postal address of that recipient | 48 hours after it was posted |
| If the recipient has an address outside the Cayman Islands, by posting it by prepaid airmail to the street or postal address of that recipient | 3 Clear Days after posting |
| By Electronic Record (other than publication on a website), to recipient’s Electronic address | Within 24 hours after it was sent |
| By publication on a website | See these Articles about the time when notice of a meeting of Members or accounts and reports, as the case may be, are published on a website |
| 51<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
Saving provision
| 32.14 | None of the preceding notice provisions shall derogate from these Articles about the delivery of written<br>resolutions of directors and written resolutions of Members. |
|---|---|
| 33. | Authentication of Electronic Records |
| --- | --- |
Application of Articles
| 33.1 | Without limitation to any other provision of these Articles, any notice, written resolution or other document<br>under these Articles that is sent by Electronic means by a Member, or by the Secretary, or by a director or other Officer of the Company,<br>shall be deemed to be authentic if either Article 33.2 or Article 33.4 applies. |
|---|
Authentication of documents sent by Members by Electronic means
| 33.2 | An Electronic Record of a notice, written resolution or other document sent by Electronic means by or<br>on behalf of one or more Members shall be deemed to be authentic if the following conditions are satisfied: |
|---|---|
| (a) | the Member or each Member, as the case may be, signed the original document, and for this purpose Original<br>Document includes several documents in like form signed by one or more of those Members; and |
| --- | --- |
| (b) | the Electronic Record of the Original Document was sent by Electronic means by, or at the direction of,<br>that Member to an address specified in accordance with these Articles for the purpose for which it was sent; and |
| --- | --- |
| (c) | Article 33.7 does not apply. |
| --- | --- |
| 33.3 | For example, where a sole Member signs a resolution and sends the Electronic Record of the original resolution,<br>or causes it to be sent, by facsimile transmission to the address in these Articles specified for that purpose, the facsimile copy shall<br>be deemed to be the written resolution of that Member unless Article 33.7 applies. |
| --- | --- |
Authentication of document sent by the Secretary or Officers of the Company by Electronic means
| 33.4 | An Electronic Record of a notice, written resolution or other document sent by or on behalf of the Secretary<br>or an Officer or Officers of the Company shall be deemed to be authentic if the following conditions are satisfied: |
|---|---|
| (a) | the Secretary or the Officer or each Officer, as the case may be, signed the original document, and for<br>this purpose Original Document includes several documents in like form signed by the Secretary or one or more of those Officers; and |
| --- | --- |
| (b) | the Electronic Record of the Original Document was sent by Electronic means by, or at the direction of,<br>the Secretary or that Officer to an address specified in accordance with these Articles for the purpose for which it was sent; and |
| --- | --- |
| 52<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| (c) | Article 33.7 does not apply. |
| --- | --- |
This Article applies whether the document is sent by or on behalf of the Secretary or Officer in his own right or as a representative of the Company.
| 33.5 | For example, where a sole director signs a resolution and scans the resolution, or causes it to be scanned,<br>as a PDF version which is attached to an email sent to the address in these Articles specified for that purpose, the PDF version shall<br>be deemed to be the written resolution of that director unless Article 33.7 applies. |
|---|
Manner of signing
| 33.6 | For the purposes of these Articles about the authentication of Electronic Records, a document will be<br>taken to be signed if it is signed manually or in any other manner permitted by these Articles. |
|---|
Saving provision
| 33.7 | A notice, written resolution or other document under these Articles will not be deemed to be authentic<br>if the recipient, acting reasonably: |
|---|---|
| (a) | believes that the signature of the signatory has been altered after the signatory had signed the original<br>document; or |
| --- | --- |
| (b) | believes that the original document, or the Electronic Record of it, was altered, without the approval<br>of the signatory, after the signatory signed the original document; or |
| --- | --- |
| (c) | otherwise doubts the authenticity of the Electronic Record of the document |
| --- | --- |
and the recipient promptly gives notice to the sender setting the grounds of its objection. If the recipient invokes this Article, the sender may seek to establish the authenticity of the Electronic Record in any way the sender thinks fit.
| 34. | Transfer by way of continuation |
|---|---|
| 34.1 | The Company may, by Special Resolution, resolve to be registered by way of continuation in a jurisdiction<br>outside: |
| --- | --- |
| (a) | the Cayman Islands; or |
| --- | --- |
| (b) | such other jurisdiction in which it is, for the time being, incorporated, registered or existing. |
| --- | --- |
| 34.2 | To give effect to any resolution made pursuant to the preceding Article, the directors may cause the following: |
| --- | --- |
| (a) | an application be made to the Registrar of Companies to deregister the Company in the Cayman Islands or<br>in the other jurisdiction in which it is for the time being incorporated, registered or existing; and |
| --- | --- |
| (b) | all such further steps as they consider appropriate to be taken to effect the transfer by way of continuation<br>of the Company. |
| --- | --- |
| 53<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| 35. | Winding up |
| --- | --- |
Distribution of assets in specie
| 35.1 | If the Company is wound up, the Members may, subject to these Articles and any other sanction required<br>by the Act, pass a Special Resolution allowing the liquidator to do either or both of the following: |
|---|---|
| (a) | to divide in specie among the Members the whole or any part of the assets of the Company and, for that<br>purpose, to value any assets and to determine how the division shall be carried out as between the Members or different classes of Members; |
| --- | --- |
| (b) | to vest the whole or any part of the assets in trustees for the benefit of Members and those liable to<br>contribute to the winding up. |
| --- | --- |
No obligation to accept liability
| 35.2 | No Member shall be compelled to accept any assets if an obligation attaches to them. |
|---|
The directors are authorised to present a windingup petition
| 35.3 | The directors have the authority to present a petition for the winding up of the Company to the Grand<br>Court of the Cayman Islands on behalf of the Company without the sanction of a resolution passed at a general meeting. |
|---|---|
| 36. | Amendment of Memorandum and Articles |
| --- | --- |
Power to change name or amend Memorandum
| 36.1 | Subject to the Act, the Company may, by Special Resolution: |
|---|---|
| (a) | change its name; or |
| --- | --- |
| (b) | change the provisions of its Memorandum with respect to its objects, powers or any other matter specified<br>in the Memorandum. |
| --- | --- |
Power to amend these Articles
| 36.2 | Subject to the Act and as provided in these Articles, the Company may, by Special Resolution, amend these<br>Articles in whole or in part. |
|---|---|
| 37. | Mergers and Consolidations |
| --- | --- |
The Company shall have the power to merge or consolidate with one or more constituent companies (as defined in the Act) upon such terms as the directors may determine and (to the extent required by the Act) with the approval of a Special Resolution.
| 54<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
|---|---|
| 38. | Business Combination |
| --- | --- |
| 38.1 | Notwithstanding any other provision of these Articles, this Article 38 shall apply during the period<br>commencing upon the adoption of these Articles and terminating upon the first to occur of the consummation of any Business Combination<br>and the distribution of the Trust Account pursuant to Article 38.10. In the event of a conflict between this Article 38 and<br>any other Articles, the provisions of this Article 38 shall prevail and this Article may not be amended prior to the consummation<br>of a Business Combination without a Special Resolution. |
| --- | --- |
| 38.2 | Prior to the consummation of any Business Combination, the Company shall either: |
| --- | --- |
| (a) | submit such Business Combination to its Members for approval; or |
| --- | --- |
| (b) | provide Members with the opportunity to have their Shares repurchased by means of a tender offer (a TenderOffer) for a per-Share repurchase price payable in cash, equal to the aggregate amount then on deposit in the Trust Account, calculated<br>as of two business days prior to the consummation of such Business Combination, including interest earned on the funds held in the Trust<br>Account not previously released to the Company to pay its income and other taxes, if any, divided by the number of Public Shares then in issue,<br>provided that the Company shall not repurchase Public Shares in an amount that would cause the Company’s net tangible assets (after<br>payment of the deferred underwriting commissions) to be less than US$5,000,001. |
| --- | --- |
| 38.3 | If the Company initiates any Tender Offer in accordance with Rule 13e-4 and Regulation 14E of<br>the Exchange Act in connection with a proposed Business Combination, it shall file Tender Offer documents with the SEC prior to completing<br>such Business Combination which contain substantially the same financial and other information about such Business Combination and the<br>redemption rights as is required under Regulation 14A of the Exchange Act. |
| --- | --- |
| 38.4 | If, alternatively, the Company holds a general meeting to approve a proposed Business Combination, the<br>Company will conduct any redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, and<br>not pursuant to the Tender Offer rules, and file proxy materials with the SEC. |
| --- | --- |
| 38.5 | At a general meeting called for the purposes of approving a Business Combination pursuant to this Article,<br>in the event that such Business Combination is approved by Ordinary Resolution, the Company shall be authorised to consummate such Business<br>Combination. |
| --- | --- |
| 38.6 | Any Member holding Public Shares who is not a Founder, Officer or director may, contemporaneously<br> with any vote on a Business Combination, elect to have their Public Shares redeemed for cash (the IPO Redemption), provided<br> that no such Member acting together with any Affiliate of his or any other person with whom he is acting in concert or as a<br> partnership, syndicate, or other group for the purposes of acquiring, holding, or disposing of Shares may exercise this redemption<br> right with respect to more than 15% of the Public Shares without the Company’s prior consent, and provided further that<br> any holder that holds Public Shares beneficially through a nominee must identify itself to the Company in connection with any<br> redemption election in order to validly redeem such Public Shares. In connection with any vote held to approve a proposed Business<br> Combination, holders of Public Shares seeking to exercise their redemption rights will be required to either tender their<br> certificates (if any) to the Company’s transfer agent or to deliver their shares to the transfer agent electronically using<br> The Depository Trust Company’s DWAC (Deposit/Withdrawal At Custodian) System, at the holder’s option, in each case up to<br> two business days prior to the initially scheduled vote on the proposal to approve a Business Combination. If so demanded, the<br> Company shall pay any such redeeming Member, regardless of whether he is voting for or against such proposed Business Combination or<br> abstains from voting, a per-Share redemption price payable in cash, equal to the aggregate amount then on deposit in the Trust<br> Account calculated as of two business days prior to the consummation of a Business Combination, including interest earned on the<br> Trust Account not previously released to the Company to pay its income and other taxes, if any, divided by the number of Public<br> Shares then in issue (such redemption price being referred to herein as the Redemption Price), provided that the Company<br> shall not repurchase Public Shares in an amount that would cause the Company’s net tangible assets to be less than<br> US$5,000,001. |
| --- | --- |
| 55<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| 38.7 | The Redemption Price shall be paid promptly following the consummation of the relevant Business Combination.<br>If the proposed Business Combination is not approved or completed for any reason then such redemptions shall be cancelled and share certificates<br>(if any) returned to the relevant Members as appropriate. |
| --- | --- |
| 38.8 | The Company has until 12 months from the closing of the IPO to consummate a Business Combination,<br>provided however that if the Board of Directors anticipates that the Company may not be able to consummate a Business Combination within 12 months<br>of the closing of the IPO, the Company may, by Resolution of Directors, at the request of the Sponsor, extend the period of time to consummate<br>a Business Combination up to two times, each by an additional three months (for a total of up to 18 months to complete a Business<br>Combination), subject to the Sponsor depositing additional funds into the Trust Account upon five days advice notice prior to the applicable<br>deadline in accordance with terms as set out in the Trust Agreement and referred to in the Registration Statement. In the event that the<br>Company does not consummate a Business Combination by 12 months after the closing of the IPO (or 18 months from the<br>closing of the IPO (subject in the latter case to valid three months extensions having been made in each case) or such later time as the<br>Members of the Company may approve in accordance with these Articles, the Company shall: |
| --- | --- |
| (a) | cease all operations except for the purpose of winding up; |
| --- | --- |
| (b) | as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares,<br>at a per-Share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on<br>the funds held in the Trust Account and not previously released to the Company to pay income and other taxes, if any (which interest shall be net<br>of taxes payable and less up to $50,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided<br>by the number of the Public Shares then in issue, which redemption will completely extinguish public Members’ rights as Members<br>(including the right to receive further liquidation distributions, if any); and |
| --- | --- |
| (c) | as promptly as reasonably possible following such redemption, subject to the approval of the Company’s<br>remaining Members and the directors, liquidate and dissolve, |
| --- | --- |
subject in each case, to its obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of Applicable Law. If the Company shall wind up for any other reason prior to the consummation of a Business Combination, the Company shall, as promptly as reasonably possible but not more than ten business days thereafter, follow the foregoing procedures set out in this Article 38.8 with respect to the liquidation of the Trust Account, subject to its obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of Applicable Law.
| 56<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
|---|---|
| 38.9 | In the event that any amendment is made to these Articles: |
| --- | --- |
| (a) | that would modify the substance or timing of the Company’s obligation to provide holders of Public<br>Shares the right to: |
| --- | --- |
| (i) | have their shares redeemed or repurchased in connection with a Business Combination pursuant to Articles 38.2(b)<br>or 38.6; or |
| --- | --- |
| (ii) | redeem 100% of the Public Shares if the Company has not consummated an initial Business Combination within<br>12 months after the closing of the IPO (or 18 months from the date of the closing of the IPO pursuant to Article 38.8 (subject<br>in the latter case to valid three months extensions having been made in each case); or |
| --- | --- |
| (b) | with respect to any other provision relating to the rights of holders of Public Shares, |
| --- | --- |
each holder of Public Shares who is not a Founder, Officer or director shall be provided with the opportunity to redeem their Public Shares upon the approval of any such amendment (an Amendment Redemption) at a per-Share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account not previously released to the Company to pay income and other taxes, if any, divided by the number of Public Shares then in issue. In connection with any vote held to approve a proposed amendment to these Articles under this Article 38.9, holders of Public Shares seeking to exercise their Amendment Redemption rights will be required to either tender their certificates (if any) to the Company’s transfer agent or to deliver their shares to the transfer agent electronically using The Depository Trust Company’s DWAC (Deposit/Withdrawal At Custodian) System, at the holder’s option, in each case up to two business days prior to the initially scheduled vote on the proposal to approve a proposed amendment to these Articles under this Article 38.9.
| 38.10 | Except for the withdrawal of interest to pay income and<br>other taxes, if any, none of the funds held in the Trust<br>Account shall be released from the Trust Account: |
|---|---|
| (a) | to the Company, until completion of any Business Combination; or |
| --- | --- |
| (b) | to the Members holding Public Shares, until the earliest of: |
| --- | --- |
| (i) | a repurchase of Shares by means of a Tender Offer pursuant to Article 38.2(b); |
| --- | --- |
| (ii) | an IPO Redemption pursuant to Article 38.6; |
| --- | --- |
| (iii) | a distribution of the Trust Account pursuant to Article 38.8; or |
| --- | --- |
| (iv) | an Amendment Redemption pursuant to Article 38.9. |
| --- | --- |
In no other circumstance shall a holder of Public Shares have any right or interest of any kind in the Trust Account.
| 38.11 | After the issue of Public Shares (including pursuant to the Over-Allotment Option), and prior to the consummation<br>of a Business Combination, the directors shall not issue additional Shares or any other securities that would entitle the holders thereof<br>to: |
|---|---|
| (a) | receive funds from the Trust Account; or |
| --- | --- |
| 57<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| (b) | vote as a class with the Public Shares: |
| --- | --- |
| (i) | on a Business Combination or on any other proposal presented to Members prior to or in connection with<br>the completion of a Business Combination; or |
| --- | --- |
| (ii) | to approve an amendment to these Articles to: |
| --- | --- |
| (A) | extend the time the Company has to consummate a Business Combination beyond 12 months after the closing<br>of the IPO or 18 months from the date of the closing of the IPO pursuant to Article 38.8 (subject in the latter case to valid<br>three months extensions having been made in each case); or |
| --- | --- |
| (B) | amend the foregoing provisions of these Articles. |
| --- | --- |
| 38.12 | The Company must complete one or more Business Combinations, which must be with one or more operating<br>businesses or assets with an aggregate fair market value equal to at least 80% of the net assets held in the trust account (excluding<br>taxes payable on the interest earned on the trust account). An initial Business Combination must not be effectuated solely with another<br>blank cheque company or a similar company with nominal operations. |
| --- | --- |
| 38.13 | The uninterested Independent Directors shall approve any transaction or transactions between the Company<br>and any of the following parties: |
| --- | --- |
| (a) | any Member owning an interest in the voting power of the Company that gives such Member a significant<br>influence over the Company; and |
| --- | --- |
| (b) | any director or Officer of the Company and any Affiliate or relative of such director or Officer. |
| --- | --- |
| 38.14 | A director may vote in respect of any Business Combination in which such director has a conflict of interest<br>with respect to the evaluation of such Business Combination. Such director must disclose such interest or conflict to the other directors. |
| --- | --- |
| 38.15 | The Company may enter into a Business Combination with a target business that is Affiliated with the Sponsor,<br>a Founder, the directors of the Company or Officers. In the event the Company seeks to complete the Business Combination with a target<br>that is Affiliated with the Sponsor, a Founder, Officers or directors, the Company, or a committee of Independent Directors, will obtain<br>an opinion from an independent investment banking firm or another independent firm that commonly renders valuation opinions for the type<br>of company we are seeking to acquire or an independent accounting firm, that such a Business Combination or transaction is fair to the<br>Company from a financial point of view. |
| --- | --- |
| 38.16 | Any Business Combination must be approved by a majority of the Independent Directors. |
| --- | --- |
| 39. | Certain Tax Filings |
| --- | --- |
| 39.1 | Each Tax Filing Authorised Person and any such other person, acting alone, as any director shall designate<br>from time to time, are authorised to file tax forms SS-4, W-8 BEN, W-8 IMY, W-9, 8832 and 2553 and such other similar tax forms as are<br>customary to file with any US state or federal governmental authorities or foreign governmental authorities in connection with the formation,<br>activities and/or elections of the Company and such other tax forms as may be approved from time to time by any director of the Company<br>or an Officer. The Company further ratifies and approves any such filing made by any Tax Filing Authorised Person or such other person<br>prior to the date of these Articles. |
| --- | --- |
| 58<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
| 40. | Business Opportunities |
| --- | --- |
| 40.1 | In recognition and anticipation of the facts that: (a) directors, managers, officers, members, partners,<br>managing members, employees and/or agents of one or more members of the Investor Group (each of the foregoing, an “Investor GroupRelated Person”) may serve as directors of the Company and/or Officers; and (b) the Investor Group engages, and may continue<br>to engage in the same or similar activities or related lines of business as those in which the Company, directly or indirectly, may engage<br>and/or other business activities that overlap with or compete with those in which the Company, directly or indirectly, may engage, the<br>provisions under this heading “Business Opportunities” are set forth to regulate and define the conduct of certain affairs<br>of the Company as they may involve the Members and the Investor Group Related Persons, and the powers, rights, duties and liabilities<br>of the Company and its Officers, directors and Members in connection therewith. |
| --- | --- |
| 40.2 | To the fullest extent permitted by Applicable Law, the directors and officers of the Company shall have<br>no duty, except and to the extent expressly assumed by contract, to refrain from engaging directly or indirectly in the same or similar<br>business activities or lines of business as the Company. To the fullest extent permitted by Applicable Law, and subject to his or her<br>fiduciary duties under Applicable Law, the Company renounces any interest or expectancy of the Company in, or in being offered an opportunity<br>to participate in, any potential transaction or matter which may be a corporate opportunity offered to any director and officer of the<br>Company, on the one hand, and the Company, on the other, unless such opportunity is expressly offered to such director or officer of the<br>Company solely in their capacity as an Officer or director of the Company and the opportunity is one the Company is permitted to complete<br>on a reasonable basis. |
| --- | --- |
| 40.3 | Except as provided elsewhere in these Articles, the Company hereby renounces any interest or expectancy<br>of the Company in, or in being offered an opportunity to participate in, any potential transaction or matter which may be a corporate<br>opportunity for both the Company and the Investor Group, about which a director of the Company and/or Officer who is also an Investor<br>Group Related Person acquires knowledge. |
| --- | --- |
| 40.4 | To the extent a court might hold that the conduct of any activity related to a corporate opportunity that<br>is renounced in this Article to be a breach of duty to the Company or its Members, the Company hereby waives, to the fullest extent permitted<br>by Applicable Law, any and all claims and causes of action that the Company may have for such activities. To the fullest extent permitted<br>by Applicable Law, the provisions of this Article apply equally to activities conducted in the future and that have been conducted in<br>the past. |
| --- | --- |
| 59<br> www.verify.gov.ky File#: 401107 | Filed: 27-Jun-2024 09:28 EST Auth Code: B84727590335 |
| --- | --- |
Exhibit 4.1
Execution Version
RIGHTS AGREEMENT
This Rights Agreement (this “Agreement”) is made as of July 2, 2024 between Eureka Acquisition Corp, a Cayman Islands company with its principal executive offices at 899 Ruining Road, Yangguang Binjiang Center, South Building, Unit 808, Shanghai 200030, PRC (the “Company”) and Continental Stock Transfer & Trust Company, a New York company, with offices at 1 State Street, 30th Floor, New York, NY 10004 (the “Rights Agent”).
WHEREAS, the Company is engaged in an initial public offering (the “Public Offering”) of units of the Company’s equity securities (each, a “Unit” and collectively, the “Units”) to Maxim Group LLC (the “Representative”), as representative of the several underwriters (the “Underwriters”), each such Unit comprised of one Class A ordinary share of the Company, par value $.0001 per share (“Ordinary Share”) and one right to receive one-fifth (1/5) of one Ordinary Share (the “Public Rights”) upon the happening of an Exchange Event (defined below), and in connection therewith, the Company has determined to issue and deliver up to 5,750,000 Public Rights (including up to 750,000 Public Rights subject to the over-allotment option) to public investors in the Public Offering;
WHEREAS, on July 2, 2024, the Company entered into a certain Unit Subscription Agreement with Hercules Capital Management Corp (the “Sponsor”), pursuant to which the Sponsor agreed to purchase an aggregate of 216,750 Units (or 228,000 if the over-allotment option is exercised in full by the Underwriters) simultaneously with the closing of the Public Offering at a purchase price of $10.00 per Unit and in connection therewith, will issue and deliver up to an aggregate of 216,750 rights (or 228,000 if the over-allotment option is exercised in full by the Underwriters) (“Private Placement Rights”);
WHEREAS, in order to finance extend the time available to consummate an intended initial Business Combination (as defined in the Company’s Second Amended and Restated Memorandum and Articles of Association), the Sponsor or an affiliate or designee of the Sponsor must, upon five days advance notice prior to the applicable deadline, must deposit an aggregate of $500,000, or up to $575,000 if the Underwriters’ over-allotment option is exercised in full ($0.10 per public share in either case), on or prior to the date of the applicable deadline, for each three-month extension (or up to an aggregate of $1,000,000 (or $1,150,000 if the Underwriters’ over-allotment option is exercised in full), or $0.20 per public share if we extend for the full six months), the form of a loan, where any such loans will be non-interest bearing and either be payable upon the consummation of the initial Business Combination, or, at the lender’s discretion, converted upon consummation of the initial Business Combination into additional private placement units at a price of $10.00 per unit (the “Extension Loan Rights”);
WHEREAS, in order to finance the Company’s transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan to the Company funds as the Company may require, of which up to $1,500,000 at a price of $10.00 per Unit, and in connection therewith, the Company will issue and deliver up to an aggregate of 150,000 rights (the “Working Capital Rights”);
WHEREAS, the Company may issue additional rights that are governed by this Agreement (“Post-IPO Rights” and together with the Private Placement Rights, the Extension Loan Rights, the Working Capital Rights, and the Public Rights, the “Rights”) in connection with, or following the consummation by the Company of, a Business Combination;
WHEREAS, the Company has filed with the Securities and Exchange Commission registration statement on Form S-1, File No. 333-277780 (the “Registration Statement”), and the prospectus forming a part thereof (collectively, the “Prospectus”), for the registration under the Securities Act of 1933, as amended, of the Units, each of the securities comprising the Units, and the Ordinary Shares underlying the Public Rights, and the Ordinary Shares to be issued to the Representative in connection with the Public Offering;
WHEREAS, the Company desires the Rights Agent to act on behalf of the Company, and the Rights Agent is willing to so act, in connection with the issuance, registration, transfer and exchange of the Rights;
WHEREAS, the Company desires to provide for the form and provisions of the Rights, the terms upon which they shall be issued, and the respective rights, limitation of rights, and immunities of the Company, the Rights Agent, and the holders of the Rights; and
WHEREAS, all acts and things have been done and performed which are necessary to make the Rights, when executed on behalf of the Company and countersigned by or on behalf of the Rights Agent, as provided herein, the valid, binding and legal obligations of the Company, and to authorize the execution and delivery of this Agreement.
NOW, THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows:
Appointment of Rights Agent. The Company hereby appoints the Rights Agent to act as agent for the Company for the Rights, and the Rights Agent hereby accepts such appointment and agrees to perform the same in accordance with the terms and conditions set forth in this Agreement.
Rights.
2.1. Form of Right. Each Right shall be issued in registered or book entry form, as requested by the Company or the holder of a Right. Any Rights issued in registered form shall be in substantially the form of Exhibit A hereto, the provisions of which are incorporated herein and shall be signed by, or bear the facsimile signature of, the Chairman of the Board and the Secretary of the Company and shall bear a facsimile of the Company’s seal. In the event the person whose facsimile signature has been placed upon any Right shall have ceased to serve in the capacity in which such person signed the Right before such Right is issued, it may be issued with the same effect as if he or she had not ceased to be such at the date of issuance.
2.2. Effect of Countersignature. Unless and until countersigned by the Rights Agent pursuant to this Agreement, a Right shall be invalid and of no effect and may not be exchanged for Ordinary Shares.
2.3. Registration.
2.3.1. Right Register. The Rights Agent shall maintain books (“Right Register”) for the registration of original issuance and the registration of transfer of the Rights. Upon the initial issuance of the Rights, the Rights Agent shall issue and register the Rights in the names of the respective holders thereof in such denominations and otherwise in accordance with instructions delivered to the Rights Agent by the Company.
2
2.3.2. Registered Holder. Prior to due presentment for registration of transfer of any Right, the Company and the Rights Agent may deem and treat the person in whose name such Right shall be registered upon the Right Register (“Registered Holder”) as the absolute owner of such Right and of each Right represented thereby (notwithstanding any notation of ownership or other writing on the Right Certificate made by anyone other than the Company or the Rights Agent), for the purpose of the exchange thereof, and for all other purposes, and neither the Company nor the Rights Agent shall be affected by any notice to the contrary.
2.4. Detachability of Rights. The securities comprising the Units, including the Rights, will begin to trade separately on (i) the first trading day following the 52^nd^ business day after the effectiveness of the Registration Statement, or (ii) such earlier date as the Representative shall determine is acceptable. In no event will separate trading of the securities comprising the Units commence until the Company (i) files a Current Report on Form 8-K with the SEC including an audited balance sheet reflecting the Company’s receipt of the gross proceeds of the Public Offering and (ii) issues a press release announcing when such separate trading will begin.
- Terms and Exchange of Rights
3.1. Rights. Except in cases where the Company is not the surviving entity after the occurrence of an Exchange Event, each holder of a Right shall automatically receive one-fifth of one Ordinary Share upon consummation of an Exchange Event. No additional consideration shall be paid by a holder of Rights in order to receive his, her or its Ordinary Shares upon an Exchange Event, as the purchase price for such Ordinary Shares has been included in the purchase price for the Units. In no event will the Company be required to net cash settle the Rights or issue fractional Ordinary Shares. The provisions of this Section 3.1 may not be modified, amended or deleted without the prior written consent of the Representative.
3.2. Exchange Event. An “Exchange Event” shall occur upon the Company’s consummation of an initial Business Combination.
3.3. Exchange of Rights.
3.3.1. Issuance of Certificates. As soon as practicable upon the occurrence of an Exchange Event, the Company shall direct holders of the Rights to return their Rights Certificates to the Rights Agent. Upon receipt of a valid Rights Certificate, the Company shall make (or cause to be made) entries in its Register of Members of the Company and issue to the Registered Holder of such Right(s) a certificate or certificates for the number of full Ordinary Shares to which he, she or it is entitled, registered in such name or names as may be directed by him, her or it. The Company shall not issue fractional shares upon exchange of Rights. At the time of an Exchange Event, the Company will either instruct the Rights Agent to round down to the nearest whole Ordinary Share or otherwise inform it how fractional shares will be addressed in accordance with Cayman Islands law.
3.3.2. Valid Issuance. All Ordinary Shares issued upon an Exchange Event in conformity with this Agreement and the Second Amended and Restated Memorandum and Articles of Association of the Company shall be validly issued, fully paid and nonassessable.
3
3.3.3. Date of Issuance. Each person in whose name any such certificate for Ordinary Shares is issued shall for all purposes be deemed to have become the holder of record of such shares on the date that the person’s name is entered in the Register of Members of the Company, which shall be the date of the Exchange Event, irrespective of the date of delivery of such certificate.
3.3.4. Company Not Surviving Following Exchange Event. Upon an Exchange Event in which the Company does not continue as the surviving entity, each holder of a Right will be required to affirmatively convert his, her or its Rights in order to receive the 1/5 of an Ordinary Share underlying each Right (without paying any additional consideration) upon consummation of the Exchange Event. Each holder of a Right will be required to indicate his, her or its election to convert the Rights into the underlying Ordinary Shares as well as to return the original certificates evidencing the Rights to the Company.
3.4. Duration of Rights. If an Exchange Event does not occur within the time period set forth in the Company’s Second Amended and Restated Memorandum and Articles of Association, as the same may be amended from time to time, the Rights shall expire and shall be worthless.
- Transfer and Exchange of Rights.
4.1. Registration of Transfer. The Rights Agent shall register the transfer, from time to time, of any outstanding Right upon the Right Register, upon surrender of such Right for transfer, properly endorsed with signatures properly guaranteed and accompanied by appropriate instructions for transfer. Upon any such transfer, a new Right representing an equal aggregate number of Rights shall be issued and the old Right shall be cancelled by the Rights Agent. The Rights so cancelled shall be delivered by the Rights Agent to the Company from time to time upon request.
4.2. Procedure for Surrender of Rights. Rights may be surrendered to the Rights Agent, together with a written request for exchange or transfer, and thereupon the Rights Agent shall issue in exchange therefor one or more new Rights as requested by the Registered Holder of the Rights so surrendered, representing an equal aggregate number of Rights; provided, however, that in the event that a Right surrendered for transfer bears a restrictive legend, the Rights Agent shall not cancel such Right and issue new Rights in exchange therefor until the Rights Agent has received an opinion of counsel for the Company stating that such transfer may be made and indicating whether the new Rights must also bear a restrictive legend.
4.3. Fractional Rights. The Rights Agent shall not be required to effect any registration of transfer or exchange which will result in the issuance of a Right Certificate for a fraction of a Right.
4.4. Service Charges. No service charge shall be made for any exchange or registration of transfer of Rights.
4.5. Right Execution and Countersignature. The Rights Agent is hereby authorized to countersign and to deliver, in accordance with the terms of this Agreement, the Rights required to be issued pursuant to the provisions of this Section 4, and the Company, whenever required by the Rights Agent, will supply the Rights Agent with Rights duly executed on behalf of the Company for such purpose.
4
- Other Provisions Relating to Rights of Holders of Rights.
5.1. No Rights as Shareholder. Until exchange of a Right for Ordinary Shares as provided for herein, a Right does not entitle the Registered Holder thereof to any of the rights of a shareholder of the Company, including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive rights to vote or to consent or to receive notice as shareholders in respect of the meetings of shareholders or the election of directors of the Company or any other matter.
5.2. Lost, Stolen, Mutilated, or Destroyed Rights. If any Right is lost, stolen, mutilated, or destroyed, the Company and the Rights Agent may on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case of a mutilated Right, include the surrender thereof), issue a new Right of like denomination, tenor, and date as the Right so lost, stolen, mutilated, or destroyed. Any such new Right shall constitute a substitute contractual obligation of the Company, whether or not the allegedly lost, stolen, mutilated, or destroyed Right shall be at any time enforceable by anyone.
5.3. Reservation of Ordinary Shares. The Company shall at all times reserve and keep available a number of its authorized but unissued Ordinary Shares that will be sufficient to permit the exchange of all outstanding Rights issued pursuant to this Agreement.
5.4. Adjustments to Conversion Ratios. The number of Ordinary Shares that the holders of Rights are entitled to receive as a result of the occurrence of an Exchange Event shall be equitably adjusted to reflect appropriately the effect of any share split, share dividend, reorganization, recapitalization, reclassification, combination, exchange of shares or other like change with respect to the Ordinary Shares occurring on or after the date hereof and prior to the Exchange Event.
- Concerning the Rights Agent and Other Matters.
6.1. Payment of Taxes. The Company will from time to time promptly pay all taxes and charges that may be imposed upon the Company or the Rights Agent in respect of the issuance or delivery of Ordinary Shares upon the exchange of Rights, but the Company shall not be obligated to pay any transfer taxes in respect of the Rights or such shares.
6.2. Resignation, Consolidation, or Merger of Rights Agent.
6.2.1. Appointment of Successor Rights Agent. The Rights Agent, or any successor to it hereafter appointed, may resign its duties and be discharged from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the Company. If the office of the Rights Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint in writing a successor Rights Agent in place of the Rights Agent. If the Company shall fail to make such appointment within a period of 30 days after it has been notified in writing of such resignation or incapacity by the Rights Agent or by the holder of the Right (who shall, with such notice, submit his, her or its Right for inspection by the Company), then the holder of any Right may apply to the Supreme Court of the State of New York for the County of New York for the appointment of a successor Rights Agent at the Company’s cost. Any successor Rights Agent, whether appointed by the Company or by such court, shall be a corporation organized and existing under the laws of the State of New York, in good standing and having its principal office in the Borough of Manhattan, City and State of New York, and authorized under such laws to exercise corporate trust powers and subject to supervision or examination by federal or state authority. After appointment, any successor Rights Agent shall be vested with all the authority, powers, rights, immunities, duties, and obligations of its predecessor Rights Agent with like effect as if originally named as Rights Agent hereunder, without any further act or deed; but if for any reason it becomes necessary or appropriate, the predecessor Rights Agent shall execute and deliver, at the expense of the Company, an instrument transferring to such successor Rights Agent all the authority, powers, and rights of such predecessor Rights Agent hereunder; and upon request of any successor Rights Agent the Company shall make, execute, acknowledge, and deliver any and all instruments in writing for more fully and effectually vesting in and confirming to such successor Rights Agent all such authority, powers, rights, immunities, duties, and obligations.
5
6.2.2. Notice of Successor Rights Agent. In the event a successor Rights Agent shall be appointed, the Company shall give notice thereof to the predecessor Rights Agent and the transfer agent for the Ordinary Shares not later than the effective date of any such appointment.
6.2.3. Merger or Consolidation of Rights Agent. Any corporation into which the Rights Agent may be merged or with which it may be consolidated or any corporation resulting from any merger or consolidation to which the Rights Agent shall be a party shall be the successor Rights Agent under this Agreement without any further act.
6.3. Fees and Expenses of Rights Agent.
6.3.1. Remuneration. The Company agrees to pay the Rights Agent reasonable remuneration for its services as such Rights Agent hereunder and will reimburse the Rights Agent upon demand for all expenditures that the Rights Agent may reasonably incur in the execution of its duties hereunder.
6.3.2. Further Assurances. The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed, acknowledged, and delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Rights Agent for the carrying out or performing of the provisions of this Agreement.
6.4. Liability of Rights Agent.
6.4.1. Reliance on Company Statement. Whenever in the performance of its duties under this Agreement, the Rights Agent shall deem it necessary or desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved and established by a statement signed by the Chief Executive Officer or Chief Financial Officer and delivered to the Rights Agent. The Rights Agent may rely upon such statement for any action taken or suffered in good faith by it pursuant to the provisions of this Agreement.
6.4.2. Indemnity. The Rights Agent shall be liable hereunder only for its own gross negligence, willful misconduct or bad faith. Subject to Section 6.6 below, the Company agrees to indemnify the Rights Agent and save it harmless against any and all liabilities, including judgments, costs and reasonable counsel fees, for anything done or omitted by the Rights Agent in the execution of this Agreement except as a result of the Rights Agent’s gross negligence, willful misconduct, or bad faith.
6.4.3. Exclusions. The Rights Agent shall have no responsibility with respect to the validity of this Agreement or with respect to the validity or execution of any Right (except its countersignature thereof); nor shall it be responsible for any breach by the Company of any covenant or condition contained in this Agreement or in any Right; nor shall it by any act hereunder be deemed to make any representation or warranty as to the authorization or reservation of any Ordinary Shares to be issued pursuant to this Agreement or any Right or as to whether any Ordinary Shares will when issued be valid and fully paid and nonassessable.
6
6.5. Acceptance of Agency. The Rights Agent hereby accepts the agency established by this Agreement and agrees to perform the same upon the terms and conditions herein set forth.
6.6. Waiver. The Rights Agent hereby waives any right of set-off or any other right, title, interest or claim of any kind (“Claim”) in, or to any distribution of, the Trust Account (as defined in that certain Investment Management Trust Agreement, dated as of the date hereof, by and between the Company and the Rights Agent as trustee thereunder) and hereby agrees not to seek recourse, reimbursement, payment or satisfaction for any Claim against the Trust Account for any reason whatsoever.
- Miscellaneous Provisions.
7.1. Successors. All the covenants and provisions of this Agreement by or for the benefit of the Company or the Rights Agent shall bind and inure to the benefit of their respective successors and assigns.
7.2. Notices. Any notice, statement or demand authorized by this Agreement to be given or made by the Rights Agent or by the holder of any Right to or on the Company shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier service within five days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Company with the Rights Agent), as follows:
Eureka Acquisition Corp
3011 Olympic View Dr
Chino Hills, California
United States 91709
Attention: Fen Zhang, Director
Email: Eric.zhang@hercules.global
Any notice, statement or demand authorized by this Agreement to be given or made by the holder of any Right or by the Company to or on the Rights Agent shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier service within five days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Rights Agent with the Company), as follows:
Continental Stock Transfer & Trust Company
1 State Street, 30^th^ Floor
New York, NY 10004
Attention: Compliance Department
Email:
7
in each case, with copies to:
Robinson & Cole LLP
Chrysler East Building
666 Third Avenue, 20th Floor
New York, NY 10017
Attn.: Arila Zhou, Esq.
Email: azhou@rc.com
and
Maxim Group LLC
300 Park Avenue
New York, NY 10174
Attn.: Larry Glassberg
Email: lglassberg@maximgrp.com
and
Ellenoff Grossman & Schole LLP
1345 Avenue of the Americas
New York, NY 10105
Attn.: Barry Grossman, Esq.,
Lijia Sanchez, Esq.
Email: bigrossman@egsllp.com, lsanchez@egsllp.com
7.3. Applicable Law. The validity, interpretation, and performance of this Agreement and of the Rights shall be governed in all respects by the laws of the State of New York, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. The Company hereby agrees that any action, proceeding or claim against it arising out of or relating in any way to this Agreement shall be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. Notwithstanding the foregoing, this provision will not apply to suits brought to enforce any liability or duty created by the Securities Exchange Act of 1934 or any other claim for which the federal district courts of the United States of America are the sole and exclusive forum. Any such process or summons to be served upon the Company may be served by transmitting a copy thereof by registered or certified mail, return receipt requested, postage prepaid, addressed to it at the address set forth in Section 7.2 hereof. Such mailing shall be deemed personal service and shall be legal and binding upon the Company in any action, proceeding or claim.
7.4. Persons Having Rights under this Agreement. Nothing in this Agreement expressed and nothing that may be implied from any of the provisions hereof is intended, or shall be construed, to confer upon, or give to, any person or corporation other than the parties hereto and the Registered Holders of the Rights and, for the purposes of Sections 3.1, 7.4 and 7.8 hereof, the Representative, any right, remedy, or claim under or by reason of this Agreement or of any covenant, condition, stipulation, promise, or agreement hereof. The Representative shall be deemed to be a third-party beneficiary of this Agreement with respect to Sections 3.1, 7.4 and 7.8 hereof. All covenants, conditions, stipulations, promises, and agreements contained in this Agreement shall be for the sole and exclusive benefit of the parties hereto (and the Representative with respect to the Sections 3.1, 7.4 and 7.8 hereof) and their successors and assigns and of the Registered Holders of the Rights. The provisions of this Section 7.4 may not be modified, amended or deleted without the prior written consent of the Representative.
8
7.5. Examination of the Right Agreement. A copy of this Agreement shall be available at all reasonable times at the office of the Rights Agent in the Borough of Manhattan, City and State of New York, for inspection by the Registered Holder of any Right. The Rights Agent may require any such holder to submit his, her or its Right for inspection by it.
7.6. Counterparts. This Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.
7.7. Effect of Headings. The Section headings herein are for convenience only and are not part of this Agreement and shall not affect the interpretation thereof.
7.8. Amendments. This Agreement may be amended by the parties hereto without the consent of any Registered Holder for the purpose of curing any ambiguity, or of curing, correcting or supplementing any defective provision contained herein or adding or changing any other provisions with respect to matters or questions arising under this Agreement as the parties may deem necessary or desirable and that the parties deem shall not adversely affect the interest of the Registered Holders. All other modifications or amendments shall require the written consent or vote of the Registered Holders of a majority of the then outstanding Rights. The provisions of this Section 7.8 may not be modified, amended or deleted without the prior written consent of the Representative.
7.9. Severability. This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.
9
IN WITNESS WHEREOF, this Agreement has been duly executed by the parties hereto as of the day and year first above written.
EUREKA ACQUISITION CORP
| By: | /s/ Fen Zhang |
|---|---|
| Name: | Fen Zhang |
| Title: | Director |
CONTINENTAL STOCK TRANSFER & TRUST COMPANY
| By: | /s/ Douglas Reed |
|---|---|
| Name: | Douglas Reed |
| Title: | Vice President |
[Signature Page to Rights Agreement]
10
EXHIBIT A
11
Exhibit 10.1
Execution Version
UNIT SUBSCRIPTION AGREEMENT
This UNIT SUBSCRIPTION AGREEMENT (this “Agreement”) is made as of this July 2, 2024, by and between Eureka Acquisition Corp, a Cayman Islands exempted company (the “Company”) and Hercules Capital Management Corp, a British Virgin Islands company (the “Purchaser”).
WHEREAS, the Company desires to sell on a private placement basis (the “Offering”) an aggregate of up to 216,750 units (the “Initial Units”) of the Company, and up to an additional 11,250 Units (“Additional Units” and together with the Initial Units, the “Units”) of the Company in the event that the underwriters’ 45-day over-allotment option (“Over-Allotment Option”) in the IPO (as defined below) is exercised in full or part, each Unit comprised of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A Ordinary Shares”) and one right (the “Right”), for a purchase price of $10.00 per Unit. Each Right entitles the holder thereof to receive one-fifth (1/5) of one Class A Ordinary Share (the “Right Shares”) to be governed by the Rights Agreement (as defined below).
WHEREAS, the Purchaser desires to purchase the 216,750 Initial Units and up to 11,250 Additional Units and the Company wishes to accept such subscription.
NOW, THEREFORE, in consideration of the promises and the mutual covenants hereinafter set forth and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and the Purchaser hereby agree as follows:
- Agreement to Subscribe
1.1 Purchase and Issuance of the Units. For the aggregate sum of $2,167,500 (the “Initial Purchase Price”), upon the terms and subject to the conditions of this Agreement, the Purchaser hereby agrees to purchase from the Company, and the Company hereby agrees to sell to the Purchaser, on the Closing Date (as defined in Section 1.2) 216,750 Initial Units at $10.00 per Initial Unit.
In addition to the foregoing, the Purchaser hereby agrees to purchase up to an additional 11,250 Additional Units at $10.00 per Additional Unit for a purchase price of up to $112,500 (the “Additional Purchase Price” and together with the Initial Purchase Price, the “Purchase Price”). The purchase and issuance of the Additional Units shall occur only in the event that the Over-Allotment Option is exercised in full or part. The total number of Additional Units to be purchased hereunder shall be in the same proportion as the amount of the Over-Allotment Option that is exercised. Each purchase of Additional Units shall occur simultaneously with the consummation of any portion of the Over-Allotment Option.
1.2 Closing. The closing of the purchase and sale of the Initial Units shall take place remotely or at the offices of Robinson & Cole LLP, Chrysler East Building, 666 Third Avenue, 20th Floor, New York, NY, 10017, simultaneously with the consummation of the Company’s initial public offering (“IPO”) of 5,000,000 units consisting of Class A Ordinary Shares and Rights and the purchase and sale of the Additional Units shall take place upon the consummation of the exercise of all or any portion of the Over-Allotment Option (each a “Closing Date”).
1
1.3 Delivery of the Purchase Price. At least one business day prior to the effective date of the Company’s registration statement relating to the IPO (“Registration Statement”), or the date of the exercise of the Over-Allotment Option, if any, the Purchaser agrees to deliver the Initial Purchase Price or Additional Purchase Price, as the case may be, by certified bank check or wire transfer of immediately available funds denominated in United States Dollars to Continental Stock Transfer & Trust Company (“CST”), which is hereby irrevocably authorized to deposit such funds on the applicable Closing Date to the trust account which will be established for the benefit of the Company’s public shareholders, managed pursuant to that certain Investment Management Trust Agreement to be entered into by and between the Company and CST and into which substantially all of the proceeds of the IPO will be deposited (the “Trust Account”). If the IPO is not consummated within 14 days of the date the Initial Purchase Price is delivered to CST, the Initial Purchase Price shall be returned to the Purchaser by certified bank check or wire transfer of immediately available funds denominated in United States Dollars, without interest or deduction.
1.4 Delivery of Unit Certificate. Upon the applicable Closing Date after delivery of the Purchase Price in accordance with Section 1.3, the Purchaser shall become irrevocably entitled to receive a unit certificate representing the Units purchased hereunder.
- Representations andWarranties of the Purchaser
The Purchaser represents and warrants to the Company that:
2.1 No Government Recommendation or Approval. It understands that no United States federal or state agency or similar agency of any other country has passed upon or made any recommendation or endorsement of the Company, the Offering, the Units, the Rights, the Right Shares, or the Class A Ordinary Shares underlying the Units (excluding the Right Shares, the “Unit Shares” and, collectively with the Units, the Rights, and the Right Shares, the “Securities”).
2.2 Organization. It is a company, validly existing and in good standing under the laws of the British Virgin Islands and possesses all requisite power and authority necessary to carry out the transactions contemplated by this Agreement.
2.3 Private Offering. It is an “accredited investor” as such term is defined in Rule 501(a) of Regulation D under the Securities Act of 1933, as amended (the “Securities Act”) or it is not a “U.S. Person” as defined in Rule 902 of Regulation S (“Regulation S”) under the Securities Act. It acknowledges that the sale contemplated hereby is being made in reliance on a private placement exemption to “Accredited Investors” within the meaning of Section 501(a) of Regulation D under the Securities Act and similar exemptions under state law or a non-U.S. Person under Regulation S.
2.4 Authority. This Agreement has been validly authorized, executed and delivered by the Purchaser and is a valid and binding agreement enforceable in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, fraudulent conveyance or similar laws affecting the enforcement of creditors’ rights generally and subject to general principles of equity (regardless of whether enforcement is sought in a proceeding at law or in equity).
2.5 No Conflicts. The execution, delivery and performance of this Agreement and the consummation by the Purchaser of the transactions contemplated hereby do not violate, conflict with or constitute a default under (i) the Purchaser’s organizational documents, (ii) any agreement, indenture or instrument to which the Purchaser is a party or (iii) any law, statute, rule or regulation to which the Purchaser is subject, or any agreement, order, judgment or decree to which the Purchaser is subject.
2
2.6 No Legal Advice from Company. It acknowledges it has had the opportunity to review this Agreement and the transactions contemplated by this Agreement and the other agreements entered into between the parties hereto with its own legal counsel and investment and tax advisors. Except for any statements or representations of the Company made in this Agreement and the other agreements entered into between the parties hereto, it is relying solely on such counsel and advisors and not on any statements or representations of the Company or any of its representatives or agents for legal, tax or investment advice with respect to this investment, the transactions contemplated by this Agreement or the securities laws of any jurisdiction.
2.7 Access to Information; Independent Investigation. Prior to the execution of this Agreement, it has had the opportunity to ask questions of and receive answers from representatives of the Company concerning an investment in the Company, as well as the finances, operations, business and prospects of the Company, and the opportunity to obtain additional information to verify the accuracy of all information so obtained. In determining whether to make this investment, it has relied solely on its own knowledge and understanding of the Company and its business based upon its own due diligence investigation and the information furnished pursuant to this paragraph. It understands that no person has been authorized to give any information or to make any representations which were not furnished pursuant to this Section 2 and it has not relied on any other representations or information in making its investment decision, whether written or oral, relating to the Company, its operations and/or its prospects.
2.8 Reliance on Representations and Warranties. It understands the Units are being offered and sold to it in reliance on exemptions from the registration requirements under the Securities Act, and analogous provisions in the laws and regulations of various states, and that the Company is relying upon the truth and accuracy of the representations, warranties, agreements, acknowledgments and understandings of the Purchaser set forth in this Agreement in order to determine the applicability of such provisions.
2.9 No Advertisements. It is not subscribing for the Units as a result of or subsequent to any advertisement, article, notice or other communication published in any newspaper, magazine, or similar media or broadcast over television or radio, or presented at any seminar or meeting.
2.10 Legend. It acknowledges and agrees the certificates evidencing the Units, the Unit Shares, the Right Shares, and the Rights, shall bear a restrictive legend (the “Legend”), in form and substance as set forth in Section 4 hereof, prohibiting the offer, sale, pledge or transfer of the securities, except (i) pursuant to an effective registration statement covering these securities under the Securities Act or (ii) pursuant to any other exemptions from the registration requirements under the Securities Act and such laws which, in the opinion of counsel for the Company, is available.
2.11 Experience, Financial Capability and Suitability. It is (i) sophisticated in financial matters and is able to evaluate the risks and benefits of the investment in the Securities and (ii) able to bear the economic risk of his investment in the Securities for an indefinite period of time because the Securities have not been registered under the Securities Act and therefore cannot be sold unless subsequently registered under the Securities Act or an exemption from such registration is available. It has substantial experience in evaluating and investing in transactions of securities in companies similar to the Company so that it is capable of evaluating the merits and risks of its investment in the Company and has the capacity to protect its own interests. It has substantial experience in evaluating and investing in transactions of securities in companies similar to the Company so that it is capable of evaluating the merits and risks of its investment in the Company and has the capacity to protect its own interests.
3
2.12 Investment Purposes. It is purchasing the Securities solely for investment purposes, for its own account and not for the account or benefit of any other person, and not with a view towards the distribution or dissemination thereof and it has no present arrangement to sell the interest in the Securities to or through any person or entity.
2.13 Restrictions on Transfer. It acknowledges and understands the Units are being offered in a transaction not involving a public offering in the United States within the meaning of the Securities Act. The Securities have not been registered under the Securities Act, and, if in the future, it decides to offer, resell, pledge or otherwise transfer the Securities, such Securities may be offered, resold, pledged or otherwise transferred only (A) pursuant to an effective registration statement filed under the Securities Act, (B) pursuant to an exemption from registration under Rule 144 promulgated under the Securities Act (“Rule 144”), if available, or (C) pursuant to any other available exemption from the registration requirements of the Securities Act, and in each case in accordance with any applicable securities laws of any state or any other jurisdiction. It agrees that if any transfer of its Securities or any interest therein is proposed to be made, as a condition precedent to any such transfer, it may be required to deliver to the Company an opinion of counsel satisfactory to the Company. Absent registration or another available exemption from registration, it agrees it will not resell the Securities. It further acknowledges that because the Company is a shell company, Rule 144 may not be available to it for the resale of the Securities until the one year anniversary following consummation of the initial Business Combination (defined below) of the Company, despite technical compliance with the requirements of Rule 144 and the release or waiver of any contractual transfer restrictions.
- Representations andWarranties of the Company
The Company represents and warrants to the Purchaser that:
3.1 Valid Issuance of Share Capital. The total number of all classes of share capital which the Company has authority to issue is (i) 390,000,000 Class A ordinary shares, (ii) 100,000,000 Class B ordinary shares and (iii) 10,000,000 shares of preference share. As of the date hereof, the Company has issued 1,437,500 Class B ordinary shares (of which up to 187,500 shares are subject to forfeiture as described in the Registration Statement related to the IPO) and has not issued any preference shares. All of the issued share capital of the Company has been duly authorized, validly issued, and are fully paid and non-assessable.
3.2 Title to Securities. Upon issuance in accordance with, and payment pursuant to, the terms hereof, the rights agreement to be entered into with CST on or prior to the closing of the IPO (the “Rights Agreement”) and the Second Amended and Restated Memorandum and Articles of Association of the Company, as the case may be, each of the Units, the Unit Shares, the Rights, and the Right Shares will be duly and validly issued, fully paid and non-assessable. On the date of issuance of the Units, the Right Shares shall have been reserved for issuance. Upon issuance in accordance with the terms hereof, the Purchaser will have or receive good title to the Units, the Unit Shares, and the Right, free and clear of all liens, claims and encumbrances of any kind other than (i) transfer restrictions hereunder and pursuant to the insider letter to be entered into on or prior to the closing of the IPO (the “Insider Letter”) and (ii) transfer restrictions under federal and state securities laws.
4
3.3 Organization and Qualification. The Company has been duly incorporated and is validly existing as a Cayman Islands exempted company and has the requisite corporate power to own its properties and assets and to carry on its business as now being conducted.
3.4 Authorization; Enforcement. (i) The Company has the requisite corporate power and authority to enter into and perform its obligations under this Agreement and to issue the Securities in accordance with the terms hereof, (ii) the execution, delivery and performance of this Agreement by the Company and the consummation by it of the transactions contemplated hereby have been duly authorized by all necessary corporate action and no further consent or authorization of the Company or its Board of Directors or shareholders is required, and (iii) this Agreement constitutes, and upon the execution and delivery thereof and the Rights and Rights Agreement, will constitute, valid and binding obligations of the Company enforceable against the Company in accordance with their respective terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, fraudulent conveyance, moratorium, reorganization, or similar laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies or by equitable principles of general application and except as enforcement of rights to indemnity and contribution may be limited by federal and state securities laws or principles of public policy.
3.5 No Conflicts. The execution, delivery and performance of this Agreement and the consummation by the Company of the transactions contemplated hereby do not (i) result in a violation of the Company’s Memorandum and Articles of Association, (ii) conflict with, or constitute a default under any agreement, indenture or instrument to which the Company is a party or (iii) conflict with any law statute, rule or regulation to which the Company is subject or any agreement, order, judgment or decree to which the Company is subject. Other than any federal, state or foreign securities filings which may be required to be made by the Company subsequent to the Closing, and any registration statement which may be filed pursuant thereto, the Company is not required under federal, state or local law, rule or regulation to obtain any consent, authorization or order of, or make any filing or registration with, any court or governmental agency or self-regulatory entity in order for it to perform any of its obligations under this Agreement or issue the Units, the Unit Shares, the Right, and the Right Shares in accordance with the terms hereof.
- Legends
4.1 Legend. The Company will issue the Units, the Unit Shares, and the Right, and when issued, the Right Shares, purchased by the Purchaser in the name of the Purchaser. The certificates evidencing Securities will bear the following Legend and appropriate “stop transfer” instructions:
THESE SECURITIES (i) HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND THESE SECURITIES MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT (A) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT FILED UNDER THE SECURITIES ACT, (B) TO A NON-U.S. PERSON IN AN OFFSHORE TRANSACTION IN ACCORDANCE WITH RULE 903 OR RULE 904 OF REGULATION S UNDER THE SECURITIES ACT, (C) PURSUANT TO THE RESALE LIMITATIONS SET FORTH IN RULE 905 OF REGULATION S UNDER THE SECURITIES ACT, (D) PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT (IF AVAILABLE) OR (E) PURSUANT TO ANY OTHER EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT, IN EACH CASE IN ACCORDANCE WITH ANY APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR ANY OTHER JURISDICTION. HEDGING TRANSACTIONS INVOLVING THESE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT.
5
“THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO AN AGREEMENT BETWEEN EUREKA ACQUISITION CORP, HERCULES CAPITAL MANAGEMENT CORP AND OTHER PARTIES AND MAY ONLY BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED DURING THE TERM OF THE LOCKUP PURSUANT TO THE TERMS SET FORTH THEREIN.”
4.2 Purchaser’s Compliance. Nothing in this Section 4 shall affect in any way the Purchaser’s obligations and agreements to comply with all applicable securities laws upon resale of the Securities.
4.3 Company’s Refusal to Register Transfer of the Securities. The Company shall refuse to register any transfer of the Securities, if in the sole judgment of the Company such purported transfer would not be made (i) pursuant to an effective registration statement filed under the Securities Act, or (ii) pursuant to an available exemption from the registration requirements of the Securities Act.
4.4 Registration Rights. The Purchaser will be entitled to certain registration rights which will be governed by a registration rights agreement (“Registration Rights Agreement”) to be entered into with the Company on or prior to the closing of the IPO.
- Lockup
The Purchaser acknowledges and agrees that the Units, the Unit Shares, the Right, and the Right Shares shall not be transferable, saleable or assignable until the consummation of an acquisition, share exchange, purchase of all or substantially all of the assets of, or any other similar business combination with one or more businesses or entities by the Company (a “Business Combination”), except to permitted transferees (as defined in the Registration Statement).
- Securities Laws Restrictions
The Purchaser agrees not to sell, transfer, pledge, hypothecate or otherwise dispose of all or any part of the Securities unless, prior thereto (a) a registration statement on the appropriate form under the Securities Act and applicable state securities laws with respect to the Securities proposed to be transferred shall then be effective or (b) the Company shall have received an opinion from counsel reasonably satisfactory to the Company, that such registration is not required because such transaction complies with the Securities Act and the rules promulgated by the Securities and Exchange Commission thereunder and with all applicable state securities laws.
- Waiver of Distributionsfrom Trust Account
In connection with the Securities purchased pursuant to this Agreement, the Purchaser hereby waives any and all right, title, interest or claim of any kind in or to any distributions from the Trust Account.
6
- Rescission Right Waiverand Indemnification
8.1 Rescission Waiver. The Purchaser understands and acknowledges that an exemption from the registration requirements of the Securities Act requires there be no general solicitation of purchasers of the Units. In this regard, if the Offering were deemed to be a general solicitation with respect to the Units, the offer and sale of such Units may not be exempt from registration and, if not, the Purchaser may have a right to rescind its purchase of the Units. In order to facilitate the completion of the Offering and in order to protect the Company, its shareholders and the Trust Account from claims that may adversely affect the Company or the interests of its shareholders, the Purchaser hereby agrees to waive, to the maximum extent permitted by applicable law, any claims, right to sue or rights in law or arbitration, as the case may be, to seek rescission of its purchase of the Units as a result of the issuance of the Units being deemed to be in violation of Section 5 of the Securities Act. The Purchaser acknowledges and agrees this waiver is being made in order to induce the Company to sell the Units to the Purchaser. The Purchaser agrees the foregoing waiver of rescission rights shall apply to any and all known or unknown actions, causes of action, suits, claims or proceedings (collectively, “Claims”) and related losses, costs, penalties, fees, liabilities and damages, whether compensatory, consequential or exemplary, and expenses in connection therewith, including reasonable attorneys’ and expert witness fees and disbursements and all other expenses reasonably incurred in investigating, preparing or defending against any Claims, whether pending or threatened, in connection with any present or future actual or asserted right to rescind the purchase of the Units hereunder or relating to the purchase of the Units and the transactions contemplated hereby.
8.2 No Recourse Against Trust Account. The Purchaser agrees not to seek recourse against the Trust Account for any reason whatsoever in connection with its purchase of the Units or any Claim that may arise now or in the future.
8.3 Section 8 Waiver. The Purchaser agrees that to the extent any waiver of rights under this Section 8 is ineffective as a matter of law, the Purchaser has offered such waiver for the benefit of the Company as an equitable right that shall survive any statutory disqualification or bar that applies to a legal right. The Purchaser acknowledges the receipt and sufficiency of consideration received from the Company hereunder in this regard.
- Terms of the Unit
The Units shall be substantially identical to the Units offered in the IPO as set forth in the Underwriting Agreement, except the Units: (i) will be subject to the transfer restrictions described herein, and (ii) are being purchased pursuant to an exemption from the registration requirements of the Securities Act and will become freely tradable only after certain conditions are met or the resale of the Units is registered under the Securities Act.
- Governing Law; Jurisdiction;Waiver of Jury Trial
This Agreement shall be governed by and construed in accordance with the laws of the State of New York for agreements made and to be wholly performed within such territory. The parties hereto hereby waive any right to a jury trial in connection with any litigation pursuant to this Agreement and the transactions contemplated hereby.
- Assignment; EntireAgreement; Amendment
11.1 Assignment. Neither this Agreement nor any rights hereunder may be assigned by any party to any other person other than by the Purchaser, without the prior consent of the Company, to one or more persons agreeing to be bound by the terms hereof. Upon such assignment by a Purchaser, the assignee(s) shall become Purchaser hereunder and have the rights and obligations provided for herein to the extent of such assignment.
7
11.2 Entire Agreement. This Agreement sets forth the entire agreement and understanding between the parties as to the subject matter hereof and supersedes any and all prior discussions, agreements and understandings of any and every nature.
11.3 Amendment. Except as expressly provided in this Agreement, neither this Agreement nor any term hereof may be amended, waived, discharged or terminated other than by a written instrument signed by the party against whom enforcement of any such amendment, waiver, discharge or termination is sought.
11.4 Binding upon Successors. This Agreement shall be binding upon and inure to the benefit of the parties hereto and to their respective heirs, legal representatives, successors and permitted assigns.
- Notices; Indemnity
12.1 Notices. All notices, requests, consents and other communications hereunder shall be in writing, shall be addressed to the receiving party’s address set forth herein or to such other address as a party may designate by notice hereunder, and shall be either (a) delivered by hand, (b) sent by overnight courier, or (c) sent by certified mail, return receipt requested, postage prepaid. All notices, requests, consents and other communications hereunder shall be deemed to have been given either (i) if by hand, at the time of the delivery thereof to the receiving party at the address of such party set forth above, (ii) if sent by overnight courier, on the next business day following the day such notice is delivered to the courier service, or (iii) if sent by certified mail, on the fifth business day following the day such mailing is made.
12.2 Indemnification. Except as set forth in Section 8, each party shall indemnify the other party against any loss, cost or damages (including reasonable attorney’s fees and expenses) incurred as a result of such party’s breach of any representation, warranty, covenant or agreement set forth in this Agreement.
- Counterparts
This Agreement may be executed in one or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or any other form of electronic delivery, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such signature page were an original thereof.
- Survival; Severability
14.1 Survival. The representations, warranties, covenants and agreements of the parties hereto shall survive the Closing until one (1) year following the consummation of an initial Business Combination.
8
14.2 Severability. In the event that any provision of this Agreement becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Agreement shall continue in full force and effect without said provision; provided that no such severability shall be effective if it materially changes the economic benefit of this Agreement to any party.
- Headings
The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement.
- Construction
The parties hereto have participated jointly in the negotiation and drafting of this Agreement. If an ambiguity or question of intent or interpretation arises, this Agreement will be construed as if drafted jointly by the parties hereto and no presumption or burden of proof will arise favoring or disfavoring any party hereto because of the authorship of any provision of this Agreement. The words “include,” “includes,” and “including” will be deemed to be followed by “without limitation.” Pronouns in masculine, feminine, and neuter genders will be construed to include any other gender, and words in the singular form will be construed to include the plural and vice versa, unless the context otherwise requires. The words “this Agreement,” “herein,” “hereof,” “hereby,” “hereunder,” and words of similar import refer to this Agreement as a whole and not to any particular subdivision unless expressly so limited. The parties hereto intend that each representation, warranty, and covenant contained herein will have independent significance. If any party hereto has breached any representation, warranty, or covenant contained herein in any respect, the fact that there exists another representation, warranty or covenant relating to the same subject matter (regardless of the relative levels of specificity) which such party hereto has not breached will not detract from or mitigate the fact that such party hereto is in breach of the first representation, warranty, or covenant.
[Remainder of page intentionally left blank]
9
This subscription is accepted by the Company as of the date first written above.
| EKA ACQUISITION CORP |
|---|
| By: |
| Name: |
| Title: |
All values are in Euros.
Accepted and agreed this
2nd day of July, 2024
| HERCULES CAPITAL MANAGEMENT CORP | |
|---|---|
| By: | Fen Zhang |
| Name: | Fen Zhang |
| Title: | Director |
[Signature Page for Unit Subscription Agreement]
10
Exhibit 10.2
Execution Version
SECURITIES TRANSFER AGREEMENT
This Securities Transfer Agreement is dated as of June 27, 2024 (this “Transfer”), by and among Hercules Capital Management Corp, a British Virgin Islands company (the “Seller”), Eureka Acquisition Corp , a Cayman Islands exempted company (the “Company”), and the parties identified on the signature page hereto (each a “Buyer” and collectively, the “Buyers”).
WHEREAS, on the terms and subject to the conditions set forth in this Transfer, the Seller wishes to transfer to the Buyers Class B ordinary shares, $0.0001 par value (“Class B Ordinary Shares”) of the Company, a blank check company, or special purpose acquisition company, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (a “Business Combination”), and the Buyers wish to purchase and receive such Initial Shares (as defined below) from the Seller.
NOW, THEREFORE, in consideration of the premises, representations, warranties and the mutual covenants contained in this Transfer, and for other good and valuable consideration, the receipt, sufficiency and adequacy of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:
Section 1. Transferof Initial Shares. Seller hereby agrees to transfer immediately following the effectiveness of the Registration Statement (as defined in Section 4) the aggregated amount of 30,000 Class B Ordinary Shares to the Buyers (collectively, the “Initial Shares”) as listed on the Schedule I attached hereto. The Buyers have agreed to pay the Seller an aggregate amount of approximately $521.73, (the “Purchase Price”), in consideration of the transfer of the Initial Shares.
Section 2. PotentialForfeiture and Purchase of Initial Shares.
(a) In the event that the Company determines for any reason not to nominate, elect or appoint any Buyer as a member of the board of directors of the Company, or if any Buyer otherwise does not become a member of the board of directors of the Company for any reason, on or prior to the closing of the Public Offering (as defined below), such Buyer shall automatically forfeit all of the Initial Shares held by such Buyer, which Initial Shares shall automatically be transferred and returned to the Seller, and the Seller shall promptly return the applicable portion of the Purchase Price to such Buyer.
(b) The applicable Buyer shall take all actions as may be reasonably necessary to consummate any forfeiture or sale contemplated by this Section 2, including entering into agreements and delivering certificates and instruments and consents as may be deemed by Seller to be necessary or appropriate, and the applicable Buyer hereby grants to Seller and any representative designated by Seller without further action by such Buyer a limited irrevocable power of attorney to effect any forfeiture or transfer contemplated hereby on behalf of such Buyer, which power of attorney shall be deemed to be coupled with an interest.
Section 3. No Conflicts. Each party represents and warrants that neither the execution and delivery of this Transfer by such party, nor the consummation or performance by such party of any of the transactions contemplated hereby, will with or without notice or lapse of time, constitute, create or result in a breach or violation of, default under, loss of benefit or right under or acceleration of performance of any obligation required under any agreement to which it is a party.
1
Section 4. InvestmentRepresentations. Each Buyer represents and warrants, with respect to himself or herself only, as set forth herein. Such Buyer hereby acknowledges that an investment in the Initial Shares involves certain significant risks. Such Buyer has no need for liquidity in its investment in the Initial Shares for the foreseeable future and is able to bear the risk of that investment for an indefinite period. Such Buyer acknowledges and hereby agrees that the Initial Shares will not be transferable under any circumstances unless registered by the Company in accordance with federal and state securities laws or sold in compliance with an exemption under such laws and such transfer complies with all applicable lock-up restrictions on such Buyer (as described in the Company’s registration statement on Form S-1, as may be amended (the “Registration Statement”), under the Securities Act of 1933, as amended (the “Act”), relating to a contemplated underwritten public offering by the Company (the “Public Offering”)). Such Buyer further understands and agrees that Buyer will be required to execute and deliver a letter agreement including, among other provisions, the foregoing transfer restrictions as described in the Registration Statement, and that any certificates evidencing the Initial Shares bear a legend referring to such transfer restrictions.
The Initial Shares are being acquired solely for such Buyer’s own account, for investment purposes only, and are not being purchased with a view to or for the resale, distribution, subdivision or fractionalization thereof; and such Buyer has no present plans to enter into any contract, undertaking, agreement or arrangement for such resale, distribution, subdivision or fractionalization. Such Buyer has been given the opportunity to (i) ask questions of and receive answers from the Seller and the Company concerning the terms and conditions of the Initial Shares, and the business and financial condition of the Company and (ii) obtain any additional information that the Seller possess or can acquire without unreasonable effort or expense that is necessary to assist such Buyer in evaluating the advisability of the purchase of the Initial Shares and an investment in the Company. Such Buyer is not relying on any oral representation made by any person as to the Company or its operations, financial condition or prospects. Such Buyer is an “accredited investor” as defined in Regulation D promulgated by the Securities and Exchange Commission under the Act. In the event such Buyer does not join the Board of Directors of the Company upon the consummation of the Public Offering (whether and either at the election of the Company or such Buyer for any reason), then the Buyer shall promptly return the Initial Shares to the Company.
Section 5. Miscellaneous. This Transfer, together with the certificates, documents, instruments and writings that are delivered pursuant hereto, constitutes the entire agreement and understanding of the parties hereto in respect of its subject matter. This Transfer may be executed in two or more counterparts, each of which will be deemed an original but all of which together will constitute one and the same instrument. This Transfer may not be amended, modified or waived as to any particular provision, except by a written instrument executed by all parties hereto. Except as otherwise provided herein, no party hereto may assign either this Transfer or any of its rights, interests, or obligations hereunder without the prior written approval of the other party.
[signature page follows]
2
IN WITNESS WHEREOF, the undersigned have executed this Transfer to be effective as of the date first set forth above.
| SELLER: | |
|---|---|
| Hercules Capital Management Corp | |
| By: | /s/ Fen Zhang |
| Name: | Fen Zhang |
| Title: | Director |
| BUYERS: | |
| /s/ M. Anthony Wong | |
| --- | |
| Name: M. Anthony Wong | |
| /s/ Lauren Simmons | |
| --- | |
| Name: Lauren Simmons | |
| /s/ Kevin McKenzie | |
| --- | |
| Name: Kevin McKenzie | |
| COMPANY: | |
| --- | --- |
| Eureka Acquisition Corp | |
| By: | /s/ Fen Zhang |
| Name: | Fen Zhang |
| Title: | Chief Executive Officer |
[Signature Page to Securities Transfer Agreement]
3
Exhibit 10.3
Execution Version
INVESTMENT MANAGEMENT TRUST AGREEMENT
This Investment Management Trust Agreement (this “Agreement”) is made effective as of July 2, 2024 by and between Eureka Acquisition Corp, a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York company (the “Trustee”).
WHEREAS, the Company’s registration statement on Form S-1, File No. 333-277780 (the “Registration Statement”) and prospectus (the “Prospectus”) for the initial public offering of the Company’s units (the “Units”), each of which consists of one Class A ordinary share of the Company, par value $0.0001 per share (the “Ordinary Share”) and one right to receive one-fifth of one Class A Ordinary Share (such initial public offering hereinafter referred to as the “Offering”), has been declared effective as of the date hereof by the U.S. Securities and Exchange Commission; and
WHEREAS, the Company has entered into an Underwriting Agreement (the “Underwriting Agreement”) with Maxim Group LLC, as the representative (the “Representative”) of the several underwriters (the “Underwriters”) named therein; and
WHEREAS, as described in the Prospectus, $50,000,000 of the gross proceeds of the Offering and sale of the Private Placement Units (as defined in the Underwriting Agreement) (or $57,500,000 if the Underwriter’s option to purchase additional units is exercised in full) will be delivered to the Trustee to be deposited and held in a segregated trust account located at all times in the United States (the “Trust Account”) for the benefit of the Company and the holders of the Ordinary Shares included in the Units issued in the Offering as hereinafter provided (the amount to be delivered to the Trustee (and any interest subsequently earned thereon) is referred to herein as the “Property,” the shareholders for whose benefit the Trustee shall hold the Property will be referred to as the “Public Shareholders,” and the Public Shareholders and the Company will be referred to together as the “Beneficiaries”); and
WHEREAS, the Company and the Trustee desire to enter into this Agreement to set forth the terms and conditions pursuant to which the Trustee shall hold the Property.
NOW THEREFORE, IT IS AGREED:
- Agreements and Covenants of Trustee. The Trustee hereby agrees and covenants to:
(a) Hold the Property in trust for the Beneficiaries in accordance with the terms of this Agreement in the Trust Account established by the Trustee in the United States at J.P. Morgan Chase Bank, N.A. (or at another U.S.-chartered commercial bank with consolidated assets of $100 billion or more) and at a brokerage institution selected by the Trustee that is reasonably satisfactory to the Company;
(b) Manage, supervise and administer the Trust Account subject to the terms and conditions set forth herein;
(c) In a timely manner, upon the written instruction of the Company, (i) invest and reinvest the Property solely in United States government securities within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less, or in money market funds meeting the conditions of paragraphs (d)(1), (d)(2), (d)(3) and (d)(4) of Rule 2a-7 promulgated under the Investment Company Act (or any successor rule), which invest only in direct U.S. government treasury obligations or (ii) deposit the Property into an interest bearing or non-interest bearing bank demand deposit account at a U.S. chartered commercial bank with consolidated assets of $100 billion or more selected by the Trustee that is reasonably satisfactory to the Company; it being understood that the Trust Account will earn no interest while account funds are uninvested awaiting the Company’s instructions hereunder and while the account funds are invested or uninvested, the Trustee may earn bank credits or other consideration during such periods;
(d) Collect and receive, when due, all interest or other income arising from the Property, which shall become part of the “Property,” as such term is used herein;
(e) Promptly notify the Company and the Representatives of all communications received by the Trustee with respect to any Property requiring action by the Company;
(f) Supply any necessary information or documents as may be requested by the Company (or its authorized agents) in connection with the Company’s preparation of the tax returns relating to assets held in the Trust Account or in connection with the preparation or completion of the audit of the Company’s financial statements by the Company’s auditors;
(g) Participate in any plan or proceeding for protecting or enforcing any right or interest arising from the Property if, as and when instructed by the Company to do so;
(h) Render to the Company monthly written statements of the activities of, and amounts in, the Trust Account reflecting all receipts and disbursements of the Trust Account;
(i) Commence liquidation of the Trust Account only after and promptly after (x) receipt of, and only in accordance with, the terms of a letter from the Company (“Termination Letter”) in a form substantially similar to that attached hereto as either Exhibit A or Exhibit B, as applicable, signed on behalf of the Company by its Chief Executive Officer, President, Chief Financial Officer, Secretary or Chairman of the board of directors of the Company (the “Board”) or other authorized officer of the Company, and complete the liquidation of the Trust Account and distribute the Property in the Trust Account, including interest not previously released to the Company to pay its franchise, income, or other taxes owed (in the context of Exhibit B, net of any taxes payable and less up to $50,000 of interest that may be released to the Company to pay dissolution expenses) , only as directed in the Termination Letter and the other documents referred to therein , or (y) upon the date which is the later of (i) 12 months (or up to 18 months if the Company extends the period of time to consummate a business combination by the full amount of time) after the closing of the Offering and (ii) such later date as may be approved by the Company’s shareholders in accordance with the Company’s amended and restated memorandum and articles of association, if a Termination Letter has not been received by the Trustee prior to such date, in which case the Trust Account shall be liquidated in accordance with the procedures set forth in the Termination Letter attached as Exhibit B and the Property in the Trust Account, including interest not previously released to the Company to pay its taxes owed (net of any taxes payable and less up to $50,000 of interest that may be released to the Company to pay dissolution expenses) shall be distributed to the Public Shareholders of record as of such date.
(j) Upon written request from the Company, which may be given from time to time in a form substantially similar to that attached hereto as Exhibit C, withdraw from the Trust Account and distribute to the Company the amount of interest earned on the Property requested by the Company to cover any tax obligation owed by the Company as a result of assets of the Company or interest or other income earned on the Property, which amount shall be delivered directly to the Company by electronic funds transfer or other method of prompt payment, and the Company shall forward such payment to the relevant taxing authority; provided, however, that to the extent there is not sufficient cash in the Trust Account to pay such tax obligation, the Trustee shall liquidate such assets held in the Trust Account as shall be designated by the Company in writing to make such distribution so long as there is no reduction in the principal amount per share initially deposited in the Trust Account. The written request of the Company referenced above shall constitute presumptive evidence that the Company is entitled to the funds, and the Trustee shall have no responsibility to look beyond said request;
2
(k) Upon written request from the Company, which may be given from time to time in a form substantially similar to that attached hereto as Exhibit D, the Trustee shall distribute to the Public Shareholders of record as of such date the amount requested by the Company to be used to redeem Ordinary Shares from Public Shareholders properly submitted in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association to modify the substance or timing of the Company’s obligation to redeem 100% of its public Ordinary Shares in connection with the consummation of an initial Business Combination or if the Company has not consummated an initial Business Combination within such time as is described in the Company’s amended and restated memorandum and articles of association. The written request of the Company referenced above shall constitute presumptive evidence that the Company is entitled to distribute said funds, and the Trustee shall have no responsibility to look beyond said request; and
(l) Not make any withdrawals or distributions from the Trust Account other than pursuant to Section 1(i), (j) or .(k). above.
- Agreements and Covenants of the Company. The Company hereby agrees and covenants to:
(a) Give all instructions to the Trustee hereunder in writing, signed by the Chairman of the Company’s Board, President, Chief Executive Officer, Chief Financial Officer, Secretary or other authorized officer of the Company. In addition, except with respect to its duties under Sections 1(i), 1(j) and 1(k). hereof, the Trustee shall be entitled to rely on, and shall be protected in relying on, any verbal or telephonic advice or instruction which it, in good faith and with reasonable care, believes to be given by any one of the persons authorized above to give written instructions, provided that the Company shall promptly confirm such instructions in writing;
(b) Subject to Section 4 hereof, hold the Trustee harmless and indemnify the Trustee from and against any and all expenses, including reasonable counsel fees and disbursements, or losses suffered by the Trustee in connection with any action taken by it hereunder and in connection with any action, suit or other proceeding brought against the Trustee involving any claim, or in connection with any claim or demand, which in any way arises out of or relates to this Agreement, the services of the Trustee hereunder, or the Property or any interest earned on the Property, except for expenses and losses resulting from the Trustee’s gross negligence, fraud or willful misconduct. Promptly after the receipt by the Trustee of notice of demand or claim or the commencement of any action, suit or proceeding, pursuant to which the Trustee intends to seek indemnification under this Section 2(b), it shall notify the Company in writing of such claim (hereinafter referred to as the “Indemnified Claim”). The Trustee shall have the right to conduct and manage the defense against such Indemnified Claim; provided that the Trustee shall obtain the consent of the Company with respect to the selection of counsel, which consent shall not be unreasonably withheld or delayed. The Trustee may not agree to settle any Indemnified Claim without the prior written consent of the Company, which such consent shall not be unreasonably withheld or delayed. The Company may participate in such action with its own counsel;
3
(c) Pay the Trustee the fees set forth on Schedule A hereto, including an initial acceptance fee, annual administration fee and transaction processing fee, which fees shall be subject to modification by the parties from time to time. It is expressly understood that the Property shall not be used to pay such fees unless and until the Company consummates its Business Combination. The Company shall pay the Trustee the initial acceptance fee and the first annual administration fee at the consummation of the Offering. The Company shall not be responsible for any other fees or charges of the Trustee except as set forth in this Section 2(c), Schedule A and as may be provided in Section 2(b) hereof;
(d) In connection with any vote of the Company’s shareholders regarding a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination involving the Company and one or more businesses (the “Business Combination”), provide to the Trustee an affidavit or certificate of the inspector of elections for the shareholder meeting verifying the vote of such shareholders regarding such Business Combination;
(e) Provide the Representatives with a copy of any Termination Letter(s) and/or any other correspondence that is sent to the Trustee with respect to any proposed withdrawal from the Trust Account promptly after it issues the same;
(f) Instruct the Trustee to make only those distributions that are permitted under this Agreement, and refrain from instructing the Trustee to make any distributions that are not permitted under this Agreement.
- Limitations of Liability. The Trustee shall have no responsibility or liability to:
(a) Imply obligations, perform duties, inquire or otherwise be subject to the provisions of any agreement or document other than this Agreement and that which is expressly set forth herein;
(b) Take any action with respect to the Property, other than as directed in Section 1 hereof , and the Trustee shall have no liability to any third party except for liability arising out of the Trustee’s gross negligence, fraud or willful misconduct, and in no event shall the Trustee be liable for the selection of investments or for investment losses incurred thereon or for losses incurred as a result of the liquidation of any such investment prior to its maturity date or the failure of the Company to provide timely written investment instruction;
(c) Institute any proceeding for the collection of any principal and income arising from, or institute, appear in or defend any proceeding of any kind with respect to, any of the Property unless and until it shall have received instructions from the Company given as provided herein to do so and the Company shall have advanced or guaranteed to it funds sufficient to pay any reasonably incurred expenses incident thereto;
(d) Refund any depreciation in principal of any Property;
(e) Assume that the authority of any person designated by the Company to give instructions hereunder shall not be continuing unless provided otherwise in such designation, or unless the Company shall have delivered a written revocation of such authority to the Trustee;
4
(f) The other parties hereto or to anyone else for any action taken or omitted by it, or any action suffered by it to be taken or omitted, in good faith and in the Trustee’s reasonable best judgment, except for the Trustee’s gross negligence, fraud or willful misconduct. The Trustee may rely conclusively and shall be protected in acting upon any order, notice, demand, certificate, opinion or advice of counsel (including counsel chosen by the Trustee, which counsel may be the Company’s counsel), statement, instrument, report or other paper or document (not only as to its due execution and the validity and effectiveness of its provisions, but also as to the truth and acceptability of any information therein contained) which the Trustee believes, in good faith and with reasonable care, to be genuine and to be signed or presented by the proper person or persons. The Trustee shall not be bound by any notice or demand, or any waiver, modification, termination or rescission of this Agreement or any of the terms hereof, unless evidenced by a written instrument delivered to the Trustee, signed by the proper party or parties and, if the duties or rights of the Trustee are affected, unless it shall give its prior written consent thereto;
(g) Verify the accuracy of the information contained in the Registration Statement;
(h) Provide any assurance that any Business Combination entered into by the Company or any other action taken by the Company is as contemplated by the Registration Statement;
(i) File information returns with respect to the Trust Account with any local, state or federal taxing authority or provide periodic written statements to the Company documenting the taxes payable by the Company, if any, relating to any interest income earned on the Property;
(j) Prepare, execute and file tax reports, income or other tax returns and pay any taxes with respect to any income generated by, and activities relating to, the Trust Account, regardless of whether such tax is payable by the Trust Account or the Company, including, but not limited to, franchise and income tax obligations, except pursuant to Section 1(j) hereof; or
(k) Verify calculations, qualify or otherwise approve the Company’s written requests for distributions pursuant to Sections l(i), l(j) or l(k) hereof.
Trust Account Waiver. The Trustee has no right of set-off or any right, title, interest or claim of any kind (“Claim”) to, or to any monies in, the Trust Account, and hereby irrevocably waives any Claim to, or to any monies in, the Trust Account that it may have now or in the future. In the event the Trustee has any Claim against the Company under this Agreement, including, without limitation, under Section 2(b) or Section 2(c) hereof, the Trustee shall pursue such Claim solely against the Company and its assets outside the Trust Account and not against the Property or any monies in the Trust Account.
Termination. This Agreement shall terminate as follows:
(a) If the Trustee gives written notice to the Company that it desires to resign under this Agreement, the Company shall use its reasonable efforts to locate a successor trustee, pending which the Trustee shall continue to act in accordance with this Agreement. At such time that the Company notifies the Trustee that a successor trustee has been appointed and has agreed to become subject to the terms of this Agreement, the Trustee shall transfer the management of the Trust Account to the successor trustee, including but not limited to the transfer of copies of the reports and statements relating to the Trust Account, whereupon this Agreement shall terminate; provided, however, that in the event that the Company does not locate a successor trustee within ninety (90) days of receipt of the resignation notice from the Trustee, the Trustee may submit an application to have the Property deposited with any court in the State of New York or with the United States District Court for the Southern District of New York and upon such deposit, the Trustee shall be immune from any liability whatsoever; or
(b) At such time that the Trustee has completed the liquidation of the Trust Account and its obligations in accordance with the provisions of Section 1(i) hereof and distributed the Property in accordance with the provisions of the Termination Letter, this Agreement shall terminate except with respect to Section 2(b).
5
- Miscellaneous.
(a) The Company and the Trustee each acknowledge that the Trustee will follow the security procedures set forth below with respect to funds transferred from the Trust Account. The Company and the Trustee will each restrict access to confidential information relating to such security procedures to authorized persons. Each party must notify the other party immediately if it has reason to believe unauthorized persons may have obtained access to such confidential information, or of any change in its authorized personnel. In executing funds transfers, the Trustee shall rely upon all information supplied to it by the Company, including, account names, account numbers, and all other identifying information relating to a Beneficiary, Beneficiary’s bank or intermediary bank. Except for any liability arising out of the Trustee’s gross negligence, fraud or willful misconduct, the Trustee shall not be liable for any loss, liability or expense resulting from any error in the information or transmission of the funds.
(b) This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. This Agreement may be executed in several original or facsimile counterparts, each one of which shall constitute an original, and together shall constitute but one instrument.
(c) This Agreement contains the entire agreement and understanding of the parties hereto with respect to the subject matter hereof. Except for Section l(i), l(j) and l(k) hereof (which sections may not be modified, amended or deleted without the affirmative vote of two-thirds of the votes cast of the then outstanding Ordinary Shares and Class B ordinary shares participated in the vote, par value $0.0001 per share, of the Company voting together as a single class; provided that no such amendment will affect any Public Shareholder who has otherwise indicated his election to redeem his Ordinary Shares in connection with a shareholder vote sought to amend this Agreement), this Agreement or any provision hereof may only be changed, amended or modified (other than to correct a typographical error) by a writing signed by each of the parties hereto. Except for any liability arising out of the Trustee’s gross negligence, fraud or willful misconduct, the Trustee may rely conclusively on the certification from the inspector or elections referenced above and shall be relieved of all liability to any party for executing the proposed amendment in reliance thereon.
(d) The parties hereto consent to the jurisdiction and venue of any state or federal court located in the City of New York, State of New York, for purposes of resolving any disputes hereunder. AS TO ANY CLAIM, CROSS-CLAIM OR COUNTERCLAIM IN ANY WAY RELATING TO THIS AGREEMENT, EACH PARTY WAIVES THE RIGHT TO TRIAL BY JURY.
(e) Any notice, consent or request to be given in connection with any of the terms or provisions of this Agreement shall be in writing and shall be sent by express mail or similar private courier service, by certified mail (return receipt requested), by hand delivery or by facsimile or email transmission:
If to the Trustee, to:
Continental Stock Transfer & Trust Company
1 State Street 30^th^ Floor
New York, NY 10004
Attn: Francis Wolf and Celeste Gonzalez
Email: fwolf@continentalstock.com
cgonzalez@continentalstock.com
6
If to the Company, to:
Fen Zhang
CEO and Director
Eureka Acquisition Corp
899 Ruining Road, Yangguang Binjiang Center
South Building, Unit 808
Shanghai 200030, PRC
Email: Eric.zhang@hercules.global
in each case, with copies to:
Robinson & Cole LLP
Chrysler East Building
666 Third Avenue, 20th Floor
New York, NY 10017
Attn.: Arila Zhou, Esq.
Email: azhou@rc.com
and
Maxim Group LLC
300 Park Avenue
New York, NY 10174
Attn.: Larry Glassberg
Email: lglassberg@maximgrp.com
and
Ellenoff Grossman & Schole LLP
1345 Avenue of the Americas
New York, NY 10105
Attn.: Barry Grossman, Esq. and
Lijia Sanchez, Esq.
Telephone: (212) 370-1300
7
(f) Each of the Company and the Trustee hereby represents that it has the full right and power and has been duly authorized to enter into this Agreement and to perform its respective obligations as contemplated hereunder. The Trustee acknowledges and agrees that it shall not make any claims or proceed against the Trust Account, including by way of set-off, and shall not be entitled to any funds in the Trust Account under any circumstance.
(g) This Agreement is the joint product of the Trustee and the Company and each provision hereof has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.
(h) This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, but all such counterparts shall together constitute one and the same instrument. Delivery of a signed counterpart of this Agreement by facsimile or electronic transmission shall constitute valid and sufficient delivery thereof.
(i) Each of the Company and the Trustee hereby acknowledges and agrees that each Representative, on behalf of the Underwriters, is a third-party beneficiary of this Agreement.
(j) Except as specified herein, no party to this Agreement may assign its rights or delegate its obligations hereunder to any other person or entity.
[Signature Page Follows]
8
IN WITNESS WHEREOF, the parties have duly executed this Investment Management Trust Agreement as of the date first written above.
Continental Stock Transfer & Trust Company, as Trustee
| By: | /s/ Francis Wolf |
|---|---|
| Name: | Francis Wolf |
| Title: | Vice President |
Eureka Acquisition Corp
| By: | /s/ Fen Zhang |
|---|---|
| Name: | Fen Zhang |
| Title: | Director |
[Signature Page to Investment Management TrustAgreement]
9
EXHIBIT A
[Letterhead of Company]
[Insert date]
Continental Stock Transfer & Trust Company
1 State Street, 30^th^ Floor
New York, NY 10004-1561
Attn: Fran Wolf & Celeste Gonzalez
| Re: | Trust Account - Termination Letter |
|---|
Dear Mr. Wolf and Ms. Gonzalez:
Pursuant to Section l(i) of the Investment Management Trust Agreement between Eureka Acquisition Corp (the “Company”) and Continental Stock Transfer & Trust Company (the “Trustee”), dated as of [ ], 202[ ] (the “Trust Agreement”), this is to advise you that the Company has entered into an agreement with [insert name] (the “Target Business”) to consummate a business combination with Target Business (the “Business Combination”) on or about [insert date]. The Company shall notify you at least seventy-two (72) hours in advance of the actual date (or such shorter time period as you may agree) of the consummation of the Business Combination (the “Consummation Date”). Capitalized terms used but not defined herein shall have the meanings set forth in the Trust Agreement.
In accordance with the terms of the Trust Agreement, we hereby authorize you to commence to liquidate all of the assets of the Trust Account and to transfer the proceeds into a segregated account held by you on behalf of the Beneficiaries to the effect that, on the Consummation Date, all of the funds held in the Trust Account will be immediately available for transfer to the account or accounts that the Company shall direct on the Consummation Date. It is acknowledged and agreed that while the funds are on deposit in the trust operating account at JP Morgan Chase, N.A., awaiting distribution, neither the Company nor the Representatives will earn any interest or dividends.
On the Consummation Date (i) counsel for the Company shall deliver to you written notification that the Business Combination has been consummated (the “Notification”) and (ii) the Company shall deliver to you (a) [an affidavit] [a certificate] of the Chief Executive Officer of the Company, which verifies that the Business Combination has been approved by a vote of the Company’s shareholders , if a vote is held and (b) a joint written instruction signed by the Company and the Representatives with respect to the transfer of the funds held in the Trust Account (the “Instruction Letter”). You are hereby directed and authorized to transfer the funds held in the Trust Account immediately upon your receipt of the Notification and the Instruction Letter, in accordance with the terms of the Instruction Letter. In the event that certain deposits held in the Trust Account may not be liquidated by the Consummation Date without penalty, you will notify the Company in writing of the same and the Company shall direct you as to whether such funds should remain in the Trust Account and be distributed after the Consummation Date to the Company. Upon the distribution of all the funds, net of any payments necessary for reasonable unreimbursed expenses related to liquidating the Trust Account, your obligations under the Trust Agreement shall be terminated.
In the event that the Business Combination is not consummated on the Consummation Date described in the notice thereof and we have not notified you on or before the original Consummation Date of a new Consummation Date, then upon receipt by the Trustee of written instructions from the Company, the funds held in the Trust Account shall be reinvested as provided in Section l(c) of the Trust Agreement on the business day immediately following the Consummation Date as set forth in such written instruction as soon thereafter as possible.
[Signature Page Follows]
10
Very truly yours,
Eureka Acquisition Corp
| By: | |
|---|---|
| Name: | Fen Zhang |
| Title: | Director |
| cc: | Maxim Group LLC |
| --- | --- |
[Signature Page to Exhibit A of the InvestmentManagement Trust Agreement]
11
EXHIBIT B
[Letterhead of Company]
[Insert date]
Continental Stock Transfer & Trust Company
1 State Street, 30^th^ Floor
New York, NY 10004
Attn: Fran Wolf and Celeste Gonzalez
| Re: | Trust Account-Termination Letter |
|---|
Dear Mr. Wolf and Ms. Gonzalez:
Pursuant to Section l(i) of the Investment Management Trust Agreement between Eureka Acquisition Corp (the “Company”) and Continental Stock Transfer & Trust Company (the “Trustee”), dated as of [ ], 20[ ] (the “Trust Agreement”), this is to advise you that the Company has been unable to effect a business combination with a Target Business within the time frame specified in the Company’s Amended and Restated Memorandum and Articles of Association, as described in the Company’s Prospectus relating to the Offering. Capitalized terms used but not defined herein shall have the meanings set forth in the Trust Agreement.
In accordance with the terms of the Trust Agreement, we hereby authorize you to liquidate all of the assets in the Trust Account on [ ], 20[ ] and to transfer the total proceeds into a segregated account held by you on behalf of the Beneficiaries to await distribution to the Public Shareholders. The Company has selected [ * ] as the record date for the purpose of determining the Public Shareholders entitled to receive their share of the liquidation proceeds. You agree to be the Paying Agent of record and, in your separate capacity as Paying Agent, agree to distribute said funds directly to the Company’s Public Shareholders in accordance with the terms of the Trust Agreement and the Amended and Restated Memorandum and Articles of Association of the Company. Upon the distribution of all the funds, net of any payments necessary for reasonable unreimbursed expenses related to liquidating the Trust Account, your obligations under the Trust Agreement shall be terminated, except to the extent otherwise provided in Section 1(i) of the Trust Agreement.
Very truly yours,
Eureka Acquisition Corp
| By: | |
|---|---|
| Name: | Fen Zhang |
| Title: | Director |
| cc: | Maxim Group LLC |
| --- | --- |
12
EXHIBIT C
[Letterhead of Company]
[Insert date]
Continental Stock Transfer & Trust Company
1 State Street, 30^th^ Floor
New York, NY 10004
Attn: Fran Wolf and Celeste Gonzalez
| Re: | Trust Account-Tax Payment Withdrawal Instruction |
|---|
Dear Mr. Wolf and Ms. Gonzalez:
Pursuant to Section l(j) of the Investment Management Trust Agreement between Eureka Acquisition Corp (the “Company”) and Continental Stock Transfer & Trust Company (the “Trustee”), dated as of , 20[ ] (the “TrustAgreement”), the Company hereby requests that you deliver to the Company$[ ] of the interest income earned on the Property as of the date hereof. Capitalized terms used but not defined herein shall have the meanings set forth in the Trust Agreement.
The Company needs such funds to pay for the tax obligations as set forth on the attached tax return or tax statement. In accordance with the terms of the Trust Agreement, you are hereby directed and authorized to transfer (via wire transfer) such funds promptly upon your receipt of this letter to the Company’s operating account at:
[WIRE INSTRUCTION INFORMATION]
Very truly yours,
Eureka Acquisition Corp
| By: | |
|---|---|
| Name: | Fen Zhang |
| Title: | Director |
| cc: | Maxim Group LLC |
| --- | --- |
13
EXHIBIT D
[Letterhead of Company]
[Insert date]
Continental Stock Transfer & Trust Company
1 State Street, 30^th^ Floor
New York, NY 10004
Attn: Fran Wolf and Celeste Gonzalez
| Re: | Trust Account-Shareholder Redemption Withdrawal Instruction |
|---|
Dear Mr. Wolf and Ms. Gonzalez:
Pursuant to Section l(k) of the Investment Management Trust Agreement between Eureka Acquisition Corp (the “Company”) and Continental Stock Transfer & Trust Company (the “Trustee”), dated as of [ ], 20[ ] (the “Trust Agreement” ), the Company hereby requests that you deliver to the redeeming Public Shareholders of the Company $[ ] of the principal and interest income earned on the Property as of the date hereof into a segregated account held by you on behalf of the Beneficiaries. Capitalized terms used but not defined herein shall have the meanings set forth in the Trust Agreement.
The Company needs such funds to pay its Public Shareholders who have properly elected to have their Ordinary Shares redeemed by the Company in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association to modify the substance or timing of the Company’s obligation to redeem 100% of its public Ordinary Shares if the Company has not consummated an initial Business Combination within such time as is described in the Company’s amended and restated memorandum and articles of association. As such, you are hereby directed and authorized to transfer (via wire transfer) such funds promptly upon your receipt of this letter into a segregated account held by you on behalf of the Beneficiaries.
Very truly yours,
Eureka Acquisition Corp
| By: | |
|---|---|
| Name: | Fen Zhang |
| Title: | Director |
| cc: | Maxim Group LLC |
| --- | --- |
14
Exhibit 10.4
Execution Version
REGISTRATION RIGHTS AGREEMENT
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of July 2, 2024, is made and entered into by and among Eureka Acquisition Corp, a Cayman Islands exempted company (the “Company”), Hercules Capital Management Corp, a British Virgin Islands company (the “Sponsor”), Maxim Group LLC (the “Representative”), and each additional undersigned party listed on the signature page hereto, if any (each such party, together with the Sponsor, the Representative, and any person or entity who hereafter becomes a party to this Agreement pursuant to Section 5.2 of this Agreement, a “Holder” and collectively the “Holders”).
RECITALS
WHEREAS, pursuant to that certain Founder Share Subscription Agreement dated as of September 29, 2023 and other arrangements between the Company and the Sponsor, the Sponsor purchased an aggregate of 1,437,500 (the “Founder Shares”) of the Company’s Class B ordinary shares, par value $0.0001 per share (the “Class B Ordinary Shares”); the Sponsor and each of the Company’s independent director nominees have entered into that certain Founder Share Transfer Agreement, dated as of June 29, 2024, to transfer 10,000 Founder Shares to each independent director nominee for their board service;
WHEREAS, the Founder Shares are convertible into the Company’s Class A ordinary shares, par value $0.0001 per share (the “Ordinary Shares”), on the terms and conditions provided in the Company’s amended and restated memorandum and articles of association;
WHEREAS, on July 2, 2024, the Company entered into that certain Unit Subscription Agreement with Hercules Capital Management Corp, a British Virgin Islands company (the “Sponsor”), pursuant to which the Sponsor agreed to purchase an aggregate of 216,750 units (or up to 228,000 units if the over-allotment option in connection with the Company’s initial public offering (the “Offering”) is exercised in full) simultaneously with the closing of the Offering (and the closing of the over-allotment option, if applicable) (the “Private Placement Units”) at a purchase price of $10.00 per Private Placement Unit. Each Private Placement Unit is comprised of one Ordinary Share (the “Private Placement Shares”) and one right to receive one-fifth of one Ordinary Share (the “Private Placement Rights”);
WHEREAS, on or about the date hereof, the Company and Maxim Group LLC (“Maxim”) entered into that certain Underwriting Agreement, pursuant to which Maxim and/or its designees will receive an aggregate of 200,000 Ordinary Shares (or up to 230,000 Ordinary Shares to the extent that the over-allotment option in connection with the Company’s initial public offering is exercised) (the “Representative Shares”), in a transaction occurring simultaneously with the closing of the Company’s initial public offering (and the closing of the over-allotment option, if applicable); and
WHEREAS, the Company and the Holders desire to enter into this Agreement, pursuant to which the Company shall grant the Holders certain registration rights with respect to certain securities of the Company, as set forth in this Agreement.
NOW, THEREFORE, in consideration of the representations, covenants and agreements contained herein, and certain other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:
ArticleI
DEFINITIONS
1.1 Definitions. The terms defined in this Article I shall, for all purposes of this Agreement, have the respective meanings set forth below:
“Adverse Disclosure” shall mean any public disclosure of material non-public information, which disclosure, in the good faith judgment of the Chief Executive Officer or principal financial officer of the Company, after consultation with counsel to the Company, (i) would be required to be made in any Registration Statement or Prospectus in order for the applicable Registration Statement or Prospectus not to contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements contained therein (in the case of any prospectus and any preliminary prospectus, in the light of the circumstances under which they were made) not misleading, (ii) would not be required to be made at such time if the Registration Statement were not being filed, and (iii) the Company has a bona fide business purpose for not making such information public.
“Agreement” shall have the meaning given in the Preamble.
“Board” shall mean the Board of Directors of the Company.
“Business Combination” shall mean any merger, share exchange, asset acquisition, share purchase, reorganization or other similar business combination with one or more businesses, involving the Company.
“Commission” shall mean the Securities and Exchange Commission.
“Company” shall have the meaning given in the Preamble.
“Demand Registration” shall have the meaning given in subsection 2.1.1.
“Demanding Holder” shall have the meaning given in subsection 2.1.1.
“Exchange Act” shall mean the Securities Exchange Act of 1934, as it may be amended from time to time.
“Form S-1” shall have the meaning given in subsection 2.1.1.
“Form S-3” shall have the meaning given in subsection 2.3.
“Founder Shares” shall have the meaning given in the Recitals hereto and shall be deemed to include the Ordinary Shares issuable upon conversion thereof.
“Founder SharesLock-up Period” shall mean, with respect to the Founder Shares, the period ending on the earlier of (A) six months after the completion of the Company’s initial Business Combination and (B) the date on which the Company consummates a liquidation, merger, share exchange, reorganization, or other similar transaction after the Company’s initial business combination that results in all of its shareholders having the right to exchange their ordinary shares for cash, securities or other property. Notwithstanding the foregoing, if the last sale price of the Company’s Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period after the Company’s initial business combination, 50% of the Founder Shares will be released from the lock-up.
2
“Founder SharesPurchase Agreement” shall have the meaning given in the Recitals hereto.
“Holders” shall have the meaning given in the Preamble.
“Insider Letter” shall mean that certain letter agreement, dated as of July 2, 2024, by and among the Company, the Sponsor and each of the Company’s officers and directors.
“Maximum Numberof Securities” shall have the meaning given in subsection 2.1.4.
“Misstatement” shall mean an untrue statement of a material fact or an omission to state a material fact required to be stated in a Registration Statement or Prospectus, or necessary to make the statements in a Registration Statement or Prospectus in the light of the circumstances under which they were made not misleading.
“Ordinary Shares” shall have the meaning given in the Recitals.
“Permitted Transferees” shall mean a person or entity to whom a Holder of Registrable Securities is permitted to transfer such Registrable Securities prior to the expiration of the Founder Shares Lock-up Period or Private Placement Lock-up Period, as the case may be, under the Insider Letter, this Agreement, and any other applicable agreement between such Holder and the Company, and to any transferee thereafter.
“Piggyback Registration” shall have the meaning given in subsection 2.2.1.
“Private PlacementLock-up Period” shall mean, with respect to Private Placement Units, including Private Placement Shares, and Private Placement Rights included in the Private Placement Units, and the Ordinary Shares underlying Private Placement Rights that are held by the initial purchasers of such Private Placement Units or their Permitted Transferees, the period ending upon the completion of the Company’s initial Business Combination.
“Private PlacementRights” shall have the meaning given in the Recitals hereto.
“Private PlacementShares” shall have the meaning given in the Recitals hereto.
“Private PlacementUnits” shall have the meaning given in the Recitals hereto.
“Pro Rata” shall have the meaning given in subsection 2.1.4.
“Prospectus” shall mean the prospectus included in any Registration Statement, as supplemented by any and all prospectus supplements and as amended by any and all post-effective amendments and including all material incorporated by reference in such prospectus.
3
“Prospectus Date” shall mean the date of the final prospectus filed with the Commission and relating to the Company’s initial public offering.
“RegistrableSecurity” shall mean (a) the Ordinary Shares issued or issuable upon the conversion of any Founder Shares, (b) the Representative Shares, (c) the Private Placement Units, (d) the Private Placement Rights (including any Ordinary Shares issued or issuable upon the conversion of any such Private Placement Rights), (e) the Private Placement Shares, (f) any outstanding Ordinary Shares or any other equity security (including the Ordinary Shares issued or issuable upon the exercise of any other equity security) of the Company held by a Holder as of the date of this Agreement, (g) any equity securities (including the Ordinary Shares issued or issuable upon the exercise of any such equity security) of the Company issuable upon conversion of any working capital loans in an amount up to $1,500,000 made to the Company by a Holder and any extension loans in connection with the extension of the timeline for the Company to complete a Business Combination, and (h) any other equity security of the Company issued or issuable with respect to any such Ordinary Shares by way of a share dividend or share split or in connection with a combination of shares, recapitalization, merger, consolidation or reorganization; provided, however, that, as to any particular Registrable Security, such securities shall cease to be Registrable Securities when: (A) a Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act and such securities shall have been sold, transferred, disposed of or exchanged in accordance with such Registration Statement; (B) such securities shall have been otherwise transferred, new certificates for such securities not bearing a legend restricting further transfer shall have been delivered by the Company and subsequent public distribution of such securities shall not require registration under the Securities Act; (C) such securities shall have ceased to be outstanding; (D) such securities may be sold without registration pursuant to Rule 144 promulgated under the Securities Act (or any successor rule promulgated thereafter by the Commission) (but with no volume or other restrictions or limitations); or (E) such securities have been sold to, or through, a broker, dealer or underwriter in a public distribution or other public securities transaction.
“Registration” shall mean a registration effected by preparing and filing a registration statement or similar document in compliance with the requirements of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such registration statement becoming effective.
“RegistrationExpenses” shall mean the out-of-pocket expenses of a Registration, including, without limitation, the following:
(A) all registration and filing fees (including fees with respect to filings required to be made with the Financial Industry Regulatory Authority, Inc.) and any securities exchange on which the Ordinary Shares are then listed;
(B) fees and expenses of compliance with securities or blue sky laws (including reasonable fees and disbursements of counsel for the Underwriters in connection with blue sky qualifications of Registrable Securities);
(C) printing, messenger, telephone and delivery expenses;
(D) reasonable fees and disbursements of counsel for the Company;
4
(E) reasonable fees and disbursements of all independent registered public accountants of the Company incurred specifically in connection with such Registration; and
(F) reasonable fees and expenses of one (1) legal counsel selected by the majority-in-interest of the Demanding Holders initiating a Demand Registration to be registered for offer and sale in the applicable Registration.
“RegistrationStatement” shall mean any registration statement that covers the Registrable Securities pursuant to the provisions of this Agreement, including the Prospectus included in such registration statement, amendments (including post-effective amendments) and supplements to such registration statement, and all exhibits to and all material incorporated by reference in such registration statement.
“Requesting Holder” shall have the meaning given in subsection 2.1.1.
“Securities Act” shall mean the Securities Act of 1933, as amended from time to time.
“Sponsor” shall have the meaning given in the Recitals hereto.
“Underwriter” shall mean a securities dealer who purchases any Registrable Securities as principal in an Underwritten Offering (as defined below) and not as part of such dealer’s market-making activities.
“UnderwrittenRegistration” or “Underwritten Offering” shall mean a Registration in which securities of the Company are sold to an Underwriter in a firm commitment underwriting for distribution to the public.
ArticleII
REGISTRATIONS
2.1 Demand Registration.
2.1.1 Request for Registration. Subject to the provisions of subsection 2.1.4 and Section 2.4 hereof, at any time and from time to time on or after the date the Company consummates the Business Combination, the Holders of at least a majority in interest of the then-outstanding number of Registrable Securities (the “Demanding Holders”) may make a written demand for Registration under the Securities Act of all or part of their Registrable Securities, which written demand shall describe the amount and type of securities to be included in such Registration and the intended method(s) of distribution thereof (such written demand a “Demand Registration”). The Company shall, within ten (10) days of the Company’s receipt of the Demand Registration, notify, in writing, all other Holders of Registrable Securities of such demand, and each Holder of Registrable Securities who thereafter wishes to include all or a portion of such Holder’s Registrable Securities in a Registration pursuant to a Demand Registration (each such Holder that includes all or a portion of such Holder’s Registrable Securities in such Registration, a “Requesting Holder”) shall so notify the Company, in writing, within five (5) days after the receipt by the Holder of the notice from the Company. Upon receipt by the Company of any such written notification from a Requesting Holder(s) to the Company, such Requesting Holder(s) shall be entitled to have their Registrable Securities included in a Registration pursuant to a Demand Registration and the Company shall effect, as soon thereafter as practicable, the Registration of all Registrable Securities requested by the Demanding Holders and Requesting Holders pursuant to such Demand Registration. Under no circumstances shall the Company be obligated to effect more than an aggregate of three (3) Registrations pursuant to a Demand Registration under this subsection 2.1.1 with respect to any or all Registrable Securities; provided, however, that a Registration shall not be counted for such purposes unless a Form S-1 or any similar long-form registration statement that may be available at such time (“Form S-1”) has become effective and all of the Registrable Securities requested by the Requesting Holders to be registered on behalf of the Requesting Holders in such Form S-1 Registration have been sold, in accordance with Section 3.1 of this Agreement.
5
2.1.2 Effective Registration. Notwithstanding the provisions of subsection 2.1.1 above or any other part of this Agreement, a Registration pursuant to a Demand Registration shall not count as a Registration unless and until (i) the Registration Statement filed with the Commission with respect to a Registration pursuant to a Demand Registration has been declared effective by the Commission and (ii) the Company has complied with all of its obligations under this Agreement with respect thereto; provided, further, that if, after such Registration Statement has been declared effective, an offering of Registrable Securities in a Registration pursuant to a Demand Registration is subsequently interfered with by any stop order or injunction of the Commission, federal or state court or any other governmental agency the Registration Statement with respect to such Registration shall be deemed not to have been declared effective, unless and until, (i) such stop order or injunction is removed, rescinded or otherwise terminated, and (ii) a majority-in-interest of the Demanding Holders initiating such Demand Registration thereafter affirmatively elect to continue with such Registration and accordingly notify the Company in writing, but in no event later than five (5) days, of such election; and provided, further, that the Company shall not be obligated or required to file another Registration Statement until the Registration Statement that has been previously filed with respect to a Registration pursuant to a Demand Registration becomes effective or is subsequently terminated.
2.1.3 Underwritten Offering. Subject to the provisions of subsection 2.1.4 and Section 2.4 hereof, if a majority-in-interest of the Demanding Holders so advise the Company as part of their Demand Registration that the offering of the Registrable Securities pursuant to such Demand Registration shall be in the form of an Underwritten Offering, then the right of such Demanding Holder or Requesting Holder (if any) to include its Registrable Securities in such Registration shall be conditioned upon such Holder’s participation in such Underwritten Offering and the inclusion of such Holder’s Registrable Securities in such Underwritten Offering to the extent provided herein. All such Holders proposing to distribute their Registrable Securities through an Underwritten Offering under this subsection 2.1.3 shall enter into an underwriting agreement in customary form with the Underwriter(s) selected for such Underwritten Offering by the majority-in-interest of the Demanding Holders initiating the Demand Registration.
2.1.4 Reduction of Underwritten Offering. If the managing Underwriter or Underwriters in an Underwritten Registration pursuant to a Demand Registration, in good faith, advises the Company, the Demanding Holders and the Requesting Holders (if any) in writing that the dollar amount or number of Registrable Securities that the Demanding Holders and the Requesting Holders (if any) desire to sell, taken together with all other Ordinary Shares or other equity securities that the Company desires to sell and the Ordinary Shares, if any, as to which a Registration has been requested pursuant to separate written contractual piggy-back registration rights held by any other shareholders who desire to sell, exceeds the maximum dollar amount or maximum number of equity securities that can be sold in the Underwritten Offering without adversely affecting the proposed offering price, the timing, the distribution method, or the probability of success of such offering (such maximum dollar amount or maximum number of such securities, as applicable, the “Maximum Number of Securities”), then the Company shall include in such Underwritten Offering, as follows: (i) first, the Registrable Securities of the Demanding Holders and the Requesting Holders (if any) (pro rata based on the respective number of Registrable Securities that each Demanding Holder and Requesting Holder (if any) has requested be included in such Underwritten Registration and the aggregate number of Registrable Securities that the Demanding Holders and Requesting Holders have requested be included in such Underwritten Registration (such proportion is referred to herein as “Pro Rata”)) that can be sold without exceeding the Maximum Number of Securities; (ii) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (i), the Registrable Securities of Holders (Pro Rata, based on the respective number of Registrable Securities that each Holder has so requested) exercising their rights to register their Registrable Securities pursuant to subsection 2.2.1 hereof, without exceeding the Maximum Number of Securities; and (iii) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (i) and (ii), the Ordinary Shares or other equity securities that the Company desires to sell, including the Unit Purchase Option issued to the representative of the underwriters of the Company’s initial public offering, or its designees, which can be sold without exceeding the Maximum Number of Securities; and (iv) fourth, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (i), (ii) and (iii), the Ordinary Shares or other equity securities of other persons or entities that the Company is obligated to register in a Registration pursuant to separate written contractual arrangements with such persons and that can be sold without exceeding the Maximum Number of Securities.
6
2.1.5 Demand Registration Withdrawal. A majority-in-interest of the Demanding Holders initiating a Demand Registration or a majority-in-interest of the Requesting Holders (if any), pursuant to a Registration under subsection 2.1.1 shall have the right to withdraw from a Registration pursuant to such Demand Registration for any or no reason whatsoever upon written notification to the Company and the Underwriter or Underwriters (if any) of their intention to withdraw from such Registration prior to the effectiveness of the Registration Statement filed with the Commission with respect to the Registration of their Registrable Securities pursuant to such Demand Registration. Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with a Registration pursuant to a Demand Registration as provided in Section 3.3 prior to its withdrawal under this subsection 2.1.5.
2.2 Piggyback Registration.
2.2.1 Piggyback Rights. If, at any time on or after the date the Company consummates a Business Combination, the Company proposes to file a Registration Statement under the Securities Act with respect to an offering of equity securities, or securities or other obligations exercisable or exchangeable for, or convertible into equity securities, for its own account or for the account of shareholders of the Company (or by the Company and by the shareholders of the Company including, without limitation, pursuant to Section 2.1 hereof), other than a Registration Statement (i) filed in connection with any employee share option or other benefit plan, (ii) for an exchange offer or offering of securities solely to the Company’s existing shareholders, (iii) for an offering of debt that is convertible into equity securities of the Company or (iv) for a dividend reinvestment plan, then the Company shall give written notice of such proposed filing to all of the Holders of Registrable Securities as soon as practicable but not less than ten (10) days before the anticipated filing date of such Registration Statement, which notice shall (A) describe the amount and type of securities to be included in such offering, the intended method(s) of distribution, and the name of the proposed managing Underwriter or Underwriters, if any, in such offering, and (B) offer to all of the Holders of Registrable Securities the opportunity to register the sale of such number of Registrable Securities as such Holders may request in writing within five (5) days after receipt of such written notice (such Registration a “PiggybackRegistration”). The Company shall, in good faith, cause such Registrable Securities to be included in such Piggyback Registration and shall use its best efforts to cause the managing Underwriter or Underwriters of a proposed Underwritten Offering to permit the Registrable Securities requested by the Holders pursuant to this subsection 2.2.1 to be included in a Piggyback Registration on the same terms and conditions as any similar securities of the Company included in such Registration and to permit the sale or other disposition of such Registrable Securities in accordance with the intended method(s) of distribution thereof. All such Holders proposing to distribute their Registrable Securities through an Underwritten Offering under this subsection 2.2.1 shall enter into an underwriting agreement in customary form with the Underwriter(s) selected for such Underwritten Offering by the Company.
7
2.2.2 Reduction of Piggyback Registration. If the managing Underwriter or Underwriters in an Underwritten Registration that is to be a Piggyback Registration, in good faith, advises the Company and the Holders of Registrable Securities participating in the Piggyback Registration in writing that the dollar amount or number of the Ordinary Shares that the Company desires to sell, taken together with (i) the Ordinary Shares, if any, as to which Registration has been demanded pursuant to separate written contractual arrangements with persons or entities other than the Holders of Registrable Securities hereunder (ii) the Registrable Securities as to which registration has been requested pursuant to Section 2.2 hereof, and (iii) the Ordinary Shares, if any, as to which Registration has been requested pursuant to separate written contractual piggy-back registration rights of other shareholders of the Company, exceeds the Maximum Number of Securities, then:
(a) If the Registration is undertaken for the Company’s account, the Company shall include in any such Registration (A) first, the Ordinary Shares or other equity securities that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; (B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (A), the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant to subsection 2.2.1 hereof, Pro Rata, which can be sold without exceeding the Maximum Number of Securities; and (C) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A) and (B), the Ordinary Shares, if any, as to which Registration has been requested pursuant to written contractual piggy-back registration rights of other shareholders of the Company, which can be sold without exceeding the Maximum Number of Securities;
(b) If the Registration is pursuant to a request by persons or entities other than the Holders of Registrable Securities, then the Company shall include in any such Registration (A) first, the Ordinary Shares or other equity securities, if any, of such requesting persons or entities, other than the Holders of Registrable Securities, which can be sold without exceeding the Maximum Number of Securities; (B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (A), the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant to subsection 2.2.1, pro rata based on the number of Registrable Securities that each Holder has requested be included in such Underwritten Registration and the aggregate number of Registrable Securities that the Holders have requested to be included in such Underwritten Registration, which can be sold without exceeding the Maximum Number of Securities; (C) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A) and (B), the Ordinary Shares or other equity securities that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; and (D) fourth, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A), (B) and (C), the Ordinary Shares or other equity securities for the account of other persons or entities that the Company is obligated to register pursuant to separate written contractual arrangements with such persons or entities, which can be sold without exceeding the Maximum Number of Securities.
8
2.2.3 Piggyback Registration Withdrawal. Any Holder of Registrable Securities shall have the right to withdraw from a Piggyback Registration for any or no reason whatsoever upon written notification to the Company and the Underwriter or Underwriters (if any) of his, her or its intention to withdraw from such Piggyback Registration prior to the effectiveness of the Registration Statement filed with the Commission with respect to such Piggyback Registration. The Company (whether on its own good faith determination or as the result of a request for withdrawal by persons pursuant to separate written contractual obligations) may withdraw a Registration Statement filed with the Commission in connection with a Piggyback Registration at any time prior to the effectiveness of such Registration Statement. Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with the Piggyback Registration as provided in Section 3.2 prior to its withdrawal under this subsection 2.2.3.
2.2.4 Unlimited Piggyback Registration Rights. For purposes of clarity, any Registration effected pursuant to Section 2.2 hereof shall not be counted as a Registration pursuant to a Demand Registration effected under Section 2.1 hereof.
2.3 Registrations on Form S-3. The Holders of Registrable Securities may at any time, and from time to time, request in writing that the Company, pursuant to Rule 415 under the Securities Act (or any successor rule promulgated thereafter by the Commission), register the resale of any or all of their Registrable Securities on Form S-3 or any similar short form registration statement that may be available at such time (“Form S-3”); provided, however, that the Company shall not be obligated to effect such request through an Underwritten Offering. Within five (5) days of the Company’s receipt of a written request from a Holder or Holders of Registrable Securities for a Registration on Form S-3, the Company shall promptly give written notice of the proposed Registration on Form S-3 to all other Holders of Registrable Securities, and each Holder of Registrable Securities who thereafter wishes to include all or a portion of such Holder’s Registrable Securities in such Registration on Form S-3 shall so notify the Company, in writing, within ten (10) days after the receipt by the Holder of the notice from the Company. As soon as practicable thereafter, but not more than twelve (12) days after the Company’s initial receipt of such written request for a Registration on Form S-3, the Company shall register all or such portion of such Holder’s Registrable Securities as are specified in such written request, together with all or such portion of Registrable Securities of any other Holder or Holders joining in such request as are specified in the written notification given by such Holder or Holders; provided, however, that the Company shall not be obligated to effect any such Registration pursuant to Section 2.3 hereof if (i) a Form S-3 is not available for such offering; or (ii) the Holders of Registrable Securities, together with the Holders of any other equity securities of the Company entitled to inclusion in such Registration, propose to sell the Registrable Securities and such other equity securities (if any) at any aggregate price to the public of less than $10,000,000.
2.4 Restrictions on Registration Rights. If (A) during the period starting with the date sixty (60) days prior to the Company’s good faith estimate of the date of the filing of, and ending on a date one hundred and twenty (120) days after the effective date of, a Company initiated Registration and provided that the Company has delivered written notice to the Holders prior to receipt of a Demand Registration pursuant to subsection 2.1.1 and it continues to actively employ, in good faith, all reasonable efforts to cause the applicable Registration Statement to become effective; (B) the Holders have requested an Underwritten Registration and the Company and the Holders are unable to obtain the commitment of underwriters to firmly underwrite the offer; or (C) in the good faith judgment of the Board such Registration would be seriously detrimental to the Company and the Board concludes as a result that it is essential to defer the filing of such Registration Statement at such time, then in each case the Company shall furnish to such Holders a certificate signed by the Chairman of the Board stating that in the good faith judgment of the Board it would be seriously detrimental to the Company for such Registration Statement to be filed in the near future and that it is therefore essential to defer the filing of such Registration Statement. In such event, the Company shall have the right to defer such filing for a period of not more than thirty (30) days.
9
ArticleIII
COMPANY PROCEDURES
3.1 General Procedures. If at any time on or after the date the Company consummates a Business Combination the Company is required to effect the Registration of Registrable Securities, the Company shall use its best efforts to effect such Registration to permit the sale of such Registrable Securities in accordance with the intended plan of distribution thereof, and pursuant thereto the Company shall, as expeditiously as possible:
3.1.1 prepare and file with the Commission as soon as practicable a Registration Statement with respect to such Registrable Securities and use its reasonable best efforts to cause such Registration Statement to become effective and remain effective until all Registrable Securities covered by such Registration Statement have been sold;
3.1.2 prepare and file with the Commission such amendments and post-effective amendments to the Registration Statement, and such supplements to the Prospectus, as may be requested by the Holders or any Underwriter of Registrable Securities or as may be required by the rules, regulations or instructions applicable to the registration form used by the Company or by the Securities Act or rules and regulations thereunder to keep the Registration Statement effective until all Registrable Securities covered by such Registration Statement are sold in accordance with the intended plan of distribution set forth in such Registration Statement or supplement to the Prospectus;
3.1.3 prior to filing a Registration Statement or prospectus, or any amendment or supplement thereto, furnish without charge to the Underwriters, if any, and the Holders of Registrable Securities included in such Registration, and such Holders’ legal counsel, copies of such Registration Statement as proposed to be filed, each amendment and supplement to such Registration Statement (in each case including all exhibits thereto and documents incorporated by reference therein), the Prospectus included in such Registration Statement (including each preliminary Prospectus), and such other documents as the Underwriters and the Holders of Registrable Securities included in such Registration or the legal counsel for any such Holders may request in order to facilitate the disposition of the Registrable Securities owned by such Holders;
3.1.4 prior to any public offering of Registrable Securities, use its best efforts to (i) register or qualify the Registrable Securities covered by the Registration Statement under such securities or “blue sky” laws of such jurisdictions in the United States as the Holders of Registrable Securities included in such Registration Statement (in light of their intended plan of distribution) may request and (ii) take such action necessary to cause such Registrable Securities covered by the Registration Statement to be registered with or approved by such other governmental authorities as may be necessary by virtue of the business and operations of the Company and do any and all other acts and things that may be necessary or advisable to enable the Holders of Registrable Securities included in such Registration Statement to consummate the disposition of such Registrable Securities in such jurisdictions; provided, however, that the Company shall not be required to qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify or take any action to which it would be subject to general service of process or taxation in any such jurisdiction where it is not then otherwise so subject;
10
3.1.5 cause all such Registrable Securities included in any registration to be listed on such exchanges or otherwise designated for trading in the same manner as similar securities issued by the Company are then listed or designated or, if no such similar securities are then listed or designated, in a manner satisfactory to the holders of a majority-in-interest of the Registrable Securities included in such registration;
3.1.6 provide a transfer agent as applicable, and registrar for all such Registrable Securities no later than the effective date of such Registration Statement;
3.1.7 advise each seller of such Registrable Securities, promptly after it shall receive notice or obtain knowledge thereof, of the issuance of any stop order by the Commission suspending the effectiveness of such Registration Statement or the initiation or threatening of any proceeding for such purpose and promptly use its reasonable best efforts to prevent the issuance of any stop order or to obtain its withdrawal if such stop order should be issued;
3.1.8 at least five (5) days prior to the filing of any Registration Statement or Prospectus or any amendment or supplement to such Registration Statement or Prospectus or any document that is to be incorporated by reference into such Registration Statement or Prospectus, furnish a copy thereof to each seller of such Registrable Securities or its counsel;
3.1.9 notify the Holders at any time when a Prospectus relating to such Registration Statement is required to be delivered under the Securities Act, of the happening of any event as a result of which the Prospectus included in such Registration Statement, as then in effect, includes a Misstatement, and then to correct such Misstatement as set forth in Section 3.4 hereof;
3.1.10 permit a representative of the Holders (such representative to be selected by a majority of the participating Holders), the Underwriters, if any, and any attorney or accountant retained by such Holders or Underwriter to participate, at each such person’s own expense, in the preparation of the Registration Statement, and cause the Company’s officers, directors and employees to supply all information reasonably requested by any such representative, Underwriter, attorney or accountant in connection with the Registration; provided, however, that such representatives or Underwriters enter into a confidentiality agreement, in form and substance reasonably satisfactory to the Company, prior to the release or disclosure of any such information;
3.1.11 obtain a “cold comfort” letter from the Company’s independent registered public accountants in the event of an Underwritten Registration which the participating Holders may rely on, in customary form and covering such matters of the type customarily covered by “cold comfort” letters as the managing Underwriter may reasonably request, and reasonably satisfactory to a majority-in-interest of the participating Holders;
3.1.12 on the date the Registrable Securities are delivered for sale pursuant to such Registration, obtain an opinion, dated such date, of counsel representing the Company for the purposes of such Registration, addressed to the Holders, the placement agent or sales agent, if any, and the Underwriters, if any, covering such legal matters with respect to the Registration in respect of which such opinion is being given as the Holders, placement agent, sales agent, or Underwriter may reasonably request and as are customarily included in such opinions and negative assurance letters, and reasonably satisfactory to a majority in interest of the participating Holders;
11
3.1.13 in the event of any Underwritten Offering, enter into and perform its obligations under an underwriting agreement, in usual and customary form, with the managing Underwriter of such offering;
3.1.14 make available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of at least twelve (12) months beginning with the first day of the Company’s first full calendar quarter after the effective date of the Registration Statement which satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder (or any successor rule promulgated thereafter by the Commission);
3.1.15 if the Registration involves the Registration of Registrable Securities involving gross proceeds in excess of $50,000,000, use its reasonable efforts to make available senior executives of the Company to participate in customary “road show” presentations that may be reasonably requested by the Underwriter in any Underwritten Offering; and
3.1.16 otherwise, in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by the Holders, in connection with such Registration.
3.2 Registration Expenses. The Registration Expenses of all Registrations shall be borne by the Company. It is acknowledged by the Holders that the Holders shall bear all incremental selling expenses relating to the sale of Registrable Securities, such as Underwriters’ commissions and discounts, brokerage fees, Underwriter marketing costs and, other than as set forth in the definition of “Registration Expenses,” all reasonable fees and expenses of any legal counsel representing the Holders.
3.3 Requirements for Participation in Underwritten Offerings. No person may participate in any Underwritten Offering for equity securities of the Company pursuant to a Registration initiated by the Company hereunder unless such person (i) agrees to sell such person’s securities on the basis provided in any underwriting arrangements approved by the Company and (ii) completes and executes all customary questionnaires, powers of attorney, indemnities, lock-up agreements, underwriting agreements and other customary documents as may be reasonably required under the terms of such underwriting arrangements.
3.4 Suspension of Sales; Adverse Disclosure. Upon receipt of written notice from the Company that a Registration Statement or Prospectus contains a Misstatement, each of the Holders shall forthwith discontinue disposition of Registrable Securities until it has received copies of a supplemented or amended Prospectus correcting the Misstatement (it being understood that the Company hereby covenants to prepare and file such supplement or amendment as soon as practicable after the time of such notice), or until it is advised in writing by the Company that the use of the Prospectus may be resumed. If the filing, initial effectiveness or continued use of a Registration Statement in respect of any Registration at any time would require the Company to make an Adverse Disclosure or would require the inclusion in such Registration Statement of financial statements that are unavailable to the Company for reasons beyond the Company’s control, the Company may, upon giving prompt written notice of such action to the Holders, delay the filing or initial effectiveness of, or suspend use of, such Registration Statement for the shortest period of time, but in no event more than thirty (30) days, determined in good faith by the Company to be necessary for such purpose. In the event the Company exercises its rights under the preceding sentence, the Holders agree to suspend, immediately upon their receipt of the notice referred to above, their use of the Prospectus relating to any Registration in connection with any sale or offer to sell Registrable Securities. The Company shall immediately notify the Holders of the expiration of any period during which it exercised its rights under this Section 3.4.
3.5 Reporting Obligations. As long as any Holder shall own Registrable Securities, the Company, at all times while it shall be a reporting company under the Exchange Act, covenants to file timely (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to Sections 13(a) or 15(d) of the Exchange Act and to promptly furnish the Holders with true and complete copies of all such filings. The Company further covenants that it shall take such further action as any Holder may reasonably request, all to the extent required from time to time to enable such Holder to sell shares of the Ordinary Shares held by such Holder without registration under the Securities Act within the limitation of the exemptions provided by Rule 144 promulgated under the Securities Act (or any successor rule promulgated thereafter by the Commission), including providing any legal opinions. Upon the request of any Holder, the Company shall deliver to such Holder a written certification of a duly authorized officer as to whether it has complied with such requirements.
12
ArticleIV
INDEMNIFICATION AND CONTRIBUTION
4.1 Indemnification.
4.1.1 The Company agrees to indemnify, to the extent permitted by law, each Holder of Registrable Securities, its officers and directors and each person who controls such Holder (within the meaning of the Securities Act) against all losses, claims, damages, liabilities and expenses (including attorneys’ fees) caused by any untrue or alleged untrue statement of material fact contained in any Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein not misleading, except insofar as the same are caused by or contained in any information furnished in writing to the Company by such Holder expressly for use therein. The Company shall indemnify the Underwriters, their officers and directors and each person who controls such Underwriters (within the meaning of the Securities Act) to the same extent as provided in the foregoing with respect to the indemnification of the Holder.
4.1.2 In connection with any Registration Statement in which a Holder of Registrable Securities is participating, such Holder shall furnish to the Company in writing such information and affidavits as the Company reasonably requests for use in connection with any such Registration Statement or Prospectus and, to the extent permitted by law, shall indemnify the Company, its directors and officers and agents and each person who controls the Company (within the meaning of the Securities Act) against any losses, claims, damages, liabilities and expenses (including without limitation reasonable attorneys’ fees) resulting from any untrue statement of material fact contained in the Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission of a material fact required to be stated therein or necessary to make the statements therein not misleading, but only to the extent that such untrue statement or omission is contained in any information or affidavit so furnished in writing by such Holder expressly for use therein; provided, however, that the obligation to indemnify shall be several, not joint and several, among such Holders of Registrable Securities, and the liability of each such Holder of Registrable Securities shall be in proportion to and limited to the net proceeds received by such Holder from the sale of Registrable Securities pursuant to such Registration Statement. The Holders of Registrable Securities shall indemnify the Underwriters, their officers, directors and each person who controls such Underwriters (within the meaning of the Securities Act) to the same extent as provided in the foregoing with respect to indemnification of the Company.
13
4.1.3 Any person entitled to indemnification herein shall (i) give prompt written notice to the indemnifying party of any claim with respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s right to indemnification hereunder to the extent such failure has not materially prejudiced the indemnifying party) and (ii) unless in such indemnified party’s reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim, permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party without its consent (but such consent shall not be unreasonably withheld). An indemnifying party who is not entitled to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party a conflict of interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim. No indemnifying party shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement which cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms of such settlement) or which settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.
4.1.4 The indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of the indemnified party or any officer, director or controlling person of such indemnified party and shall survive the transfer of securities. The Company and each Holder of Registrable Securities participating in an offering also agrees to make such provisions as are reasonably requested by any indemnified party for contribution to such party in the event the Company’s or such Holder’s indemnification is unavailable for any reason.
4.1.5 If the indemnification provided under Section 4.1 hereof from the indemnifying party is unavailable or insufficient to hold harmless an indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying party, in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified party as a result of such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying party and the indemnified party, as well as any other relevant equitable considerations. The relative fault of the indemnifying party and indemnified party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact, was made by, or relates to information supplied by, such indemnifying party or indemnified party, and the indemnifying party’s and indemnified party’s relative intent, knowledge, access to information and opportunity to correct or prevent such action; provided, however, that the liability of any Holder under this subsection 4.1.5 shall be limited to the amount of the net proceeds received by such Holder in such offering giving rise to such liability. The amount paid or payable by a party as a result of the losses or other liabilities referred to above shall be deemed to include, subject to the limitations set forth in subsections 4.1.1, 4.1.2 and 4.1.3 above, any legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding. The parties hereto agree that it would not be just and equitable if contribution pursuant to this subsection 4.1.5 were determined by pro rata allocation or by any other method of allocation, which does not take account of the equitable considerations referred to in this subsection 4.1.5. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant to this subsection 4.1.5 from any person who was not guilty of such fraudulent misrepresentation.
14
ArticleV
MISCELLANEOUS
5.1 Notices. Any notice or communication under this Agreement must be in writing and given by (i) deposit in the United States mail, addressed to the party to be notified, postage prepaid and registered or certified with return receipt requested, (ii) delivery in person or by courier service providing evidence of delivery, or (iii) transmission by hand delivery, electronic mail, telecopy, telegram or facsimile. Each notice or communication that is mailed, delivered, or transmitted in the manner described above shall be deemed sufficiently given, served, sent, and received, in the case of mailed notices, on the third business day following the date on which it is mailed and, in the case of notices delivered by courier service, hand delivery, electronic mail, telecopy, telegram or facsimile, at such time as it is delivered to the addressee (with the delivery receipt or the affidavit of messenger) or at such time as delivery is refused by the addressee upon presentation. Any notice or communication under this Agreement must be addressed, if to the Company, to: 3011 Olympic View Dr, Chino Hills, California, United States 91709, and, if to any Holder, at such Holder’s address or contact information as set forth in the Company’s books and records. Any party may change its address for notice at any time and from time to time by written notice to the other parties hereto, and such change of address shall become effective thirty (30) days after delivery of such notice as provided in this Section 5.1.
5.2 Assignment; No Third Party Beneficiaries.
5.2.1 This Agreement and the rights, duties and obligations of the Company hereunder may not be assigned or delegated by the Company in whole or in part.
5.2.2 Prior to the expiration of the Founder Shares Lock-up Period or the Private Placement Lock-up Period, as the case may be, no Holder may assign or delegate such Holder’s rights, duties or obligations under this Agreement, in whole or in part, except in connection with a transfer of Registrable Securities by such Holder to a Permitted Transferee but only if such Permitted Transferee agrees to become bound by the transfer restrictions set forth in this Agreement.
5.2.3 This Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties and its successors and the permitted assigns of the Holders, which shall include Permitted Transferees.
5.2.4 This Agreement shall not confer any rights or benefits on any persons that are not parties hereto, other than as expressly set forth in this Agreement and Section 5.2 hereof.
15
5.2.5 No assignment by any party hereto of such party’s rights, duties and obligations hereunder shall be binding upon or obligate the Company unless and until the Company shall have received (i) written notice of such assignment as provided in Section 5.1 hereof and (ii) the written agreement of the assignee, in a form reasonably satisfactory to the Company, to be bound by the terms and provisions of this Agreement (which may be accomplished by an addendum or certificate of joinder to this Agreement). Any transfer or assignment made other than as provided in this Section 5.2 shall be null and void.
5.3 Counterparts. This Agreement may be executed in multiple counterparts (including facsimile or PDF counterparts), each of which shall be deemed an original, and all of which together shall constitute the same instrument, but only one of which need be produced.
5.4 Governing Law; Venue. NOTWITHSTANDING THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO, THE PARTIES EXPRESSLY AGREE THAT (I) THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED UNDER THE LAWS OF THE STATE OF NEW YORK AS APPLIED TO AGREEMENTS AMONG NEW YORK RESIDENTS ENTERED INTO AND TO BE PERFORMED ENTIRELY WITHIN NEW YORK, WITHOUT REGARD TO THE CONFLICT OF LAW PROVISIONS OF SUCH JURISDICTION AND (II) THE VENUE FOR ANY ACTION TAKEN WITH RESPECT TO THIS AGREEMENT SHALL BE ANY STATE OR FEDERAL COURT IN NEW YORK COUNTY IN THE STATE OF NEW YORK.
5.5 Amendments and Modifications. Upon the written consent of the Company and the Holders of at least a majority in interest of the Registrable Securities at the time in question, compliance with any of the provisions, covenants and conditions set forth in this Agreement may be waived, or any of such provisions, covenants or conditions may be amended or modified; provided, however, that notwithstanding the foregoing, any amendment hereto or waiver hereof that adversely affects one Holder, solely in its capacity as a holder of the shares of the Company, in a manner that is materially different from the other Holders (in such capacity) shall require the consent of the Holder so affected. No course of dealing between any Holder or the Company and any other party hereto or any failure or delay on the part of a Holder or the Company in exercising any rights or remedies under this Agreement shall operate as a waiver of any rights or remedies of any Holder or the Company. No single or partial exercise of any rights or remedies under this Agreement by a party shall operate as a waiver or preclude the exercise of any other rights or remedies hereunder or thereunder by such party.
5.6 Other Registration Rights. The Company represents and warrants that no person, other than a Holder of Registrable Securities, has any right to require the Company to register any securities of the Company for sale or to include such securities of the Company in any Registration filed by the Company for the sale of securities for its own account or for the account of any other person. Further, the Company represents and warrants that this Agreement supersedes any other registration rights agreement or agreement with similar terms and conditions and in the event of a conflict between any such agreement or agreements and this Agreement, the terms of this Agreement shall prevail.
5.7 Term. This Agreement shall terminate upon the earlier of (i) the tenth anniversary of the date of this Agreement or (ii) the date as of which (A) all of the Registrable Securities have been sold pursuant to a Registration Statement (but in no event prior to the applicable period referred to in Section 4(a)(3) of the Securities Act and Rule 174 thereunder (or any successor rule promulgated thereafter by the Commission)) or (B) the Holders of all Registrable Securities are permitted to sell the Registrable Securities under Rule 144 (or any similar provision) under the Securities Act without limitation on the amount of securities sold or the manner of sale. The provisions of Section 3.5 and Article IV shall survive any termination.
5.8 Forfeiture. In the event the over-allotment option granted to the Underwriter of the Offering is not exercised in full, the Holder acknowledges and agrees that it (and, if applicable, any transferee of any of the Class B Ordinary Shares purchased and issued to the Holder hereunder) shall forfeit any and all rights to such number of the Class B Ordinary Shares purchased and issued to the Holder hereunder (up to an aggregate of all of the 187,500 Class B Ordinary Shares so purchased and issued and pro rata based upon the percentage of the over-allotment option exercised) such that immediately following such forfeiture, the Holder (and any such transferees of the Holder) will own, in total, an aggregate number of the ordinary shares (not including the ordinary shares underlying any private placement units or any securities or rights purchased by the Holder in the Offering or in the aftermarket) equal to 20% of the issued and outstanding ordinary shares of the Company immediately following the Offering. If any of the Class B Ordinary Shares are forfeited in accordance with this clause 5.8, then after such time the Holder (or any successor in interest), shall no longer have any rights as a holder of such forfeited Class B Ordinary Shares, and the Company shall take such action as is appropriate to redeem and cancel such forfeited Class B Ordinary Shares, which may include by way of the compulsory redemption and cancellation of such Class B Ordinary Shares for nil consideration. In addition, the Holder hereby irrevocably grants the Company a limited power of attorney for the purpose of effectuating the foregoing and agrees to take any and all action reasonably requested by the Company necessary to effect any adjustment in this clause 5.8 (including any such redemption as is referred to herein above).
[SIGNATURE PAGES FOLLOW]
16
IN WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.
| COMPANY: |
|---|
| EKA ACQUISITION CORP |
| a Cayman Islands exempted company |
| By: |
| Name: |
| Title: |
| HOLDERS: |
| HERCULES CAPITAL MANAGEMENT CORP |
| a British Virgin Islands company |
| By: |
| Name: |
| Title: |
| /s/ M. Anthony Wong |
| M. Anthony Wong |
| /s/ Lauren Simmons |
| Lauren Simmons |
| /s/ Kevin McKenzie |
| Kevin McKenzie |
| MAXIM GROUP LLC |
| By: |
| Name: |
| Title: |
All values are in Euros.
[Signature Page to Registration Rights Agreement]
17
Exhibit 10.5
Execution Version
July 2, 2024
Eureka Acquisition Corp.
3011 Olympic View Dr
Chino Hills, California
United States 91709
Maxim Group LLC
300 Park Avenue
New York, New York 10022
Re: Initial Public Offering
Ladies and Gentlemen:
This letter is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and between Eureka Acquisition Corp, a Cayman Islands exempted company (the “Company”), and Maxim Group LLC, as representative (the “Representative”) of the underwriters (the “Underwriters”), relating to an underwritten initial public offering (the “IPO”) of the Company’s units (the “Units”), each comprised of one Class A ordinary share of the Company, par value $0.0001 per share, (the “Ordinary Shares”) and one right to receive one-fifth (1/5) of one Ordinary Share (the “Rights”). Certain capitalized terms used herein are defined in paragraph 17 hereof.
In order to induce the Company and the Representative to enter into the Underwriting Agreement and to proceed with the IPO, and in recognition of the benefit that such IPO will confer upon the undersigned as a shareholder of the Company, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the undersigned hereby agrees with the Company as follows:
If the Company solicits approval of its shareholders of a Business Combination, the undersigned will vote all Ordinary Shares and Founder Shares beneficially owned by him, her or it, whether acquired before, in or after the IPO, in favor of such Business Combination.
(a) Unless the Company’s shareholders are previously given the option to redeem their shares in connection with amending applicable documents to extend the time that the Company has to complete a Business Combination and the Company fails to consummate a Business Combination within 12 months from the closing of the Company’s IPO (or, in the event that the Company extended the period of time to consummate a business combination up to two times, each by an additional three months, up to 18 months from the closing of the Company’s IPO), the undersigned shall take all reasonable steps to (i) cause the Trust Fund (lesser tax payables and up to $50,000 of interest to pay dissolution expenses) to be liquidated and distributed to the holders of the IPO Shares and (ii) cause the Company to liquidate as soon as reasonably practicable.
(b) The undersigned hereby waives any and all right, title, interest or claim of any kind in or to any distribution of the Trust Fund and any remaining net assets of the Company as a result of such liquidation with respect to his, her or its Insider Shares including any shares underlying the Private Units and any shares underlying the Working Capital Units (“Claim”) and hereby waives any Claim the undersigned may have in the future as a result of, or arising out of, any contracts or agreements with the Company and will not seek recourse against the Trust Fund for any reason whatsoever. The undersigned acknowledges and agrees that there will be no distribution from the Trust Fund with respect to any Rights underlying the Private Units and Working Capital Units, all of which will terminate on the Company’s liquidation.
In the event of the liquidation of the Trust Fund, the undersigned agrees to indemnify and hold harmless the Company against any and all loss, liability, claims, damage and expense whatsoever (including, but not limited to, any and all legal or other expenses reasonably incurred in investigating, preparing or defending against any litigation, whether pending or threatened, or any claim whatsoever) which the Company may become subject as a result of any claim by any target business or vendor or other person who is owed money by the Company for services rendered or products sold or contracted for, but only to the extent necessary to ensure that such loss, liability, claim, damage or expense does not reduce the amount of funds in the Trust Fund; provided that such indemnity shall not apply if such target business, vendor or other person has executed an agreement waiving any claims against the Trust Fund.^1^
In the event that the Company does not consummate a Business Combination and must liquidate and its remaining net assets are insufficient to complete such liquidation, the undersigned agrees to advance such funds necessary to complete such liquidation and agrees not to seek recourse for such expenses.^2^
In the event that the Company fails to consummate a Business Combination within twelve (12) months, the Sponsor may procure the Company to, and the Company may, extend the time period by which the Company must consummate a Business Combination by an additional three (3)-month up to two times for a total of eighteen (18) months. If the Sponsor elects to extend, for each 3-month extension, the Insiders, their affiliates or designees will deposit into the Trust Fund an amount equal to 1% of the gross proceeds of the IPO, representing $0.10 for each Ordinary Share sold in the IPO on or prior to the date of the deadline. Such payment would be in the form of a non-interest-bearing loan (the “Extension Loans”). The Extension Loans will either be paid upon consummation of a Business Combination, or at the lender’s discretion, converted upon consummation of a Business Combination into Working Capital Units (as defined below).
(a) The undersigned agrees that it, he or she shall not Transfer any Class B Ordinary Shares purchased by or issued to the undersigned (the “Founder Shares”), including the Ordinary Shares converted therefrom, until the earlier of (A) six months after the completion of the Company’s initial Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company’s shareholders having the right to exchange their Ordinary Shares for cash, securities or other property. Notwithstanding the foregoing, if the last sale price of the Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing from the Company’s initial Business Combination, 50% of the Founder Shares will be released from the lock-up (the “Founder Shares Lock-up Period”).
| ^1^ | Hercules Capital Management Corp Only. |
|---|---|
| ^2^ | Hercules Capital Management Corp Only. |
| --- | --- |
2
(b) The undersigned agrees that it, he or she shall not Transfer any Private Units (including any shares underlying the Private Units), until the completion of a Business Combination (the “Private Lock-up Period”, together with the Founder Shares Lock-up Period, the “Lock-up Periods”).
(c) Notwithstanding the provisions set forth in Sections 6(a) and (b), Transfers of the Founder Shares or Private Units (including any shares underlying the Private Units) are permitted (a) to the Company’s officers or directors, any affiliates or family members of any of the Company’s officers or directors, any members of the Sponsor, or any affiliates of the Sponsor; (b) in the case of an individual, transfers by gift to a member of the individual’s immediate family, to a trust, the beneficiary of which is a member of the individual’s immediate family or an affiliate of such person, or to a charitable organization; (c) in the case of an individual, transfers by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, transfers pursuant to a qualified domestic relations order; (e) transfers in the event of the Company’s liquidation prior to the completion of an initial Business Combination; (f) transfers by virtue of the laws of the Cayman Islands or the Sponsor’s organizational documents upon dissolution of the Sponsor; provided, however, that in the case of clauses (a) through (d), these permitted transferees must enter into a written agreement agreeing to be bound by the restrictions herein.
In order to minimize potential conflicts of interest which may arise from multiple affiliations, the undersigned agrees to present to the Company for its consideration, prior to presentation to any other person or entity, any suitable opportunity to acquire a target business, until the earlier of the consummation by the Company of a Business Combination or the liquidation of the Company, subject to any pre-existing fiduciary and contractual obligations the undersigned might have.
The undersigned acknowledges and agrees that prior to entering into a Business Combination with a target business that is affiliated with any Insiders of the Company or their affiliates, including any company that is a portfolio company of, or otherwise affiliated with, or has received financial investment from, an entity with which any Insider or their affiliates is affiliated, such transaction must be approved by a majority of the Company’s disinterested independent directors and the Company must obtain an opinion from an independent investment banking firm that such Business Combination is fair to the Company’s unaffiliated shareholders from a financial point of view.
Except as set forth in the Registration Statement, neither the undersigned, any member of the family of the undersigned, nor any affiliate of the undersigned will be entitled to receive and will not accept any compensation or other cash payment prior to, or for services rendered in connection with, the consummation of the Business Combination; provided that the Company shall be allowed to repay working capital loans made by the undersigned or its affiliates/designees to the Company in cash upon consummation of the Business Combination. Notwithstanding the foregoing, the undersigned and any affiliate of the undersigned shall be entitled to reimbursement from the Company for their out-of-pocket expenses incurred in connection with identifying, investigating and consummating a Business Combination with approval from the Chief Financial Officer.
Neither the undersigned, any member of the family of the undersigned, nor any affiliate of the undersigned will be entitled to receive or accept a finder’s fee or any other compensation in the event the undersigned, any member of the family of the undersigned or any affiliate of the undersigned originates a Business Combination.
3
The undersigned, as applicable, agrees to be a director/officer of the Company until the earlier of the consummation by the Company of a Business Combination or the liquidation of the Company. The undersigned’s biographical information previously furnished to the Company and the Representative is true and accurate in all material respects, does not omit any material information with respect to the undersigned’s biography and contains all of the information required to be disclosed pursuant to Item 401 of Regulation S-K, promulgated under the Securities Act of 1933. The undersigned’s FINRA Questionnaire previously furnished to the Company and the Representative is true and accurate in all material respects. The undersigned represents and warrants that:
| (a) | He, she or it has never had a petition under the federal bankruptcy laws or any state insolvency law been filed by or against (i) him, her or it, or any partnership in which he or she was a general partner at or within two years before the time of filing; or (ii) any corporation or business association of which he or she was an executive officer at or within two years before the time of such filing; |
|---|---|
| (b) | He, she or it has never had a receiver, fiscal agent or similar officer been appointed by a court for his business or property, or any such partnership; |
| --- | --- |
| (c) | He, she or it has never been convicted of fraud in a civil or criminal proceeding; |
| --- | --- |
| (d) | He, she or it has never been convicted in a criminal proceeding or named the subject of a pending criminal proceeding (excluding traffic violations and minor offenses); |
| --- | --- |
| (e) | He, she or it has never been the subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining or otherwise limiting him, her or it from (i) acting as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool operator, floor broker, leverage transaction merchant, any other person regulated by the Commodity Futures Trading Commission (“CFTC”) or an associated person of any of the foregoing, or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated person, director or employee of any investment company, bank, savings and loan association or insurance company, or from engaging in or continuing any conduct or practice in connection with any such activity; or (ii) engaging in any type of business practice; or (iii) engaging in any activity in connection with the purchase or sale of any security or commodity or in connection with any violation of federal or state securities or federal commodities laws; |
| --- | --- |
| (f) | He, she, or it has never been the subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any federal or state authority barring, suspending or otherwise limiting for more than 60 days his, her or its right to engage in any activity described in 11(e)(i) above, or to be associated with persons engaged in any such activity; |
| --- | --- |
| (g) | He, she, or it has never been found by a court of competent jurisdiction in a civil action or by the SEC to have violated any federal or state securities law, where the judgment in such civil action or finding by the SEC has not been subsequently reversed, suspended or vacated; |
| --- | --- |
4
| (h) | He, she, or it has never been found by a court of competent jurisdiction in a civil action or by the CFTC to have violated any federal commodities law, where the judgment in such civil action or finding by the CFTC has not been subsequently reversed, suspended or vacated; |
|---|---|
| (i) | He, she, or it has never been the subject of, or a party to, any Federal, State or foreign judicial or administrative order, judgment, decree or finding, not subsequently reversed, suspended or vacated, relating to an alleged violation of (i) any Federal, State or foreign securities or commodities law or regulation, (ii) any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and desist order, or removal or prohibition order or (iii) any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; |
| --- | --- |
| (j) | He, she or it has never been the subject of, or party to, any sanction or order, not subsequently reversed, suspended or vacated, or any self-regulatory organization, any registered entity, or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member; |
| --- | --- |
| (k) | He, she or it has never been convicted of any felony or misdemeanor: (i) in connection with the purchase or sale of any security; (ii) involving the making of any false filing with the SEC; or (iii) arising out of the conduct of the business of an underwriter, broker, dealer, municipal securities dealer, investment advisor or paid solicitor of purchasers of securities; |
| --- | --- |
| (l) | He, she or it was never subject to a final order of a state or foreign securities commission (or an agency of officer of a state performing like functions); a state or foreign authority that supervises or examines banks, savings associations, or credit unions; a state or foreign insurance commission (or an agency or officer of a state performing like functions); an appropriate federal or foreign banking agency; the CFTC; or the National Credit Union Administration that is based on a violation of any law or regulation that prohibits fraudulent, manipulative, or deceptive conduct; |
| --- | --- |
| (m) | He, she or it has never been subject to any order, judgment or decree of any court of competent jurisdiction, that, at the time of the sale of the Units, restrained or enjoined him, her or it from engaging or continuing to engage in any conduct or practice: (i) in connection with the purchase or sale of any security; (ii) involving the making of any false filing with the SEC or any foreign regulatory agency with similar functions; or (iii) arising out of the conduct of the business of an underwriter, broker, dealer, municipal securities dealer, investment adviser or paid solicitor of purchasers of securities; |
| --- | --- |
| (n) | He, she or it has never been subject to any order of the SEC or any foreign regulatory agency with similar functions that orders him, her or it to cease and desist from committing or causing a future violation of: (i) any scienter-based anti-fraud provision of the federal securities laws, including, but not limited to, Section 17(a)(1) of the Securities Act, Section 10(b) of the Exchange Act and Rule 10b-5 thereunder, Section 15(c) and Section 206(1) of the Advisers Act or any other rule or regulation thereunder; or (ii) Section 5 of the Securities Act; |
| --- | --- |
5
| (o) | He, she or it has never filed (as a registrant or issuer), or been named as an underwriter in any registration statement or Regulation A offering statement filed with the SEC that was the subject of a refusal order, stop order, or order suspending the Regulation A exemption, or is, currently, the subject of an investigation or proceeding to determine whether a stop order or suspension order should be issued; |
|---|---|
| (p) | He, she or it has never been subject to a United States Postal Service false representation order, or is currently subject to a temporary restraining order or preliminary injunction with respect to conduct alleged by the United States Postal Service to constitute a scheme or device for obtaining money or property through the mail by means of false representations; |
| --- | --- |
| (q) | He, she or it is not subject to a final order of a state securities commission (or an agency of officer of a state performing like functions); a state authority that supervises or examines banks, savings associations, or credit unions; a state insurance commission (or an agency or officer of a state performing like functions); an appropriate federal banking agency; the CFTC; or the National Credit Union Administration that bars the undersigned from: (i) association with an entity regulated by such commission, authority, agency or officer; (ii) engaging in the business of securities, insurance or banking; or (iii) engaging in savings association or credit union activities; |
| --- | --- |
| (r) | He, she or it is not subject to an order of the SEC entered pursuant to section 15(b) or 15B(c) of the Securities Exchange Act of 1934 (the “Exchange Act”) or section 203(e) or 203(f) of the Investment Advisers Act of 1940 (the “Advisers Act”) that: (i) suspends or revokes the undersigned’s registration as a broker, dealer, municipal securities dealer or investment adviser; (ii) places limitations on the activities, functions or operations of, or imposes civil money penalties on, such person; or (iii) bars the undersigned from being associated with any entity or from participating in the offering of any penny stock; and |
| --- | --- |
| (s) | He, she or it has never been suspended or expelled from membership in, or suspended or barred from association with a member of, a securities self-regulatory organization (e.g., a registered national securities exchange or a registered national or affiliated securities association) for any act or omission to act constituting conduct inconsistent with just and equitable principles of trade. |
| --- | --- |
The undersigned has full right and power, without violating any agreement by which he, she or it is bound, to enter into this letter agreement and to serve as a director and/or officer of the Company, as applicable.
6
In the event the over-allotment option granted to the Underwriters of the IPO is not exercised in full, the Sponsor acknowledges and agrees that it (and, if applicable, any transferee of any of the Class B Ordinary Shares purchased and issued to the undersigned hereunder) shall forfeit any and all rights to such number of the Class B Ordinary Shares purchased and issued to the undersigned hereunder (up to an aggregate of all of the 187,500 Class B Ordinary Shares so purchased and issued and pro rata based upon the percentage of the over-allotment option exercised) such that immediately following such forfeiture, the undersigned (and any such transferees of the undersigned) will own, in total, an aggregate number of the ordinary shares (not including the ordinary shares underlying any private placement units (whether comprised in any such units or standing alone) that may be issued to the undersigned upon exercise of any securities or rights purchased by the undersigned in the IPO or in the aftermarket) equal to 20% of the issued and outstanding ordinary shares of the Company immediately following the IPO. If any of the Class B Ordinary Shares are forfeited in accordance with this clause 13, then after such time the undersigned (or any successor in interest), shall no longer have any rights as a holder of such forfeited Class B Ordinary Shares, and the Company shall take such action as is appropriate to redeem and cancel such forfeited Class B Ordinary Shares, which may include by way of the compulsory redemption and cancellation of such Class B Ordinary Shares for nil consideration. In addition, the undersigned hereby irrevocably grants the Company a limited power of attorney for the purpose of effectuating the foregoing and agrees to take any and all action reasonably requested by the Company necessary to effect any adjustment in this clause 13 (including any such redemption as is referred to herein above).^3^
The undersigned hereby waives his, her or its right to exercise redemption rights with respect to any ordinary shares owned or to be owned by the undersigned, directly or indirectly, whether purchased by the undersigned prior to the IPO, in the IPO or in the aftermarket, and agrees that he, she or it will not seek redemption with respect to or otherwise sell, such shares in connection with any vote to approve a Business Combination with respect thereto, a vote to amend the provisions of the Company’s Second Amended and Restated Memorandum and Articles of Association, or a tender offer by the Company prior to a Business Combination.
The undersigned hereby agrees to not propose, or vote in favor of, an amendment to the Company’s Second Amended and Restated Memorandum and Articles of Association with respect to the Company’s pre-Business Combination activities prior to the consummation of a Business Combination unless the Company offers holders of IPO Shares the right to receive their pro rata portion of the funds then held in the Trust Fund.
This letter agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York without giving effect to conflicts of law principals that would result in the application of the substantive laws of another jurisdiction. The parties hereto (i) all agree that any action, proceeding, claim or dispute arising out of, or relating in any way to, this Letter Agreement shall be brought and enforced in the courts of New York City, in the State of New York, and irrevocably submit to such jurisdiction and venue, which jurisdiction and venue shall be exclusive and (ii) waive any objection to such exclusive jurisdiction and venue or that such courts represent an inconvenient forum.
| ^3^ | Hercules Capital Management Corp only. |
|---|
7
As used herein, (i) a “Business Combination” shall mean a merger, share exchange, asset acquisition, contractual arrangement, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities; (ii) “Insiders” shall mean all officers, directors and shareholders of the Company immediately prior to the IPO; (iii) “Insider Shares” shall mean all of any Ordinary Shares underlying the Private Units and the Founder Shares; (iv) “IPO Shares” shall mean the Ordinary Shares issued in the Company’s IPO; (v) “Private Units” shall mean (x) the Units purchased in the private placement taking place simultaneously with the consummation of the Company’s IPO and (y) the additional Units that may be purchased in connection with the exercise of the over-allotment option by the Underwriters in the IPO as described in the Registration Statement; (vi) “Registration Statement” means the registration statement on Form S-1 filed by the Company with respect to the IPO; (vii) “Sponsor” means Hercules Capital Management Corp; (viii) “Trust Fund” shall mean the trust fund into which a portion of the net proceeds of the Company’s IPO will be deposited; (ix) “Working Capital Units” shall mean private units issuable upon conversion of working capital loans (including the Extension Loans, if any), at $10.00 per unit, upon the consummation of a Business Combination.
Any notice, consent or request to be given in connection with any of the terms or provisions of this letter agreement shall be in writing and shall be sent by express mail or similar private courier service, by certified mail (return receipt requested), by hand delivery or facsimile transmission.
If to the Company:
Eureka Acquisition Corp
3011 Olympic View Dr
Chino Hills, California
United States 91709
Attn: Eric Zhang
Email: eric.zhang@hercules.global
Copy (which copy shall not constitute notice) to:
Robinson & Cole LLP
Chrysler East Building
666 Third Avenue, 20th floor
New York, NY 10017
Attn: Arila E. Zhou, Esq.
Email: azhou@rc.com
No party hereto may assign either this letter agreement or any of its rights, interests, or obligations hereunder without the prior written consent of the other party. Any purported assignment in violation of this paragraph shall be void and ineffectual and shall not operate to transfer or assign any interest or title to the purported assignee. This letter agreement shall be binding on the parties hereto and any successors and assigns thereof.
The undersigned acknowledges and understands that the Underwriters and the Company will rely upon the agreements, representations and warranties set forth herein in proceeding with the IPO.
[Signature Page Follows]
8
| Sincerely, | |
|---|---|
| HERCULES CAPITAL MANAGEMENT CORP | |
| By: | |
| Fen Zhang | |
| Director | |
| Acknowledged and Agreed: | |
| EKA ACQUISITION CORP | |
| By: | |
| Fen Zhang | |
| Director |
All values are in Euros.
[Signature Page to Letter Agreement]
9
Exhibit 10.6
Execution Version
FORM OF INDEMNITY AGREEMENT
THIS INDEMNITY AGREEMENT (this “Agreement”) is made on [●], 2024.
Between:
| (1) | EUREKA ACQUISITION CORP, an exempted company incorporated under the laws of the Cayman Islands with registered office at Ogier Global (Cayman) Limited, 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands (the “Company”); and |
|---|---|
| (2) | [●] (“Indemnitee”). |
| --- | --- |
Whereas:
| (A) | Highly competent persons have become more reluctant to serve publicly-held corporations as directors, officers or in other capacities unless they are provided with adequate protection through insurance or adequate indemnification against inordinate risks of claims and actions against them arising out of their service to and activities on behalf of such corporations; |
|---|---|
| (B) | The board of directors of the Company (the “Board”) has determined that, in order to attract and retain qualified individuals, the Company will attempt to maintain on an ongoing basis, at its sole expense, liability insurance to protect persons serving the Company and its subsidiaries from certain liabilities. Although the furnishing of such insurance has been a customary and widespread practice among publicly traded corporations and other business enterprises, the Company believes that, given current market conditions and trends, such insurance may be available to it in the future only at higher premiums and with more exclusions. At the same time, directors, officers and other persons in service to corporations or business enterprises are being increasingly subjected to expensive and time-consuming litigation relating to, among other things, matters that traditionally would have been brought only against the Company or business enterprise itself. The second amended and restated memorandum and articles of association of the Company (the “Articles”) provide for the indemnification of the officers and directors of the Company; |
| --- | --- |
| (C) | The uncertainties relating to such insurance and to indemnification have increased the difficulty of attracting and retaining such persons; |
| --- | --- |
| (D) | The Board has determined that the increased difficulty in attracting and retaining such persons is detrimental to the best interests of the Company’s shareholders and that the Company should act to assure such persons that there will be increased certainty of such protection in the future; |
| --- | --- |
| (E) | It is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify and to advance expenses on behalf of, such persons to the fullest extent permitted by applicable law so that they will serve or continue to serve the Company free from undue concern that they will not be so protected against liabilities; |
| --- | --- |
| (F) | This Agreement is a supplement to and in furtherance of the indemnification of the officers and directors of the Company under the Articles and any resolutions adopted pursuant thereto, and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder; and |
| --- | --- |
| (G) | Indemnitee may not be willing to serve as an officer or director of the Company without adequate protection, and the Company desires Indemnitee to serve in such capacity. Indemnitee is willing to serve, continue to serve and to take on additional service for or on behalf of the Company on the condition that he be so indemnified. |
| --- | --- |
1
TERMS AND CONDITIONS
NOW, THEREFORE, in consideration of the premises and the covenants contained herein and subject to the provisions of the letter agreement dated as of [●], 2024 between the Company and Indemnitee pursuant to the Underwriting Agreement between the Company and the representative of the underwriters in connection with the Company’s initial public offering, the Company and Indemnitee do hereby covenant and agree as follows:
| 1 | SERVICES TO THE COMPANY |
|---|
Indemnitee will serve or continue to serve as an officer, director, investment advisor, administrator or liquidator of the Company, as applicable, for so long as Indemnitee is duly elected, appointed or retained or until Indemnitee tenders his resignation or until Indemnitee is removed. The foregoing notwithstanding, this Agreement shall continue in full force and effect after Indemnitee has ceased to serve as a director, officer, investment advisor, administrator or liquidator of the Company, as provided in Section 17. This Agreement, however, shall not impose any obligation on Indemnitee or the Company to continue Indemnitee’s service to the Company beyond any period otherwise required by law or by other agreements or commitments of the parties, if any.
| 2 | DEFINITIONS |
|---|
As used in this Agreement:
| 2.1 | References to “agent” shall mean any person who is or was a director, officer or employee of the Company or a subsidiary of the Company or other person authorized by the Company to act for the Company, to include such person serving in such capacity as a director, officer, employee, advisor, fiduciary or other official of another corporation, partnership, limited liability company, joint venture, trust or other enterprise at the request of, for the convenience of, or to represent the interests of the Company or a subsidiary of the Company. |
|---|---|
| 2.2 | The terms “Beneficial Owner” and “Beneficial Ownership” shall have the meanings set forth in Rule 13d-3 promulgated under the Exchange Act (as defined below) as in effect on the date hereof. |
| --- | --- |
| 2.3 | A “Change in Control” shall be deemed to occur upon the earliest to occur after the date of this Agreement of any of the following events: |
| --- | --- |
| (a) | Acquisition of Shares by Third Party. Other than an affiliate of Hercules Capital Management Corp, any Person (as defined below) is or becomes the Beneficial Owner, directly or indirectly, of securities of the Company representing fifteen percent (15%) or more of the combined voting power of the Company’s then outstanding securities entitled to vote generally in the election of directors, unless (1) the change in the relative Beneficial Ownership of the Company’s securities by any Person results solely from a reduction in the aggregate number of outstanding shares entitled to vote generally in the election of directors, or (2) such acquisition was approved in advance by the Continuing Directors (as defined below) and such acquisition would not constitute a Change in Control under part (c) of this definition; |
| --- | --- |
2
| (b) | Change in Board of Directors. Individuals who, as of the date hereof, constitute the Board, and any new director whose election by the Board was approved by a vote of a majority of the directors then still in office who were directors on the date hereof (collectively, the “Continuing Directors”), cease for any reason to constitute at least a majority of the members of the Board; |
|---|---|
| (c) | Corporate Transactions. The effective date of a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination, involving the Company and one or more businesses (a “Business Combination”), in each case, unless, following such Business Combination: (1) all or substantially all of the individuals and entities who were the Beneficial Owners of securities entitled to vote generally in the election of directors immediately prior to such Business Combination beneficially own, directly or indirectly, more than 51% of the combined voting power of the then outstanding securities of the Company entitled to vote generally in the election of directors resulting from such Business Combination (including, without limitation, a corporation which as a result of such transaction owns the Company or all or substantially all of the Company’s assets either directly or through one or more Subsidiaries) in substantially the same proportions as their ownership immediately prior to such Business Combination, of the securities entitled to vote generally in the election of directors; (2) other than an affiliate of Hercules Capital Management Corp, no Person (excluding any corporation resulting from such Business Combination) is the Beneficial Owner, directly or indirectly, of 15% or more of the combined voting power of the then outstanding securities entitled to vote generally in the election of directors of the surviving corporation except to the extent that such ownership existed prior to the Business Combination; and (3) at least a majority of the Board of Directors of the corporation resulting from such Business Combination were Continuing Directors at the time of the execution of the initial agreement, or of the action of the Board of Directors, providing for such Business Combination; |
| --- | --- |
| (d) | Liquidation. The approval by the shareholders of the Company of a complete liquidation of the Company or an agreement or series of agreements for the sale or disposition by the Company of all or substantially all of the Company’s assets, other than factoring the Company’s current receivables or escrows due (or, if such approval is not required, the decision by the Board to proceed with such a liquidation, sale, or disposition in one transaction or a series of related transactions); or |
| --- | --- |
| (e) | Other Events. There occurs any other event of a nature that would be required to be reported in response to Item 6(e) of Schedule 14A of Regulation 14A (or a response to any similar item on any similar schedule or form) promulgated under the Exchange Act (as defined below), whether or not the Company is then subject to such reporting requirement. |
| --- | --- |
3
| 2.4 | “Corporate Status” describes the status of a person who is or was a director, officer, trustee, general partner, manager, managing member, fiduciary, employee or agent of the Company or of any other Enterprise (as defined below) which such person is or was serving at the request of the Company. |
|---|---|
| 2.5 | “Cayman Court” shall mean the Courts of the Cayman Islands. |
| --- | --- |
| 2.6 | “Disinterested Director” shall mean a director of the Company who is not and was not a party to the Proceeding (as defined below) in respect of which indemnification is sought by Indemnitee. |
| --- | --- |
| 2.7 | “Enterprise” shall mean the Company and any other corporation, constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger to which the Company (or any of its wholly owned subsidiaries) is a party, limited liability company, partnership, joint venture, trust, employee benefit plan or other enterprise of which Indemnitee is or was serving at the request of the Company as a director, officer, trustee, general partner, manager, managing member, fiduciary, employee or agent. |
| --- | --- |
| 2.8 | “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended. |
| --- | --- |
| 2.9 | “Expenses” shall include all direct and indirect costs, fees and expenses of any type or nature whatsoever, including, without limitation, all attorneys’ fees and costs, retainers, court costs, transcript costs, fees of experts, witness fees, travel expenses, fees of private investigators and professional advisors, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, fax transmission charges, secretarial services and all other disbursements, obligations or expenses in connection with prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing to be a witness in, settlement or appeal of, or otherwise participating in, a Proceeding (as defined below), including reasonable compensation for time spent by Indemnitee for which he or she is not otherwise compensated by the Company or any third party. Expenses also shall include Expenses incurred in connection with any appeal resulting from any Proceeding (as defined below), including without limitation the principal, premium, security for, and other costs relating to any cost bond, supersedes bond, or other appeal bond or its equivalent. Expenses, however, shall not include amounts paid in settlement by Indemnitee or the amount of judgments or fines against Indemnitee. |
| --- | --- |
| 2.10 | “Independent Counsel” shall mean a law firm or a member of a law firm with significant experience in matters of corporate law and neither presently is, nor in the past five years has been, retained to represent: (i) the Company or Indemnitee in any matter material to either such party (other than with respect to matters concerning Indemnitee under this Agreement, or of other indemnitees under similar indemnification agreements); or (ii) any other party to the Proceeding (as defined below) giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term “Independent Counsel” shall not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee’s rights under this Agreement. |
| --- | --- |
4
| 2.11 | References to “fines” shall include any excise tax assessed on Indemnitee with respect to any employee benefit plan; references to “serving at the request of the Company” shall include any service as a director, officer, employee, agent or fiduciary of the Company which imposes duties on, or involves services by, such director, officer, employee, agent or fiduciary with respect to an employee benefit plan, its participants or beneficiaries; and if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in the best interests of the participants and beneficiaries of an employee benefit plan, Indemnitee shall be deemed to have acted in a manner “not opposed to the best interests of the Company” as referred to in this Agreement. |
|---|---|
| 2.12 | The term “Person” shall have the meaning as set forth in Sections 13(d) and 14(d) of the Exchange Act as in effect on the date hereof; provided, however, that “Person” shall exclude: (i) the Company; (ii) any Subsidiaries (as defined below) of the Company; (iii) any employment benefit plan of the Company or of a Subsidiary (as defined below) of the Company or of any corporation owned, directly or indirectly, by the shareholders of the Company in substantially the same proportions as their ownership of share of the Company; and (iv) any trustee or other fiduciary holding securities under an employee benefit plan of the Company or of a Subsidiary (as defined below) of the Company or of a corporation owned directly or indirectly by the shareholders of the Company in substantially the same proportions as their ownership of share of the Company. |
| --- | --- |
| 2.13 | The term “Proceeding” shall include any threatened, pending or completed action, suit, arbitration, mediation, alternate dispute resolution mechanism, investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding, whether brought in the right of the Company or otherwise and whether of a civil (including intentional or unintentional tort claims), criminal, administrative, or investigative or related nature, in which Indemnitee was, is, will or might be involved as a party or otherwise by reason of the fact that Indemnitee is or was a director or officer of the Company, by reason of any action (or failure to act) taken by him or of any action (or failure to act) on his part while acting as a director or officer of the Company, or by reason of the fact that he is or was serving at the request of the Company as a director, officer, trustee, general partner, manager, managing member, fiduciary, employee or agent of any other Enterprise, in each case whether or not serving in such capacity at the time any liability or expense is incurred for which indemnification, reimbursement, or advancement of expenses can be provided under this Agreement. |
| --- | --- |
| 2.14 | The term “Subsidiary,” with respect to any Person, shall mean any corporation, limited liability company, partnership, joint venture, trust or other entity of which a majority of the voting power of the voting equity securities or equity interest is owned, directly or indirectly, by that Person. |
| --- | --- |
| 2.15 | References to the phrase “to the fullest extent permitted by applicable law” in this Agreement shall include, but not be limited to: (i) to the fullest extent permitted by any provision of the Companies Act (Revised) of the Cayman Islands (the “Companies Act”) or the corresponding provision of any successor statute, and (ii) to the fullest extent authorized or permitted by any amendments to or replacements of the Companies Act adopted after the date of this Agreement that increase the extent to which a corporation may indemnify its officers and directors. |
| --- | --- |
5
| 3 | INDEMNITY IN THIRD-PARTY PROCEEDINGS |
|---|
To the fullest extent permitted by applicable law, and subject to the exclusions set out in Section 9 below, the Company shall indemnify Indemnitee in accordance with the provisions of this Section 3 if Indemnitee was, is, or is threatened to be made, a party to or a participant (as a witness, deponent or otherwise) in any Proceeding, other than a Proceeding by or in the right of the Company to procure a judgment in its favor by reason of Indemnitee’s Corporate Status. Pursuant to this Section 3, Indemnitee shall be indemnified against all Expenses, judgments, liabilities, fines, penalties and amounts paid in settlement (including all interest, assessments and other charges paid or payable in connection with or in respect of such Expenses, judgments, fines, penalties and amounts paid in settlement) actually and reasonably incurred by Indemnitee or on his behalf in connection with such Proceeding or any claim, issue or matter therein, provided that Indemnitee acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the Company and, in the case of a criminal Proceeding, had no reasonable cause to believe that his conduct was unlawful.
| 4 | INDEMNITY IN PROCEEDINGS BY OR IN THE RIGHT OF THE COMPANY |
|---|
To the fullest extent permitted by applicable law, and subject to the exclusions set out in Section 9 below, the Company shall indemnify Indemnitee in accordance with the provisions of this Section 4 if Indemnitee was, is, or is threatened to be made, a party to or a participant (as a witness, deponent or otherwise) in any Proceeding by or in the right of the Company to procure a judgment in its favor by reason of Indemnitee’s Corporate Status. Pursuant to this Section 4, Indemnitee shall be indemnified against all Expenses actually and reasonably incurred by him or on his behalf in connection with such Proceeding or any claim, issue or matter therein, provided that Indemnitee acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the Company. No indemnification for Expenses shall be made under this Section 4 in respect of any claim, issue or matter as to which Indemnitee shall have been finally adjudged by a court to be liable to the Company, unless and only to the extent that any court in which the Proceeding was brought or the Cayman Court shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnification.
| 5 | INDEMNIFICATION FOR EXPENSES OF A PARTY WHO IS WHOLLY OR PARTLY SUCCESSFUL |
|---|
Notwithstanding any other provisions of this Agreement except for Section 27, to the extent that Indemnitee was or is, by reason of Indemnitee’s Corporate Status, a party to (or a participant in) and is successful, on the merits or otherwise, in any Proceeding or in defense of any claim, issue or matter therein, in whole or in part, the Company shall, to the fullest extent permitted by applicable law and subject to the exclusions set out in Section 9 below, indemnify Indemnitee against all Expenses actually and reasonably incurred by him in connection therewith. If Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than all claims, issues or matters in such Proceeding, the Company shall, to the fullest extent permitted by applicable law, indemnify Indemnitee against all Expenses actually and reasonably incurred by him or on his behalf in connection with each successfully resolved claim, issue or matter. For purposes of this Section 5 and without limitation, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim, issue or matter.
6
| 6 | INDEMNIFICATION FOR EXPENSES OF A WITNESS |
|---|
Notwithstanding any other provision of this Agreement except for Section 27, to the extent that Indemnitee is, by reason of his Corporate Status, a witness or deponent in any Proceeding to which Indemnitee is not a party or threatened to be made a party, he shall, to the fullest extent permitted by applicable law, be indemnified against all Expenses actually and reasonably incurred by him or on his behalf in connection therewith.
| 7 | ADDITIONAL INDEMNIFICATION |
|---|---|
| 7.1 | Notwithstanding any limitation in Sections 3, 4, or 5, except for Section 27, the Company shall, to the fullest extent permitted by applicable law, indemnify Indemnitee if Indemnitee is a party to or threatened to be made a party to any Proceeding (including a Proceeding by or in the right of the Company to procure a judgment in its favor) against all Expenses, judgments, fines, penalties and amounts paid in settlement (including all interest, assessments and other charges paid or payable in connection with or in respect of such Expenses, judgments, fines, penalties and amounts paid in settlement) actually and reasonably incurred by Indemnitee in connection with the Proceeding. No indemnification shall be available under this Section 7.1 on account of Indemnitee’s conduct which constitutes a breach of Indemnitee’s duty of loyalty to the Company or its shareholders or is an act or omission not in good faith or which involves intentional misconduct or a knowing violation of the law. |
| --- | --- |
| 8 | CONTRIBUTION IN THE EVENT OF JOINT LIABILITY |
|---|---|
| 8.1 | To the fullest extent permissible under applicable law, if the indemnification provided for in this Agreement is unavailable to Indemnitee in whole or in part for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall pay, in the first instance, the entire amount incurred by Indemnitee, whether for judgments, liabilities, fines, penalties, amounts paid or to be paid in settlement and/or for Expenses, in connection with any Proceeding in such proportion as is deemed fair and reasonable in light of all of the circumstances of such Proceeding in order to reflect (i) the relative benefits received by the Company and Indemnitee as a result of the event(s) and/or transaction(s) giving rise to such Proceeding; and/or (ii) the relative fault of the Company (and its directors, officers, employees and agents) and Indemnitee in connection with such event(s) and/or transaction(s). The relative fault of the Company on the one hand and of the Indemnitee on the other hand shall be determined by reference to, among other things, the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent the circumstances resulting in such judgments, fines, penalties, excise taxes, amounts paid or to be paid in settlement and/or for Expenses. |
| --- | --- |
7
| 9 | EXCLUSIONS |
|---|
Notwithstanding any provision in this Agreement, the Company shall not be obligated under this Agreement to make any indemnification, advance expenses in connection with any claim made against Indemnitee:
| (a) | for which payment has actually been received by or on behalf of Indemnitee under any insurance policy or other indemnity or advancement provision, except with respect to any excess beyond the amount actually received under any insurance policy, contract, agreement, other indemnity or advancement provision or otherwise; |
|---|---|
| (b) | for an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company within the meaning of Section 16(b) of the Exchange Act or similar provisions of state statutory law or common law; |
| --- | --- |
| (c) | except as otherwise provided in Sections 14.5 and 14.6 hereof, prior to a Change in Control, in connection with any Proceeding (or any part of any Proceeding) initiated by Indemnitee, including any Proceeding (or any part of any Proceeding) initiated by Indemnitee against the Company or its directors, officers, employees or other indemnitees, unless (i) the Board authorized the Proceeding (or any part of any Proceeding) prior to its initiation or (ii) the Company provides the indemnification, in its sole discretion, pursuant to the powers vested in the Company under applicable law. Indemnitee shall seek payments or advances from the Company only to the extent that such payments or advances are unavailable from any insurance policy of the Company covering Indemnitee. |
| --- | --- |
| (d) | to the extent that Indemnitee is indemnified and actually received such payment other than pursuant to this Agreement; |
| --- | --- |
| (e) | in connection with a judicial action by or in the right of the Company, in respect of any claim, issue or matter as to which the Indemnitee shall have been adjudicated by final judgment in a court of law to be liable for fraud or willful neglect or dishonesty in the performance of his duty to the Company unless and only to the extent that any court in which such action was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, the Indemnitee is fairly and reasonably entitled to indemnification for such Expenses as such court shall deem proper; or |
| --- | --- |
| (f) | for any judgment, fine or penalty which the Company is prohibited by applicable law from paying as indemnification. |
| --- | --- |
| 10 | ADVANCES OF EXPENSES; DEFENSE OF CLAIM |
|---|---|
| 10.1 | Notwithstanding any provision of this Agreement to the contrary except for Section 27, and to the fullest extent not prohibited by applicable law, the Company shall pay the Expenses incurred by Indemnitee (or reasonably expected by Indemnitee to be incurred by Indemnitee within three months) in connection with any Proceeding within ten (10) days after the receipt by the Company of a statement or statements requesting such advances from time to time, prior to the final disposition of any Proceeding. Advances shall, to the fullest extent permitted by law, be unsecured and interest free. Advances shall be made without regard to Indemnitee’s ability to repay the Expenses and without regard to Indemnitee’s ultimate entitlement to be indemnified under the other provisions of this Agreement. Advances shall include any and all reasonable Expenses incurred pursuing a Proceeding to enforce this right of advancement, including Expenses incurred preparing and forwarding statements to the Company to support the advances claimed. To the fullest extent required by applicable law, such payments of Expenses in advance of the final disposition of the Proceeding shall be made only upon the Company’s receipt of an undertaking, by or on behalf of Indemnitee, to repay the advance to the extent that it is ultimately determined that Indemnitee is not entitled to be indemnified by the Company under the provisions of this Agreement, the Articles, applicable law or otherwise. This Section 10.1 shall not apply to any claim made by Indemnitee for which an indemnification is excluded pursuant to Section 9. |
| --- | --- |
8
| 10.2 | The Company will be entitled to participate in the Proceeding at its own expense. |
|---|---|
| 10.3 | The Company shall not settle any action, claim or Proceeding (in whole or in part) which would impose any Expense, judgment, fine, penalty or limitation on Indemnitee without Indemnitee’s prior written consent. |
| --- | --- |
| 11 | PROCEDURE FOR NOTIFICATION AND APPLICATION FOR INDEMNIFICATION |
|---|---|
| 11.1 | Indemnitee agrees to notify promptly the Company in writing upon being served with any summons, citation, subpoena, complaint, indictment, information or other document relating to any Proceeding or matter which may be subject to indemnification, or advancement of Expenses covered hereunder. The failure of Indemnitee to so notify the Company shall not relieve the Company of any obligation which it may have to Indemnitee under this Agreement, or otherwise. |
| --- | --- |
| 11.2 | Indemnitee may deliver to the Company a written application to indemnify Indemnitee in accordance with this Agreement. Such application(s) may be delivered from time to time and at such time(s) as Indemnitee deems appropriate in his or her sole discretion. Following such a written application for indemnification by Indemnitee, Indemnitee’s entitlement to indemnification shall be determined according to Section 12.1 of this Agreement. |
| --- | --- |
| 12 | PROCEDURE UPON APPLICATION FOR INDEMNIFICATION |
|---|---|
| 12.1 | A determination, if required by applicable law, with respect to Indemnitee’s entitlement to indemnification shall be made in the specific case by one of the following methods: (i) if no Change in Control has occurred, (x) by a majority vote of the Disinterested Directors, even though less than a quorum of the Board, (y) by a committee of Disinterested Directors, even though less than a quorum of the Board, or (z) if there are no Disinterested Directors, or if such Disinterested Directors so direct, by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee, or (ii) if a Change in Control has occurred, by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee. The Company will promptly advise Indemnitee in writing with respect to any determination that Indemnitee is or is not entitled to indemnification, including a description of any reason or basis for which indemnification has been denied. If it is so determined that Indemnitee is entitled to indemnification, payment to Indemnitee shall be made within ten (10) days after such determination. Indemnitee shall reasonably cooperate with the person, persons or entity making such determination with respect to Indemnitee’s entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance request any documentation or information which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary to such determination. Any costs or Expenses (including reasonable attorneys’ fees and disbursements) incurred by Indemnitee in so cooperating with the person, persons or entity making such determination shall be borne by the Company (irrespective of the determination as to Indemnitee’s entitlement to indemnification) and the Company hereby agrees to indemnify Indemnitee therefrom. |
| --- | --- |
9
| 12.2 | In the event the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 12.1 hereof, the Independent Counsel shall be selected as provided in this Section 12.2. The Independent Counsel shall be selected by Indemnitee (unless Indemnitee shall request that such selection be made by the Board), and Indemnitee shall give written notice to the Company advising it of the identity of the Independent Counsel so selected and certifying that the Independent Counsel so selected meets the requirements of “Independent Counsel” as defined in Section 2 of this Agreement. If the Independent Counsel is selected by the Board, the Company shall give written notice to Indemnitee advising him of the identity of the Independent Counsel so selected and certifying that the Independent Counsel so selected meets the requirements of “Independent Counsel” as defined in Section 2 of this Agreement. In either event, Indemnitee or the Company, as the case may be, may, within ten (10) days after such written notice of selection shall have been received, deliver to the Company or to Indemnitee, as the case may be, a written objection to such selection; provided, however, that such objection may be asserted only on the ground that the Independent Counsel so selected does not meet the requirements of “Independent Counsel” as defined in Section 2 of this Agreement, and the objection shall set forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the person so selected shall act as Independent Counsel. If such written objection is so made and substantiated, the Independent Counsel so selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court of competent jurisdiction has determined that such objection is without merit. If, within twenty (20) days after submission by Indemnitee of a written request for indemnification pursuant to Section 11.2 hereof, no Independent Counsel shall have been selected and not objected to, either the Company or Indemnitee may petition the Cayman Court for resolution of any objection which shall have been made by the Company or Indemnitee to the other’s selection of Independent Counsel and/or for the appointment as Independent Counsel of a person selected by the Cayman Court, and the person with respect to whom all objections are so resolved or the person so appointed shall act as Independent Counsel under Section 12.1 hereof. Upon the due commencement of any judicial proceeding or arbitration pursuant to Section 14.1 of this Agreement, Independent Counsel shall be discharged and relieved of any further responsibility in such capacity (subject to the applicable standards of professional conduct then prevailing). |
|---|---|
| 12.3 | The Company agrees to pay the reasonable fees and expenses of Independent Counsel and to fully indemnify such Independent Counsel against any and all Expenses, claims, liabilities and damages arising out of or relating to this Agreement or its engagement pursuant hereto. |
| --- | --- |
| 13 | PRESUMPTIONS AND EFFECT OF CERTAIN PROCEEDINGS |
|---|---|
| 13.1 | In making a determination with respect to entitlement to indemnification hereunder, the person, persons or entity making such determination shall, to the fullest extent permitted by applicable law, presume that Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification in accordance with Section 11.2 of this Agreement, and the Company shall, to the fullest extent permitted by applicable law, have the burden of proof to overcome that presumption in connection with the making by any person, persons or entity of any determination contrary to that presumption. Neither the failure of the Company (including by its directors or Independent Counsel) to have made a determination prior to the commencement of any action pursuant to this Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor an actual determination by the Company (including by its directors or Independent Counsel) that Indemnitee has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that Indemnitee has not met the applicable standard of conduct. |
| --- | --- |
10
| 13.2 | If the person, persons or entity empowered or selected under Section 12 of this Agreement to determine whether Indemnitee is entitled to indemnification shall not have made a determination within thirty (30) days after receipt by the Company of the request therefor, the requisite determination of entitlement to indemnification, to the fullest extent permitted by applicable law, shall be deemed to have been made and Indemnitee shall be entitled to such indemnification, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s statement not materially misleading, in connection with the request for indemnification, or (ii) a final judicial determination that any or all such indemnification is expressly prohibited under applicable law; provided, however, that such 30-day period may be extended for a reasonable time, not to exceed an additional fifteen (15) days, if the person, persons or entity making the determination with respect to entitlement to indemnification in good faith requires such additional time for the obtaining or evaluating of documentation and/or information relating thereto. |
|---|---|
| 13.3 | The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself adversely affect the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable cause to believe that his conduct was unlawful. |
| --- | --- |
| 13.4 | For purposes of any determination of good faith, Indemnitee shall be deemed to have acted in good faith if Indemnitee’s action is based on the records or books of account of the Enterprise, including financial statements, or on information supplied to Indemnitee by the directors, managers, managing members, or officers of the Enterprise in the course of their duties, or on the advice of legal counsel for the Enterprise, its Board, any committee of the Board or any director, trustee, general partner, manager, or managing member or on information or records given or reports made to the Enterprise, its Board, any committee of the Board or any director, trustee, general partner, manager or managing member by an independent certified public accountant or by an appraiser or other expert selected by the Enterprise, its Board, any committee of the Board or any director, trustee, general partner, manager or managing member. The provisions of this Section 13.4 shall not be deemed to be exclusive or to limit in any way the other circumstances in which Indemnitee may be deemed or found to have met the applicable standard of conduct set forth in this Agreement. |
| --- | --- |
| 13.5 | The knowledge and/or actions, or failure to act, of any other director, officer, trustee, partner, manager, managing member, fiduciary, agent or employee of the Enterprise shall not be imputed to Indemnitee for purposes of determining the right to indemnification under this Agreement. |
| --- | --- |
11
| 14 | REMEDIES OF INDEMNITEE |
|---|---|
| 14.1 | In the event that (i) a determination is made pursuant to Section 12 of this Agreement that Indemnitee is not entitled to indemnification under this Agreement, (ii) advancement of Expenses, to the fullest extent permitted by applicable law, is not timely made pursuant to Section 10 of this Agreement, (iii) no determination of entitlement to indemnification shall have been made pursuant to Section 12.1 of this Agreement within thirty (30) days after receipt by the Company of the request for indemnification, (iv) payment of indemnification is not made pursuant to Sections 5, 6, 7 or the last sentence of Section 12.1 of this Agreement within ten (10) days after receipt by the Company of a written request therefor, (v) a contribution payment is not made in a timely manner pursuant to Section 8 of this Agreement, (vi) payment of indemnification pursuant to Section 3 or 4 of this Agreement is not made within ten (10) days after a determination has been made that Indemnitee is entitled to indemnification, or (vii) payment to Indemnitee pursuant to any rights under this Agreement or otherwise is not made within ten (10) days after receipt by the Company of a written request therefor, Indemnitee shall be entitled to an adjudication by the Cayman Court of his entitlement to such indemnification, contribution or advancement rights. Alternatively, Indemnitee, at his option, may seek an award in arbitration to be conducted by a single arbitrator pursuant to the Commercial Arbitration Rules of the American Arbitration Association. Except as set forth herein, the provisions of Cayman Islands law (without regard to its conflict of laws rules) shall apply to any such arbitration. The Company shall not oppose Indemnitee’s right to seek any such adjudication or award in arbitration. |
| --- | --- |
| 14.2 | In the event that a determination shall have been made pursuant to Section 12.1 of this Agreement that Indemnitee is not entitled to indemnification, any judicial proceeding or arbitration commenced pursuant to this Section 14 shall be conducted in all respects as a de novo trial, or arbitration, on the merits and Indemnitee shall not be prejudiced by reason of that adverse determination. In any judicial proceeding or arbitration commenced pursuant to this Section 14, the Company shall have the burden of proving Indemnitee is not entitled to be indemnified or to receive advances of Expenses, as the case may be, and the Company may not refer to or introduce into evidence any determination pursuant to Section 12.1 of this Agreement adverse to Indemnitee for any purpose. If Indemnitee commences a judicial proceeding or arbitration pursuant to this Section 14, Indemnitee shall not be required to reimburse the Company for any advances pursuant to Section 10 until a final determination is made with respect to Indemnitee’s entitlement to indemnification (as to which all rights of appeal have been exhausted or lapsed). |
| --- | --- |
| 14.3 | If a determination shall have been made pursuant to Section 12.1 of this Agreement that Indemnitee is entitled to indemnification, the Company shall be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this Section 14, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s statement not materially misleading, in connection with the request for indemnification, or (ii) a prohibition of such indemnification under applicable law. |
| --- | --- |
| 14.4 | The Company shall be precluded from asserting in any judicial proceeding or arbitration commenced pursuant to this Section 14 that the procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court or before any such arbitrator that the Company is bound by all the provisions of this Agreement. |
| --- | --- |
12
| 14.5 | The Company shall indemnify Indemnitee to the fullest extent permitted by law against all Expenses and, if requested by Indemnitee, shall (within ten (10) days after the Company’s receipt of such written request) pay to Indemnitee, to the fullest extent permitted by applicable law, such Expenses which are incurred by Indemnitee in connection with any judicial proceeding or arbitration brought by Indemnitee (i) to enforce his rights under, or to recover damages for breach of, this Agreement or any other indemnification, advancement or contribution agreement or provision of the Articles now or hereafter in effect; or (ii) for recovery or advances under any insurance policy maintained by any person for the benefit of Indemnitee, regardless of the outcome and whether Indemnitee ultimately is determined to be entitled to such indemnification, advancement, contribution or insurance recovery, as the case may be (unless such judicial proceeding or arbitration was not brought by Indemnitee in good faith). |
|---|---|
| 14.6 | Interest shall be paid by the Company to Indemnitee at a rate to be agreed between the Company and the Indemnitee for amounts which the Company indemnifies, or is obliged to indemnify for the period commencing with the date on which Indemnitee requests indemnification, contribution, reimbursement or advancement of any Expenses and ending with the date on which such payment is made to Indemnitee by the Company. |
| --- | --- |
| 15 | SECURITY |
|---|
Notwithstanding anything herein to the contrary except for Section 27, to the extent requested by Indemnitee and approved by the Board, the Company may at any time and from time to time provide security to Indemnitee for the Company’s obligations hereunder through an irrevocable bank line of credit, funded trust or other collateral. Any such security, once provided to Indemnitee, may not be revoked or released without the prior written consent of Indemnitee.
| 16 | NON-EXCLUSIVITY; SURVIVAL OF RIGHTS; INSURANCE; SUBROGATION |
|---|---|
| 16.1 | The rights of Indemnitee as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may at any time be entitled under applicable law, the Articles, any agreement, a vote of shareholders or a resolution of directors, or otherwise. No amendment, alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee under this Agreement in respect of any Proceeding (regardless of when such Proceeding is first threatened, commenced or completed) arising out of, or related to, any action taken or omitted by such Indemnitee in his Corporate Status prior to such amendment, alteration or repeal. To the extent that a change in applicable law, whether by statute or judicial decision, permits greater indemnification or advancement of Expenses than would be afforded currently under the Articles or this Agreement, then this Agreement (without any further action by the parties hereto) shall automatically be deemed to be amended to require that the Company indemnify Indemnitee to the fullest extent permitted by law. No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right and remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy. |
| --- | --- |
13
| 16.2 | The Articles permit the Company to purchase and maintain insurance or furnish similar protection or make other arrangements (“Indemnification Arrangements”) insuring the Company’s directors, officers, auditors and/or trustee of an employee benefit scheme of the Company against any liability asserted against him or incurred by or on behalf of him (other than liability arising out of that person’s own dishonesty) or in their respective capacity as a director, officer, employee or agent of the Company, whether or not the Company would have the power to indemnify him against such liability under the provisions of this Agreement, as it may then be in effect. The purchase, establishment, and maintenance of any such Indemnification Arrangement shall not in any way limit or affect the rights and obligations of the Company or of Indemnitee under this Agreement except as expressly provided herein, and the execution and delivery of this Agreement by the Company and Indemnitee shall not in any way limit or affect the rights and obligations of the Company or the other party or parties thereto under any such Indemnification Arrangement. |
|---|---|
| 16.3 | To the extent that the Company maintains an insurance policy or policies providing liability insurance for directors, officers, trustees, partners, managers, managing members, fiduciaries, employees, or agents of the Company or of any other Enterprise which such person serves at the request of the Company, Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the maximum extent of the coverage available for any such director, officer, trustee, partner, manager, managing member, fiduciary, employee or agent under such policy or policies. If, at the time the Company receives notice from any source of a Proceeding as to which Indemnitee is a party or a participant (as a witness, deponent or otherwise), the Company has director and officer liability insurance in effect, the Company shall give prompt notice of such Proceeding to the insurers in accordance with the procedures set forth in the respective policies. The Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of Indemnitee, all amounts payable as a result of such Proceeding in accordance with the terms of such policies. |
| --- | --- |
| 16.4 | In the event of any payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such rights. |
| --- | --- |
| 16.5 | The Company’s obligation to indemnify or advance Expenses hereunder to Indemnitee who is or was serving at the request of the Company as a director, officer, trustee, partner, manager, managing member, fiduciary, employee or agent of any other Enterprise shall be reduced by any amount Indemnitee has actually received as indemnification or advancement of expenses from such Enterprise. Notwithstanding any other provision of this Agreement to the contrary except for Section 27, (i) Indemnitee shall have no obligation to reduce, offset, allocate, pursue or apportion any indemnification, advancement, contribution or insurance coverage among multiple parties possessing such duties to Indemnitee prior to the Company’s satisfaction and performance of all its obligations under this Agreement, and (ii) the Company shall perform fully its obligations under this Agreement without regard to whether Indemnitee holds, may pursue or has pursued any indemnification, advancement, contribution or insurance coverage rights against any person or entity other than the Company. |
| --- | --- |
14
| 17 | DURATION OF AGREEMENT |
|---|
All agreements and obligations of the Company contained herein shall continue during the period Indemnitee serves as a director or officer of the Company or as a director, officer, trustee, partner, manager, managing member, fiduciary, employee or agent of any other corporation, partnership, joint venture, trust, employee benefit plan or other Enterprise which Indemnitee serves at the request of the Company and shall continue thereafter so long as Indemnitee shall be subject to any possible Proceeding (including any rights of appeal thereto and any Proceeding commenced by Indemnitee pursuant to Section 14 of this Agreement) by reason of his Corporate Status, whether or not he is acting in any such capacity at the time any liability or expense is incurred for which indemnification or advancement can be provided under this Agreement.
| 18 | SEVERABILITY |
|---|
If any provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (a) the validity, legality and enforceability of the remaining provisions of this Agreement (including, without limitation, each portion of any Section, paragraph or sentence of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to the fullest extent permitted by law; (b) such provision or provisions shall be deemed reformed to the extent necessary to conform to applicable law and to give the maximum effect to the intent of the parties hereto; and (c) to the fullest extent possible, the provisions of this Agreement (including, without limitation, each portion of any Section, paragraph or sentence of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested thereby.
| 19 | ENFORCEMENT AND BINDING EFFECT |
|---|---|
| 19.1 | The Company expressly confirms and agrees that it has entered into this Agreement and assumed the obligations imposed on it hereby in order to induce Indemnitee to serve as a director, officer or key employee of the Company, and the Company acknowledges that Indemnitee is relying upon this Agreement in serving as a director or officer of the Company. |
| --- | --- |
| 19.2 | Without limiting any of the rights of Indemnitee under the Articles as they may be amended from time to time, this Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject matter hereof. |
| --- | --- |
| 19.3 | The indemnification and advancement of expenses rights provided by or granted pursuant to this Agreement shall be binding upon and be enforceable by the parties hereto and their respective successors and assigns (including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially all of the business and/or assets of the Company), shall continue as to an Indemnitee who has ceased to be a director or officer of the Company or a director, officer, trustee, general partner, manager, managing member, fiduciary, employee or agent of any other Enterprise at the Company’s request, and shall inure to the benefit of Indemnitee and his or her spouse, assigns, heirs, devisees, executors and administrators and other legal representatives. |
| --- | --- |
15
| 19.4 | The Company shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all, substantially all or a substantial part, of the business and/or assets of the Company, by written agreement in form and substance satisfactory to Indemnitee, expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no such succession had taken place. |
|---|---|
| 19.5 | The Company and Indemnitee agree herein that a monetary remedy for breach of this Agreement, at some later date, may be inadequate, impracticable and difficult of proof, and further agree that such breach may cause Indemnitee irreparable harm. Accordingly, the parties hereto agree that Indemnitee may enforce this Agreement by seeking, among other things, injunctive relief and/or specific performance hereof, without any necessity of showing actual damage or irreparable harm and that by seeking injunctive relief and/or specific performance, Indemnitee shall not be precluded from seeking or obtaining any other relief to which he may be entitled. The Company and Indemnitee further agree that Indemnitee shall be entitled to such specific performance and injunctive relief, including temporary restraining orders, preliminary injunctions and permanent injunctions, without the necessity of posting bonds or other undertaking in connection therewith. The Company acknowledges that in the absence of a waiver, a bond or undertaking may be required of Indemnitee by a court of competent jurisdiction and the Company hereby waives any such requirement of such a bond or undertaking. |
| --- | --- |
| 20 | MODIFICATION AND WAIVER |
|---|
No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by the Company and Indemnitee. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions of this Agreement nor shall any waiver constitute a continuing waiver.
| 21 | NOTICES |
|---|
All notices, requests, demands and other communications under this Agreement shall be in writing and shall be deemed to have been duly given (i) if delivered by hand and receipted for by the party to whom said notice or other communication shall have been directed, or (ii) mailed by certified or registered mail with postage prepaid, on the third (3rd) business day after the date on which it is so mailed:
| (a) | If to Indemnitee, at the address indicated on the signature page of this Agreement or such other address as Indemnitee shall provide in writing to the Company. |
|---|---|
| (b) | If to the Company, to: |
| --- | --- |
Eureka Acquisition Corp
3011 Olympic View Dr
Chino Hills, California
United States 91709
Attn: Fen Zhang
16
With a copy, which shall not constitute notice, to:
Robinson & Cole LLP
Chrysler East Building
666 Third Avenue, 20th Floor
New York, NY 10017
Attn.: Arila Zhou, Esq.
Email: azhou@rc.com
or to any other address as may have been furnished to Indemnitee in writing by the Company.
| 22 | APPLICABLE LAW AND CONSENT TO JURISDICTION |
|---|
This Agreement and the legal relations among the parties shall be governed by, and construed and enforced in accordance with, the laws of the Cayman Islands, without regard to its conflict of laws rules. Except with respect to any arbitration commenced by Indemnitee pursuant to Section 14.1 of this Agreement, the Company and Indemnitee hereby irrevocably and unconditionally: (a) agree that any action or proceeding arising out of or in connection with this Agreement shall be brought only in the Cayman Court and not in any other state or federal court in the United States of America or any court in any other country; (b) consent to submit to the exclusive jurisdiction of the Cayman Court for purposes of any action or proceeding arising out of or in connection with this Agreement; (c) waive any objection to the laying of venue of any such action or proceeding in the Cayman Court; and (d) waive, and agree not to plead or to make, any claim that any such action or proceeding brought in the Cayman Court has been brought in an improper or inconvenient forum, or is subject (in whole or in part) to a jury trial.
| 23 | IDENTICAL COUNTERPARTS |
|---|
This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of which together shall constitute one and the same Agreement. Only one such counterpart signed by the party against whom enforceability is sought needs to be produced to evidence the existence of this Agreement.
17
| 24 | MISCELLANEOUS |
|---|
Use of the masculine pronoun shall be deemed to include usage of the feminine pronoun where appropriate. The headings of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed to constitute part of this Agreement or to affect the construction thereof.
| 25 | ADDITIONAL ACTS |
|---|
If for the validation of any of the provisions in this Agreement any act, resolution, approval or other procedure is required, the Company undertakes to cause such act, resolution, approval or other procedure to be affected or adopted in a manner that will enable the Company to fulfil its obligations under this Agreement.
| 26 | WAIVER OF CLAIMS TO TRUST ACCOUNT |
|---|
Indemnitee hereby agrees that it does not have any right, title, interest or claim of any kind (each, a “Claim”) in or to any monies in the trust account established in connection with the Company’s initial public offering for the benefit of the Company and holders of shares issued in such offering, and hereby waives any Claim it may have in the future as a result of, or arising out of, any services provided to the Company and will not seek recourse against such trust account for any reason whatsoever.
| 27 | MAINTENANCE OF INSURANCE |
|---|
The Company shall use commercially reasonable efforts to obtain and maintain in effect during the entire period for which the Company is obligated to indemnify the Indemnitee under this Agreement, one or more policies of insurance with reputable insurance companies to provide the officers/directors of the Company with coverage for losses from wrongful acts and omissions and to ensure the Company’s performance of its indemnification obligations under this Agreement. The Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the maximum extent of the coverage available for any such director or officer under such policy or policies. In all such insurance policies, the Indemnitee shall be named as an insured in such a manner as to provide the Indemnitee with the same rights and benefits as are accorded to the most favorably insured of the Company’s directors and officers.
[SIGNATURE PAGE FOLLOWS]
18
IN WITNESS WHEREOF, the parties hereto have caused this Indemnity Agreement to be signed on the day and year first above written.
| EKA ACQUISITION CORP |
|---|
| By: |
| Name: |
| Title: |
| INDEMNITEE |
| By: |
| Name: |
| Address: |
All values are in Euros.
[Signature Page to Indemnity Agreement]
19
Exhibit 10.7
Execution Version
EUREKA ACQUISITION CORP
3011 Olympic View Dr
Chino Hills, California
United States 91709
July 2 2024
Hercules Capital Management Corp
899 Ruining Road, Yangguang Binjiang Center
South Building, Unit 808
Shanghai 200030, PRC
Re: Administrative Services Agreement
Ladies and Gentlemen:
This letter agreement by and between Eureka Acquisition Corp (the “Company”) and Hercules Capital Management Corp (the “Sponsor”), dated as of the date hereof, will confirm our agreement that, commencing on the date the securities of the Company are first listed on the Nasdaq Capital Market (the “Listing Date”), pursuant to a Registration Statement on Form S-1 and prospectus filed with the Securities and Exchange Commission (the “Registration Statement”) and continuing until the earlier of the consummation by the Company of an initial business combination or the Company’s liquidation (in each case as described in the Registration Statement) (such earlier date hereinafter referred to as the “Termination Date”):
(i) Hercules Capital Management Corp, the Company’s sponsor, shall make available, or cause to be made available, to the Company, office space and administrative and support services. In exchange therefor, the Company shall pay an affiliate of the Sponsor the sum of $10,000 per month on the Listing Date and continuing monthly thereafter until the Termination Date; and
(ii) Hercules Capital Management Corp hereby irrevocably waives any and all right, title, interest, causes of action and claims of any kind as a result of, or arising out of, this letter agreement (each, a “Claim”) in or to, and any and all right to seek payment of any amounts due to it out of, the trust account established for the benefit of the public shareholders of the Company and into which substantially all of the proceeds of the Company’s initial public offering will be deposited (the “Trust Account”), and hereby irrevocably waives any Claim it may have in the future, which Claim would reduce, encumber or otherwise adversely affect the Trust Account or any monies or other assets in the Trust Account, and further agrees not to seek recourse, reimbursement, payment or satisfaction of any Claim against the Trust Account or any monies or other assets in the Trust Account for any reason whatsoever.
This letter agreement constitutes the entire agreement and understanding of the parties hereto in respect of its subject matter and supersedes all prior understandings, agreements, or representations by or among the parties hereto, written or oral, to the extent they relate in any way to the subject matter hereof or the transactions contemplated hereby.
This letter agreement may not be amended, modified or waived as to any particular provision, except by a written instrument executed by the parties hereto.
No party hereto may assign either this letter agreement or any of its rights, interests, or obligations hereunder without the prior written approval of the other party. Any purported assignment in violation of this paragraph shall be void and ineffectual and shall not operate to transfer or assign any interest or title to the purported assignee.
This letter agreement constitutes the entire relationship of the parties hereto, and any litigation between the parties (whether grounded in contract, tort, statute, law or equity) shall be governed by, construed in accordance with, and interpreted pursuant to the laws of the State of New York, without giving effect to its choice of laws principles.
This letter agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of which together shall constitute one and the same letter agreement.
[Signature Page Follows]
| Very truly yours, |
|---|
| EKA ACQUISITION CORP |
| By: |
| Name: |
| Title: |
| AGREED TO AND ACCEPTED BY: |
| HERCULES CAPITAL MANAGEMENT CORP |
| By: |
| Name: |
| Title: |
All values are in Euros.
[Signature Page to Administrative Services Agreement]
Exhibit 99.1
Eureka Acquisition Corp Announces Pricing of$50 Million Initial Public Offering
Shanghai, July 1, 2024 (GLOBE NEWSWIRE) --Eureka Acquisition Corp (the “Company”), a blank check company incorporated as a Cayman Islands exempted company and led by Chairman and Chief Executive Officer, Dr. Fen Zhang, today announced the pricing of its initial public offering of 5,000,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one right. Each right entitles the holder to receive one-fifth (1/5) of one Class A ordinary share. The units are expected to trade on the Nasdaq Capital Market (“Nasdaq”) under the ticker symbol “EURKU” beginning on July 2, 2024. Once the securities comprising the units begin separate trading, the Class A ordinary shares and the rights will be traded on Nasdaq under the symbols “EURK” and “EURKR,” respectively. The offering is expected to close on July 3, 2024, subject to customary closing conditions.
Maxim Group LLC is acting as the sole book-running manager for the offering. The Company has granted the underwriters a 45-day option to purchase up to 750,000 additional units at the initial public offering price to cover over-allotments, if any.
A registration statement on Form S-1 (File No. 333-277780) relating to the securities to be sold in the initial public offering was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on July 1, 2024. The offering is being made only by means of a prospectus. When available, copies of the prospectus relating to this offering may be obtained from Maxim Group LLC, 300 Park Avenue, 16^th^ Floor, New York, NY 10022, or by accessing the SEC’s website, www.sec.gov.
This press release shall not constitute anoffer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in whichsuch offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such stateor jurisdiction.
About Eureka Acquisition Corp
Eureka Acquisition Corp is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, incorporated for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
Forward-Looking Statements
This press release contains statements that constitute “forward-looking statements,” including with respect to the Company’s initial public offering (“IPO”) and search for an initial business combination. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of Eureka Acquisition Corp, including those set forth in the Risk Factors section of Eureka Acquisition Corp’s registration statement and preliminary prospectus for the IPO filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. Eureka Acquisition Corp undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Contact Information:
Fen Zhang
Chairman and Chief Executive Officer
Email: eric.zhang@hercules.global
Tel: +86 135 0189 0555
Exhibit 99.2
Eureka Acquisition Corp Announces Closing of$50 Million Initial Public Offering
Shanghai, July 3, 2024 (GLOBE NEWSWIRE) --Eureka Acquisition Corp (the “Company”), a blank check company incorporated as a Cayman Islands exempted company today announced the closing of its previously announced initial public offering of 5,000,000 units at an offering price of $10.00 per unit, for aggregate gross proceeds to the Company of $50,000,000. Each unit consists of one Class A ordinary share and one right. Each right entitles the holder to receive one-fifth (1/5) of one Class A ordinary share upon consummation of an initial business combination. The units began trading on the Nasdaq Capital Market (“Nasdaq”) under the ticker symbol “EURKU” on July 2, 2024. Once the securities comprising the units begin separate trading, the Class A ordinary shares and the rights are expected to be traded on Nasdaq under the symbols “EURK” and “EURKR,” respectively.
The Company has granted the underwriters a 45-day option to purchase up to an additional 750,000 units at an offering price of $10.00 per unit to cover over-allotments, if any.
Maxim Group LLC acted as the sole book-running manager for the offering.
Robinson & Cole LLP served as the U.S. counsel and Ogier served as the Cayman Islands counsel to Eureka Acquisition Corp, and Ellenoff Grossman & Schole LLP served as the U.S. counsel to the representative of the underwriters in this offering.
A registration statement on Form S-1 (File No. 333-277780) relating to the securities sold in the initial public offering was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on July 1, 2024. The offering has been made only by means of a prospectus, copies of which may be obtained from Maxim Group LLC, 300 Park Avenue, 16th Floor, New York, NY 10022, or by accessing the SEC’s website, www.sec.gov.
This press release shall not constitute anoffer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in whichsuch offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such stateor jurisdiction.
About Eureka Acquisition Corp
Eureka Acquisition Corp is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, incorporated for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
Forward-Looking Statements
This press release contains statements that constitute “forward-looking statements,” including with respect to the Company’s initial public offering (“IPO”), underwriters’ exercise of over-allotment option and search for an initial business combination. No assurance can be given that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of Eureka Acquisition Corp, including those set forth in the Risk Factors section of Eureka Acquisition Corp’s registration statement and prospectus for the IPO filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. Eureka Acquisition Corp undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Contact Information:
Fen Zhang
Chairman and Chief Executive Officer
Email: eric.zhang@hercules.global
Tel: +86 135 0189 0555